BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= psy6526
(696 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|4DGJ|A Chain A, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|B Chain B, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|C Chain C, Structure Of A Human Enteropeptidase Light Chain Variant
pdb|4DGJ|D Chain D, Structure Of A Human Enteropeptidase Light Chain Variant
Length = 235
Score = 110 bits (276), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 55/112 (49%), Positives = 75/112 (66%), Gaps = 4/112 (3%)
Query: 577 RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKD 635
R ++ GWG V G A L+ VP++SN+ C+Q P + +T NM+CAGY EGG D
Sbjct: 124 RNCSIAGWGTVVYQGTTADILQEADVPLLSNERCQQQMPEY--NITENMICAGYEEGGID 181
Query: 636 SCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
SCQGDSGG L+ ++ + R+ +AGV S+G CA PN PGVY RV+ + EWIQ+
Sbjct: 182 SCQGDSGGPLMCQE-NNRWFLAGVTSFGYECALPNRPGVYARVSRFTEWIQS 232
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 36/133 (27%), Positives = 65/133 (48%), Gaps = 7/133 (5%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDL-IAVISEH 77
IVGG + +PWVV L + CG +L+S ++++AAHCV A++ H
Sbjct: 1 IVGGSDAKEGAWPWVVGLYYDDRLLCGASLVSSDWLVSAAHCVYGRNLEPSKWTAILGLH 60
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDPK 137
++ + Q R + +++ +P YN + D+DIA++ L+ + + + P + +
Sbjct: 61 MKSNLTSPQTVPRLIDEIVINPHYN---RRRKDNDIAMMHLEFKVNYTDYIQPISLPE-- 115
Query: 138 SELTQFKPGNQKS 150
E F PG S
Sbjct: 116 -ENQVFPPGRNCS 127
>pdb|2F91|A Chain A, 1.2a Resolution Structure Of A Crayfish Trypsin Complexed
With A Peptide Inhibitor, Sgti
Length = 237
Score = 110 bits (274), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 54/108 (50%), Positives = 71/108 (65%), Gaps = 2/108 (1%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG E G L+ VP++S+++CR G + L +M+CAG EGGKDSCQGD
Sbjct: 130 VTGWGTTSEGGNTPDVLQKVTVPLVSDEDCRADYGADEILD-SMICAGVPEGGKDSCQGD 188
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNN 688
SGG L D +L AG+VSWG GCARP PGVYT V+++++WI+ N
Sbjct: 189 SGGPLAASDTGSTYL-AGIVSWGYGCARPGYPGVYTEVSYHVDWIKAN 235
Score = 53.5 bits (127), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 31/117 (26%), Positives = 57/117 (48%), Gaps = 8/117 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQA----GKFFCGGTLISDRYVLTAAHCVRSSK-RHKDLIAV 73
IVGG + E+P+ ++ ++ FCG ++ ++ Y +TA HCV + + +
Sbjct: 1 IVGGTDATLGEFPYQLSFQETFIGFSFHFCGASIYNENYAITAGHCVYGDDYENPSGLQI 60
Query: 74 ISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
++ +V E + V K++ H ++ D+DI+LLKL L F V+P
Sbjct: 61 VAGELDMSVNEGSEQIITVSKIILHENFD---YNLLDNDISLLKLSGSLTFNDNVAP 114
>pdb|1MCT|A Chain A, The Refined 1.6 Angstroms Resolution Crystal Structure Of
The Complex Formed Between Porcine Beta-trypsin And
Mcti-a, A Trypsin Inhibitor Of Squash Family
pdb|1QQU|A Chain A, Crystal Structure Of Porcine Beta Trypsin With Bound
Acetate Ion
pdb|1FMG|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.04%
Polydocanol
pdb|1FN6|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.1%
Polydocanol
pdb|1FNI|A Chain A, Crystal Structure Of Porcine Beta Trypsin With 0.01%
Polydocanol
Length = 223
Score = 110 bits (274), Expect = 4e-24, Method: Composition-based stats.
Identities = 57/138 (41%), Positives = 84/138 (60%), Gaps = 10/138 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQ-IASDLRATQVPVMSNQE 609
+K +SPA + R + + GWG + SG S L+ + PV+SN
Sbjct: 88 IKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSNSS 147
Query: 610 CRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C+ +PG ++TGNM+C G+++GGKDSCQGDSGG ++ +G+ + G+VSWG GCA+
Sbjct: 148 CKSSYPG---QITGNMICVGFLQGGKDSCQGDSGGPVV---CNGQ--LQGIVSWGYGCAQ 199
Query: 669 PNSPGVYTRVNHYMEWIQ 686
N PGVYT+V +Y+ WIQ
Sbjct: 200 KNKPGVYTKVCNYVNWIQ 217
Score = 69.7 bits (169), Expect = 6e-12, Method: Composition-based stats.
Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++THP +N + D+DI L+KL +P V+
Sbjct: 55 -IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVA 101
>pdb|4AN7|A Chain A, Kunitz Type Trypsin Inhibitor Complex With Porcine Trypsin
Length = 231
Score = 109 bits (273), Expect = 5e-24, Method: Composition-based stats.
Identities = 57/138 (41%), Positives = 84/138 (60%), Gaps = 10/138 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQ-IASDLRATQVPVMSNQE 609
+K +SPA + R + + GWG + SG S L+ + PV+S+
Sbjct: 96 IKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSS 155
Query: 610 CRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C+ +PG ++TGNM+C G++EGGKDSCQGDSGG ++ +G+ + G+VSWG GCA+
Sbjct: 156 CKSSYPG---QITGNMICVGFLEGGKDSCQGDSGGPVV---CNGQ--LQGIVSWGYGCAQ 207
Query: 669 PNSPGVYTRVNHYMEWIQ 686
N PGVYT+V +Y+ WIQ
Sbjct: 208 KNKPGVYTKVCNYVNWIQ 225
Score = 72.8 bits (177), Expect = 6e-13, Method: Composition-based stats.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 10/113 (8%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + + + E
Sbjct: 7 DKIVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSRIQVR-----LGE 60
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
HN V E + K++THP +N + D+DI L+KL +P V+
Sbjct: 61 HN-IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVA 109
>pdb|1TFX|A Chain A, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1TFX|B Chain B, Complex Of The Second Kunitz Domain Of Tissue Factor
Pathway Inhibitor With Porcine Trypsin
pdb|1LDT|T Chain T, Complex Of Leech-Derived Tryptase Inhibitor With Porcine
Trypsin
pdb|1AVW|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Orthorhombic Crystal Form
pdb|1AVX|A Chain A, Complex Porcine Pancreatic TrypsinSOYBEAN TRYPSIN
Inhibitor, Tetragonal Crystal Form
pdb|1EJA|A Chain A, Structure Of Porcine Trypsin Complexed With Bdellastasin,
An Antistasin-Type Inhibitor
pdb|1S5S|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S6F|A Chain A, Porcine Trypsin Covalent Complex With Borate And
Guanidine- 3 Inhibitor
pdb|1S6H|A Chain A, Porcine Trypsin Complexed With Guanidine-3-Propanol
Inhibitor
pdb|1S81|A Chain A, Porcine Trypsin With No Inhibitor Bound
pdb|1S82|A Chain A, Porcine Trypsin Complexed With Borate And Ethylene Glycol
pdb|1S83|A Chain A, Porcine Trypsin Complexed With 4-amino Propanol
pdb|1S84|A Chain A, Porcine Trypsin Covalent Complex With 4-Amino Butanol,
Borate And Ethylene Glycol
pdb|1S85|A Chain A, Porcine Trypsin Complexed With P-Hydroxymethyl Benzamidine
And Borate
pdb|1H9I|E Chain E, Complex Of Eeti-Ii Mutant With Porcine Trypsin
pdb|1V6D|A Chain A, The Crystal Structure Of The Trypsin Complex With
Synthetic Heterochiral Peptide
pdb|1TX6|A Chain A, Trypsin:bbi Complex
pdb|1TX6|B Chain B, Trypsin:bbi Complex
pdb|1TX6|C Chain C, Trypsin:bbi Complex
pdb|1TX6|D Chain D, Trypsin:bbi Complex
pdb|1Z7K|A Chain A, Crystal Structure Of Trypsin- Ovomucoid Turkey Egg White
Inhibitor Complex
pdb|1YF4|A Chain A, Crystal Structure Of Trypsin-Vasopressin Complex
Length = 223
Score = 109 bits (272), Expect = 5e-24, Method: Composition-based stats.
Identities = 57/138 (41%), Positives = 84/138 (60%), Gaps = 10/138 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQ-IASDLRATQVPVMSNQE 609
+K +SPA + R + + GWG + SG S L+ + PV+S+
Sbjct: 88 IKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSS 147
Query: 610 CRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C+ +PG ++TGNM+C G++EGGKDSCQGDSGG ++ +G+ + G+VSWG GCA+
Sbjct: 148 CKSSYPG---QITGNMICVGFLEGGKDSCQGDSGGPVV---CNGQ--LQGIVSWGYGCAQ 199
Query: 669 PNSPGVYTRVNHYMEWIQ 686
N PGVYT+V +Y+ WIQ
Sbjct: 200 KNKPGVYTKVCNYVNWIQ 217
Score = 69.7 bits (169), Expect = 6e-12, Method: Composition-based stats.
Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++THP +N + D+DI L+KL +P V+
Sbjct: 55 -IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVA 101
>pdb|3MYW|A Chain A, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
pdb|3MYW|B Chain B, The Bowman-Birk Type Inhibitor From Mung Bean In Ternary
Complex With Porcine Trypsin
Length = 223
Score = 109 bits (272), Expect = 5e-24, Method: Composition-based stats.
Identities = 57/138 (41%), Positives = 84/138 (60%), Gaps = 10/138 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQ-IASDLRATQVPVMSNQE 609
+K +SPA + R + + GWG + SG S L+ + PV+S+
Sbjct: 88 IKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSS 147
Query: 610 CRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C+ +PG ++TGNM+C G++EGGKDSCQGDSGG ++ +G+ + G+VSWG GCA+
Sbjct: 148 CKSAYPG---QITGNMICVGFLEGGKDSCQGDSGGPVV---CNGQ--LQGIVSWGYGCAQ 199
Query: 669 PNSPGVYTRVNHYMEWIQ 686
N PGVYT+V +Y+ WIQ
Sbjct: 200 KNKPGVYTKVCNYVNWIQ 217
Score = 69.7 bits (169), Expect = 5e-12, Method: Composition-based stats.
Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCAANSVPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++THP +N + D+DI L+KL +P V+
Sbjct: 55 -IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVA 101
>pdb|2A31|A Chain A, Trypsin In Complex With Borate
pdb|2A32|A Chain A, Trypsin In Complex With Benzene Boronic Acid
Length = 223
Score = 109 bits (272), Expect = 6e-24, Method: Composition-based stats.
Identities = 57/138 (41%), Positives = 84/138 (60%), Gaps = 10/138 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQ-IASDLRATQVPVMSNQE 609
+K +SPA + R + + GWG + SG S L+ + PV+S+
Sbjct: 88 IKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSS 147
Query: 610 CRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C+ +PG ++TGNM+C G++EGGKDSCQGDSGG ++ +G+ + G+VSWG GCA+
Sbjct: 148 CKSSYPG---QITGNMICVGFLEGGKDSCQGDSGGPVV---CNGQ--LQGIVSWGYGCAQ 199
Query: 669 PNSPGVYTRVNHYMEWIQ 686
N PGVYT+V +Y+ WIQ
Sbjct: 200 KNKPGVYTKVCNYVNWIQ 217
Score = 67.8 bits (164), Expect = 2e-11, Method: Composition-based stats.
Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 10/110 (9%)
Query: 20 VGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNR 79
VGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + + + EHN
Sbjct: 2 VGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSRIQVR-----LGEHN- 54
Query: 80 ATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++THP +N + D+DI L+KL +P V+
Sbjct: 55 IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVA 101
>pdb|1AN1|E Chain E, Leech-Derived Tryptase InhibitorTRYPSIN COMPLEX
pdb|1C9P|A Chain A, Complex Of Bdellastasin With Porcine Trypsin
Length = 223
Score = 109 bits (272), Expect = 7e-24, Method: Composition-based stats.
Identities = 57/138 (41%), Positives = 84/138 (60%), Gaps = 10/138 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQ-IASDLRATQVPVMSNQE 609
+K +SPA + R + + GWG + SG S L+ + PV+S+
Sbjct: 88 IKLSSPATLXSRVATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSS 147
Query: 610 CRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C+ +PG ++TGNM+C G++EGGKDSCQGDSGG ++ +G+ + G+VSWG GCA+
Sbjct: 148 CKSSYPG---QITGNMICVGFLEGGKDSCQGDSGGPVV---CNGQ--LQGIVSWGYGCAQ 199
Query: 669 PNSPGVYTRVNHYMEWIQ 686
N PGVYT+V +Y+ WIQ
Sbjct: 200 KNKPGVYTKVCNYVNWIQ 217
Score = 69.3 bits (168), Expect = 7e-12, Method: Composition-based stats.
Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++THP +N + D+DI L+KL +P V+
Sbjct: 55 -IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLXSRVA 101
>pdb|2ANY|A Chain A, Expression, Crystallization And The Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 108 bits (270), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 51/113 (45%), Positives = 78/113 (69%), Gaps = 4/113 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG +E G+I + L+ +P+++N+EC +++ + K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDY--KITQRMVCAGYKEGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRDA 692
DSGG L+ + +G + + G+ SWG GCAR PGVYT+V YM+WI T+ +
Sbjct: 187 DSGGPLVCKH-NGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSS 238
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 65/128 (50%), Gaps = 21/128 (16%)
Query: 19 IVGGWTTEVNEYPWVVALE---QAGKFFCGGTLISDRYVLTAAHC-----VRSSKRHKDL 70
IVGG + E+PW V+L+ A + CGG+LI ++VLTAAHC ++ R
Sbjct: 1 IVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 71 IAVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEF----KP 126
I +S+ + T + ++ +++ H Y +HDIAL+KL APLE+ KP
Sbjct: 61 ILELSDITKDTPFS------QIKEIIIHQNYK---VSEGNHDIALIKLQAPLEYTEFQKP 111
Query: 127 TVSPDNKD 134
P D
Sbjct: 112 ISLPSKGD 119
>pdb|2ANW|A Chain A, Expression, Crystallization And Three-Dimensional
Structure Of The Catalytic Domain Of Human Plasma
Kallikrein: Implications For Structure-Based Design Of
Protease Inhibitors
Length = 241
Score = 108 bits (269), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 51/113 (45%), Positives = 78/113 (69%), Gaps = 4/113 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG +E G+I + L+ +P+++N+EC +++ + K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDY--KITQRMVCAGYKEGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRDA 692
DSGG L+ + +G + + G+ SWG GCAR PGVYT+V YM+WI T+ +
Sbjct: 187 DSGGPLVCKH-NGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSS 238
Score = 60.5 bits (145), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 43/128 (33%), Positives = 67/128 (52%), Gaps = 20/128 (15%)
Query: 19 IVGGWTTEVNEYPWVVALE---QAGKFFCGGTLISDRYVLTAAHC-----VRSSKRHKDL 70
IVGG + E+PW V+L+ A + CGG+LI ++VLTAAHC ++ R
Sbjct: 1 IVGGTNSSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSG 60
Query: 71 IAVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPL---EFKPT 127
I +S+ + T + ++ +++ H Y +HDIAL+KL APL EF+
Sbjct: 61 ILNLSDITKDTPFS------QIKEIIIHQNYK---VSEGNHDIALIKLQAPLNYTEFQKP 111
Query: 128 VSPDNKDD 135
+S +K D
Sbjct: 112 ISLPSKGD 119
>pdb|1EKB|B Chain B, The Serine Protease Domain Of Enteropeptidase Bound To
Inhibitor Val- Asp-asp-asp-asp-lys-chloromethane
Length = 235
Score = 108 bits (269), Expect = 1e-23, Method: Compositional matrix adjust.
Identities = 54/112 (48%), Positives = 75/112 (66%), Gaps = 4/112 (3%)
Query: 577 RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKD 635
R ++ GWG + G A L+ VP++SN++C+Q P + +T NM+CAGY GG D
Sbjct: 124 RICSIAGWGALIYQGSTADVLQEADVPLLSNEKCQQQMPEY--NITENMVCAGYEAGGVD 181
Query: 636 SCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
SCQGDSGG L+ ++ + R+L+AGV S+G CA PN PGVY RV + EWIQ+
Sbjct: 182 SCQGDSGGPLMCQE-NNRWLLAGVTSFGYQCALPNRPGVYARVPRFTEWIQS 232
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 35/113 (30%), Positives = 61/113 (53%), Gaps = 4/113 (3%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDL-IAVISEH 77
IVGG + +PWVVAL + CG +L+S ++++AAHCV AV+ H
Sbjct: 1 IVGGSDSREGAWPWVVALYFDDQQVCGASLVSRDWLVSAAHCVYGRNMEPSKWKAVLGLH 60
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ + QIETR + +++ +P YN + ++DIA++ L+ + + + P
Sbjct: 61 MASNLTSPQIETRLIDQIVINPHYN---KRRKNNDIAMMHLEMKVNYTDYIQP 110
>pdb|1TGS|Z Chain Z, Three-Dimensional Structure Of The Complex Between
Pancreatic Secretory Inhibitor (Kazal Type) And
Trypsinogen At 1.8 Angstroms Resolution. Structure
Solution, Crystallographic Refinement And Preliminary
Structural Interpretation
pdb|2TGP|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2TPI|Z Chain Z, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3TPI|Z Chain Z, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|4TPI|Z Chain Z, The Refined 2.2-angstroms (0.22-nm) X-ray Crystal
Structure Of The Ternary Complex Formed By Bovine
Trypsinogen, Valine-valine And The Arg15 Analogue Of
Bovine Pancreatic Trypsin Inhibitor
pdb|1BTZ|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTX|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTW|A Chain A, Episelection: Novel Ki ~nanomolar Inhibitors Of Serine
Proteases Selected By Binding Or Chemistry On An Enzyme
Surface
pdb|1BTP|A Chain A, Unique Binding Of A Novel Synthetic Inhibitor, N-[3-[4-[4-
(Amidinophenoxy)-Carbonyl]phenyl]-2-Methyl-2-Propenoyl]-
N- Allylglycine Methanesulfonate To Bovine Trypsin,
Revealed By The Crystal Structure Of The Complex
pdb|1BTY|A Chain A, Crystal Structure Of Beta-Trypsin In Complex With
Benzamidine
pdb|1TGB|A Chain A, Crystal Structure Of Bovine Trypsinogen At 1.8 Angstroms
Resolution. Ii. Crystallographic Refinement, Refined
Crystal Structure And Comparison With Bovine Trypsin
pdb|1TGC|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TGN|A Chain A, Structure Of Bovine Trypsinogen At 1.9 Angstroms
Resolution
pdb|1TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1TNG|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNH|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNI|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNJ|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNK|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|1TNL|A Chain A, Prediction Of Novel Serine Protease Inhibitors
pdb|2TGA|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|2TGD|A Chain A, Lack Of The Transition State Stabilization Site Is A
Factor In The Inactivity Of Trypsinogen, A Serine
Protease Zymogen. Structure Of Dfp Inhibited Bovine
Trypsinogen At 2.1 Angstroms Resolution
pdb|2TGT|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
Length = 229
Score = 107 bits (267), Expect = 2e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 124 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 180
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 181 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 223
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 10/113 (8%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V
Sbjct: 5 DKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLG 57
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 58 EDNINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 107
>pdb|1G3B|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Magnesium(Ii) Chelate
pdb|1G3C|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff Base
Iron(Iii) Chelate
pdb|1G3D|A Chain A, Bovine Beta-Trypsin Bound To Meta-Amidino Schiff Base
Copper (Ii) Chelate
pdb|1G3E|A Chain A, Bovine Beta-Trypsin Bound To Para-Amidino Schiff-Base
Copper (Ii) Chelate
Length = 228
Score = 107 bits (267), Expect = 2e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 123 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 179
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 180 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 222
Score = 61.6 bits (148), Expect = 1e-09, Method: Composition-based stats.
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 10/113 (8%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V
Sbjct: 4 DKIVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLG 56
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 57 EDNINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 106
>pdb|3QK1|A Chain A, Crystal Structure Of Enterokinase-Like Trypsin Variant
Length = 229
Score = 107 bits (266), Expect = 3e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 175 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 58.5 bits (140), Expect = 1e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 57/111 (51%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYN---KRRKNNDIMLIKLKSAASLNSRVA 101
>pdb|1NTP|A Chain A, Use Of The Neutron Diffraction HD EXCHANGE TECHNIQUE TO
Determine The Conformational Dynamics Of Trypsin
Length = 223
Score = 107 bits (266), Expect = 3e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 175 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 54.3 bits (129), Expect = 2e-07, Method: Composition-based stats.
Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 10/110 (9%)
Query: 20 VGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNR 79
VGG+T N P+ V+L +G FCGG+LI ++V++AAHC +S I V +
Sbjct: 2 VGGYTCGANTVPYQVSL-NSGYHFCGGSLIDSQWVVSAAHCYKSG------IQVRLGEDN 54
Query: 80 ATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP Y++ + ++DI L+KL + V+
Sbjct: 55 INVVEGNEQFISASKSIVHPSYDSN---TLNNDIMLIKLKSAASLDSRVA 101
>pdb|2FI5|E Chain E, Crystal Structure Of A Bpti Variant (Cys38->ser) In
Complex With Trypsin
pdb|2FTM|A Chain A, Crystal Structure Of Trypsin Complexed With The Bpti
Variant (Tyr35- >gly)
Length = 224
Score = 107 bits (266), Expect = 3e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 119 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 175
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 176 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 218
Score = 57.8 bits (138), Expect = 2e-08, Method: Composition-based stats.
Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 10/102 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
V E + K + HP YN+ + ++DI L+KL +
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKS 92
>pdb|2FI4|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser) In
Complex With Trypsin
pdb|2FTL|E Chain E, Crystal Structure Of Trypsin Complexed With Bpti At 100k
Length = 223
Score = 107 bits (266), Expect = 3e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 175 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 57.8 bits (138), Expect = 2e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLXSRVA 101
>pdb|1TAB|E Chain E, Structure Of The Trypsin-Binding Domain Of Bowman-Birk
Type Protease Inhibitor And Its Interaction With Trypsin
pdb|1TPA|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|2PTC|E Chain E, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1PPC|E Chain E, Geometry Of Binding Of The Benzamidine-and Arginine-based
Inhibitors
N-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-
amidinophenylalanyl- Piperidine (napap) And
(2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4-
Tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine
Carboxylic Acid (mqpa) To Human Alpha-thrombin: X-ray
Crystallographic Determination Of The Napap-trypsin
Complex And Modeling Of Napap- Thrombin And
Mqpa-thrombin
pdb|1PPE|E Chain E, The Refined 2.0 Angstroms X-Ray Crystal Structure Of The
Complex Formed Between Bovine Beta-Trypsin And Cmti-I, A
Trypsin Inhibitor From Squash Seeds (Cucurbita Maxima):
Topological Similarity Of The Squash Seed Inhibitors
With The Carboxypeptidase A Inhibitor From Potatoes
pdb|1PPH|E Chain E, Geometry Of Binding Of The Nalpha-Tosylated Piperidides Of
M-Amidino-, P-Amidino-And P-Guanidino Phenylalanine To
Thrombin And Trypsin: X- Ray Crystal Structures Of Their
Trypsin Complexes And Modeling Of Their Thrombin
Complexes
pdb|1SMF|E Chain E, Studies On An Artificial Trypsin Inhibitor Peptide Derived
From The Mung Bean Inhibitor
pdb|1JRT|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1JRS|A Chain A, Hemiacetal Complex Between Leupeptin And Trypsin
pdb|1CE5|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzamidine
pdb|2BZA|A Chain A, Bovine Pancreas Beta-Trypsin In Complex With Benzylamine
pdb|1QCP|A Chain A, Crystal Structure Of The Rwj-51084 Bovine Pancreatic Beta-
Trypsin At 1.8 A
pdb|1SBW|A Chain A, Crystal Structure Of Mung Bean Inhibitor Lysine Active
Fragment Complex With Bovine Beta-Trypsin At 1.8a
Resolution
pdb|1YYY|1 Chain 1, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1SFI|A Chain A, High Resolution Structure Of A Potent, Cyclic Protease
Inhibitor From Sunflower Seeds
pdb|1TIO|A Chain A, High Packing Density Form Of Bovine Beta-trypsin In
Cyclohexane
pdb|2TIO|A Chain A, Low Packing Density Form Of Bovine Beta-Trypsin In
Cyclohexane
pdb|2BTC|E Chain E, Bovine Trypsin In Complex With Squash Seed Inhibitor
(Cucurbita Pepo Trypsin Inhibitor Ii)
pdb|3BTE|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta-Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTD|E Chain E, The Crystal Structures Of The Complexes Between The Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTF|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti.
pdb|3BTG|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTH|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTK|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTM|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTQ|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTT|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|3BTW|E Chain E, The Crystal Structures Of The Complexes Between Bovine
Beta- Trypsin And Ten P1 Variants Of Bpti
pdb|1QBN|A Chain A, Bovine Trypsin 2-[amino(Imino)methyl]-2-Hydroxyphenoxy]-6-
[3-(4,5-Dihydro-1h-Imidazol-2-Yl)phenoxy]pyridine-4-
Carboxylic Acid (Zk-806688) Complex
pdb|1QBO|A Chain A, Bovine Trypsin
7-[[6-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
2-Methyl-Benzimidazol-1-Yl]methyl]naphthalene-2-
Carboximidamid Zk-806711 Inhibitor Complex
pdb|1QB9|A Chain A, Bovine Trypsin
7-[[2-[[1-(1-Iminoethyl)piperidin-4-Yl]oxy]-
9h-Carbozol-9-Yl] Methyl]naphthalene-2-Carboximidamide
(Zk- 806450) Complex
pdb|1QB1|A Chain A, Bovine Trypsin With 1-[2-[5-[amino(imino)methyl]-2-
Hydroxyphenoxy]-6-[3-(4,
5-dihydro-1-methyl-1h-imidazol-2-
Yl)phenoxy]pyridin-4-yl]piperidine-3-carboxylic Acid
(zk- 806974)
pdb|1QB6|A Chain A, Bovine Trypsin 3,3'-[3,5-Difluoro-4-Methyl-2, 6-
Pyridinediylbis(Oxy)]bis(Benzenecarboximidamide) (Zk-
805623) Complex
pdb|1QA0|A Chain A, Bovine Trypsin 2-Aminobenzimidazole Complex
pdb|1F2S|E Chain E, Crystal Structure Of The Complex Formed Between Bovine
Beta- Trypsin And Mcti-A, A Trypsin Inhibitor Of Squash
Family At 1.8 A Resolution
pdb|1D6R|A Chain A, Crystal Structure Of Cancer Chemopreventive Bowman-Birk
Inhibitor In Ternary Complex With Bovine Trypsin At 2.3
A Resolution. Structural Basis Of Janus-Faced Serine
Protease Inhibitor Specificity
pdb|1C9T|A Chain A, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|B Chain B, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|C Chain C, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|D Chain D, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|E Chain E, Complex Of Bdellastasin With Bovine Trypsin
pdb|1C9T|F Chain F, Complex Of Bdellastasin With Bovine Trypsin
pdb|1QL7|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1QL8|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1G9I|E Chain E, Crystal Structure Of Beta-Trysin Complex In Cyclohexane
pdb|1EJM|A Chain A, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|C Chain C, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1EJM|E Chain E, Crystal Structure Of The Bpti Ala16leu Mutant In Complex
With Bovine Trypsin
pdb|1JIR|A Chain A, Crystal Structure Of Trypsin Complex With Amylamine In
Cyclohexane
pdb|1J8A|A Chain A, Crystal Structure Of Benzamidine Inhibited Bovine
Pancreatic Trypsin At 105k To 1.21a Resolution From
Laboratory Source With High Number Of Waters Modelled
pdb|1G36|A Chain A, Trypsin Inhibitor Complex
pdb|1K1P|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1O|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1N|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1M|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1L|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1J|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1K1I|A Chain A, Bovine Trypsin-Inhibitor Complex
pdb|1EB2|A Chain A, Trypsin Inhibitor Complex (Bpo)
pdb|1GJ6|A Chain A, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1N6X|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1N6Y|A Chain A, Rip-Phasing On Bovine Trypsin
pdb|1OYQ|A Chain A, Trypsin Inhibitor Complex
pdb|1O2H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O2O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2P|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Q|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2R|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2S|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2T|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2U|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2V|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2W|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2X|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Y|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O2Z|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O30|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O31|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O32|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O33|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O34|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O35|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O36|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O37|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O38|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O39|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3A|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3B|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3C|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3D|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3E|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3F|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3G|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3H|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3I|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3J|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3K|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3L|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3M|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1O3N|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1O3O|A Chain A, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-directed Serine Protease
Inhibitors
pdb|1NC6|A Chain A, Potent, Small Molecule Inhibitors Of Human Mast Cell
Tryptase. Anti-Asthmatic Action Of A Dipeptide-Based
Transition State Analogue Containing Benzothiazole
Ketone
pdb|1P2I|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2J|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2K|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OX1|A Chain A, Crystal Structure Of The Bovine Trypsin Complex With A
Synthetic 11 Peptide Inhibitor
pdb|1RXP|A Chain A, Structure Of Trypsin (Orthorhombic) With 1-(4-Tert-
Butylcarbamoyl- Piperazine-1-Carbonyl)-3-(3-Guanidino-
Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid
pdb|1S0Q|A Chain A, Native Bovine Pancreatic Trypsin
pdb|1S0R|A Chain A, Bovine Pancreatic Trypsin Inhibited With Benzamidine At
Atomic Resolution
pdb|2A7H|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|1TX7|A Chain A, Bovine Trypsin Complexed With P-
Amidinophenylmethylphosphinic Acid (Ampa)
pdb|2BLV|A Chain A, Trypsin Before A High Dose X-Ray "burn"
pdb|2BLW|A Chain A, Trypsin After A High Dose X-Ray "burn"
pdb|1TX8|A Chain A, Bovine Trypsin Complexed With Amso
pdb|1Y3U|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3V|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3W|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3X|A Chain A, Trypsin Inhibitor Complex
pdb|1Y3Y|A Chain A, Trypsin Inhibitor Complex
pdb|1YP9|A Chain A, Trypsin Inhibitor Complex
pdb|2AYW|A Chain A, Crystal Structure Of The Complex Formed Between Trypsin
And A Designed Synthetic Highly Potent Inhibitor In The
Presence Of Benzamidine At 0.97 A Resolution
pdb|2FI3|E Chain E, Crystal Structure Of A Bpti Variant (Cys14->ser,
Cys38->ser) In Complex With Trypsin
pdb|2FX4|A Chain A, Bovine Trypsin Bound By 4-piperidinebutyrate To Make
Acylenzyme Complex
pdb|2FX6|A Chain A, Bovine Trypsin Complexed With 2-Aminobenzamidazole
pdb|2AGE|X Chain X, Succinyl-Aapr-Trypsin Acyl-Enzyme At 1.15 A Resolution
pdb|2AGG|X Chain X, Succinyl-Aapk-Trypsin Acyl-Enzyme At 1.28 A Resolution
pdb|2AGI|X Chain X, The Leupeptin-Trypsin Covalent Complex At 1.14 A
Resolution
pdb|2AH4|X Chain X, Guanidinobenzoyl-Trypsin Acyl-Enzyme At 1.13 A Resolution
pdb|2G5N|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G5V|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2G8T|A Chain A, Indole-Amidine Complexes With Bovine Trypsin
pdb|2F3C|E Chain E, Crystal Structure Of Infestin 1, A Kazal-Type
Serineprotease Inhibitor, In Complex With Trypsin
pdb|2G81|E Chain E, Crystal Structure Of The Bowman-Birk Inhibitor From Vigna
Unguiculata Seeds In Complex With Beta-Trypsin At 1.55
Angstrons Resolution
pdb|2G55|A Chain A, Anomalous Substructure Of Trypsin (P3121)
pdb|2OTV|A Chain A, Crystal Structure Of The Complex Formed Between Bovine
Trypsin And Nicotinamide At 1.56 A Resolution
pdb|2J9N|A Chain A, Robotically Harvested Trypsin Complexed With Benzamidine
Containing Polypeptide Mediated Crystal Contacts
pdb|2OXS|A Chain A, Crytal Structure Of The Trypsin Complex With Benzamidine
At High Temperature (35 C)
pdb|2UUY|A Chain A, Structure Of A Tick Tryptase Inhibitor In Complex With
Bovine Trypsin
pdb|2ILN|A Chain A, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2ILN|B Chain B, Crystal Structure Of The Bowman-Birk Inhibitor From Snail
Medic Seeds In Complex With Bovine Trypsin
pdb|2CMY|A Chain A, Crystal Complex Between Bovine Trypsin And Veronica
Hederifolia Trypsin Inhibitor
pdb|1AQ7|A Chain A, Trypsin With Inhibitor Aeruginosin 98-b
pdb|1AUJ|A Chain A, Bovine Trypsin Complexed To Meta-Cyano-Benzylic Inhibitor
pdb|1AZ8|A Chain A, Bovine Trypsin Complexed To Bis-Phenylamidine Inhibitor
pdb|1BJU|A Chain A, Beta-Trypsin Complexed With Acpu
pdb|1BJV|A Chain A, Beta-Trypsin Complexed With Appu
pdb|1GBT|A Chain A, Structure Of An Acyl-Enzyme Intermediate During Catalysis:
(Guanidinobenzoyl) Trypsin
pdb|1MAX|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MAY|A Chain A, Beta-Trypsin Phosphonate Inhibited
pdb|1MTS|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTU|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTV|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1MTW|A Chain A, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin
pdb|1TLD|A Chain A, Crystal Structure Of Bovine Beta-Trypsin At 1.5 Angstroms
Resolution In A Crystal Form With Low Molecular Packing
Density. Active Site Geometry, Ion Pairs And Solvent
Structure
pdb|1TPO|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPP|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|1TPS|A Chain A, Atomic Structure Of The Trypsin-A90720a Complex: A Unified
Approach To Structure And Function
pdb|1TYN|A Chain A, Atomic Structure Of The Trypsin-cyclotheonamide A Complex:
Lessons For The Design Of Serine Protease Inhibitors
pdb|1XUF|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUG|A Chain A, Trypsin-Babim-Zn+2, Ph 8.2
pdb|1XUH|A Chain A, Trypsin-Keto-Babim-Co+2, Ph 8.2
pdb|1XUI|A Chain A, Trypsin-Keto-Babim, Zn+2-Free, Ph 8.2
pdb|1XUJ|A Chain A, Trypsin-Keto-Babim-Zn+2, Ph 8.2
pdb|1XUK|A Chain A, Trypsin-Babim-Sulfate, Ph 5.9
pdb|2PLX|A Chain A, Trypsin Complexed To A Synthetic Peptide From Veronica
Hederifolia
pdb|2PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|3PTB|A Chain A, The Geometry Of The Reactive Site And Of The Peptide
Groups In Trypsin, Trypsinogen And Its Complexes With
Inhibitors
pdb|3PTN|A Chain A, On The Disordered Activation Domain In Trypsinogen.
Chemical Labelling And Low-Temperature Crystallography
pdb|1C1N|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1O|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1P|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1Q|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1R|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1T|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2D|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2E|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2F|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2G|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2H|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2I|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2J|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2K|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2L|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C2M|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5P|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Q|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5R|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5S|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5T|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5U|A Chain A, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5V|A Chain A, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GHZ|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI0|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI1|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI2|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI3|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI4|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI5|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI6|A Chain A, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2O9Q|A Chain A, The Crystal Structure Of Bovine Trypsin Complexed With A
Small Inhibition Peptide Orb2k
pdb|2QN5|T Chain T, Crystal Structure And Functional Study Of The Bowman-Birk
Inhibitor From Rice Bran In Complex With Bovine Trypsin
pdb|2QYI|A Chain A, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2QYI|C Chain C, Crystal Structure Of A Binary Complex Between An
Engineered Trypsin Inhibitor And Bovine Trypsin
pdb|2ZDK|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDL|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDM|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZDN|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFS|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZFT|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZHD|A Chain A, Exploring Trypsin S3 Pocket
pdb|3D65|E Chain E, Crystal Structure Of Textilinin-1, A Kunitz-Type Serine
Protease Inhibitor From The Australian Common Brown
Snake Venom, In Complex With Trypsin
pdb|3E8L|A Chain A, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|3E8L|B Chain B, The Crystal Structure Of The Double-Headed Arrowhead
Protease Inhibitor A In Complex With Two Trypsins
pdb|2ZQ1|A Chain A, Exploring Trypsin S3 Pocket
pdb|2ZQ2|A Chain A, Exploring Trypsin S3 Pocket
pdb|3ITI|A Chain A, Structure Of Bovine Trypsin With The Mad Triangle B3c
pdb|3GY2|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY3|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY4|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY5|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY6|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Bis-Benzamidines Diminazene And Pentamidine
pdb|3GY7|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3GY8|A Chain A, A Comparative Study On The Inhibition Of Bovine
Beta-Trypsin Benzamidines Diminazene And Pentamidine By
X-Ray Crystallog Itc
pdb|3AAS|A Chain A, Bovine Beta-Trypsin Bound To Meta-Guanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAU|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diguanidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|A Chain A, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3AAV|B Chain B, Bovine Beta-Trypsin Bound To Meta-Diamidino Schiff Base
Copper (Ii) Chelate
pdb|3M35|A Chain A, Trypsin In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3MFJ|A Chain A, Bovine Trypsin At 0.8 A Resolution, Restrained Refinement
pdb|3MI4|A Chain A, Bovine Trypsin At 0.8 A Resolution, Non-Restrained
Refinemen
pdb|3I29|A Chain A, Crystal Structure Of A Binary Complex Between An Mutant
Tryp Inhibitor With Bovine Trypsin
pdb|3A7T|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide
pdb|3A7V|A Chain A, Crystal Structure Of Trypsin Complexed With
3-Formylbenzimidamide
pdb|3A7W|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((Tetrahydro-2h-
Pyran-2-Yloxyimino)methyl)benzimidamide (Soaking 4hours)
pdb|3A7X|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
45seconds)
pdb|3A7Y|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
3-Yloxyimino)methyl)benzimidamide (Soaking 2hours)
pdb|3A7Z|A Chain A, Crystal Structure Of Trypsin Complexed With
(E)-4-((1-Methylpiperidin-
4-Yloxyimino)methyl)benzimidamide (Soaking 3hours)
pdb|3A80|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic Acid
(Soaking 40seconds)
pdb|3A81|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 8
Hours)
pdb|3A82|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid
pdb|3A83|A Chain A, Crystal Structure Of Trypsin Complexed With
Pre-Synthesized (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide
pdb|3A84|A Chain A, Crystal Structure Of Trypsin Complexed With(E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 5
Seconds)
pdb|3A85|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 15
Seconds)
pdb|3A86|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking 30
Seconds)
pdb|3A87|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 5
Minutes)
pdb|3A88|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 30
Minutes)
pdb|3A89|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((2-
Nicotinoylhydrazono)methyl)benzimidamide (Soaking 4
Hours)
pdb|3A8A|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Formylbenzimidamide And Aniline
pdb|3A8B|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-4-((4-
Bromophenylimino)methyl)benzimidamide
pdb|3A8C|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Soaking
With Mixture Of
[(E)-2-(4-Carbamimidoylbenzylideneaminooxy)acetic Acid]
And [(E)-2-
(4-Carbamimidoylbenzylideneaminooxy)-2-Methylpropanoic
Acid])
pdb|3A8D|A Chain A, Crystal Structure Of Trypsin Complexed With (E)-2-(4-
Carbamimidoylbenzylideneaminooxy)acetic Acid (Under
Aniline-Free Condition)
pdb|3LJJ|A Chain A, Bovine Trypsin In Complex With Ub-Thr 10
pdb|3LJO|A Chain A, Bovine Trypsin In Complex With Ub-Thr 11
pdb|2XTT|B Chain B, Bovine Trypsin In Complex With Evolutionary Enhanced
Schistocerca Gregaria Protease Inhibitor 1 (Sgpi-1-P02)
pdb|3NK8|A Chain A, Trypsin In Complex With Fluorine-Containing Fragment
pdb|3NKK|A Chain A, Trypsin In Complex With Fluorine Containing Fragment
pdb|3M7Q|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Pancreatic Trypsin
pdb|3RDZ|A Chain A, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3RDZ|B Chain B, Crystal Structure Of Rbti-Trypsin Complex At 2.26 Angstrom
Resolution
pdb|3ATI|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3ATK|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3ATL|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamidine
pdb|3ATM|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXA|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine
pdb|3RXB|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobutanoic Acid
pdb|3RXC|A Chain A, Crystal Structure Of Trypsin Complexed With
2-Aminopyridine
pdb|3RXD|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine
pdb|3RXE|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide
pdb|3RXF|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminopyridine
pdb|3RXG|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Aminocyclohexanol
pdb|3RXH|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Imidazol-4-Yl) Ethanamine
pdb|3RXI|A Chain A, Crystal Structure Of Trypsin Complexed With
2-(1h-Indol-3-Yl) Ethanamine
pdb|3RXJ|A Chain A, Crystal Structure Of Trypsin Complexed With
4-Guanidinobenzoic Acid
pdb|3RXK|A Chain A, Crystal Structure Of Trypsin Complexed With Methyl
4-Amino-1-Methyl- Pyrrolidine-2-Carboxylate
pdb|3RXL|A Chain A, Crystal Structure Of Trypsin Complexed With
(2,5-Dimethyl-3-Furyl) Methanamine
pdb|3RXM|A Chain A, Crystal Structure Of Trypsin Complexed With
[2-(2-Thienyl)thiazol-4- Yl]methanamine
pdb|3RXO|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Pyrrol-1-Ylphenyl) Methanamine
pdb|3RXP|A Chain A, Crystal Structure Of Trypsin Complexed With
(1,5-Dimethylpyrazol-3- Yl)methanamine
pdb|3RXQ|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F01
And F05, Cocktail Experiment)
pdb|3RXR|A Chain A, Crystal Structure Of Trypsin Complexed With
Cycloheptanamine (F01 And F03, Cocktail Experiment)
pdb|3RXS|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamine (F04 And A06, Cocktail
Experiment)
pdb|3RXT|A Chain A, Crystal Structure Of Trypsin Complexed With
(3-Methoxyphenyl) Methanamin (F04 And F03, Cocktail
Experiment)
pdb|3RXU|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And A06, Cocktail Experiment)
pdb|3RXV|A Chain A, Crystal Structure Of Trypsin Complexed With Benzamide (F05
And F03, Cocktail Experiment)
pdb|3T25|A Chain A, Tmao-Grown Orthorhombic Trypsin (Bovine)
pdb|3T26|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Sarcosine
pdb|3T27|A Chain A, Orthorhombic Trypsin (Bovine) In The Presence Of Betaine
pdb|3T28|A Chain A, Tmao-Grown Trypsin (Bovine)-Previously Unreported
Tetragonal Crystal Form
pdb|3T29|A Chain A, Tmao-Grown Trigonal Trypsin (Bovine)
pdb|4AB8|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4AB9|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABA|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABB|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABD|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABE|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABF|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABG|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABH|A Chain A, Fragments Bound To Bovine Trypsin For The Sampl Challenge
pdb|4ABI|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Pta)sfti-1(1,14), That Was 1,4-
Disubstituted With A 1,2,3-Trizol To Mimic A Trans Amide
Bond
pdb|4ABJ|A Chain A, Co-Complex Structure Of Bovine Trypsin With A Modified
Bowman-Birk Inhibitor (Ica)sfti-1(1,14), That Was 1,5-
Disubstituted With 1,2,3-Trizol To Mimic A Cis Amide
Bond
pdb|3VPK|A Chain A, Crystal Structure Of 6-guanidinohexanoyl Trypsin
pdb|3UNR|A Chain A, Bond Length Analysis Of Asp, Glu And His Residues In
Trypsin At 1.2a Resolution
pdb|3RU4|T Chain T, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
pdb|1C1S|A Chain A, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|4I8G|A Chain A, Bovine Trypsin At 0.8 Resolution
pdb|4I8H|A Chain A, Bovine Trypsin At 0.75 Resolution
pdb|4I8J|A Chain A, Bovine Trypsin At 0.87 A Resolution
pdb|4I8K|A Chain A, Bovine Trypsin At 0.85 Resolution
pdb|4I8L|A Chain A, Bovine Trypsin At 0.87 Resolution
pdb|4AOQ|A Chain A, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|B Chain B, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOQ|C Chain C, Cationic Trypsin In Complex With Mutated Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii) (f14a)
pdb|4AOR|A Chain A, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|B Chain B, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
pdb|4AOR|C Chain C, Cationic Trypsin In Complex With The Spinacia Oleracea
Trypsin Inhibitor Iii (soti-iii)
Length = 223
Score = 107 bits (266), Expect = 3e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 175 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|3OTJ|E Chain E, A Crystal Structure Of Trypsin Complexed With Bpti (Bovine
Pancreatic Trypsin Inhibitor) By X-RayNEUTRON JOINT
REFINEMENT
Length = 223
Score = 106 bits (265), Expect = 3e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 175 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 56.2 bits (134), Expect = 5e-08, Method: Composition-based stats.
Identities = 36/110 (32%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 20 VGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNR 79
VGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 2 VGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGEDN 54
Query: 80 ATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 55 INVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|3VEQ|B Chain B, A Binary Complex Betwwen Bovine Pancreatic Trypsin And A
Engineered Mutant Trypsin Inhibitor
Length = 223
Score = 106 bits (265), Expect = 4e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 175 GDSGGPVVCA---GK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|1Y59|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5A|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5B|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
pdb|1Y5U|T Chain T, Dianhydrosugar-Based Benzamidine, Factor Xa Specific
Inhibitor In Complex With Bovine Trypsin Mutant
Length = 223
Score = 106 bits (265), Expect = 4e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 175 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|1TAW|A Chain A, Bovine Trypsin Complexed To Appi
pdb|1ZR0|A Chain A, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
pdb|1ZR0|C Chain C, Crystal Structure Of Kunitz Domain 1 Of Tissue Factor
Pathway Inhibitor-2 With Bovine Trypsin
Length = 223
Score = 106 bits (264), Expect = 5e-23, Method: Composition-based stats.
Identities = 51/108 (47%), Positives = 72/108 (66%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSTSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 175 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|5PTP|A Chain A, Structure Of Hydrolase (Serine Proteinase)
Length = 223
Score = 105 bits (261), Expect = 1e-22, Method: Composition-based stats.
Identities = 50/108 (46%), Positives = 72/108 (66%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GD GG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 175 GDXGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|2D8W|A Chain A, Structure Of Hyper-Vil-Trypsin
Length = 223
Score = 104 bits (260), Expect = 1e-22, Method: Composition-based stats.
Identities = 50/108 (46%), Positives = 72/108 (66%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAG +EGGKDSCQ
Sbjct: 118 ISGWGNTKSSGTSXPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGXLEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 175 GDSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 58.5 bits (140), Expect = 1e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCXKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|1F5R|A Chain A, Rat Trypsinogen Mutant Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 231
Score = 104 bits (259), Expect = 2e-22, Method: Composition-based stats.
Identities = 55/139 (39%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 96 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLKCLDAPLLPQAD 155
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 156 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 207
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 208 PDNPGVYTKVCNYVDWIQD 226
Score = 66.6 bits (161), Expect = 4e-11, Method: Composition-based stats.
Identities = 37/109 (33%), Positives = 65/109 (59%), Gaps = 10/109 (9%)
Query: 21 GGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRA 80
GG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN-I 63
Query: 81 TVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 64 NVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 109
>pdb|3UIR|A Chain A, Crystal Structure Of The Plasmin-Textilinin-1 Complex
pdb|3UIR|B Chain B, Crystal Structure Of The Plasmin-Textilinin-1 Complex
Length = 247
Score = 104 bits (259), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 57/144 (39%), Positives = 87/144 (60%), Gaps = 6/144 (4%)
Query: 551 LKAASPAMVKYRATKRGDGS-HRVYSKRTGT-VVGWGRVEESGQI-ASDLRATQVPVMSN 607
LK +SPA++ + S + V + RT + GWG E G A L+ Q+PV+ N
Sbjct: 106 LKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIEN 163
Query: 608 QECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCA 667
+ C ++ ++ +CAG++ GG DSCQGDSGG L+ + D ++++ GV SWG+GCA
Sbjct: 164 KVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCA 222
Query: 668 RPNSPGVYTRVNHYMEWIQNNTRD 691
RPN PGVY RV+ ++ WI+ R+
Sbjct: 223 RPNKPGVYVRVSRFVTWIEGVMRN 246
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 41/120 (34%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 18 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R ++
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 76
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDP 136
H + E ++ V ++ P DIALLKL +P V P P
Sbjct: 77 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 126
>pdb|1BUI|A Chain A, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
pdb|1BUI|B Chain B, Structure Of The Ternary
Microplasmin-Staphylokinase-Microplasmin Complex: A
Proteinase-Cofactor-Substrate Complex In Action
Length = 250
Score = 103 bits (258), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 57/144 (39%), Positives = 87/144 (60%), Gaps = 6/144 (4%)
Query: 551 LKAASPAMVKYRATKRGDGS-HRVYSKRTGT-VVGWGRVEESGQI-ASDLRATQVPVMSN 607
LK +SPA++ + S + V + RT + GWG E G A L+ Q+PV+ N
Sbjct: 109 LKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIEN 166
Query: 608 QECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCA 667
+ C ++ ++ +CAG++ GG DSCQGDSGG L+ + D ++++ GV SWG+GCA
Sbjct: 167 KVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCA 225
Query: 668 RPNSPGVYTRVNHYMEWIQNNTRD 691
RPN PGVY RV+ ++ WI+ R+
Sbjct: 226 RPNKPGVYVRVSRFVTWIEGVMRN 249
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 41/120 (34%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 18 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R ++
Sbjct: 20 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 79
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDP 136
H + E ++ V ++ P DIALLKL +P V P P
Sbjct: 80 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 129
>pdb|1FY8|E Chain E, Crystal Structure Of The Deltaile16val17 Rat Anionic
Trypsinogen-Bpti Complex
Length = 231
Score = 103 bits (258), Expect = 2e-22, Method: Composition-based stats.
Identities = 55/139 (39%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 96 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 155
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 156 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 207
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 208 PDNPGVYTKVCNYVDWIQD 226
Score = 66.6 bits (161), Expect = 4e-11, Method: Composition-based stats.
Identities = 37/109 (33%), Positives = 65/109 (59%), Gaps = 10/109 (9%)
Query: 21 GGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRA 80
GG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN-I 63
Query: 81 TVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 64 NVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 109
>pdb|3BN9|B Chain B, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3BN9|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Fab Inhibitor
E2
pdb|3NCL|A Chain A, Crystal Structure Of Mt-Sp1 Bound To Benzamidine
Phosphonate Inhibitor
pdb|3NPS|A Chain A, Crystal Structure Of Membrane-Type Serine Protease 1
(Mt-Sp1) In Complex With The Fab Inhibitor S4
pdb|3SO3|A Chain A, Structures Of Fab-Protease Complexes Reveal A Highly
Specific Non- Canonical Mechanism Of Inhibition
Length = 241
Score = 103 bits (258), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 54/128 (42%), Positives = 72/128 (56%), Gaps = 2/128 (1%)
Query: 562 RATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLT 621
R D SH + + V GWG + G A L+ ++ V++ C ++T
Sbjct: 114 RPISLPDASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENL--LPQQIT 171
Query: 622 GNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHY 681
MMC G++ GG DSCQGDSGG L + DGR AGVVSWG GCA+ N PGVYTR+ +
Sbjct: 172 PRMMCVGFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLF 231
Query: 682 MEWIQNNT 689
+WI+ NT
Sbjct: 232 RDWIKENT 239
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 39/123 (31%), Positives = 69/123 (56%), Gaps = 9/123 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-FFCGGTLISDRYVLTAAHCVRSSK--RHKDLI---A 72
+VGG + E+PW V+L G+ CG +LIS ++++AAHC + R+ D A
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 73 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDN 132
+ H+++ ++ RR+ ++++HP +N + D+DIALL+L+ P E+ V P +
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFND---FTFDYDIALLELEKPAEYSSMVRPIS 117
Query: 133 KDD 135
D
Sbjct: 118 LPD 120
>pdb|1EAW|A Chain A, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAW|C Chain C, Crystal Structure Of The Mtsp1 (Matriptase)-Bpti
(Aprotinin) Complex
pdb|1EAX|A Chain A, Crystal Structure Of Mtsp1 (Matriptase)
pdb|2GV6|A Chain A, Crystal Structure Of Matriptase With Inhibitor Cj-730
pdb|2GV7|A Chain A, Structure Of Matriptase In Complex With Inhibitor Cj-672
Length = 241
Score = 103 bits (258), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 53/122 (43%), Positives = 71/122 (58%), Gaps = 2/122 (1%)
Query: 568 DGSHRVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCA 627
D SH + + V GWG + G A L+ ++ V++ C ++T MMC
Sbjct: 120 DASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVINQTTCENL--LPQQITPRMMCV 177
Query: 628 GYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
G++ GG DSCQGDSGG L + DGR AGVVSWG GCA+ N PGVYTR+ + +WI+
Sbjct: 178 GFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE 237
Query: 688 NT 689
NT
Sbjct: 238 NT 239
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 67/118 (56%), Gaps = 9/118 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-FFCGGTLISDRYVLTAAHCVRSSK--RHKDLI---A 72
+VGG + E+PW V+L G+ CG +LIS ++++AAHC + R+ D A
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 73 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ H+++ ++ RR+ ++++HP +N + D+DIALL+L+ P E+ V P
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFND---FTFDYDIALLELEKPAEYSSMVRP 115
>pdb|1EZS|C Chain C, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZS|D Chain D, Crystal Structure Of Ecotin Mutant M84r, W67a, G68a, Y69a,
D70a Bound To Rat Anionic Trypsin Ii
pdb|1EZU|C Chain C, Ecotin Y69f, D70p Bound To D102n Trypsin
pdb|1EZU|D Chain D, Ecotin Y69f, D70p Bound To D102n Trypsin
Length = 223
Score = 103 bits (257), Expect = 3e-22, Method: Composition-based stats.
Identities = 55/139 (39%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 67.8 bits (164), Expect = 2e-11, Method: Composition-based stats.
Identities = 38/111 (34%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ +++I L+KL +P++ V+
Sbjct: 55 -INVLEGDEQFVNAAKIIKHPNFD---RKTLNNNIMLIKLSSPVKLNARVA 101
>pdb|3TGI|E Chain E, Wild-Type Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
pdb|1ANE|A Chain A, Anionic Trypsin Wild Type
pdb|3FP6|E Chain E, Anionic Trypsin In Complex With Bovine Pancreatic Trypsin
Inhibitor (Bpti) Determined To The 1.49 A Resolution
Limit
Length = 223
Score = 103 bits (257), Expect = 3e-22, Method: Composition-based stats.
Identities = 55/139 (39%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 69.7 bits (169), Expect = 5e-12, Method: Composition-based stats.
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 101
>pdb|1F0T|A Chain A, Bovine Trypsin Complexed With Rpr131247
pdb|1F0U|A Chain A, Bovine Trypsin Complexed With Rpr128515
pdb|1EZX|C Chain C, Crystal Structure Of A Serpin:protease Complex
pdb|1LQE|A Chain A, Crystal Structure Of Trypsin In Complex With 79.
pdb|1UTN|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTO|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-ray Structures And Association Constant Measurements
pdb|1UTP|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTQ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|2BY5|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY6|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY7|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY8|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BY9|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
pdb|2BYA|X Chain X, Is Radiation Damage Dependent On The Dose-Rate Used During
Macromolecular Crystallography Data Collection
Length = 243
Score = 103 bits (257), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 138 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 194
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 195 GDSGGPVVCS---GK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 237
Score = 63.9 bits (154), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 10/113 (8%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V
Sbjct: 19 DKIVGGYTCGANTVPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLG 71
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 72 EDNINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 121
>pdb|1TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|1TRM|B Chain B, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
pdb|2TRM|A Chain A, The Three-Dimensional Structure Of Asn102 Mutant Of
Trypsin. Role Of Asp102 In Serine Protease Catalysis
Length = 223
Score = 103 bits (257), Expect = 3e-22, Method: Composition-based stats.
Identities = 55/139 (39%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 67.8 bits (164), Expect = 2e-11, Method: Composition-based stats.
Identities = 38/111 (34%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ +++I L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNNIMLIKLSSPVKLNARVA 101
>pdb|1AND|A Chain A, Anionic Trypsin Mutant With Arg 96 Replaced By His
Length = 223
Score = 103 bits (257), Expect = 3e-22, Method: Composition-based stats.
Identities = 55/139 (39%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 69.7 bits (169), Expect = 5e-12, Method: Composition-based stats.
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---HKTLNNDIMLIKLSSPVKLNARVA 101
>pdb|1QRZ|A Chain A, Catalytic Domain Of Plasminogen
pdb|1QRZ|B Chain B, Catalytic Domain Of Plasminogen
pdb|1QRZ|C Chain C, Catalytic Domain Of Plasminogen
pdb|1QRZ|D Chain D, Catalytic Domain Of Plasminogen
Length = 246
Score = 103 bits (257), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 55/144 (38%), Positives = 85/144 (59%), Gaps = 6/144 (4%)
Query: 551 LKAASPAMV--KYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQI-ASDLRATQVPVMSN 607
LK +SPA++ K ++ V + + GWG E G A L+ Q+PV+ N
Sbjct: 105 LKLSSPAVITDKVIPACLPSPNYMVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIEN 162
Query: 608 QECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCA 667
+ C ++ ++ +CAG++ GG DSCQGDSGG L+ + D ++++ GV SWG+GCA
Sbjct: 163 KVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCA 221
Query: 668 RPNSPGVYTRVNHYMEWIQNNTRD 691
RPN PGVY RV+ ++ WI+ R+
Sbjct: 222 RPNKPGVYVRVSRFVTWIEGVLRN 245
Score = 67.0 bits (162), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 41/120 (34%), Positives = 57/120 (47%), Gaps = 11/120 (9%)
Query: 18 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
R+VGG + +PW V+L + G+ FCGGTLIS +VLTAAHC+ S R ++
Sbjct: 16 RVVGGCVAHPHSWPWQVSLRTRFGQHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 75
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDP 136
H + E ++ V ++ P DIALLKL +P V P P
Sbjct: 76 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 125
>pdb|3P8G|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Benzamidine
pdb|3P8F|A Chain A, Crystal Structure Of Mt-Sp1 In Complex With Sfti-1
Length = 241
Score = 103 bits (257), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 53/122 (43%), Positives = 70/122 (57%), Gaps = 2/122 (1%)
Query: 568 DGSHRVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCA 627
D SH + + V GWG + G A L+ ++ V+ C ++T MMC
Sbjct: 120 DASHVFPAGKAIWVTGWGHTQYGGTGALILQKGEIRVIQQTTCENL--LPQQITPRMMCV 177
Query: 628 GYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
G++ GG DSCQGDSGG L + DGR AGVVSWG GCA+ N PGVYTR+ + +WI+
Sbjct: 178 GFLSGGVDSCQGDSGGPLSSVEADGRIFQAGVVSWGDGCAQRNKPGVYTRLPLFRDWIKE 237
Query: 688 NT 689
NT
Sbjct: 238 NT 239
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 38/118 (32%), Positives = 67/118 (56%), Gaps = 9/118 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-FFCGGTLISDRYVLTAAHCVRSSK--RHKDLI---A 72
+VGG + E+PW V+L G+ CG +LIS ++++AAHC + R+ D A
Sbjct: 1 VVGGTDADEGEWPWQVSLHALGQGHICGASLISPNWLVSAAHCYIDDRGFRYSDPTQWTA 60
Query: 73 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ H+++ ++ RR+ ++++HP +N + D+DIALL+L+ P E+ V P
Sbjct: 61 FLGLHDQSQRSAPGVQERRLKRIISHPFFND---FTFDYDIALLELEKPAEYSSMVRP 115
>pdb|1QL9|A Chain A, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99rt
pdb|1J14|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99rt
Length = 223
Score = 103 bits (257), Expect = 3e-22, Method: Composition-based stats.
Identities = 55/139 (39%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 70.5 bits (171), Expect = 3e-12, Method: Composition-based stats.
Identities = 38/111 (34%), Positives = 68/111 (61%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ + ++++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDRE---TYNNDIMLIKLSSPVKLNARVA 101
>pdb|1ZZZ|A Chain A, Trypsin Inhibitors With Rigid Tripeptidyl Aldehydes
Length = 237
Score = 103 bits (256), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 51/108 (47%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 132 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 188
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 189 GDSGGPVVCS---GK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 231
Score = 63.9 bits (154), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 10/113 (8%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V
Sbjct: 13 DKIVGGYTCGANTVPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLG 65
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 66 EDNINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 115
>pdb|1SLX|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Zinc-Bound
pdb|1SLV|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Copper- Bound
pdb|1SLU|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin
Length = 223
Score = 103 bits (256), Expect = 4e-22, Method: Composition-based stats.
Identities = 55/139 (39%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 69.7 bits (169), Expect = 5e-12, Method: Composition-based stats.
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 101
>pdb|2WUB|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUB|C Chain C, Crystal Structure Of Hgfa In Complex With The Allosteric
Non-Inhibitory Antibody Fab40.Deltatrp
pdb|2WUC|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Non- Inhibitory Antibody Fab40.Deltatrp And
Ac-Kqlr-Chloromethylketone
pdb|3K2U|A Chain A, Crystal Structure Of Hgfa In Complex With The Allosteric
Inhibitory Antibody Fab40
Length = 257
Score = 103 bits (256), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 77/232 (33%), Positives = 114/232 (49%), Gaps = 30/232 (12%)
Query: 482 LAHIYGYRPFSKEILPTENWFVSFIGAGEGWHNYHHSFPWDYRAAEMGQHF-NITTLVID 540
LA IY F L W VS H + HS P D + +GQHF N TT V
Sbjct: 15 LAAIYIGDSFCAGSLVHTCWVVS------AAHCFSHSPPRDSVSVVLGQHFFNRTTDVTQ 68
Query: 541 -FCAERGWAWGLKAA-SPA---MVKYRATKRGDGS-------HRVYSKRTGT-------- 580
F E+ + L + +P+ +V R K+GD + G+
Sbjct: 69 TFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKC 128
Query: 581 -VVGWGRVEES-GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG ++E+ +S LR VP++++ +C + ++ NM+CAGY + D+CQ
Sbjct: 129 QIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQ 188
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
GDSGG L E +G + G++SWG GC R + PGVYTRV +Y++WI + R
Sbjct: 189 GDSGGPLACEK-NGVAYLYGIISWGDGCGRLHKPGVYTRVANYVDWINDRIR 239
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 8/102 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH- 77
I+GG ++ +PW+ A+ G FC G+L+ +V++AAHC S + V+ +H
Sbjct: 1 IIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 78 -NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
NR T + + + +N DHD+ L++L
Sbjct: 60 FNRTTDVTQTFGIEKYIPYTLYSVFNPS-----DHDLVLIRL 96
>pdb|2R0L|A Chain A, Short Form Hgfa With Inhibitory Fab75
Length = 248
Score = 103 bits (256), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 77/232 (33%), Positives = 114/232 (49%), Gaps = 30/232 (12%)
Query: 482 LAHIYGYRPFSKEILPTENWFVSFIGAGEGWHNYHHSFPWDYRAAEMGQHF-NITTLVID 540
LA IY F L W VS H + HS P D + +GQHF N TT V
Sbjct: 15 LAAIYIGDSFCAGSLVHTCWVVS------AAHCFSHSPPRDSVSVVLGQHFFNRTTDVTQ 68
Query: 541 -FCAERGWAWGLKAA-SPA---MVKYRATKRGDGS-------HRVYSKRTGT-------- 580
F E+ + L + +P+ +V R K+GD + G+
Sbjct: 69 TFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKC 128
Query: 581 -VVGWGRVEES-GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG ++E+ +S LR VP++++ +C + ++ NM+CAGY + D+CQ
Sbjct: 129 QIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQ 188
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
GDSGG L E +G + G++SWG GC R + PGVYTRV +Y++WI + R
Sbjct: 189 GDSGGPLACEK-NGVAYLYGIISWGDGCGRLHKPGVYTRVANYVDWINDRIR 239
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 8/102 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH- 77
I+GG ++ +PW+ A+ G FC G+L+ +V++AAHC S + V+ +H
Sbjct: 1 IIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQHF 59
Query: 78 -NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
NR T + + + +N DHD+ L++L
Sbjct: 60 FNRTTDVTQTFGIEKYIPYTLYSVFNPS-----DHDLVLIRL 96
>pdb|1L4Z|A Chain A, X-Ray Crystal Structure Of The Complex Of Microplasminogen
With Alpha Domain Of Streptokinase In The Presence
Cadmium Ions
Length = 248
Score = 103 bits (256), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 56/144 (38%), Positives = 87/144 (60%), Gaps = 6/144 (4%)
Query: 551 LKAASPAMVKYRATKRGDGS-HRVYSKRTGT-VVGWGRVEESGQI-ASDLRATQVPVMSN 607
LK +SPA++ + S + V + RT + GWG E G A L+ Q+PV+ N
Sbjct: 107 LKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIEN 164
Query: 608 QECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCA 667
+ C ++ ++ +CAG++ GG DSCQGD+GG L+ + D ++++ GV SWG+GCA
Sbjct: 165 KVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCA 223
Query: 668 RPNSPGVYTRVNHYMEWIQNNTRD 691
RPN PGVY RV+ ++ WI+ R+
Sbjct: 224 RPNKPGVYVRVSRFVTWIEGVMRN 247
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 41/120 (34%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 18 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R ++
Sbjct: 18 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 77
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDP 136
H + E ++ V ++ P DIALLKL +P V P P
Sbjct: 78 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 127
>pdb|1L4D|A Chain A, Crystal Structure Of Microplasminogen-streptokinase Alpha
Domain Complex
Length = 249
Score = 103 bits (256), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 56/144 (38%), Positives = 87/144 (60%), Gaps = 6/144 (4%)
Query: 551 LKAASPAMVKYRATKRGDGS-HRVYSKRTGT-VVGWGRVEESGQI-ASDLRATQVPVMSN 607
LK +SPA++ + S + V + RT + GWG E G A L+ Q+PV+ N
Sbjct: 108 LKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIEN 165
Query: 608 QECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCA 667
+ C ++ ++ +CAG++ GG DSCQGD+GG L+ + D ++++ GV SWG+GCA
Sbjct: 166 KVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCA 224
Query: 668 RPNSPGVYTRVNHYMEWIQNNTRD 691
RPN PGVY RV+ ++ WI+ R+
Sbjct: 225 RPNKPGVYVRVSRFVTWIEGVMRN 248
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 41/120 (34%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 18 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R ++
Sbjct: 19 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 78
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDP 136
H + E ++ V ++ P DIALLKL +P V P P
Sbjct: 79 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 128
>pdb|1DDJ|A Chain A, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|B Chain B, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|C Chain C, Crystal Structure Of Human Plasminogen Catalytic Domain
pdb|1DDJ|D Chain D, Crystal Structure Of Human Plasminogen Catalytic Domain
Length = 247
Score = 103 bits (256), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 56/144 (38%), Positives = 87/144 (60%), Gaps = 6/144 (4%)
Query: 551 LKAASPAMVKYRATKRGDGS-HRVYSKRTGT-VVGWGRVEESGQI-ASDLRATQVPVMSN 607
LK +SPA++ + S + V + RT + GWG E G A L+ Q+PV+ N
Sbjct: 106 LKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIEN 163
Query: 608 QECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCA 667
+ C ++ ++ +CAG++ GG DSCQGD+GG L+ + D ++++ GV SWG+GCA
Sbjct: 164 KVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCA 222
Query: 668 RPNSPGVYTRVNHYMEWIQNNTRD 691
RPN PGVY RV+ ++ WI+ R+
Sbjct: 223 RPNKPGVYVRVSRFVTWIEGVMRN 246
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 41/120 (34%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 18 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R ++
Sbjct: 17 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 76
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDP 136
H + E ++ V ++ P DIALLKL +P V P P
Sbjct: 77 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 126
>pdb|1BML|A Chain A, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
pdb|1BML|B Chain B, Complex Of The Catalytic Domain Of Human Plasmin And
Streptokinase
Length = 250
Score = 103 bits (256), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 56/144 (38%), Positives = 87/144 (60%), Gaps = 6/144 (4%)
Query: 551 LKAASPAMVKYRATKRGDGS-HRVYSKRTGT-VVGWGRVEESGQI-ASDLRATQVPVMSN 607
LK +SPA++ + S + V + RT + GWG E G A L+ Q+PV+ N
Sbjct: 109 LKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIEN 166
Query: 608 QECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCA 667
+ C ++ ++ +CAG++ GG DSCQGD+GG L+ + D ++++ GV SWG+GCA
Sbjct: 167 KVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDAGGPLVCFEKD-KYILQGVTSWGLGCA 225
Query: 668 RPNSPGVYTRVNHYMEWIQNNTRD 691
RPN PGVY RV+ ++ WI+ R+
Sbjct: 226 RPNKPGVYVRVSRFVTWIEGVMRN 249
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 41/120 (34%), Positives = 56/120 (46%), Gaps = 11/120 (9%)
Query: 18 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R ++
Sbjct: 20 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 79
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDP 136
H + E ++ V ++ P DIALLKL +P V P P
Sbjct: 80 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIPACLPSP 129
>pdb|1SLW|B Chain B, Rat Anionic N143h, E151h Trypsin Complexed To A86h Ecotin;
Nickel- Bound
Length = 223
Score = 103 bits (256), Expect = 4e-22, Method: Composition-based stats.
Identities = 55/139 (39%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATIALPSSCAPAGTQCLISGWGHTLSSGVNHPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 69.7 bits (169), Expect = 5e-12, Method: Composition-based stats.
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 101
>pdb|1RJX|B Chain B, Human Plasminogen Catalytic Domain, K698m Mutant
Length = 247
Score = 103 bits (256), Expect = 5e-22, Method: Compositional matrix adjust.
Identities = 55/143 (38%), Positives = 86/143 (60%), Gaps = 4/143 (2%)
Query: 551 LKAASPAMVKYRATKRGDGS-HRVYSKRTGT-VVGWGRVEESGQIASDLRATQVPVMSNQ 608
LK +SPA++ + S + V + RT + GWG + + A L Q+PV+ N+
Sbjct: 106 LKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFG-AGLLMEAQLPVIENK 164
Query: 609 ECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C ++ ++ +CAG++ GG DSCQGDSGG L+ + D ++++ GV SWG+GCAR
Sbjct: 165 VCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCAR 223
Query: 669 PNSPGVYTRVNHYMEWIQNNTRD 691
PN PGVY RV+ ++ WI+ R+
Sbjct: 224 PNKPGVYVRVSRFVTWIEGVMRN 246
Score = 63.5 bits (153), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 43/133 (32%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 10 CGVPNRMDR-----IVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRS 63
CG P + +VGG + +PW V+L + G FCGGTLIS +VLTAAHC+
Sbjct: 4 CGKPQVEPKKCPGAVVGGCVAYPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEK 63
Query: 64 SKRHKDLIAVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLE 123
S R ++ H + E ++ V ++ P DIALLKL +P
Sbjct: 64 SPRPSSYKVILGAHQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAV 113
Query: 124 FKPTVSPDNKDDP 136
V P P
Sbjct: 114 ITDKVIPACLPSP 126
>pdb|1K9O|E Chain E, Crystal Structure Of Michaelis Serpin-Trypsin Complex
pdb|1YKT|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLC|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|1YLD|A Chain A, TrypsinBPTI COMPLEX MUTANT
pdb|3FP7|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Cleaved At The
Scissile Bond (Lys15-Ala16) Determined To The 1.46 A
Resolution Limit
pdb|3FP8|E Chain E, Anionic Trypsin Variant S195a In Complex With Bovine
Pancreatic Trypsin Inhibitor (Bpti) Determined To The
1.46 A Resolution Limit
Length = 223
Score = 102 bits (255), Expect = 6e-22, Method: Composition-based stats.
Identities = 54/139 (38%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGD+GG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDAGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 70.1 bits (170), Expect = 4e-12, Method: Composition-based stats.
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 101
>pdb|1OPH|B Chain B, Non-Covalent Complex Between Alpha-1-Pi-Pittsburgh And
S195a Trypsin
Length = 243
Score = 102 bits (255), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 50/108 (46%), Positives = 73/108 (67%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAGY+EGGKDSCQ
Sbjct: 138 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAGYLEGGKDSCQ 194
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GD+GG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 195 GDAGGPVVCS---GK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 237
Score = 63.9 bits (154), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 10/113 (8%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D+IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V
Sbjct: 19 DKIVGGYTCGANTVPYQVSLN-SGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLG 71
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 72 EDNINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 121
>pdb|1YBW|A Chain A, Protease Domain Of Hgfa With No Inhibitor
pdb|1YBW|B Chain B, Protease Domain Of Hgfa With No Inhibitor
pdb|1YC0|A Chain A, Short Form Hgfa With First Kunitz Domain From Hai-1
pdb|2R0K|A Chain A, Protease Domain Of Hgfa With Inhibitor Fab58
Length = 283
Score = 102 bits (254), Expect = 7e-22, Method: Compositional matrix adjust.
Identities = 77/232 (33%), Positives = 114/232 (49%), Gaps = 30/232 (12%)
Query: 482 LAHIYGYRPFSKEILPTENWFVSFIGAGEGWHNYHHSFPWDYRAAEMGQHF-NITTLVID 540
LA IY F L W VS H + HS P D + +GQHF N TT V
Sbjct: 50 LAAIYIGDSFCAGSLVHTCWVVS------AAHCFSHSPPRDSVSVVLGQHFFNRTTDVTQ 103
Query: 541 -FCAERGWAWGLKAA-SPA---MVKYRATKRGDGS-------HRVYSKRTGT-------- 580
F E+ + L + +P+ +V R K+GD + G+
Sbjct: 104 TFGIEKYIPYTLYSVFNPSDHDLVLIRLKKKGDRCATRSQFVQPICLPEPGSTFPAGHKC 163
Query: 581 -VVGWGRVEES-GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG ++E+ +S LR VP++++ +C + ++ NM+CAGY + D+CQ
Sbjct: 164 QIAGWGHLDENVSGYSSSLREALVPLVADHKCSSPEVYGADISPNMLCAGYFDCKSDACQ 223
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
GDSGG L E +G + G++SWG GC R + PGVYTRV +Y++WI + R
Sbjct: 224 GDSGGPLACEK-NGVAYLYGIISWGDGCGRLHKPGVYTRVANYVDWINDRIR 274
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 29/103 (28%), Positives = 50/103 (48%), Gaps = 8/103 (7%)
Query: 18 RIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
RI+GG ++ +PW+ A+ G FC G+L+ +V++AAHC S + V+ +H
Sbjct: 35 RIIGGSSSLPGSHPWLAAI-YIGDSFCAGSLVHTCWVVSAAHCFSHSPPRDSVSVVLGQH 93
Query: 78 --NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
NR T + + + +N DHD+ L++L
Sbjct: 94 FFNRTTDVTQTFGIEKYIPYTLYSVFNPS-----DHDLVLIRL 131
>pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUR|B Chain B, The X-Ray Crystal Structure Of Full-Length Type Ii Human
Plasminogen
pdb|4DUU|A Chain A, The X-Ray Crystal Structure Of Full-Length Type I Human
Plasminogen
pdb|4A5T|S Chain S, Structural Basis For The Conformational Modulation
Length = 791
Score = 102 bits (254), Expect = 8e-22, Method: Compositional matrix adjust.
Identities = 55/144 (38%), Positives = 86/144 (59%), Gaps = 6/144 (4%)
Query: 551 LKAASPAMVKYRATKRG-DGSHRVYSKRTGT-VVGWGRVEESGQIASDL-RATQVPVMSN 607
LK +SPA++ + + V + RT + GWG E G + L + Q+PV+ N
Sbjct: 650 LKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWG--ETQGTFGAGLLKEAQLPVIEN 707
Query: 608 QECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCA 667
+ C ++ ++ +CAG++ GG DSCQGDSGG L+ + D ++++ GV SWG+GCA
Sbjct: 708 KVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKD-KYILQGVTSWGLGCA 766
Query: 668 RPNSPGVYTRVNHYMEWIQNNTRD 691
RPN PGVY RV+ ++ WI+ R+
Sbjct: 767 RPNKPGVYVRVSRFVTWIEGVMRN 790
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 40/114 (35%), Positives = 55/114 (48%), Gaps = 11/114 (9%)
Query: 18 RIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
R+VGG + +PW V+L + G FCGGTLIS +VLTAAHC+ S R ++
Sbjct: 561 RVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGA 620
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
H + E ++ V ++ P DIALLKL +P V P
Sbjct: 621 HQEVNL-EPHVQEIEVSRLFLEPTRK---------DIALLKLSSPAVITDKVIP 664
>pdb|1ANB|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Glu
Length = 223
Score = 102 bits (253), Expect = 9e-22, Method: Composition-based stats.
Identities = 54/139 (38%), Positives = 80/139 (57%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+V WG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVEWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 70.1 bits (170), Expect = 4e-12, Method: Composition-based stats.
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 101
>pdb|1ANC|A Chain A, Anionic Trypsin Mutant With Ser 214 Replaced By Lys
Length = 223
Score = 102 bits (253), Expect = 9e-22, Method: Composition-based stats.
Identities = 54/139 (38%), Positives = 80/139 (57%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+V WG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVKWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 70.1 bits (170), Expect = 4e-12, Method: Composition-based stats.
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 101
>pdb|3TGK|E Chain E, Trypsinogen Mutant D194n And Deletion Of Ile 16-Val 17
Complexed With Bovine Pancreatic Trypsin Inhibitor
(Bpti)
Length = 231
Score = 102 bits (253), Expect = 1e-21, Method: Composition-based stats.
Identities = 54/139 (38%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 96 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 155
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQG+SGG ++ +G + G+VSWG GCA
Sbjct: 156 CEASYPG---KITDNMVCVGFLEGGKDSCQGNSGGPVV---CNGE--LQGIVSWGYGCAL 207
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 208 PDNPGVYTKVCNYVDWIQD 226
Score = 66.6 bits (161), Expect = 4e-11, Method: Composition-based stats.
Identities = 37/109 (33%), Positives = 65/109 (59%), Gaps = 10/109 (9%)
Query: 21 GGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRA 80
GG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 11 GGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN-I 63
Query: 81 TVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 64 NVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 109
>pdb|1DPO|A Chain A, Structure Of Rat Trypsin
Length = 223
Score = 102 bits (253), Expect = 1e-21, Method: Composition-based stats.
Identities = 54/139 (38%), Positives = 80/139 (57%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGD GG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKDSCQGDCGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 70.1 bits (170), Expect = 4e-12, Method: Composition-based stats.
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 101
>pdb|1A0J|A Chain A, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|B Chain B, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|C Chain C, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species.
pdb|1A0J|D Chain D, Crystal Structure Of A Non-Psychrophilic Trypsin From A
Cold-Adapted Fish Species
Length = 223
Score = 101 bits (251), Expect = 1e-21, Method: Composition-based stats.
Identities = 52/109 (47%), Positives = 71/109 (65%), Gaps = 10/109 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
V GWG + S D LR +P++S+ C +PG ++T NM CAG++EGGKDSCQ
Sbjct: 118 VSGWGNLSGSSSNYPDTLRCLDLPILSSSSCNSAYPG---QITSNMFCAGFMEGGKDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
GDSGG ++ +G+ + GVVSWG GCA+ N PGVYT+V +Y WI +
Sbjct: 175 GDSGGPVV---CNGQ--LQGVVSWGYGCAQRNKPGVYTKVCNYRSWISS 218
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 43/111 (38%), Positives = 62/111 (55%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ N + +L Q+G FCGG+LIS +V++AAHC +S + + + EHN
Sbjct: 1 IVGGYECRKNSASYQASL-QSGYHFCGGSLISSTWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
A V E + VKV+ HP YN +++ D+DI L+KL P VS
Sbjct: 55 IA-VNEGTEQFIDSVKVIMHPSYN---SRNLDNDIMLIKLSKPASLNSYVS 101
>pdb|1F7Z|A Chain A, Rat Trypsinogen K15a Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 233
Score = 101 bits (251), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 55/139 (39%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 98 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 157
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 158 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 209
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 210 PDNPGVYTKVCNYVDWIQD 228
Score = 72.4 bits (176), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 40/113 (35%), Positives = 68/113 (60%), Gaps = 10/113 (8%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + E
Sbjct: 9 DAIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGE 62
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
HN V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 63 HN-INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 111
>pdb|1AMH|A Chain A, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
pdb|1AMH|B Chain B, Uncomplexed Rat Trypsin Mutant With Asp 189 Replaced With
Ser (D189s)
Length = 223
Score = 101 bits (251), Expect = 2e-21, Method: Composition-based stats.
Identities = 54/139 (38%), Positives = 80/139 (57%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGK SCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKSSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 200 PDNPGVYTKVCNYVDWIQD 218
Score = 69.7 bits (169), Expect = 5e-12, Method: Composition-based stats.
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 101
>pdb|1TRN|A Chain A, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
pdb|1TRN|B Chain B, Crystal Structure Of Human Trypsin 1: Unexpected
Phosphorylation Of Tyrosine 151
Length = 224
Score = 100 bits (250), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 56/115 (48%), Positives = 75/115 (65%), Gaps = 13/115 (11%)
Query: 578 TGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEPKLTGNMMCAGYVEG 632
TGT + GWG SG D L+ PV+S +C +PG K+T NM C G++EG
Sbjct: 112 TGTKCLISGWGNTASSGADXPDELQCLDAPVLSQAKCEASYPG---KITSNMFCVGFLEG 168
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
GKDSCQGDSGG ++ +G+ + GVVSWG GCA+ N PGVYT+V +Y++WI+N
Sbjct: 169 GKDSCQGDSGGPVV---CNGQ--LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKN 218
Score = 62.4 bits (150), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 38/111 (34%), Positives = 63/111 (56%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ E N P+ V+L +G FCGG+LI++++V++A HC +S + + + EHN
Sbjct: 1 IVGGYNCEENSVPYQVSL-NSGYHFCGGSLINEQWVVSAGHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP+Y+ K+ ++DI L+KL + VS
Sbjct: 55 -IEVLEGNEQFINAAKIIRHPQYD---RKTLNNDIMLIKLSSRAVINARVS 101
>pdb|1FXY|A Chain A, Coagulation Factor Xa-Trypsin Chimera Inhibited With
D-Phe-Pro-Arg- Chloromethylketone
Length = 228
Score = 100 bits (249), Expect = 3e-21, Method: Compositional matrix adjust.
Identities = 56/115 (48%), Positives = 75/115 (65%), Gaps = 13/115 (11%)
Query: 578 TGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEPKLTGNMMCAGYVEG 632
TGT + GWG SG D L+ PV+S +C +PG K+T NM C G++EG
Sbjct: 116 TGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPG---KITSNMFCVGFLEG 172
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
GKDSCQGDSGG ++ +G+ + GVVSWG GCA+ N PGVYT+V +Y++WI+N
Sbjct: 173 GKDSCQGDSGGPVV---CNGQ--LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKN 222
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 66/113 (58%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG+ + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGYNCKDGEVPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1EPT|C Chain C, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
pdb|1AKS|B Chain B, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
Length = 98
Score = 100 bits (249), Expect = 3e-21, Method: Composition-based stats.
Identities = 47/93 (50%), Positives = 68/93 (73%), Gaps = 9/93 (9%)
Query: 595 SDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGR 653
S L+ + PV+SN C+ +PG ++TGNM+C G+++GGKDSCQGDSGG ++ +G+
Sbjct: 8 SLLQCLKAPVLSNSSCKSSYPG---QITGNMICVGFLQGGKDSCQGDSGGPVV---CNGQ 61
Query: 654 FLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
+ G+VSWG GCA+ N PGVYT+V +Y+ WIQ
Sbjct: 62 --LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 92
>pdb|3TGJ|E Chain E, S195a Trypsinogen Complexed With Bovine Pancreatic Trypsin
Inhibitor (Bpti)
Length = 233
Score = 100 bits (248), Expect = 4e-21, Method: Compositional matrix adjust.
Identities = 54/139 (38%), Positives = 81/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 98 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 157
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGD+GG ++ +G + G+VSWG GCA
Sbjct: 158 CEASYPG---KITDNMVCVGFLEGGKDSCQGDAGGPVV---CNGE--LQGIVSWGYGCAL 209
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 210 PDNPGVYTKVCNYVDWIQD 228
Score = 73.6 bits (179), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 40/113 (35%), Positives = 69/113 (61%), Gaps = 10/113 (8%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D+IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + E
Sbjct: 9 DKIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGE 62
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
HN V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 63 HN-INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 111
>pdb|1UHB|B Chain B, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 98
Score = 100 bits (248), Expect = 4e-21, Method: Composition-based stats.
Identities = 47/93 (50%), Positives = 68/93 (73%), Gaps = 9/93 (9%)
Query: 595 SDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGR 653
S L+ + PV+S+ C+ +PG ++TGNM+C G++EGGKDSCQGDSGG ++ +G+
Sbjct: 8 SLLQCLKAPVLSDSSCKSSYPG---QITGNMICVGFLEGGKDSCQGDSGGPVV---CNGQ 61
Query: 654 FLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
+ G+VSWG GCA+ N PGVYT+V +Y+ WIQ
Sbjct: 62 --LQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQ 92
>pdb|1O5E|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5F|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1P57|B Chain B, Extracellular Domain Of Human Hepsin
Length = 255
Score = 99.8 bits (247), Expect = 5e-21, Method: Compositional matrix adjust.
Identities = 50/109 (45%), Positives = 66/109 (60%), Gaps = 3/109 (2%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
TV GWG + GQ A L+ +VP++SN C + ++ M CAGY EGG D+CQG
Sbjct: 130 TVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDACQG 189
Query: 640 DSGGALLMED---LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
DSGG + ED R+ + G+VSWG GCA PGVYT+V+ + EWI
Sbjct: 190 DSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWI 238
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 36/113 (31%), Positives = 57/113 (50%), Gaps = 1/113 (0%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH- 77
IVGG T + +PW V+L G CGG+L+S +VLTAAHC R V +
Sbjct: 1 IVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFAGAV 60
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+A+ + Q+ + VV + + ++ + +DIAL+ L +PL + P
Sbjct: 61 AQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQP 113
>pdb|1H9H|E Chain E, Complex Of Eeti-Ii With Porcine Trypsin
Length = 231
Score = 99.4 bits (246), Expect = 5e-21, Method: Composition-based stats.
Identities = 59/142 (41%), Positives = 85/142 (59%), Gaps = 13/142 (9%)
Query: 551 LKAASPAMVKYR-ATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDLR--ATQVPVMSN 607
+K +SPA + R AT S + GWG + SG L + + PV+S+
Sbjct: 91 IKLSSPATLNSRVATVSLPRSCAAAGTECSLISGWGNTKSSGSSYPSLLQCSLKAPVLSD 150
Query: 608 QECRQ-FPGFEPKLTGNMMCAGYVEGGKDSC-QGDSGGALLMEDLDGRFLIAGVVSWGIG 665
C+ +PG ++TGNM+C G++EGGKDSC QGDSGG ++ +G+ + G+VSWG G
Sbjct: 151 SSCKSSYPG---QITGNMICVGFLEGGKDSCSQGDSGGPVVCS--NGQ--LQGIVSWGYG 203
Query: 666 C-ARPNSPGVYTRVNHYMEWIQ 686
C A+ N PGVYT+V +Y+ WIQ
Sbjct: 204 CSAQKNKPGVYTKVCNYVNWIQ 225
Score = 62.0 bits (149), Expect = 1e-09, Method: Composition-based stats.
Identities = 38/112 (33%), Positives = 60/112 (53%), Gaps = 9/112 (8%)
Query: 19 IVGGWT-TEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG+T + N P+ V+L F GG+LI+ ++V++AAHC S+ + + EH
Sbjct: 1 IVGGYTCSAANSIPYQVSLNSGSHFCSGGSLINSQWVVSAAHCSYKSR----IQVRLGEH 56
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
N V E + K++THP +N + D+DI L+KL +P V+
Sbjct: 57 N-IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVA 104
>pdb|3T2N|A Chain A, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
pdb|3T2N|B Chain B, Human Hepsin Protease In Complex With The Fab Fragment Of
An Inhibitory Antibody
Length = 372
Score = 99.4 bits (246), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 50/109 (45%), Positives = 66/109 (60%), Gaps = 3/109 (2%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
TV GWG + GQ A L+ +VP++SN C + ++ M CAGY EGG D+CQG
Sbjct: 247 TVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDACQG 306
Query: 640 DSGGALLMED---LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
DSGG + ED R+ + G+VSWG GCA PGVYT+V+ + EWI
Sbjct: 307 DSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWI 355
Score = 63.5 bits (153), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 1/116 (0%)
Query: 16 MDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
+DRIVGG T + +PW V+L G CGG+L+S +VLTAAHC R V +
Sbjct: 115 VDRIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFA 174
Query: 76 EH-NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+A+ + Q+ + VV + + ++ + +DIAL+ L +PL + P
Sbjct: 175 GAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQP 230
>pdb|1Z8G|A Chain A, Crystal Structure Of The Extracellular Region Of The
Transmembrane Serine Protease Hepsin With Covalently
Bound Preferred Substrate
Length = 372
Score = 99.4 bits (246), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 50/109 (45%), Positives = 66/109 (60%), Gaps = 3/109 (2%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
TV GWG + GQ A L+ +VP++SN C + ++ M CAGY EGG D+CQG
Sbjct: 247 TVTGWGNTQYYGQQAGVLQEARVPIISNDVCNGADFYGNQIKPKMFCAGYPEGGIDACQG 306
Query: 640 DSGGALLMED---LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
DSGG + ED R+ + G+VSWG GCA PGVYT+V+ + EWI
Sbjct: 307 DSGGPFVCEDSISRTPRWRLCGIVSWGTGCALAQKPGVYTKVSDFREWI 355
Score = 63.5 bits (153), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 1/116 (0%)
Query: 16 MDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
+DRIVGG T + +PW V+L G CGG+L+S +VLTAAHC R V +
Sbjct: 115 VDRIVGGRDTSLGRWPWQVSLRYDGAHLCGGSLLSGDWVLTAAHCFPERNRVLSRWRVFA 174
Query: 76 EH-NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+A+ + Q+ + VV + + ++ + +DIAL+ L +PL + P
Sbjct: 175 GAVAQASPHGLQLGVQAVVYHGGYLPFRDPNSEENSNDIALVHLSSPLPLTEYIQP 230
>pdb|2RA3|A Chain A, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
pdb|2RA3|B Chain B, Human Cationic Trypsin Complexed With Bovine Pancreatic
Trypsin Inhibitor (bpti)
Length = 224
Score = 99.4 bits (246), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 55/115 (47%), Positives = 75/115 (65%), Gaps = 13/115 (11%)
Query: 578 TGT---VVGWGRVEESGQIASD-LRATQVPVMSNQECR-QFPGFEPKLTGNMMCAGYVEG 632
TGT + GWG SG D L+ PV+S +C +PG K+T NM C G++EG
Sbjct: 112 TGTKCLISGWGNTASSGADYPDELQCLDAPVLSQAKCEASYPG---KITSNMFCVGFLEG 168
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
GKDSCQGD+GG ++ +G+ + GVVSWG GCA+ N PGVYT+V +Y++WI+N
Sbjct: 169 GKDSCQGDAGGPVV---CNGQ--LQGVVSWGDGCAQKNKPGVYTKVYNYVKWIKN 218
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 38/111 (34%), Positives = 63/111 (56%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ E N P+ V+L +G FCGG+LI++++V++A HC +S + + + EHN
Sbjct: 1 IVGGYNCEENSVPYQVSLN-SGYHFCGGSLINEQWVVSAGHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP+Y+ K+ ++DI L+KL + VS
Sbjct: 55 -IEVLEGNEQFINAAKIIRHPQYD---RKTLNNDIMLIKLSSRAVINAHVS 101
>pdb|1CO7|E Chain E, R117h Mutant Rat Anionic Trypsin Complexed With Bovine
Pancreatic Trypsin Inhibitor (Bpti)
Length = 245
Score = 99.0 bits (245), Expect = 7e-21, Method: Compositional matrix adjust.
Identities = 54/139 (38%), Positives = 80/139 (57%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + S + + GWG SG DL + P++ +
Sbjct: 110 IKLSSPVKLNAHVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 169
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGKDSCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 170 CEASYPG---KITDNMVCVGFLEGGKDSCQGDSGGPVVC---NGE--LQGIVSWGYGCAL 221
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++PGVYT+V +Y++WIQ+
Sbjct: 222 PDNPGVYTKVCNYVDWIQD 240
Score = 73.2 bits (178), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 40/113 (35%), Positives = 69/113 (61%), Gaps = 10/113 (8%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D+IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + E
Sbjct: 21 DKIVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGE 74
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
HN V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 75 HN-INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNAHVA 123
>pdb|2OQ5|A Chain A, Crystal Structure Of Desc1, A New Member Of The Type Ii
Transmembrane Serine Proteinases Family
Length = 232
Score = 99.0 bits (245), Expect = 8e-21, Method: Compositional matrix adjust.
Identities = 46/109 (42%), Positives = 65/109 (59%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V G+G ++ G + LR QV ++ C + + +T M+CAG +EG D+CQGD
Sbjct: 122 VTGFGALKNDGYSQNHLRQAQVTLIDATTCNEPQAYNDAITPRMLCAGSLEGKTDACQGD 181
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNT 689
SGG L+ D + +AG+VSWG CA+PN PGVYTRV +WI + T
Sbjct: 182 SGGPLVSSDARDIWYLAGIVSWGDECAKPNKPGVYTRVTALRDWITSKT 230
Score = 59.3 bits (142), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 66/129 (51%), Gaps = 11/129 (8%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG E E+PW +L+ G CG TLI+ ++++AAHC + K A
Sbjct: 1 IVGGTEVEEGEWPWQASLQWDGSHRCGATLINATWLVSAAHCFTTYKNPARWTASFG--- 57
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDPKS 138
T+ ++++ R + +++ H KY SHD+DI+L +L +P+ + V D
Sbjct: 58 -VTIKPSKMK-RGLRRIIVHEKYK---HPSHDYDISLAELSSPVPYTNAVHRVCLPDASY 112
Query: 139 ELTQFKPGN 147
E F+PG+
Sbjct: 113 E---FQPGD 118
>pdb|1J15|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J16|A Chain A, Benzamidine In Complex With Rat Trypsin Mutant X99175190RT
pdb|1J17|T Chain T, Factor Xa Specific Inhibitor In Complex With Rat Trypsin
Mutant X99175190RT
Length = 223
Score = 98.6 bits (244), Expect = 9e-21, Method: Composition-based stats.
Identities = 52/138 (37%), Positives = 78/138 (56%), Gaps = 8/138 (5%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARP 669
C F +T NM+C G++EGGKD+CQGDSGG ++ +G + G+VSWG GCA P
Sbjct: 148 CEASSSF--IITDNMVCVGFLEGGKDACQGDSGGPVV---CNGE--LQGIVSWGYGCALP 200
Query: 670 NSPGVYTRVNHYMEWIQN 687
++PGVYT+V +Y++WIQ+
Sbjct: 201 DNPGVYTKVCNYVDWIQD 218
Score = 70.5 bits (171), Expect = 3e-12, Method: Composition-based stats.
Identities = 38/111 (34%), Positives = 68/111 (61%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ + ++++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFDRE---TYNNDIMLIKLSSPVKLNARVA 101
>pdb|1BRB|E Chain E, Crystal Structures Of Rat Anionic Trypsin Complexed With
The Protein Inhibitors Appi And Bpti
pdb|1BRC|E Chain E, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
pdb|1BRA|A Chain A, Relocating A Negative Charge In The Binding Pocket Of
Trypsin
Length = 223
Score = 97.8 bits (242), Expect = 2e-20, Method: Composition-based stats.
Identities = 53/139 (38%), Positives = 79/139 (56%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDL-RATQVPVMSNQE 609
+K +SP + R S + + GWG SG DL + P++ +
Sbjct: 88 IKLSSPVKLNARVATVALPSSCAPAGTQCLISGWGNTLSSGVNEPDLLQCLDAPLLPQAD 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C +PG K+T NM+C G++EGGK SCQGDSGG ++ +G + G+VSWG GCA
Sbjct: 148 CEASYPG---KITDNMVCVGFLEGGKGSCQGDSGGPVV---CNGE--LQGIVSWGYGCAL 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
P++P VYT+V +Y++WIQ+
Sbjct: 200 PDNPDVYTKVCNYVDWIQD 218
Score = 69.7 bits (169), Expect = 5e-12, Method: Composition-based stats.
Identities = 39/111 (35%), Positives = 67/111 (60%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T + N P+ V+L +G FCGG+LI+D++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCQENSVPYQVSL-NSGYHFCGGSLINDQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HP ++ K+ ++DI L+KL +P++ V+
Sbjct: 55 -INVLEGNEQFVNAAKIIKHPNFD---RKTLNNDIMLIKLSSPVKLNARVA 101
>pdb|1MBQ|A Chain A, Anionic Trypsin From Pacific Chum Salmon
Length = 220
Score = 96.7 bits (239), Expect = 4e-20, Method: Composition-based stats.
Identities = 48/107 (44%), Positives = 66/107 (61%), Gaps = 9/107 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TV GWG S + L+ +P++S +C +PG +T M CAGY+EGGKDSCQ
Sbjct: 117 TVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGYLEGGKDSCQ 173
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
GDSGG ++ +G + GVVSWG GCA P +PGVY +V + +W+
Sbjct: 174 GDSGGPVV---CNGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
Score = 53.9 bits (128), Expect = 3e-07, Method: Composition-based stats.
Identities = 37/114 (32%), Positives = 58/114 (50%), Gaps = 14/114 (12%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S + + EHN
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVEVR-----LGEHN 54
Query: 79 RATV--YETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
E I + RV++ HP Y++ D+DI L+KL V P
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKSATLNTYVQP 102
>pdb|2WPM|S Chain S, Factor Ixa Superactive Mutant, Egr-Cmk Inhibited
Length = 235
Score = 96.3 bits (238), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 48/113 (42%), Positives = 70/113 (61%), Gaps = 3/113 (2%)
Query: 578 TGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSC 637
+G V GWGRV G+ A L+ +VP++ C + F +T NM CAG+ EGG+DSC
Sbjct: 124 SGYVSGWGRVFHKGRAALVLQYLRVPLVDRATCLRSTKF--TITNNMFCAGFHEGGRDSC 181
Query: 638 QGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
QGDSGG + E ++G + G++SWG CA G+YT+V+ Y+ WI+ T+
Sbjct: 182 QGDSGGPHVTE-VEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 39/112 (34%), Positives = 67/112 (59%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+VGG + ++PW V L FCGG+++++++++TAAHCV + + + V EHN
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK---ITVVAGEHN 57
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
T+ + R V++++ H +NA +++HDIALL+LD PL V+P
Sbjct: 58 IEETEHTE-QKRNVIRIIPHHNFNA-AINTYNHDIALLELDEPLVLNSYVTP 107
>pdb|2WPH|S Chain S, Factor Ixa Superactive Triple Mutant
pdb|2WPJ|S Chain S, Factor Ixa Superactive Triple Mutant, Nacl-Soaked
pdb|2WPK|S Chain S, Factor Ixa Superactive Triple Mutant, Ethylene
Glycol-Soaked
pdb|2WPL|S Chain S, Factor Ixa Superactive Triple Mutant, Edta-Soaked
Length = 235
Score = 95.9 bits (237), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 48/113 (42%), Positives = 70/113 (61%), Gaps = 3/113 (2%)
Query: 578 TGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSC 637
+G V GWGRV G+ A L+ +VP++ C + F +T NM CAG+ EGG+DSC
Sbjct: 124 SGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF--TITNNMFCAGFHEGGRDSC 181
Query: 638 QGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
QGDSGG + E ++G + G++SWG CA G+YT+V+ Y+ WI+ T+
Sbjct: 182 QGDSGGPHVTE-VEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
Score = 80.1 bits (196), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 39/112 (34%), Positives = 67/112 (59%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+VGG + ++PW V L FCGG+++++++++TAAHCV + + + V EHN
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK---ITVVAGEHN 57
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
T+ + R V++++ H +NA +++HDIALL+LD PL V+P
Sbjct: 58 IEETEHTE-QKRNVIRIIPHHNFNA-AINTYNHDIALLELDEPLVLNSYVTP 107
>pdb|2WPI|S Chain S, Factor Ixa Superactive Double Mutant
Length = 235
Score = 95.9 bits (237), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 48/113 (42%), Positives = 70/113 (61%), Gaps = 3/113 (2%)
Query: 578 TGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSC 637
+G V GWGRV G+ A L+ +VP++ C + F +T NM CAG+ EGG+DSC
Sbjct: 124 SGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF--TITNNMFCAGFHEGGRDSC 181
Query: 638 QGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
QGDSGG + E ++G + G++SWG CA G+YT+V+ Y+ WI+ T+
Sbjct: 182 QGDSGGPHVTE-VEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 40/112 (35%), Positives = 67/112 (59%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+VGG + ++PW V L FCGG+++++++++TAAHCV + + + V EHN
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK---ITVVAGEHN 57
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
T+ + R V++++ H YNA +++HDIALL+LD PL V+P
Sbjct: 58 IEETEHTE-QKRNVIRIIPHHNYNA-AINTYNHDIALLELDEPLVLNSYVTP 107
>pdb|2F83|A Chain A, Crystal Structure At 2.9 Angstroms Resolution Of Human
Plasma Coagulation Factor Xi Zymogen
Length = 625
Score = 95.5 bits (236), Expect = 9e-20, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 73/111 (65%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 516 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 573
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 574 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 623
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/116 (30%), Positives = 58/116 (50%), Gaps = 7/116 (6%)
Query: 18 RIVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
RIVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 387 RIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYS 446
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N++ + E V +++ H +Y + +DIALLKL+ + + + P
Sbjct: 447 GILNQSEIKE-DTSFFGVQEIIIHDQYKMAES---GYDIALLKLETTVNYTDSQRP 498
>pdb|1PFX|C Chain C, Porcine Factor Ixa
pdb|1X7A|C Chain C, Porcine Factor Ixa Complexed To 1-{3-[amino(Imino)
Methyl]phenyl}-N-[4-(1h-Benzimidazol-1-Yl)-2-
Fluorophenyl]-
3-(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide
Length = 235
Score = 95.1 bits (235), Expect = 1e-19, Method: Compositional matrix adjust.
Identities = 48/113 (42%), Positives = 70/113 (61%), Gaps = 3/113 (2%)
Query: 578 TGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSC 637
+G V GWGRV G+ A+ L+ +VP++ C + F + NM CAG+ EGGKDSC
Sbjct: 124 SGYVSGWGRVFNRGRSATILQYLKVPLVDRATCLRSTKF--TIYSNMFCAGFHEGGKDSC 181
Query: 638 QGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
QGDSGG + E ++G + G++SWG CA G+YT+V+ Y+ WI+ T+
Sbjct: 182 QGDSGGPHVTE-VEGTSFLTGIISWGEECAVKGKYGIYTKVSRYVNWIKEKTK 233
Score = 77.8 bits (190), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 42/112 (37%), Positives = 64/112 (57%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG + ++PW V L FCGG++I++++V+TAAHC+ + + V E+N
Sbjct: 1 IVGGENAKPGQFPWQVLLNGKIDAFCGGSIINEKWVVTAAHCIEPGVK---ITVVAGEYN 57
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
T+ + R V++ + H YNA K + HDIALL+LD PL V+P
Sbjct: 58 TEETEPTE-QRRNVIRAIPHHSYNATVNK-YSHDIALLELDEPLTLNSYVTP 107
>pdb|1V2S|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Ssfi.Glu)bt.D1
pdb|1V2T|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(ssfi.glu)bt.b4
Length = 223
Score = 95.1 bits (235), Expect = 1e-19, Method: Composition-based stats.
Identities = 50/107 (46%), Positives = 70/107 (65%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKDSCQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDSCQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIK 217
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|1BIT|A Chain A, The Crystal Structure Of Anionic Salmon Trypsin In A
Second Crystal Form
Length = 237
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/107 (44%), Positives = 67/107 (62%), Gaps = 9/107 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TV GWG S ++ L+ +P++S +C +PG +T M CAGY+EGGKDSCQ
Sbjct: 132 TVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGYLEGGKDSCQ 188
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
GDSGG ++ +G + GVVSWG GCA P +PGVY +V + +W+
Sbjct: 189 GDSGGPVV---CNGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 230
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 37/116 (31%), Positives = 61/116 (52%), Gaps = 14/116 (12%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D+IVGG+ + V+L +G FCGG+L+++ +V++AAHC +S + + E
Sbjct: 14 DKIVGGYECKAYSQAHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVEVR-----LGE 67
Query: 77 HNRATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
HN ++ I + RV++ HP Y++ D+DI L+KL P V P
Sbjct: 68 HNIKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQP 117
>pdb|3BG8|A Chain A, Crystal Structure Of Factor Xia In Complex With
Clavatadine A
Length = 238
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 73/111 (65%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 187 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N++ + E V +++ H +Y +DIALLKL+ + + + P
Sbjct: 61 ILNQSEIKE-DTSFFGVQEIIIHDQYK---MAESGYDIALLKLETTVNYTDSQRP 111
>pdb|1UTJ|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTK|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTL|M Chain M, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
pdb|1UTM|A Chain A, Trypsin Specificity As Elucidated By Lie Calculations,
X-Ray Structures And Association Constant Measurements
Length = 242
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/107 (44%), Positives = 67/107 (62%), Gaps = 9/107 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TV GWG S ++ L+ +P++S +C +PG +T M CAGY+EGGKDSCQ
Sbjct: 137 TVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGYLEGGKDSCQ 193
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
GDSGG ++ +G + GVVSWG GCA P +PGVY +V + +W+
Sbjct: 194 GDSGGPVV---CNGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 235
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 38/116 (32%), Positives = 62/116 (53%), Gaps = 14/116 (12%)
Query: 17 DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
D+IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S + + E
Sbjct: 19 DKIVGGYECKPYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVEVR-----LGE 72
Query: 77 HNRATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
HN ++ I + RV++ HP Y++ D+DI L+KL P V P
Sbjct: 73 HNIKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQP 122
>pdb|1ZJD|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Kunitz Protease Inhibitor
Domain Of Protease Nexin Ii
Length = 237
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 73/111 (65%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 187 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N+A + E V +++ H +Y +DIALLKL+ + + + P
Sbjct: 61 ILNQAEIKE-DTSFFGVQEIIIHDQYK---MAESGYDIALLKLETTVNYADSQRP 111
>pdb|1ZLR|A Chain A, Factor Xi Catalytic Domain Complexed With
2-Guanidino-1-(4-(4,4,5,5-
Tetramethyl-1,3,2-Dioxaborolan-2-Yl)phenyl)ethyl
Nicotinate
Length = 237
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 73/111 (65%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 187 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N+A + E V +++ H +Y +DIALLKL+ + + + P
Sbjct: 61 ILNQAEIAE-DTSFFGVQEIIIHDQYK---MAESGYDIALLKLETTVNYADSQRP 111
>pdb|1ZHR|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine
(S434a-T475a-C482s-K437a Mutant)
pdb|1ZPB|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 4-Methyl-Pentanoic Acid {1-[4-
Guanidino-1-(Thiazole-2-Carbonyl)-Butylcarbamoyl]-2-
Methyl- Propyl}-Amide
pdb|1ZPC|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
2-[2-(3-Chloro-Phenyl)-2-Hydroxy-
Acetylamino]-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]- 3-Methyl-Butyramide
pdb|2FDA|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Coagulation Factor Xia In Complex With
Alpha-Ketothiazole Arginine Derived Ligand
pdb|1ZMJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With 4-(Guanidinomethyl)-Phenylboronic Acid
pdb|1ZML|A Chain A, Crystal Structure Of The Catalytic Domain Of Factor Xi In
Complex With (R)-1-(4-(4-(Hydroxymethyl)-1,3,2-
Dioxaborolan-2-Yl)phenethyl)guanidine
pdb|1ZMN|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
(R)-1-(4-(4-(Hydroxymethyl)-1,3,
2-Dioxaborolan-2-Yl)phenyl)guanidine
pdb|1ZOM|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With A Peptidomimetic Inhibitor
pdb|1ZSJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
N-(7-Carbamimidoyl-Naphthalen-1-
Yl)-3-Hydroxy-2-Methyl-Benzamide
pdb|1ZSK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With
6-Carbamimidoyl-4-(3-Hydroxy-2-
Methyl-Benzoylamino)-Naphthalene-2-Carboxylic Acid
Methyl Ester
pdb|1ZTJ|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Benzylamino-2-
Methylsulfanyl-6-Oxo-6h-Pyrimidin-1-Yl)-N-[4-Guanidino-
1- (Thiazole-2-Carbonyl)-Butyl]-Acetamide
pdb|1ZTK|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With 2-(5-Amino-6-Oxo-2-M-Tolyl-6h-
Pyrimidin-1-Yl)-N-[4-Guanidino-1-(Thiazole-2-Carbonyl)-
Butyl]-Acetamide
pdb|1ZTL|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With N-[4-Guanidino-1-(Thiazole-2-
Carbonyl)-Butyl]-2-{6-Oxo-5-[(Quinolin-8-Ylmethyl)-
Amino]- 2-M-Tolyl-6h-Pyrimidin-1-Yl}-Acetamide
Length = 238
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 73/111 (65%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 187 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N+A + E V +++ H +Y +DIALLKL+ + + + P
Sbjct: 61 ILNQAEIAE-DTSFFGVQEIIIHDQYK---MAESGYDIALLKLETTVNYADSQRP 111
>pdb|3SOR|A Chain A, Factor Xia In Complex With A Clorophenyl-tetrazole
Inhibitor
pdb|3SOS|A Chain A, Benzothiazinone Inhibitor In Complex With Fxia
Length = 238
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 73/111 (65%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 187 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N++ + E V +++ H +Y +DIALLKL+ + + + P
Sbjct: 61 ILNQSEIKE-DTSFFGVQEIIIHDQYK---MAESGYDIALLKLETTVNYTDSQRP 111
>pdb|1ZPZ|A Chain A, Factor Xi Catalytic Domain Complexed With N-((R)-1-(4-
Bromophenyl)ethyl)urea-Asn-Val-Arg-Alpha-Ketothiazole
pdb|1ZRK|A Chain A, Factor Xi Complexed With 3-Hydroxypropyl 3-(7-
Amidinonaphthalene-1-Carboxamido)benzenesulfonate
pdb|1ZSL|A Chain A, Factor Xi Complexed With A Pyrimidinone Inhibitor
Length = 238
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 73/111 (65%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 187 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N++ + E V +++ H +Y +DIALLKL+ + + + P
Sbjct: 61 ILNQSEIAE-DTSFFGVQEIIIHDQYK---MAESGYDIALLKLETTVNYTDSQRP 111
>pdb|2NWN|A Chain A, New Pharmacophore For Serine Protease Inhibition Revealed
By Crystal Structure Of Human Urokinase-Type Plasminogen
Activator Complexed With A Cyclic Peptidyl Inhibitor,
Upain-1
pdb|2O8T|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145Q) IN COMPLEX WITH
Inhibitors
pdb|3KGP|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KHV|A Chain A, Crystal Structures Of Urokinase-Type Plasminogen Activator
In Complex With 4-(Aminomethyl) Benzoic Acid And 4-
(Aminomethyl-Phenyl)-Methanol
pdb|3KID|U Chain U, The Crystal Structures Of 2-Aminobenzothiazole-Based
Inhibitors In Complexes With Urokinase-Type Plasminogen
Activator
pdb|3M61|U Chain U, Crystal Structure Of Complex Of Urokinase And A Upain-1
Variant(W3a) In Ph4.6 Condition
pdb|3OX7|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph4.6
pdb|3OY5|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh027 At Ph7.4
pdb|3OY6|U Chain U, The Crystal Structure Of Upa Complex With Peptide
Inhibitor Mh036 At Ph4.6
pdb|3QN7|A Chain A, Potent And Selective Bicyclic Peptide Inhibitor (Uk18) Of
Human Urokinase-Type Plasminogen Activator(Upa)
Length = 253
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 45/112 (40%), Positives = 74/112 (66%), Gaps = 2/112 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T++
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 247
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+LIS +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
+ S N T E + E V ++ H Y+A +H +DIALLK+ +
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRS 105
>pdb|1XX9|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
pdb|1XX9|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotinm84r
Length = 238
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 73/111 (65%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 187 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N++ + E V +++ H +Y +DIALLKL+ + + + P
Sbjct: 61 ILNQSEIKE-DTSFFGVQEIIIHDQYK---MAESGYDIALLKLETTVNYTDSQRP 111
>pdb|1XXD|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXD|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Mutated Ecotin
pdb|1XXF|A Chain A, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
pdb|1XXF|B Chain B, Crystal Structure Of The Fxia Catalytic Domain In Complex
With Ecotin Mutant (Ecotinp)
Length = 238
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 73/111 (65%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 187 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N+A + E V +++ H +Y +DIALLKL+ + + + P
Sbjct: 61 ILNQAEIKE-DTSFFGVQEIIIHDQYK---MAESGYDIALLKLETTVNYADSQRP 111
>pdb|1KIG|H Chain H, Bovine Factor Xa
Length = 241
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 46/115 (40%), Positives = 71/115 (61%), Gaps = 3/115 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+++S L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRLSSTLKMLEVPYVDRSTCKLSSSF--TITPNMFCAGYDTQ 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+D+CQGDSGG + D + + G+VSWG GCAR GVYT+V+++++WI
Sbjct: 177 PEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKFGVYTKVSNFLKWIDK 230
Score = 63.5 bits (153), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 10/114 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL-EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG E PW L + + FCGGT++++ YVLTAAHC+ +KR +
Sbjct: 1 IVGGRDCAEGECPWQALLVNEENEGFCGGTILNEFYVLTAAHCLHQAKRF-----TVRVG 55
Query: 78 NRATVYETQIETRRVVKV-LTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V++ + H ++ + ++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGNEMAHEVEMTVKHSRFVKE---TYDFDIAVLRLKTPIRFRRNVAP 106
>pdb|1DAN|H Chain H, Complex Of Active Site Inhibited Human Blood Coagulation
Factor Viia With Human Recombinant Soluble Tissue Factor
pdb|1QFK|H Chain H, Structure Of Human Factor Viia And Its Implications For
The Triggering Of Blood Coagulation
pdb|1CVW|H Chain H, Crystal Structure Of Active Site-inhibited Human
Coagulation Factor Viia (des-gla)
pdb|1FAK|H Chain H, Human Tissue Factor Complexed With Coagulation Factor Viia
Inhibited With A Bpti-Mutant
pdb|1DVA|H Chain H, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1DVA|I Chain I, Crystal Structure Of The Complex Between The Peptide
Exosite Inhibitor E-76 And Coagulation Factor Viia
pdb|1JBU|H Chain H, Coagulation Factor Vii Zymogen (Egf2PROTEASE) IN COMPLEX
WITH Inhibitory Exosite Peptide A-183
pdb|1KLI|H Chain H, Cofactor-And Substrate-Assisted Activation Of Factor Viia
pdb|1KLJ|H Chain H, Crystal Structure Of Uninhibited Factor Viia
pdb|1J9C|H Chain H, Crystal Structure Of Tissue Factor-Factor Viia Complex
pdb|1W0Y|H Chain H, Tf7a_3771 Complex
pdb|1YGC|H Chain H, Short Factor Viia With A Small Molecule Inhibitor
pdb|1Z6J|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
Viia/tissue Factor/pyrazinone Inhibitor
pdb|1W2K|H Chain H, Tf7a_4380 Complex
pdb|1WQV|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Propylsulfonamide-D- Thr-Met-P-Aminobenzamidine
pdb|1W7X|H Chain H, Factor7- 413 Complex
pdb|1W8B|H Chain H, Factor7 - 413 Complex
pdb|1WSS|H Chain H, Human Factor Viia-Tissue Factor In Complex With Peprid
Mimetic Inhibitor That Has Two Charge Groups In P2 And
P4
pdb|1WTG|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Biphenylalanine-Gln-P-
Aminobenzamidine
pdb|1WUN|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-Trp-Gln-P-Aminobenzamidine
pdb|1WV7|H Chain H, Human Factor Viia-tissue Factor Complexed With
Ethylsulfonamide-d-5-propoxy-trp-gln-p-aminobenzamidine
pdb|2B7D|H Chain H, Factor Viia Inhibitors: Chemical Optimization, Preclinical
Pharmacokinetics, Pharmacodynamics, And Efficacy In A
Baboon Thrombosis Model
pdb|2F9B|H Chain H, Discovery Of Novel Heterocyclic Factor Viia Inhibitors
pdb|2FLB|H Chain H, Discovery Of A Novel Hydroxy Pyrazole Based Factor Ixa
Inhibitor
pdb|2A2Q|H Chain H, Complex Of Active-Site Inhibited Human Coagulation Factor
Viia With Human Soluble Tissue Factor In The Presence Of
Ca2+, Mg2+, Na+, And Zn2+
pdb|2AER|H Chain H, Crystal Structure Of Benzamidine-Factor ViiaSOLUBLE TISSUE
Factor Complex.
pdb|2AEI|H Chain H, Crystal Structure Of A Ternary Complex Of Factor
ViiaTISSUE FACTOR And
2-[[6-[3-(Aminoiminomethyl)phenoxy]-3,
5-Difluro-4-[(1-Methyl-3-
Phenylpropyl)amino]-2-Pyridinyl]oxy]-Benzoic Acid
pdb|2FIR|H Chain H, Crystal Structure Of Dfpr-ViiaSTF
pdb|2C4F|H Chain H, Crystal Structure Of Factor Vii.Stf Complexed With
Pd0297121
pdb|2FLR|H Chain H, Novel 5-azaindole Factor Viia Inhibitors
pdb|2B8O|H Chain H, Crystal Structure Of Glu-gly-arg-chloromethyl
Ketone-factor Viia/soluble Tissue Factor Complex
pdb|2PUQ|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia In Complex With Soluble Tissue Factor
pdb|2EC9|H Chain H, Crystal Structure Analysis Of Human Factor Viia , Souluble
Tissue Factor Complexed With Bcx-3607
pdb|2ZP0|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Benzylsulfonamide-D- Ile-Gln-P-Aminobenzamidine
pdb|2ZWL|H Chain H, Human Factor Viia-Tissue Factor Complexed With Highly
Selective Peptide Inhibitor
pdb|2ZZU|H Chain H, Human Factor Viia-Tissue Factor Complexed With
Ethylsulfonamide-D-5-
(3-Carboxybenzyloxy)-Trp-Gln-P-Aminobenzamidine
pdb|3TH2|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH3|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|3TH4|H Chain H, Mg2+ Is Required For Optimal Folding Of The
Gamma-Carboxyglutamic Acid (Gla) Domains Of Vitamin
K-Dependent Clotting Factors At Physiological Ca2+
pdb|1O5D|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|2BZ6|H Chain H, Orally Available Factor7a Inhibitor
pdb|4ISI|H Chain H, Structure Of Factor Viia In Complex With The Inhibitor
(6s)-n-(4-
Carbamimidoylbenzyl)-1-chloro-3-(cyclobutylamino)-8,
8-diethyl-4-oxo-
4,6,7,8-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide
Length = 254
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 54/128 (42%), Positives = 71/128 (55%), Gaps = 10/128 (7%)
Query: 572 RVYSKRT------GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFP---GFEPKLTG 622
R +S+RT V GWG++ + G A +L VP + Q+C Q G P +T
Sbjct: 114 RTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITE 173
Query: 623 NMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYM 682
M CAGY +G KDSC+GDSGG G + + G+VSWG GCA GVYTRV+ Y+
Sbjct: 174 YMFCAGYSDGSKDSCKGDSGGPHATH-YRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYI 232
Query: 683 EWIQNNTR 690
EW+Q R
Sbjct: 233 EWLQKLMR 240
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 43/112 (38%), Positives = 62/112 (55%), Gaps = 4/112 (3%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG E PW V L G CGGTLI+ +V++AAHC K ++LIAV+ EH+
Sbjct: 1 IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD 60
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ ++ ++RRV +V+ Y + +HDIALL+L P+ V P
Sbjct: 61 LSE-HDGDEQSRRVAQVIIPSTYV---PGTTNHDIALLRLHQPVVLTDHVVP 108
>pdb|1ZHM|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Coagulation Factor Xia In Complex With Benzamidine
(s434a- T475a-k437 Mutant)
Length = 238
Score = 94.0 bits (232), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 73/111 (65%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG + +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 187 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N+A + E V +++ H +Y +DIALLKL+ + + + P
Sbjct: 61 ILNQAEIAE-DTSFFGVQEIIIHDQYK---MAESGYDIALLKLETTVNYADSQRP 111
>pdb|1V2N|T Chain T, Potent Factor Xa Inhibitor In Complex With Bovine Trypsin
Variant X(99175190)BT
Length = 223
Score = 94.0 bits (232), Expect = 2e-19, Method: Composition-based stats.
Identities = 49/107 (45%), Positives = 70/107 (65%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|1V2O|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.B4
pdb|1V2P|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssyi)bt.A4
Length = 223
Score = 94.0 bits (232), Expect = 3e-19, Method: Composition-based stats.
Identities = 49/107 (45%), Positives = 70/107 (65%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ + +T NM CAGY+EGGKDSCQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSY--IITSNMFCAGYLEGGKDSCQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 57.8 bits (138), Expect = 2e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|1BZX|E Chain E, The Crystal Structure Of Anionic Salmon Trypsin In Complex
With Bovine Pancreatic Trypsin Inhibitor
pdb|2STA|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (Cucurbita Maxima Trypsin Inhibitor I)
pdb|2STB|E Chain E, Anionic Salmon Trypsin In Complex With Squash Seed
Inhibitor (cucurbita Pepo Trypsin Inhibitor Ii)
Length = 222
Score = 94.0 bits (232), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 48/107 (44%), Positives = 67/107 (62%), Gaps = 9/107 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TV GWG S ++ L+ +P++S +C +PG +T M CAGY+EGGKDSCQ
Sbjct: 117 TVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGYLEGGKDSCQ 173
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
GDSGG ++ +G + GVVSWG GCA P +PGVY +V + +W+
Sbjct: 174 GDSGGPVV---CNGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 60/114 (52%), Gaps = 14/114 (12%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S + + EHN
Sbjct: 1 IVGGYECKPYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVEVR-----LGEHN 54
Query: 79 RATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
++ I + RV++ HP Y++ D+DI L+KL P V P
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQP 102
>pdb|1HJ8|A Chain A, 1.00 Aa Trypsin From Atlantic Salmon
Length = 222
Score = 94.0 bits (232), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 48/107 (44%), Positives = 67/107 (62%), Gaps = 9/107 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TV GWG S ++ L+ +P++S +C +PG +T M CAGY+EGGKDSCQ
Sbjct: 117 TVSGWGNTMSSTADSNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGYLEGGKDSCQ 173
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
GDSGG ++ +G + GVVSWG GCA P +PGVY +V + +W+
Sbjct: 174 GDSGGPVV---CNGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 60/114 (52%), Gaps = 14/114 (12%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S + + EHN
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVEVR-----LGEHN 54
Query: 79 RATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
++ I + RV++ HP Y++ D+DI L+KL P V P
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQP 102
>pdb|2TBS|A Chain A, Cold-Adaption Of Enzymes: Structural Comparison Between
Salmon And Bovine Trypsins
Length = 222
Score = 94.0 bits (232), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 48/107 (44%), Positives = 66/107 (61%), Gaps = 9/107 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECR-QFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TV GWG S + L+ +P++S +C +PG +T M CAGY+EGGKDSCQ
Sbjct: 117 TVSGWGNTMSSTADSDKLQCLNIPILSYSDCNDSYPGM---ITNAMFCAGYLEGGKDSCQ 173
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
GDSGG ++ +G + GVVSWG GCA P +PGVY +V + +W+
Sbjct: 174 GDSGGPVV---CNGE--LQGVVSWGYGCAEPGNPGVYAKVCIFSDWL 215
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 14/114 (12%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ + V+L +G FCGG+L+++ +V++AAHC +S + + EHN
Sbjct: 1 IVGGYECKAYSQAHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVEVR-----LGEHN 54
Query: 79 RATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
++ I + RV++ HP Y++ D+DI L+KL P V P
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQP 102
>pdb|1SGT|A Chain A, Refined Crystal Structure Of Streptomyces Griseus Trypsin
At 1.7 Angstroms Resolution
Length = 223
Score = 93.6 bits (231), Expect = 3e-19, Method: Composition-based stats.
Identities = 50/118 (42%), Positives = 66/118 (55%), Gaps = 2/118 (1%)
Query: 574 YSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVE-G 632
Y++ T TV GWG E G L VP +S+ CR G E + +CAGY + G
Sbjct: 105 YNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNE-LVANEEICAGYPDTG 163
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
G D+CQGDSGG + +D ++ G+VSWG GCARP PGVYT V+ + I + R
Sbjct: 164 GVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAAR 221
Score = 50.4 bits (119), Expect = 4e-06, Method: Composition-based stats.
Identities = 40/113 (35%), Positives = 53/113 (46%), Gaps = 19/113 (16%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIA---VIS 75
+VGG E+P++V L CGG L + VLTAAHCV S + + A V+
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ A V R KVL P YN G D AL+KL P+ +PT+
Sbjct: 57 LQSGAAV------KVRSTKVLQAPGYNGTG-----KDWALIKLAQPIN-QPTL 97
>pdb|1V2K|T Chain T, Factor Xa Specific Inhibitor In Complex With Bovine
Trypsin Variant X(Triple.Glu)bt.D2
pdb|1V2L|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.D1
pdb|1V2M|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant
X(Triple.Glu)bt.A1
Length = 223
Score = 93.6 bits (231), Expect = 3e-19, Method: Composition-based stats.
Identities = 49/107 (45%), Positives = 70/107 (65%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|1OS8|A Chain A, Recombinant Streptomyces Griseus Trypsin
Length = 223
Score = 93.6 bits (231), Expect = 3e-19, Method: Composition-based stats.
Identities = 50/118 (42%), Positives = 66/118 (55%), Gaps = 2/118 (1%)
Query: 574 YSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVE-G 632
Y++ T TV GWG E G L VP +S+ CR G E + +CAGY + G
Sbjct: 105 YNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNE-LVANEEICAGYPDTG 163
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
G D+CQGDSGG + +D ++ G+VSWG GCARP PGVYT V+ + I + R
Sbjct: 164 GVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAAR 221
Score = 50.1 bits (118), Expect = 5e-06, Method: Composition-based stats.
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 13/110 (11%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+VGG E+P++V L CGG L + VLTAAHCV S + + A +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ ++ R KVL P YN G D AL+KL P+ +PT+
Sbjct: 57 LQSSSAVKV---RSTKVLQAPGYNGTG-----KDWALIKLAQPIN-QPTL 97
>pdb|4FU7|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU8|A Chain A, Crystal Structure Of The Urokinase
pdb|4FU9|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUB|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUC|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUD|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUE|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUF|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUG|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUH|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUI|A Chain A, Crystal Structure Of The Urokinase
pdb|4FUJ|A Chain A, Crystal Structure Of The Urokinase
pdb|4DVA|U Chain U, The Crystal Structure Of Human Urokinase-type Plasminogen
Activator Catalytic Domain
pdb|4DW2|U Chain U, The Crystal Structure Of Upa In Complex With The Fab
Fragment Of Mab- 112
Length = 246
Score = 93.6 bits (231), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 45/111 (40%), Positives = 73/111 (65%), Gaps = 2/111 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T+
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK 246
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+LIS +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
+ S N T E + E V ++ H Y+A +H +DIALLK+ +
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRS 105
>pdb|3PLK|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 93.6 bits (231), Expect = 3e-19, Method: Composition-based stats.
Identities = 48/107 (44%), Positives = 70/107 (65%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PG+YT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGIYTKVCNYVSWIK 217
Score = 59.3 bits (142), Expect = 6e-09, Method: Composition-based stats.
Identities = 36/111 (32%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+L++ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLLNSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|3PMJ|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLB|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PLP|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
pdb|3PM3|A Chain A, Bovine Trypsin Variant X(Tripleile227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 93.6 bits (231), Expect = 3e-19, Method: Composition-based stats.
Identities = 48/107 (44%), Positives = 70/107 (65%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PG+YT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGIYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|1ZHP|A Chain A, Crystal Structure Of The Catalytic Domain Of Coagulation
Factor Xi In Complex With Benzamidine (S434a-T475a-K505
Mutant)
Length = 238
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 48/111 (43%), Positives = 72/111 (64%), Gaps = 4/111 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG +I + L+ ++P+++N+EC +++ G K+T M+CAGY EGGKD+C+G
Sbjct: 129 VTGWGYRALRDKIQNTLQKAKIPLVTNEECQKRYRGH--KITHKMICAGYREGGKDACKG 186
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L + + L+ G+ SWG GCA+ PGVYT V Y++WI T+
Sbjct: 187 DSGGPLSCKHNEVWHLV-GITSWGEGCAQRERPGVYTNVVEYVDWILEKTQ 236
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 7/115 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAG---KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + E+PW V L + CGG++I ++++LTAAHC + K L
Sbjct: 1 IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSG 60
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N+A + E V +++ H +Y +DIALLKL+ + + + P
Sbjct: 61 ILNQAEIKE-DTSFFGVQEIIIHDQYK---MAESGYDIALLKLETTVNYADSQRP 111
>pdb|1SC8|U Chain U, Urokinase Plasminogen Activator B-Chain-J435 Complex
pdb|1VJ9|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt464 Complex
pdb|1VJA|U Chain U, Urokinase Plasminogen Activator B-Chain-Jt463 Complex
Length = 262
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 45/112 (40%), Positives = 73/112 (65%), Gaps = 2/112 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 152 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 211
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T++
Sbjct: 212 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 262
Score = 53.5 bits (127), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 23/153 (15%)
Query: 18 RIVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIA 72
+I+GG T + PW A+ + + + CGG+LIS +V++A HC + +D I
Sbjct: 15 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIV 74
Query: 73 VI--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA-------PLE 123
+ S N T E + E V ++ H Y+A +H +DIALLK+ + P
Sbjct: 75 YLGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSR 130
Query: 124 FKPTVS-PDNKDDPK----SELTQFKPGNQKSY 151
T+S P +DP+ E+T F N Y
Sbjct: 131 TIQTISLPSMYNDPQFGTSCEITGFGKENSTDY 163
>pdb|1RFN|A Chain A, Human Coagulation Factor Ixa In Complex With P-Amino
Benzamidine
pdb|3LC3|A Chain A, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC3|C Chain C, Benzothiophene Inhibitors Of Factor Ixa
pdb|3LC5|A Chain A, Selective Benzothiophine Inhibitors Of Factor Ixa
Length = 235
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 47/113 (41%), Positives = 69/113 (61%), Gaps = 3/113 (2%)
Query: 578 TGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSC 637
+G V GWGRV G+ A L+ +VP++ C + F + NM CAG+ EGG+DSC
Sbjct: 124 SGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF--TIYNNMFCAGFHEGGRDSC 181
Query: 638 QGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
QGDSGG + E ++G + G++SWG CA G+YT+V+ Y+ WI+ T+
Sbjct: 182 QGDSGGPHVTE-VEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 41/112 (36%), Positives = 67/112 (59%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+VGG + ++PW V L FCGG+++++++++TAAHCV + + + V EHN
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK---ITVVAGEHN 57
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
T+ + R V++++ H YNA K ++HDIALL+LD PL V+P
Sbjct: 58 IEETEHTE-QKRNVIRIIPHHNYNAAINK-YNHDIALLELDEPLVLNSYVTP 107
>pdb|3ELA|H Chain H, Crystal Structure Of Active Site Inhibited Coagulation
Factor Viia Mutant In Complex With Soluble Tissue Factor
Length = 254
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 54/128 (42%), Positives = 71/128 (55%), Gaps = 10/128 (7%)
Query: 572 RVYSKRT------GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFP---GFEPKLTG 622
R +S+RT V GWG++ + G A L+ VP + Q+C Q G P +T
Sbjct: 114 RTFSERTLAFVRFSLVSGWGQLLDRGATALVLQVLNVPRLMTQDCLQQSRKVGDSPNITE 173
Query: 623 NMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYM 682
M CAGY +G KDSC+GDSGG G + + G+VSWG GCA GVYTRV+ Y+
Sbjct: 174 YMFCAGYSDGSKDSCKGDSGGPHATH-YRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYI 232
Query: 683 EWIQNNTR 690
EW+Q R
Sbjct: 233 EWLQKLMR 240
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 43/112 (38%), Positives = 62/112 (55%), Gaps = 4/112 (3%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG E PW V L G CGGTLI+ +V++AAHC K ++LIAV+ EH+
Sbjct: 1 IVGGKDCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHD 60
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ ++ ++RRV +V+ Y + +HDIALL+L P+ V P
Sbjct: 61 LSE-HDGDEQSRRVAQVIIPSTYV---PGTTNHDIALLRLHQPVVLTDHVVP 108
>pdb|1W0Z|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W10|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W11|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W12|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W13|U Chain U, Urokinase Type Plasminogen Activator
pdb|1W14|U Chain U, Urokinase Type Plasminogen Activator
pdb|3MHW|U Chain U, The Complex Crystal Structure Of Urokianse And 2-
Aminobenzothiazole
Length = 247
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 45/112 (40%), Positives = 73/112 (65%), Gaps = 2/112 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T++
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 247
Score = 52.8 bits (125), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 23/152 (15%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+LIS +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA-------PLEF 124
+ S N T E + E V ++ H Y+A +H +DIALLK+ + P
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 125 KPTVS-PDNKDDPK----SELTQFKPGNQKSY 151
T+S P +DP+ E+T F N Y
Sbjct: 117 IQTISLPSMYNDPQFGTSCEITGFGKENSTDY 148
>pdb|2ZPQ|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
pdb|2ZPQ|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 1 From Chum
Salmon
Length = 222
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 48/107 (44%), Positives = 66/107 (61%), Gaps = 9/107 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TV GWG S + L+ +P++S +C +PG +T M CAGY+EGGKDSCQ
Sbjct: 117 TVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGYLEGGKDSCQ 173
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
GDSGG ++ +G + GVVSWG GCA P +PGVY +V + +W+
Sbjct: 174 GDSGGPVV---CNGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 37/114 (32%), Positives = 60/114 (52%), Gaps = 14/114 (12%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +S + + EHN
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKSRVEVR-----LGEHN 54
Query: 79 RATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
++ I + RV++ HP Y++ D+DI L+KL P V P
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQP 102
>pdb|2VNT|A Chain A, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|B Chain B, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|C Chain C, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|D Chain D, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|E Chain E, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
pdb|2VNT|F Chain F, Urokinase-Type Plasminogen Activator Inhibitor Complex
With A 1-(7-Sulphoamidoisoquinolinyl)guanidine
Length = 276
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 45/112 (40%), Positives = 73/112 (65%), Gaps = 2/112 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 160 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 219
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T++
Sbjct: 220 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 270
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 23/153 (15%)
Query: 18 RIVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIA 72
+I+GG T + PW A+ + + + CGG+L+S +V++A HC + +D I
Sbjct: 23 KIIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIV 82
Query: 73 VI--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA-------PLE 123
+ S N T E + E V ++ H Y+A +H +DIALLK+ + P
Sbjct: 83 YLGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSR 138
Query: 124 FKPTVS-PDNKDDPK----SELTQFKPGNQKSY 151
T+ P +DP+ E+T F N Y
Sbjct: 139 TIQTICLPSMYNDPQFGTSCEITGFGKENSTDY 171
>pdb|1EJN|A Chain A, Urokinase Plasminogen Activator B-Chain Inhibitor Complex
pdb|1F5K|U Chain U, Urokinase Plasminogen Activator B-Chain-Benzamidine
Complex
pdb|1F5L|A Chain A, Urokinase Plasminogen Activator B-Chain-Amiloride Complex
pdb|1F92|A Chain A, Urokinase Plasminogen Activator B Chain-Uki-1d Complex
pdb|2R2W|U Chain U, Urokinase Plasminogen Activator B-Chain-Gppe Complex
pdb|2VIN|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIO|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIP|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIQ|A Chain A, Fragment-based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-type
Plasminogen Activator
pdb|2VIV|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
pdb|2VIW|A Chain A, Fragment-Based Discovery Of Mexiletine Derivatives As
Orally Bioavailable Inhibitors Of Urokinase-Type
Plasminogen Activator
Length = 253
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 45/112 (40%), Positives = 73/112 (65%), Gaps = 2/112 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T++
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 247
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 23/152 (15%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+LIS +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA-------PLEF 124
+ S N T E + E V ++ H Y+A +H +DIALLK+ + P
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 125 KPTVS-PDNKDDPK----SELTQFKPGNQKSY 151
T+S P +DP+ E+T F N Y
Sbjct: 117 IQTISLPSMYNDPQFGTSCEITGFGKENSTDY 148
>pdb|3PWB|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PWC|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3PYH|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Complex
With Small Molecule Inhibitor
pdb|3Q00|A Chain A, Bovine Trypsin Variant X(Tripleglu217ile227) In Comlex
With Small Molecule Inhibitor
Length = 223
Score = 93.2 bits (230), Expect = 4e-19, Method: Composition-based stats.
Identities = 48/107 (44%), Positives = 70/107 (65%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PG+YT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGEGCAQKNKPGIYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|1H4W|A Chain A, Structure Of Human Trypsin Iv (Brain Trypsin)
Length = 224
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 54/139 (38%), Positives = 82/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQE 609
+K +SPA++ R + + + + GWG G D L+ PV++ E
Sbjct: 88 IKLSSPAVINARVSTISLPTAPPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAE 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C+ +PG K+T +M C G++EGGKDSCQ DSGG ++ +G+ + GVVSWG GCA
Sbjct: 148 CKASYPG---KITNSMFCVGFLEGGKDSCQRDSGGPVV---CNGQ--LQGVVSWGHGCAW 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
N PGVYT+V +Y++WI++
Sbjct: 200 KNRPGVYTKVYNYVDWIKD 218
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 44/111 (39%), Positives = 66/111 (59%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T E N P+ V+L +G FCGG+LIS+++V++AAHC ++ + + + EHN
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGSHFCGGSLISEQWVVSAAHCYKTRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + VK++ HPKYN + D+DI L+KL +P VS
Sbjct: 55 -IKVLEGNEQFINAVKIIRHPKYNRD---TLDNDIMLIKLSSPAVINARVS 101
>pdb|2O8U|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|2O8W|A Chain A, Crystal Structure And Binding Epitopes Of Urokinase-Type
Plasminogen Activator (C122aN145QS195A) IN COMPLEX WITH
Inhibitors
pdb|3PB1|E Chain E, Crystal Structure Of A Michaelis Complex Between
Plasminogen Activator Inhibitor-1 And Urokinase-Type
Plasminogen Activator
Length = 253
Score = 93.2 bits (230), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 44/112 (39%), Positives = 74/112 (66%), Gaps = 2/112 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
D+GG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T++
Sbjct: 197 DAGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 247
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+LIS +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
+ S N T E + E V ++ H Y+A +H +DIALLK+
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKI 103
>pdb|3UQV|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 93.2 bits (230), Expect = 5e-19, Method: Composition-based stats.
Identities = 49/107 (45%), Positives = 69/107 (64%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKDSCQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDSCQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PG YT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|2ZPR|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
pdb|2ZPR|B Chain B, Crystal Structure Of Anionic Trypsin Isoform 2 From Chum
Salmon
Length = 222
Score = 93.2 bits (230), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 48/107 (44%), Positives = 65/107 (60%), Gaps = 9/107 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TV GWG S L+ +P++S +C +PG +T M CAGY+EGGKDSCQ
Sbjct: 117 TVSGWGNTMSSTADGDKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGYLEGGKDSCQ 173
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
GDSGG ++ +G + GVVSWG GCA P +PGVY +V + +W+
Sbjct: 174 GDSGGPVV---CNGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNDWL 215
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 39/115 (33%), Positives = 62/115 (53%), Gaps = 16/115 (13%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV-ISEH 77
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC +K +AV + EH
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHC------YKSRVAVRLGEH 53
Query: 78 NRATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N ++ I + RV++ HP Y++ D+DI L+KL P V P
Sbjct: 54 NIKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQP 102
>pdb|3IG6|B Chain B, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
pdb|3IG6|D Chain D, Low Molecular Weigth Human Urokinase Type Plasminogen
Activator 2-[6-
(3'-Aminomethyl-Biphenyl-3-Yloxy)-4-(3-Dimethylamino-
Pyrrolidin-1-
Yl)-3,
5-Difluoro-Pyridin-2-Yloxy]-4-Dimethylamino-Benzoic Acid
Complex
Length = 253
Score = 93.2 bits (230), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 45/112 (40%), Positives = 73/112 (65%), Gaps = 2/112 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T++
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 247
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 23/152 (15%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+LIS +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA-------PLEF 124
+ S N T E + E V ++ H Y+A +H +DIALLK+ + P
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 125 KPTVS-PDNKDDPK----SELTQFKPGNQKSY 151
T+ P +DP+ E+T F N Y
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDY 148
>pdb|1LMW|B Chain B, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
pdb|1LMW|D Chain D, Lmw U-Pa Structure Complexed With Egrcmk (Glu-Gly-Arg
Chloromethyl Ketone)
Length = 253
Score = 92.8 bits (229), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 45/112 (40%), Positives = 73/112 (65%), Gaps = 2/112 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T++
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 247
Score = 50.1 bits (118), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 23/152 (15%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+L+S +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA-------PLEF 124
+ S N T E + E V ++ H Y+A +H +DIALLK+ + P
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 125 KPTVS-PDNKDDPK----SELTQFKPGNQKSY 151
T+ P +DP+ E+T F N Y
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDY 148
>pdb|1V2U|T Chain T, Benzamidine In Complex With Bovine Trypsin Varinat X(Ssai)
Bt.D1
pdb|1V2V|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssai)
Bt.C1
pdb|1V2W|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssai)bt.B4
Length = 223
Score = 92.8 bits (229), Expect = 5e-19, Method: Composition-based stats.
Identities = 49/107 (45%), Positives = 69/107 (64%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ +T NM CAGY+EGGKDSCQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKS--ASSAIITSNMFCAGYLEGGKDSCQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|1GJ7|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJ8|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJA|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJB|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1O3P|B Chain B, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1C5W|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5X|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Y|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5Z|B Chain B, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1GJ9|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJD|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
pdb|1GJC|B Chain B, Engineering Inhibitors Highly Selective For The S1 Sites
Of Ser190 Trypsin-Like Serine Protease Drug Targets
Length = 253
Score = 92.8 bits (229), Expect = 5e-19, Method: Compositional matrix adjust.
Identities = 45/112 (40%), Positives = 73/112 (65%), Gaps = 2/112 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T++
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 247
Score = 48.9 bits (115), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+L+S +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
+ S N T E + E V ++ H Y+A +H +DIALLK+ +
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRS 105
>pdb|2EEK|A Chain A, Crystal Structure Of Atlantic Cod Trypsin Complexed With
Benzamidine
Length = 220
Score = 92.8 bits (229), Expect = 5e-19, Method: Composition-based stats.
Identities = 46/109 (42%), Positives = 65/109 (59%), Gaps = 9/109 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TV GWG S L+ +P++S+ +C +PG +T +M CAGY+EGGKDSCQ
Sbjct: 117 TVSGWGNTMSSVADGDKLQCLSLPILSHADCANSYPGM---ITQSMFCAGYLEGGKDSCQ 173
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
GDSGG ++ ++ GVVSWG GCA + PGVY +V W+++
Sbjct: 174 GDSGGPVVCNG-----VLQGVVSWGYGCAERDHPGVYAKVCVLSGWVRD 217
Score = 47.8 bits (112), Expect = 2e-05, Method: Composition-based stats.
Identities = 36/107 (33%), Positives = 56/107 (52%), Gaps = 18/107 (16%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH- 77
IVGG+ + V+L +G FCGG+L+S +V++AAHC +S R + + EH
Sbjct: 1 IVGGYECTKHSQAHQVSL-NSGYHFCGGSLVSKDWVVSAAHCYKSVLRVR-----LGEHH 54
Query: 78 ---NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAP 121
N T E I + V++ HP Y++ ++DI L+KL P
Sbjct: 55 IRVNEGT--EQYISSSSVIR---HPNYSSYNI---NNDIMLIKLTKP 93
>pdb|4B1T|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
pdb|4B1T|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
( Ta) In Complex With Eglin C
Length = 223
Score = 92.8 bits (229), Expect = 5e-19, Method: Composition-based stats.
Identities = 48/107 (44%), Positives = 70/107 (65%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
D+GG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 176 DAGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|1OSS|A Chain A, T190p Streptomyces Griseus Trypsin In Complex With
Benzamidine
Length = 223
Score = 92.8 bits (229), Expect = 6e-19, Method: Composition-based stats.
Identities = 50/118 (42%), Positives = 65/118 (55%), Gaps = 2/118 (1%)
Query: 574 YSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVE-G 632
Y++ T TV GWG E G L VP +S+ CR G E + +CAGY + G
Sbjct: 105 YNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNE-LVANEEICAGYPDTG 163
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
G D CQGDSGG + +D ++ G+VSWG GCARP PGVYT V+ + I + R
Sbjct: 164 GVDPCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAAR 221
Score = 50.1 bits (118), Expect = 4e-06, Method: Composition-based stats.
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 13/110 (11%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+VGG E+P++V L CGG L + VLTAAHCV S + + A +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ ++ R KVL P YN G D AL+KL P+ +PT+
Sbjct: 57 LQSSSAVKV---RSTKVLQAPGYNGTG-----KDWALIKLAQPIN-QPTL 97
>pdb|3MWI|U Chain U, The Complex Crystal Structure Of Urokianse And
5-Nitro-1h-Indole-2- Amidine
Length = 246
Score = 92.8 bits (229), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 45/111 (40%), Positives = 72/111 (64%), Gaps = 2/111 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T+
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTK 246
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 23/152 (15%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+LIS +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLISPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA-------PLEF 124
+ S N T E + E V ++ H Y+A +H +DIALLK+ + P
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 125 KPTVS-PDNKDDPK----SELTQFKPGNQKSY 151
T++ P +DP+ E+T F N Y
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKENSTDY 148
>pdb|2ZPS|A Chain A, Crystal Structure Of Anionic Trypsin Isoform 3 From Chum
Salmon
Length = 222
Score = 92.8 bits (229), Expect = 6e-19, Method: Compositional matrix adjust.
Identities = 48/107 (44%), Positives = 65/107 (60%), Gaps = 9/107 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TV GWG S + L+ +P++S +C +PG +T M CAGY+EGGKDSCQ
Sbjct: 117 TVSGWGNTMSSTADKNKLQCLNIPILSYSDCNNSYPGM---ITNAMFCAGYLEGGKDSCQ 173
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
GDSGG ++ +G + GVVSWG GCA P +PGVY +V + W+
Sbjct: 174 GDSGGPVV---CNGE--LQGVVSWGYGCAEPGNPGVYAKVCIFNNWL 215
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 60/114 (52%), Gaps = 14/114 (12%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ + P V+L +G FCGG+L+++ +V++AAHC ++ + + EHN
Sbjct: 1 IVGGYECKAYSQPHQVSL-NSGYHFCGGSLVNENWVVSAAHCYKTRVEVR-----LGEHN 54
Query: 79 RATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
++ I + RV++ HP Y++ D+DI L+KL P V P
Sbjct: 55 IKVTEGSEQFISSSRVIR---HPNYSSYNI---DNDIMLIKLSKPATLNTYVQP 102
>pdb|4B2A|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
pdb|4B2A|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tga) In Complex With Eglin C
Length = 223
Score = 92.4 bits (228), Expect = 7e-19, Method: Composition-based stats.
Identities = 48/107 (44%), Positives = 70/107 (65%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
D+GG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 176 DAGGPVV---CSGK--LQGIVSWGEGCAQKNKPGVYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|1OWE|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWH|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQA|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQO|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
Length = 245
Score = 92.4 bits (228), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 45/110 (40%), Positives = 72/110 (65%), Gaps = 2/110 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKEQSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNT 689
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 49.3 bits (116), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+L+S +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
+ S N T E + E V ++ H Y+A +H +DIALLK+ +
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRS 105
>pdb|1V2J|T Chain T, Benzamidine In Complex With Bovine Trypsin Variant X(Ssri)
Bt.C1
pdb|1V2R|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Ssri)bt.B4
Length = 223
Score = 92.4 bits (228), Expect = 7e-19, Method: Composition-based stats.
Identities = 49/107 (45%), Positives = 69/107 (64%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ +T NM CAGY+EGGKDSCQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKS--ASSRIITSNMFCAGYLEGGKDSCQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 58.2 bits (139), Expect = 1e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|1V2Q|T Chain T, Trypsin Inhibitor In Complex With Bovine Trypsin Variant
X(Sswi)bt.B4
Length = 223
Score = 92.4 bits (228), Expect = 8e-19, Method: Composition-based stats.
Identities = 49/107 (45%), Positives = 70/107 (65%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ + +T NM CAGY+EGGKDSCQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSW--IITSNMFCAGYLEGGKDSCQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGVYTKVCNYVSWIK 217
Score = 57.4 bits (137), Expect = 2e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|3KCG|H Chain H, Crystal Structure Of The Antithrombin-Factor Ixa-
Pentasaccharide Complex
Length = 235
Score = 92.4 bits (228), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 46/113 (40%), Positives = 69/113 (61%), Gaps = 3/113 (2%)
Query: 578 TGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSC 637
+G V GWGRV G+ A L+ +VP++ C + F + NM CAG+ EGG+DSC
Sbjct: 124 SGYVSGWGRVFHKGRSALVLQYLRVPLVDRATCLRSTKF--TIYNNMFCAGFHEGGRDSC 181
Query: 638 QGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
QGD+GG + E ++G + G++SWG CA G+YT+V+ Y+ WI+ T+
Sbjct: 182 QGDAGGPHVTE-VEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTK 233
Score = 80.9 bits (198), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 41/112 (36%), Positives = 67/112 (59%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+VGG + ++PW V L FCGG+++++++++TAAHCV + + + V EHN
Sbjct: 1 VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVK---ITVVAGEHN 57
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
T+ + R V++++ H YNA K ++HDIALL+LD PL V+P
Sbjct: 58 IEETEHTE-QKRNVIRIIPHHNYNAAINK-YNHDIALLELDEPLVLNSYVTP 107
>pdb|3GYL|B Chain B, Structure Of Prostasin At 1.3 Angstroms Resolution In
Complex With A Calcium Ion.
pdb|3GYM|A Chain A, Structure Of Prostasin In Complex With Aprotinin
pdb|3GYM|B Chain B, Structure Of Prostasin In Complex With Aprotinin
Length = 261
Score = 92.4 bits (228), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 49/120 (40%), Positives = 69/120 (57%), Gaps = 9/120 (7%)
Query: 580 TVVGWGRVEESGQIASD--LRATQVPVMSNQECRQFPGFEPK------LTGNMMCAGYVE 631
TV GWG V S + + L+ +VP++S + C + K + +M+CAGYVE
Sbjct: 125 TVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVE 184
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
GGKD+CQGDSGG L ++G + + G+VSWG C N PGVYT + Y WIQ+ +
Sbjct: 185 GGKDACQGDSGGPLSC-PVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTE 243
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 36/112 (32%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I GG + ++PW V++ G CGG+L+S+++VL+AAHC S+ HK+ V +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCF-PSEHHKEAYEVKLGAH 59
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ Y + + ++ HP Y +G++ DIALL+L P+ F + P
Sbjct: 60 QLDSYSEDAKVSTLKDIIPHPSYLQEGSQG---DIALLQLSRPITFSRYIRP 108
>pdb|3E0P|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With A
Covalent Benzoxazole Inhibitor
pdb|3E16|B Chain B, X-Ray Structure Of Human Prostasin In Complex With
Benzoxazole Warhead Peptidomimic, Lysine In P3
pdb|3E1X|B Chain B, The Crystal Structure Of Apo Prostasin At 1.7 Angstroms
Resolution
pdb|3FVF|B Chain B, The Crystal Structure Of Prostasin Complexed With Camostat
At 1.6 Angstroms Resolution
pdb|3E0N|B Chain B, The X-Ray Structure Of Human Prostasin In Complex With
Dffr- Chloromethyl Ketone Inhibitor
Length = 271
Score = 92.4 bits (228), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 49/120 (40%), Positives = 69/120 (57%), Gaps = 9/120 (7%)
Query: 580 TVVGWGRVEESGQIASD--LRATQVPVMSNQECRQFPGFEPK------LTGNMMCAGYVE 631
TV GWG V S + + L+ +VP++S + C + K + +M+CAGYVE
Sbjct: 125 TVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNSLYNIDAKPEEPHFVQEDMVCAGYVE 184
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
GGKD+CQGDSGG L ++G + + G+VSWG C N PGVYT + Y WIQ+ +
Sbjct: 185 GGKDACQGDSGGPLSC-PVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTE 243
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 36/112 (32%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I GG + ++PW V++ G CGG+L+S+++VL+AAHC S+ HK+ V +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCF-PSEHHKEAYEVKLGAH 59
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ Y + + ++ HP Y +G++ DIALL+L P+ F + P
Sbjct: 60 QLDSYSEDAKVSTLKDIIPHPSYLQEGSQG---DIALLQLSRPITFSRYIRP 108
>pdb|4DG4|A Chain A, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|B Chain B, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|D Chain D, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
pdb|4DG4|G Chain G, Human Mesotrypsin-S39y Complexed With Bovine Pancreatic
Trypsin Inhibitor (Bpti)
Length = 224
Score = 92.4 bits (228), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 53/139 (38%), Positives = 82/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQE 609
+K +SPA++ R + + + + GWG G D L+ PV++ E
Sbjct: 88 IKLSSPAVINARVSTISLPTAPPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAE 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C+ +PG K+T +M C G++EGGKDSCQ D+GG ++ +G+ + GVVSWG GCA
Sbjct: 148 CKASYPG---KITNSMFCVGFLEGGKDSCQRDAGGPVV---CNGQ--LQGVVSWGHGCAW 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
N PGVYT+V +Y++WI++
Sbjct: 200 KNRPGVYTKVYNYVDWIKD 218
Score = 72.4 bits (176), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 43/111 (38%), Positives = 65/111 (58%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T E N P+ V+L +G FCGG+LIS+++V++AAHC ++ + + + EHN
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGYHFCGGSLISEQWVVSAAHCYKTRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HPKYN + D+DI L+KL +P VS
Sbjct: 55 -IKVLEGNEQFINAAKIIRHPKYNRD---TLDNDIMLIKLSSPAVINARVS 101
>pdb|2R9P|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|B Chain B, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|C Chain C, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|2R9P|D Chain D, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor(Bpti)
pdb|3L33|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L33|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor(Appi)
pdb|3L3T|A Chain A, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|B Chain B, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|C Chain C, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3L3T|D Chain D, Human Mesotrypsin Complexed With Amyloid Precursor Protein
Inhibitor Variant (Appir15k)
pdb|3P92|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17G)
pdb|3P95|A Chain A, Human Mesotrypsin Complexed With Bovine Pancreatic Trypsin
Inhibitor Variant (Bpti-K15rR17D)
Length = 224
Score = 92.0 bits (227), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 53/139 (38%), Positives = 82/139 (58%), Gaps = 10/139 (7%)
Query: 551 LKAASPAMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASD-LRATQVPVMSNQE 609
+K +SPA++ R + + + + GWG G D L+ PV++ E
Sbjct: 88 IKLSSPAVINARVSTISLPTAPPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAE 147
Query: 610 CR-QFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCAR 668
C+ +PG K+T +M C G++EGGKDSCQ D+GG ++ +G+ + GVVSWG GCA
Sbjct: 148 CKASYPG---KITNSMFCVGFLEGGKDSCQRDAGGPVV---CNGQ--LQGVVSWGHGCAW 199
Query: 669 PNSPGVYTRVNHYMEWIQN 687
N PGVYT+V +Y++WI++
Sbjct: 200 KNRPGVYTKVYNYVDWIKD 218
Score = 73.2 bits (178), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 43/111 (38%), Positives = 65/111 (58%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T E N P+ V+L +G FCGG+LIS+++V++AAHC ++ + + + EHN
Sbjct: 1 IVGGYTCEENSLPYQVSL-NSGSHFCGGSLISEQWVVSAAHCYKTRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++ HPKYN + D+DI L+KL +P VS
Sbjct: 55 -IKVLEGNEQFINAAKIIRHPKYNRD---TLDNDIMLIKLSSPAVINARVS 101
>pdb|3UNS|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UOP|A Chain A, Bovine Trypsin Variant X(triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UQO|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 92.0 bits (227), Expect = 1e-18, Method: Composition-based stats.
Identities = 48/107 (44%), Positives = 69/107 (64%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PG YT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|3DFJ|A Chain A, Crystal Structure Of Human Prostasin
pdb|3DFL|A Chain A, Crystal Structure Of Human Prostasin Complexed To 4-
Guanidinobenzoic Acid
Length = 263
Score = 92.0 bits (227), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 49/120 (40%), Positives = 69/120 (57%), Gaps = 9/120 (7%)
Query: 580 TVVGWGRVEESGQIASD--LRATQVPVMSNQECRQFPGFEPK------LTGNMMCAGYVE 631
TV GWG V S + + L+ +VP++S + C + K + +M+CAGYVE
Sbjct: 125 TVTGWGHVAPSVSLLTPKPLQQLEVPLISRETCNALYNIDAKPEEPHFVQEDMVCAGYVE 184
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
GGKD+CQGDSGG L ++G + + G+VSWG C N PGVYT + Y WIQ+ +
Sbjct: 185 GGKDACQGDSGGPLSC-PVEGLWYLTGIVSWGDACGARNRPGVYTLASSYASWIQSKVTE 243
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 36/112 (32%), Positives = 61/112 (54%), Gaps = 4/112 (3%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I GG + ++PW V++ G CGG+L+S+++VL+AAHC S+ HK+ V +
Sbjct: 1 ITGGSSAVAGQWPWQVSITYEGVHVCGGSLVSEQWVLSAAHCF-PSEHHKEAYEVKLGAH 59
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ Y + + ++ HP Y +G++ DIALL+L P+ F + P
Sbjct: 60 QLDSYSEDAKVSTLKDIIPHPSYLQEGSQG---DIALLQLSRPITFSRYIRP 108
>pdb|1O5A|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1O5B|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (ala190 Upa)
pdb|1O5C|B Chain B, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
Length = 253
Score = 92.0 bits (227), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 44/112 (39%), Positives = 73/112 (65%), Gaps = 2/112 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + D+CQG
Sbjct: 137 ITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDACQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T++
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKE 247
Score = 48.9 bits (115), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+L+S +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
+ S N T E + E V ++ H Y+A +H +DIALLK+
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKI 103
>pdb|2Y5F|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5G|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2Y5H|A Chain A, Factor Xa - Cation Inhibitor Complex
Length = 234
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.7 bits (169), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1FAX|A Chain A, Coagulation Factor Xa Inhibitor Complex
Length = 254
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.7 bits (169), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTAAEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1FV9|A Chain A, Crystal Structure Of Human Microurokinase In Complex With
2- Amino-5-Hydroxy-Benzimidazole
Length = 245
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 45/110 (40%), Positives = 71/110 (64%), Gaps = 2/110 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNT 689
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 23/152 (15%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+L+S +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA-------PLEF 124
+ S N T E + E V ++ H Y+A +H +DIALLK+ + P
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 125 KPTVS-PDNKDDPK----SELTQFKPGNQKSY 151
T++ P +DP+ E+T F N Y
Sbjct: 117 IQTIALPSMYNDPQFGTSCEITGFGKENSTDY 148
>pdb|2BOK|A Chain A, Factor Xa- Cation
pdb|2JKH|A Chain A, Factor Xa - Cation Inhibitor Complex
pdb|2VVC|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVC|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVU|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VVV|A Chain A, Aminopyrrolidine-Related Triazole Factor Xa Inhibitor
pdb|2VWL|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWM|B Chain B, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWN|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2VWO|A Chain A, Aminopyrrolidine Factor Xa Inhibitor
pdb|2XBV|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGEQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.7 bits (169), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1OWD|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWI|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1OWJ|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1OWK|A Chain A, Substituted 2-Naphthamidine Inhibitors Of Urokinase
pdb|1SQT|A Chain A, Substituted 2-naphthamidine Inhibitors Of Urokinase
pdb|1U6Q|A Chain A, Substituted 2-naphthamadine Inhibitors Of Urokinase
Length = 245
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 45/110 (40%), Positives = 71/110 (64%), Gaps = 2/110 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKENSTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNT 689
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T
Sbjct: 197 DSGGPLVCS-LQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 23/152 (15%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+L+S +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA-------PLEF 124
+ S N T E + E V ++ H Y+A +H +DIALLK+ + P
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRSKEGRCAQPSRT 116
Query: 125 KPTVS-PDNKDDPK----SELTQFKPGNQKSY 151
T+ P +DP+ E+T F N Y
Sbjct: 117 IQTICLPSMYNDPQFGTSCEITGFGKENSTDY 148
>pdb|1GI8|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi- Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI7|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GI9|B Chain B, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
Length = 245
Score = 91.7 bits (226), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 45/110 (40%), Positives = 71/110 (64%), Gaps = 2/110 (1%)
Query: 581 VVGWGRVEESGQI-ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ G+G+ + + L+ T V ++S++EC+Q + ++T M+CA + DSCQG
Sbjct: 137 ITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQG 196
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNT 689
DSGG L+ L GR + G+VSWG GCA + PGVYTRV+H++ WI+++T
Sbjct: 197 DSGGPLVC-SLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHT 245
Score = 49.3 bits (116), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 34/109 (31%), Positives = 56/109 (51%), Gaps = 11/109 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGK-----FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
I+GG T + PW A+ + + + CGG+L+S +V++A HC + +D I
Sbjct: 1 IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVY 60
Query: 74 I--SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
+ S N T E + E V ++ H Y+A +H +DIALLK+ +
Sbjct: 61 LGRSRLNSNTQGEMKFE---VENLILHKDYSAD-TLAHHNDIALLKIRS 105
>pdb|1EZQ|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr128515
pdb|1F0R|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208815
pdb|1F0S|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208707
pdb|1KSN|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Fxv673
pdb|1NFU|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr132747
pdb|1NFW|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr209685
pdb|1NFX|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr208944
pdb|1NFY|A Chain A, Crystal Structure Of Human Coagulation Factor Xa Complexed
With Rpr200095
pdb|1LPG|B Chain B, Crystal Structure Of Fxa In Complex With 79.
pdb|1LPK|B Chain B, Crystal Structure Of Fxa In Complex With 125.
pdb|1LPZ|B Chain B, Crystal Structure Of Fxa In Complex With 41.
pdb|1LQD|B Chain B, Crystal Structure Of Fxa In Complex With 45.
pdb|1P0S|H Chain H, Crystal Structure Of Blood Coagulation Factor Xa In
Complex With Ecotin M84r
pdb|2BOH|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound
"1"
pdb|2CJI|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J2U|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J34|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J38|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J4I|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J94|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2J95|A Chain A, Crystal Structure Of A Human Factor Xa Inhibitor Complex
pdb|2UWL|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWO|A Chain A, Selective And Dual Action Orally Active Inhibitors Of
Thrombin And Factor Xa
pdb|2UWP|A Chain A, Factor Xa Inhibitor Complex
pdb|2VH0|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Biaryl Pyrrolidin-2-Ones Incorporating Basic
Heterocyclic Motifs
pdb|2VH6|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Biaryl P4 Motifs
pdb|2WYG|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2WYJ|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Monoaryl P4 Motifs
pdb|2Y7X|A Chain A, The Discovery Of Potent And Long-Acting Oral Factor Xa
Inhibitors With Tetrahydroisoquinoline And Benzazepine
P4 Motifs
pdb|2Y7Z|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y80|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y81|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|2Y82|A Chain A, Structure And Property Based Design Of Factor Xa
Inhibitors: Pyrrolidin-2-Ones With Aminoindane And
Phenylpyrrolidine P4 Motifs
pdb|4A7I|B Chain B, Factor Xa In Complex With A Potent 2-Amino-Ethane
Sulfonamide Inhibitor
Length = 254
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1C5M|D Chain D, Structural Basis For Selectivity Of A Small Molecule, S1-
Binding, Sub-Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
Length = 255
Score = 91.3 bits (225), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1MQ5|A Chain A, Crystal Structure Of
3-chloro-n-[4-chloro-2-[[(4-chlorophenyl)
Amino]carbonyl]phenyl]-4-[(4-methyl-1-
piperazinyl)methyl]-2- Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1MQ6|A Chain A, Crystal Structure Of
3-Chloro-N-[4-Chloro-2-[[(5-Chloro-2-Pyridinyl)
Amino]carbonyl]-6-Methoxyphenyl]-4-[[(4,
5-Dihydro-2-Oxazolyl)
Methylamino]methyl]-2-Thiophenecarboxamide Complexed
With Human Factor Xa
pdb|1V3X|A Chain A, Factor Xa In Complex With The Inhibitor
1-[6-Methyl-4,5,6,7-
Tetrahydrothiazolo(5,4-C)pyridin-2-Yl] Carbonyl-2-
Carbamoyl-4-(6-Chloronaphth-2-Ylsulphonyl)piperazine
pdb|1WU1|A Chain A, Factor Xa In Complex With The Inhibitor
4-[(5-Chloroindol-2-Yl)
Sulfonyl]-2-(2-Methylpropyl)-1-[[5-(Pyridin-4-Yl)
Pyrimidin-2- Yl]carbonyl]piperazine
pdb|2D1J|A Chain A, Factor Xa In Complex With The Inhibitor 2-[[4-[(5-
Chloroindol-2-Yl)sulfonyl]piperazin-1-Yl]
Carbonyl]thieno[3,2-B]pyridine N-Oxide
pdb|2H9E|H Chain H, Crystal Structure Of FxaSELECTIDENAPC2 TERNARY COMPLEX
pdb|2P3U|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-N-(4-Chloro-2-{[(5-Chloropyridin-2-Yl)
Amino]carbonyl}-6-Methoxyphenyl)-4-[(1-Methyl-1h-
Imidazol- 2-Yl)methyl]thiophene-2-Carboxamide {pfizer
320663}
pdb|2P3T|B Chain B, Crystal Structure Of Human Factor Xa Complexed With 3-
Chloro-4-(2-Methylamino-Imidazol-1-Ylmethyl)-Thiophene-
2- Carboxylic Acid [4-Chloro-2-(5-Chloro-Pyridin-2-
Ylcarbamoyl)-6-Methoxy-Phenyl]-Amide
pdb|2EI6|A Chain A, Factor Xa In Complex With The Inhibitor (-)-Cis-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI7|A Chain A, Factor Xa In Complex With The Inhibitor Trans-N1-[(5-
Chloroindol-2-Yl)carbonyl]-N2-[(5-Methyl-4,5,6,7-
Tetrahydrothiazolo[5,4-C]pyridin-2-Yl)carbonyl]-1,2-
Cyclohexanediamine
pdb|2EI8|A Chain A, Factor Xa In Complex With The Inhibitor (1s,2r,4s)-N1-[(5-
Chloroindol-2-Yl)carbonyl]-4-(N,N-Dimethylcarbamoyl)-N2-
[(5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,
4-C]pyridin-2-Yl) Carbonyl]-1,2-Cyclohexanediamine
pdb|3IIT|A Chain A, Factor Xa In Complex With A Cis-1,2-Diaminocyclohexane
Derivative
pdb|3Q3K|A Chain A, Factor Xa In Complex With A Phenylenediamine Derivative
pdb|3TK5|A Chain A, Factor Xa In Complex With D102-4380
pdb|3TK6|A Chain A, Factor Xa In Complex With D46-5241
Length = 233
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.7 bits (169), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1XKA|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|C Chain C, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1XKB|D Chain D, Factor Xa Complexed With A Synthetic Inhibitor
Fx-2212a,(2s)-(3'-
Amidino-3-Biphenylyl)-5-(4-Pyridylamino)pentanoic Acid
pdb|1G2L|A Chain A, Factor Xa Inhibitor Complex
pdb|1G2M|A Chain A, Factor Xa Inhibitor Complex
pdb|1IOE|A Chain A, Human Coagulation Factor Xa In Complex With M55532
pdb|1IQE|A Chain A, Human Coagulation Factor Xa In Complex With M55590
pdb|1IQF|A Chain A, Human Coagulation Factor Xa In Complex With M55165
pdb|1IQG|A Chain A, Human Coagulation Factor Xa In Complex With M55159
pdb|1IQH|A Chain A, Human Coagulation Factor Xa In Complex With M55143
pdb|1IQI|A Chain A, Human Coagulation Factor Xa In Complex With M55125
pdb|1IQJ|A Chain A, Human Coagulation Factor Xa In Complex With M55124
pdb|1IQK|A Chain A, Human Coagulation Factor Xa In Complex With M55113
pdb|1IQL|A Chain A, Human Coagulation Factor Xa In Complex With M54476
pdb|1IQM|A Chain A, Human Coagulation Factor Xa In Complex With M54471
pdb|1IQN|A Chain A, Human Coagulation Factor Xa In Complex With M55192
pdb|2P3F|H Chain H, Crystal Structure Of The Factor XaNAP5 COMPLEX
Length = 235
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.7 bits (169), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1FJS|A Chain A, Crystal Structure Of The Inhibitor Zk-807834 (Ci-1031)
Complexed With Factor Xa
pdb|1Z6E|A Chain A, Factor Xa In Complex With The Inhibitor
1-(3'-Amino-1,2-Benzisoxazol-
5'-Yl)-N-(4-(2'-((Dimethylamino)methyl)-1h-Imidazol-1-
Yl)-2-
Fluorophenyl)-3-(Trifluoromethyl)-1h-Pyrazole-5-
Carboxamide (Razaxaban; Dpc906; Bms-561389)
pdb|2BMG|B Chain B, Crystal Structure Of Factor Xa In Complex With 50
pdb|2FZZ|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-Amino-1,2-
Benzisoxazol-5-Yl)-6-(2'-(((3r)-3-Hydroxy-1-
Pyrrolidinyl)
Methyl)-4-Biphenylyl)-3-(Trifluoromethyl)-1,4,5,6-
Tetrahydro-7h-Pyrazolo[3,4-C]pyridin-7-One
pdb|2G00|A Chain A, Factor Xa In Complex With The Inhibitor 3-(6-(2'-
((Dimethylamino)methyl)-4-Biphenylyl)-7-Oxo-3-
(Trifluoromethyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3,4-
C]pyridin-1-Yl)benzamide
pdb|2P93|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-(2-(4-(2-
Oxopyridin-1(2h)-Yl)benzamido)ethyl)thiophene-2-
Carboxamide
pdb|2P94|A Chain A, Factor Xa In Complex With The Inhibitor
3-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido)cyclohexyl)-1h-
Indole-6-Carboxamide
pdb|2P95|A Chain A, Factor Xa In Complex With The Inhibitor
5-Chloro-N-((1r,2s)-
2-(4-(2-Oxopyridin-1(2h)-Yl)benzamido) Cyclopentyl)
Thiophene-2-Carboxamide
pdb|2PR3|A Chain A, Factor Xa Inhibitor
pdb|2Q1J|A Chain A, The Discovery Of Glycine And Related Amino Acid-Based
Factor Xa Inhibitors
pdb|2P16|A Chain A, Factor Xa In Complex With The Inhibitor Apixaban (Bms-
562247) Aka 1-(4-Methoxyphenyl)-7-Oxo-6-(4-(2-Oxo-1-
Piperidinyl)phenyl)-4,5,6,7-Tetrahydro-1h-Pyrazolo[3, 4-
C]pyridine-3-Carboxamide
pdb|2RA0|A Chain A, X-Ray Structure Of Fxa In Complex With 7-Fluoroindazole
pdb|2PHB|A Chain A, An Orally Efficacious Factor Xa Inhibitor
pdb|3CEN|A Chain A, Factor Xa In Complex With The Inhibitor
N-(2-(((5-Chloro-2- Pyridinyl)
Amino)sulfonyl)phenyl)-4-(2-Oxo-1(2h)-
Pyridinyl)benzamide
pdb|3CS7|A Chain A, Factor Xa In Complex With The Inhibitor
1-(4-Methoxyphenyl)-
6-(4-(1-(Pyrrolidin-1-Ylmethyl)cyclopropyl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|2W26|A Chain A, Factor Xa In Complex With Bay59-7939
pdb|2W3I|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-disubstituted
Pyrrolidine-1,2-dicarboxamide Inhibitor 2
pdb|2W3K|A Chain A, Crystal Structure Of Fxa In Complex With 4,4-Disubstituted
Pyrrolidine-1,2-Dicarboxamide Inhibitor 1
pdb|3FFG|A Chain A, Factor Xa In Complex With The Inhibitor (R)-6-(2'-((3-
Hydroxypyrrolidin-1-Yl)methyl)biphenyl-4-Yl)-1-(3-(5-
Oxo-4, 5-Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-3-
(Trifluoromethyl)-5,6-Dihydro-1h-Pyrazolo[3,4-C]pyridin-
7(4h)-One
pdb|3KQB|A Chain A, Factor Xa In Complex With The Inhibitor N-(3-Fluoro-2'-
(Methylsulfonyl)biphenyl-4-Yl)-1-(3-(5-Oxo-4,
5-Dihydro-1h-
Triazol-3-Yl)phenyl)-3-(Trifluoromethyl)-1h-
Pyrazole-5-Car
pdb|3KQC|A Chain A, Factor Xa In Complex With The Inhibitor 6-(2'-
(Methylsulfon Biphenyl-4-Yl)-1-(3-(5-Oxo-4,5-Dihydro-1h-
1,2,4-Triazol-3- Phenyl)-3-(Trifluoromethyl)-5,6-
Dihydro-1h-Pyrazolo[3,4-C] 7(4h)-One
pdb|3KQD|A Chain A, Factor Xa In Complex With The Inhibitor 1-(3-(5-Oxo-4,5-
Dih 2,4-Triazol-3-Yl)phenyl)-6-(2'-(Pyrrolidin-1-
Ylmethyl)biph Yl)-3-(Trifluoromethyl)-5,6-Dihydro-
1h-Pyrazolo[3,4-C]pyri One
pdb|3KQE|A Chain A, Factor Xa In Complex With The Inhibitor 3-Methyl-1-(3-(5-
Ox Dihydro-1h-1,2,4-Triazol-3-Yl)phenyl)-6-(2'-
(Pyrrolidin-1- Biphenyl-4-Yl)-5,6-Dihydro-1h-
Pyrazolo[3,4-C]pyridin-7(4h)
pdb|3LIW|A Chain A, Factor Xa In Complex With
(R)-2-(1-Adamantylcarbamoylamino)-
3-(3-Carbamidoyl-Phenyl)-N-Phenethyl-Propionic Acid
Amide
pdb|3M36|A Chain A, Factor Xa In Complex With The Inhibitor 1-[3-(Aminomethyl)
Phenyl]-N-[3-Fluoro-2'-(Methylsulfonyl)biphenyl-4-Yl]-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc423)
pdb|3M37|A Chain A, Factor Xa In Complex With The Inhibitor 1-[2-(Aminomethyl)
Phenyl]-N-(3-Fluoro-2'-Sulfamoylbiphenyl-4-Yl)-3-
(Trifluoromethyl)-1h-Pyrazole-5-Carboxamide (Dpc602)
Length = 234
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.7 bits (169), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1HCG|A Chain A, Structure Of Human Des(1-45) Factor Xa At 2.2 Angstroms
Resolution
pdb|3KL6|A Chain A, Discovery Of Tetrahydropyrimidin-2(1h)-One Derivative
Tak-44 Potent, Selective And Orally Active Factor Xa
Inhibitor
pdb|2XBW|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBX|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XBY|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC0|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC4|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
pdb|2XC5|A Chain A, Factor Xa In Complex With A Pyrrolidine-3,4-Dicarboxylic
Acid Inhibitor
Length = 241
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.3 bits (168), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|3ENS|B Chain B, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3ENS|D Chain D, Crystal Structure Of Human Fxa In Complex With Methyl
(2z)-3-[(3-
Chloro-1h-indol-7-yl)amino]-2-cyano-3-{[(3s)-2-oxo-1-(2-
oxo-2- Pyrrolidin-1-ylethyl)azepan-3-yl]amino}acrylate
pdb|3HPT|B Chain B, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3HPT|D Chain D, Crystal Structure Of Human Fxa In Complex With
(S)-2-Cyano-1-(2-
Methylbenzofuran-5-Yl)-3-(2-Oxo-1-(2-Oxo-2-(Pyrrolidin-
1-Yl)ethyl) Azepan-3-Yl)guanidine
pdb|3K9X|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3K9X|D Chain D, X-Ray Crystal Structure Of Human Fxa In Complex With
(S)-N-((2- Methylbenzofuran-5-Ylamino)(2-Oxo-1-(2-Oxo-2-
(Pyrrolidin-1-Yl) Ethyl)azepan-3-
Ylamino)methylene)nicotinamide
pdb|3SW2|B Chain B, X-Ray Crystal Structure Of Human Fxa In Complex With
6-Chloro-N-((3s)-
2-Oxo-1-(2-Oxo-2-((5s)-8-Oxo-5,6-Dihydro-1h-1,
5-Methanopyrido[1,2-
A][1,5]diazocin-3(2h,4h,
8h)-Yl)ethyl)piperidin-3-Yl)naphthalene-2- Sulfonamide
Length = 238
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.7 bits (169), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1A0L|A Chain A, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|B Chain B, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|C Chain C, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
pdb|1A0L|D Chain D, Human Beta-Tryptase: A Ring-Like Tetramer With Active
Sites Facing A Central Pore
Length = 244
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 49/116 (42%), Positives = 73/116 (62%), Gaps = 12/116 (10%)
Query: 581 VVGWGRVEESGQIASD--LRATQVPVMSNQECRQ------FPGFEPKLT-GNMMCAGYVE 631
V GWG V+ ++ L+ +VP+M N C + G + ++ +M+CAG
Sbjct: 127 VTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTR 186
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+DSCQGDSGG L+ + ++G +L AGVVSWG GCA+PN PG+YTRV +Y++WI +
Sbjct: 187 --RDSCQGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/111 (39%), Positives = 64/111 (57%), Gaps = 13/111 (11%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG +++PW V+L G + FCGG+LI ++VLTAAHCV KDL A+
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDV--KDLAALRV 58
Query: 76 EHNRATVYETQIETRRVVKVLTHPK-YNAQ-GAKSHDHDIALLKLDAPLEF 124
+ +Y Q + V +++ HP+ Y AQ GA DIALL+L+ P++
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYTAQIGA-----DIALLELEEPVKV 103
>pdb|2ZEB|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEB|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|A Chain A, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|B Chain B, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|C Chain C, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
pdb|2ZEC|D Chain D, Potent, Nonpeptide Inhibitors Of Human Mast Cell Tryptase
Length = 243
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 49/116 (42%), Positives = 73/116 (62%), Gaps = 12/116 (10%)
Query: 581 VVGWGRVEESGQIASD--LRATQVPVMSNQECRQ------FPGFEPKLT-GNMMCAGYVE 631
V GWG V+ ++ L+ +VP+M N C + G + ++ +M+CAG
Sbjct: 127 VTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTR 186
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+DSCQGDSGG L+ + ++G +L AGVVSWG GCA+PN PG+YTRV +Y++WI +
Sbjct: 187 --RDSCQGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 44/111 (39%), Positives = 64/111 (57%), Gaps = 13/111 (11%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG +++PW V+L G + FCGG+LI ++VLTAAHCV KDL A+
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDV--KDLAALRV 58
Query: 76 EHNRATVYETQIETRRVVKVLTHPK-YNAQ-GAKSHDHDIALLKLDAPLEF 124
+ +Y Q + V +++ HP+ Y AQ GA DIALL+L+ P++
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYTAQIGA-----DIALLELEEPVKV 103
>pdb|2BQ6|B Chain B, Crystal Structure Of Factor Xa In Complex With 21
pdb|2BQ7|B Chain B, Crystal Structure Of Factor Xa In Complex With 43
pdb|2BQW|B Chain B, Crystal Structure Of Factor Xa In Complex With Compound 45
Length = 249
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 134 LMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 191
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 192 QEDACQGDSGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 248
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 43/118 (36%), Positives = 68/118 (57%), Gaps = 8/118 (6%)
Query: 14 NRMDRIVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIA 72
N + RIVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 11 NNLTRIVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG 70
Query: 73 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 71 -----DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 121
>pdb|2BM2|A Chain A, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|B Chain B, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|C Chain C, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2BM2|D Chain D, Human Beta-Ii Tryptase In Complex With 4-(3-Aminomethyl-
Phenyl)-Piperidin-1-Yl-(5-Phenethyl- Pyridin-3-Yl)-
Methanone
pdb|2FWW|A Chain A, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|B Chain B, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|C Chain C, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FWW|D Chain D, Human Beta-Tryptase Ii Complexed With 4-Piperidinebutyrate
To Make Acylenzyme
pdb|2FXR|A Chain A, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|B Chain B, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|C Chain C, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FXR|D Chain D, Human Beta Tryptase Ii Complexed With Activated Ketone
Inhibitor Cra-29382
pdb|2FPZ|A Chain A, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|B Chain B, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|C Chain C, Human Tryptase With 2-Amino Benzimidazole
pdb|2FPZ|D Chain D, Human Tryptase With 2-Amino Benzimidazole
pdb|2FS8|A Chain A, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|B Chain B, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|C Chain C, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS8|D Chain D, Human Beta-Tryptase Ii With Inhibitor Cra-29382
pdb|2FS9|A Chain A, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|B Chain B, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|C Chain C, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2FS9|D Chain D, Human Beta Tryptase Ii With Inhibitor Cra-28427
pdb|2GDD|A Chain A, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|B Chain B, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|C Chain C, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2GDD|D Chain D, Human Beta Ii Tryptase With Inhibitor Cra-27592
pdb|2ZA5|A Chain A, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|B Chain B, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|C Chain C, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|2ZA5|D Chain D, Crystal Structure Of Human Tryptase With Potent
Non-Peptide Inhibitor
pdb|4A6L|A Chain A, Beta-Tryptase Inhibitor
pdb|4A6L|B Chain B, Beta-Tryptase Inhibitor
pdb|4A6L|C Chain C, Beta-Tryptase Inhibitor
pdb|4A6L|D Chain D, Beta-Tryptase Inhibitor
pdb|3V7T|A Chain A, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|B Chain B, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|C Chain C, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
pdb|3V7T|D Chain D, Crystal Structure Of Human Beta-Tryptase Complexed With A
Synthetic Inhibitor With A Tropanylamide Scaffold
Length = 245
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 49/116 (42%), Positives = 73/116 (62%), Gaps = 12/116 (10%)
Query: 581 VVGWGRVEESGQIASD--LRATQVPVMSNQECRQ------FPGFEPKLT-GNMMCAGYVE 631
V GWG V+ ++ L+ +VP+M N C + G + ++ +M+CAG
Sbjct: 127 VTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTR 186
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+DSCQGDSGG L+ + ++G +L AGVVSWG GCA+PN PG+YTRV +Y++WI +
Sbjct: 187 --RDSCQGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/111 (39%), Positives = 64/111 (57%), Gaps = 13/111 (11%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG +++PW V+L G + FCGG+LI ++VLTAAHCV KDL A+
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDV--KDLAALRV 58
Query: 76 EHNRATVYETQIETRRVVKVLTHPK-YNAQ-GAKSHDHDIALLKLDAPLEF 124
+ +Y Q + V +++ HP+ Y AQ GA DIALL+L+ P++
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYTAQIGA-----DIALLELEEPVKV 103
>pdb|1HJ9|A Chain A, Atomic Resolution Structures Of Trypsin Provide Insight
Into Structural Radiation Damage
Length = 223
Score = 91.3 bits (225), Expect = 2e-18, Method: Composition-based stats.
Identities = 46/108 (42%), Positives = 67/108 (62%), Gaps = 10/108 (9%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CA +EG DSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAYGLEGKGDSCQ 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GC N PGVYT+V +Y+ WI+
Sbjct: 175 GDSGGPVVCS---GK--LQGIVSWGSGCQAKNKPGVYTKVCNYVSWIK 217
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|3I77|A Chain A, 3599170-Loops Of Fxa In Sgt
Length = 230
Score = 90.9 bits (224), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 50/119 (42%), Positives = 66/119 (55%), Gaps = 2/119 (1%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVE- 631
Y++ T TV GWG E G L VP +S+ CR F + M+CAGY +
Sbjct: 111 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSF-ILVANEMICAGYPDT 169
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
GG D+CQGDSGG + +D ++ G+VSWG GCARP PGVYT V+ + I + R
Sbjct: 170 GGVDTCQGDSGGPMFRKDNADEWIQVGIVSWGYGCARPGYPGVYTEVSTFASAIASAAR 228
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 35/111 (31%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 19 IVGGWTTEVNEYPWVVAL-EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
+VGG E+P++V L + + FCGG L + VLTAAHCV S + + A
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVV 60
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ + ++ R KVL P + + ++ D AL+KL P+ +PT+
Sbjct: 61 DLQSSSAVKV---RSTKVLQAPGFTKE---TYGKDWALIKLAQPIN-QPTL 104
>pdb|4B2C|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
pdb|4B2C|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tpa) In Complex With Eglin C
Length = 223
Score = 90.9 bits (224), Expect = 2e-18, Method: Composition-based stats.
Identities = 47/107 (43%), Positives = 69/107 (64%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
D+GG ++ G+ + G+VSWG GCA+ N PG YT+V +Y+ WI+
Sbjct: 176 DAGGPVV---CSGK--LQGIVSWGSGCAQKNKPGFYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|3UNQ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UPE|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|A Chain A, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
pdb|3UUZ|B Chain B, Bovine Trypsin Variant X(Triplephe227) In Complex With
Small Molecule Inhibitor
Length = 223
Score = 90.9 bits (224), Expect = 2e-18, Method: Composition-based stats.
Identities = 47/107 (43%), Positives = 69/107 (64%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PG YT++ +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGSGCAQKNKPGFYTKLCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|4B2B|A Chain A, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
pdb|4B2B|C Chain C, Structure Of The Factor Xa-Like Trypsin Variant Triple-Ala
(Tgpa) In Complex With Eglin C
Length = 223
Score = 90.5 bits (223), Expect = 3e-18, Method: Composition-based stats.
Identities = 47/107 (43%), Positives = 69/107 (64%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM CAGY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCAGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
D+GG ++ G+ + G+VSWG GCA+ N PG YT+V +Y+ WI+
Sbjct: 176 DAGGPVV---CSGK--LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|3TVJ|B Chain B, Catalytic Fragment Of Masp-2 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 242
Score = 90.5 bits (223), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 50/132 (37%), Positives = 76/132 (57%), Gaps = 7/132 (5%)
Query: 566 RGDGSHRVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC----RQFPGFEPKLT 621
R + + + GT GWG + + G +A +L +P++ +Q+C + P +T
Sbjct: 111 RKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVT 169
Query: 622 GNMMCAGYVEGGKDSCQGDSGGALLMEDLDG-RFLIAGVVSWG-IGCARPNSPGVYTRVN 679
NM+CAG GGKDSC+GDSGGAL+ D + R+ + G+VSWG + C GVYT+V
Sbjct: 170 ANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVI 229
Query: 680 HYMEWIQNNTRD 691
+Y+ WI+N D
Sbjct: 230 NYIPWIENIISD 241
Score = 42.0 bits (97), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 50/113 (44%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV-ISEH 77
I GG + ++PW V + G G L+ D +VLTAAH V K + + +
Sbjct: 1 IYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTL 58
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
R + + TQ + V H Y D+DIAL+KL+ + ++P
Sbjct: 59 KRLSPHYTQAWSE---AVFIHEGYTHDAG--FDNDIALIKLNNKVVINSNITP 106
>pdb|2GD4|H Chain H, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
pdb|2GD4|B Chain B, Crystal Structure Of The Antithrombin-S195a Factor
Xa-Pentasaccharide Complex
Length = 241
Score = 90.1 bits (222), Expect = 3e-18, Method: Compositional matrix adjust.
Identities = 43/118 (36%), Positives = 70/118 (59%), Gaps = 3/118 (2%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
+ +++TG V G+GR E G+ ++ L+ +VP + C+ F +T NM CAGY
Sbjct: 119 LMTQKTGIVSGFGRTHEKGRQSTRLKMLEVPYVDRNSCKLSSSF--IITQNMFCAGYDTK 176
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGD+GG + D + + G+VSWG GCAR G+YT+V +++WI + +
Sbjct: 177 QEDACQGDAGGPHVTRFKD-TYFVTGIVSWGEGCARKGKYGIYTKVTAFLKWIDRSMK 233
Score = 69.7 bits (169), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 41/113 (36%), Positives = 65/113 (57%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IVGG + E PW + + + + FCGGT++S+ Y+LTAAHC+ +KR K +
Sbjct: 1 IVGGQECKDGECPWQALLINEENEGFCGGTILSEFYILTAAHCLYQAKRFKVRVG----- 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+R T E E V+V+ K+N +++D DIA+L+L P+ F+ V+P
Sbjct: 56 DRNTEQEEGGEAVHEVEVVI--KHNRFTKETYDFDIAVLRLKTPITFRMNVAP 106
>pdb|1ZJK|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-2
Length = 403
Score = 90.1 bits (222), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 50/132 (37%), Positives = 76/132 (57%), Gaps = 7/132 (5%)
Query: 566 RGDGSHRVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC----RQFPGFEPKLT 621
R + + + GT GWG + + G +A +L +P++ +Q+C + P +T
Sbjct: 272 RKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVT 330
Query: 622 GNMMCAGYVEGGKDSCQGDSGGALLMEDLDG-RFLIAGVVSWG-IGCARPNSPGVYTRVN 679
NM+CAG GGKDSC+GDSGGAL+ D + R+ + G+VSWG + C GVYT+V
Sbjct: 331 ANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVI 390
Query: 680 HYMEWIQNNTRD 691
+Y+ WI+N D
Sbjct: 391 NYIPWIENIISD 402
Score = 43.1 bits (100), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 35/124 (28%), Positives = 55/124 (44%), Gaps = 10/124 (8%)
Query: 10 CGVPNRMD--RIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRH 67
CG+ R +I GG + ++PW V + G G L+ D +VLTAAH V K
Sbjct: 151 CGLSARTTGGQIYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLTAAHAVYEQKHD 208
Query: 68 KDLIAV-ISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKP 126
+ + + R + + TQ + V H Y D+DIAL+KL+ +
Sbjct: 209 ASALDIRMGTLKRLSPHYTQAWSE---AVFIHEGYTHDAG--FDNDIALIKLNNKVVINS 263
Query: 127 TVSP 130
++P
Sbjct: 264 NITP 267
>pdb|2F9N|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
pdb|2F9N|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant K192qD216G IN COMPLEX WITH LEUPEPTIN
Length = 245
Score = 90.1 bits (222), Expect = 4e-18, Method: Compositional matrix adjust.
Identities = 49/116 (42%), Positives = 73/116 (62%), Gaps = 12/116 (10%)
Query: 581 VVGWGRVEESGQIASD--LRATQVPVMSNQECRQ------FPGFEPKLT-GNMMCAGYVE 631
V GWG V+ + L+ +VP+M N C + G + ++ +M+CAG +
Sbjct: 127 VTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAGNSQ 186
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+DSCQGDSGG L+ + ++G +L AGVVSWG GCA+PN PG+YTRV +Y++WI +
Sbjct: 187 --RDSCQGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 56.6 bits (135), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 9/113 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG +++PW V+L ++ FCGG+LI ++VLTAAHCV KDL +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDV--KDLATLRV 58
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ +Y Q + V +++ HP++ + DIALL+L+ P+ V
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYIIQTGA---DIALLELEEPVNISSRV 107
>pdb|3V0X|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 90.1 bits (222), Expect = 4e-18, Method: Composition-based stats.
Identities = 47/107 (43%), Positives = 68/107 (63%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM C GY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCVGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PG YT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIK 217
Score = 60.1 bits (144), Expect = 4e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLXSRVA 101
>pdb|3UWI|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|B Chain B, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|C Chain C, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|D Chain D, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|E Chain E, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|F Chain F, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|G Chain G, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|H Chain H, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|I Chain I, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|J Chain J, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|K Chain K, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|L Chain L, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|M Chain M, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|N Chain N, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|O Chain O, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3UY9|P Chain P, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V12|A Chain A, Bovine Trypsin Variant X(tripleglu217phe227) In Complex
With Small Molecule Inhibitor
pdb|3V13|A Chain A, Bovine Trypsin Variant X(Tripleglu217phe227) In Complex
With Small Molecule Inhibitor
Length = 223
Score = 90.1 bits (222), Expect = 4e-18, Method: Composition-based stats.
Identities = 47/107 (43%), Positives = 68/107 (63%), Gaps = 8/107 (7%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+ GWG + SG D L+ + P++S+ C+ F +T NM C GY+EGGKD+CQG
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSASSF--IITSNMFCVGYLEGGKDACQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
DSGG ++ G+ + G+VSWG GCA+ N PG YT+V +Y+ WI+
Sbjct: 176 DSGGPVV---CSGK--LQGIVSWGEGCAQKNKPGFYTKVCNYVSWIK 217
Score = 60.5 bits (145), Expect = 3e-09, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 60/111 (54%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN++ ++++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSE---TYNNDIMLIKLKSAASLNSRVA 101
>pdb|2FMJ|A Chain A, 220-Loop Mutant Of Streptomyces Griseus Trypsin
Length = 222
Score = 89.7 bits (221), Expect = 5e-18, Method: Composition-based stats.
Identities = 48/117 (41%), Positives = 63/117 (53%), Gaps = 1/117 (0%)
Query: 574 YSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGG 633
Y++ T TV GWG E G L VP +S+ CR G E + +CAGY GG
Sbjct: 105 YNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSAYGNE-LVANEEICAGYDTGG 163
Query: 634 KDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
D+CQGDSGG + +D ++ G+VSWG GCAR GVYT V+ + I + R
Sbjct: 164 VDTCQGDSGGPMFRKDNADEWIQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAAR 220
Score = 50.4 bits (119), Expect = 4e-06, Method: Composition-based stats.
Identities = 37/110 (33%), Positives = 52/110 (47%), Gaps = 13/110 (11%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+VGG E+P++V L CGG L + VLTAAHCV S + + A +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ ++ R KVL P YN G D AL+KL P+ +PT+
Sbjct: 57 LQSSSAVKV---RSTKVLQAPGYNGTG-----KDWALIKLAQPIN-QPTL 97
>pdb|1Q3X|A Chain A, Crystal Structure Of The Catalytic Region Of Human Masp-2
pdb|1Q3X|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-2
Length = 328
Score = 89.7 bits (221), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 50/132 (37%), Positives = 76/132 (57%), Gaps = 7/132 (5%)
Query: 566 RGDGSHRVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC----RQFPGFEPKLT 621
R + + + GT GWG + + G +A +L +P++ +Q+C + P +T
Sbjct: 197 RKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVT 255
Query: 622 GNMMCAGYVEGGKDSCQGDSGGALLMEDLDG-RFLIAGVVSWG-IGCARPNSPGVYTRVN 679
NM+CAG GGKDSC+GDSGGAL+ D + R+ + G+VSWG + C GVYT+V
Sbjct: 256 ANMLCAGLESGGKDSCRGDSGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVI 315
Query: 680 HYMEWIQNNTRD 691
+Y+ WI+N D
Sbjct: 316 NYIPWIENIISD 327
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 36/124 (29%), Positives = 55/124 (44%), Gaps = 10/124 (8%)
Query: 10 CGVPNRM--DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRH 67
CG+ R RI GG + ++PW V + G G L+ D +VLTAAH V K
Sbjct: 76 CGLSARTTGGRIYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLTAAHAVYEQKHD 133
Query: 68 KDLIAV-ISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKP 126
+ + + R + + TQ + V H Y D+DIAL+KL+ +
Sbjct: 134 ASALDIRMGTLKRLSPHYTQAWSE---AVFIHEGYTHDAG--FDNDIALIKLNNKVVINS 188
Query: 127 TVSP 130
++P
Sbjct: 189 NITP 192
>pdb|4FXG|H Chain H, Complement C4 In Complex With Masp-2
pdb|4FXG|J Chain J, Complement C4 In Complex With Masp-2
Length = 242
Score = 89.7 bits (221), Expect = 5e-18, Method: Compositional matrix adjust.
Identities = 49/132 (37%), Positives = 76/132 (57%), Gaps = 7/132 (5%)
Query: 566 RGDGSHRVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC----RQFPGFEPKLT 621
R + + + GT GWG + + G +A +L +P++ +Q+C + P +T
Sbjct: 111 RKEAESFMRTDDIGTASGWG-LTQRGFLARNLMYVDIPIVDHQKCTAAYEKPPYPRGSVT 169
Query: 622 GNMMCAGYVEGGKDSCQGDSGGALLMEDLDG-RFLIAGVVSWG-IGCARPNSPGVYTRVN 679
NM+CAG GGKDSC+GD+GGAL+ D + R+ + G+VSWG + C GVYT+V
Sbjct: 170 ANMLCAGLESGGKDSCRGDAGGALVFLDSETERWFVGGIVSWGSMNCGEAGQYGVYTKVI 229
Query: 680 HYMEWIQNNTRD 691
+Y+ WI+N D
Sbjct: 230 NYIPWIENIISD 241
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 50/113 (44%), Gaps = 8/113 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV-ISEH 77
I GG + ++PW V + G G L+ D +VLTAAH V K + + +
Sbjct: 1 IYGGQKAKPGDFPWQVLI--LGGTTAAGALLYDNWVLTAAHAVYEQKHDASALDIRMGTL 58
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
R + + TQ + V H Y D+DIAL+KL+ + ++P
Sbjct: 59 KRLSPHYTQAWSE---AVFIHEGYTHDAG--FDNDIALIKLNNKVVINSNITP 106
>pdb|2TLD|E Chain E, Crystal Structure Of An Engineered Subtilisin Inhibitor
Complexed With Bovine Trypsin
Length = 220
Score = 89.4 bits (220), Expect = 6e-18, Method: Composition-based stats.
Identities = 49/108 (45%), Positives = 71/108 (65%), Gaps = 13/108 (12%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG + SG D L+ + P++S+ C+ +PG ++T NM CAG +EGG DSCQ
Sbjct: 118 ISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPG---QITSNMFCAG-LEGG-DSCQ 172
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ G+ + G+VSWG GCA+ N PGVYT+V +Y+ WI+
Sbjct: 173 GDSGGPVVCS---GK--LQGIVSWGSGCAK-NKPGVYTKVCNYVSWIK 214
Score = 58.2 bits (139), Expect = 1e-08, Method: Composition-based stats.
Identities = 37/111 (33%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S I V +
Sbjct: 1 IVGGYTCGANTVPYQVSL-NSGYHFCGGSLINSQWVVSAAHCYKSG------IQVRLGED 53
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K + HP YN+ + ++DI L+KL + V+
Sbjct: 54 NINVVEGNEQFISASKSIVHPSYNSN---TLNNDIMLIKLKSAASLNSRVA 101
>pdb|2F9O|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9O|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g
pdb|2F9P|A Chain A, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|B Chain B, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|C Chain C, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
pdb|2F9P|D Chain D, Crystal Structure Of The Recombinant Human Alpha I
Tryptase Mutant D216g In Complex With Leupeptin
Length = 245
Score = 88.6 bits (218), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 48/116 (41%), Positives = 73/116 (62%), Gaps = 12/116 (10%)
Query: 581 VVGWGRVEESGQIASD--LRATQVPVMSNQECRQ------FPGFEPKLT-GNMMCAGYVE 631
V GWG V+ + L+ +VP+M N C + G + ++ +M+CAG +
Sbjct: 127 VTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAGNSQ 186
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+DSC+GDSGG L+ + ++G +L AGVVSWG GCA+PN PG+YTRV +Y++WI +
Sbjct: 187 --RDSCKGDSGGPLVCK-VNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 56.6 bits (135), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 9/113 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG +++PW V+L ++ FCGG+LI ++VLTAAHCV KDL +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCVGPDV--KDLATLRV 58
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ +Y Q + V +++ HP++ + DIALL+L+ P+ V
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYIIQTGA---DIALLELEEPVNISSRV 107
>pdb|1GDU|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1PQ5|A Chain A, Trypsin At Ph 5, 0.85 A
pdb|1PQ7|A Chain A, Trypsin At 0.8 A, Ph5 BORAX
pdb|1PQ8|A Chain A, Trypsin At Ph 4 At Atomic Resolution
pdb|2G51|A Chain A, Anomalous Substructure Of Trypsin (P1)
pdb|2G52|A Chain A, Anomalous Substructure Of Trypsin (P21)
pdb|1TRY|A Chain A, Structure Of Inhibited Trypsin From Fusarium Oxysporum At
1.55 Angstroms
pdb|2VU8|E Chain E, Crystal Structure Of An Insect Inhibitor With A Fungal
Trypsin
Length = 224
Score = 86.7 bits (213), Expect = 4e-17, Method: Composition-based stats.
Identities = 48/109 (44%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 578 TGTVVGWGRVEESGQ-IASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
+ TV GWG E G +L VP++S CR G +T M CAG GGKDS
Sbjct: 117 SATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYG-TSAITNQMFCAGVSSGGKDS 175
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
CQGDSGG + +D + G VSWG GCARPN GVY V +I
Sbjct: 176 CQGDSGGPI----VDSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
Score = 51.2 bits (121), Expect = 2e-06, Method: Composition-based stats.
Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG + ++P++V++ + G +CGG+L++ VLTAAHCV + I S
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPL 122
+ + + + RV HP Y+ +++D+A+LKL +
Sbjct: 61 TSGGITSSLSSVRV-----HPSYSG-----NNNDLAILKLSTSI 94
>pdb|1XVM|A Chain A, Trypsin From Fusarium Oxysporum- Room Temperature To
Atomic Resolution
pdb|1XVO|A Chain A, Trypsin From Fusarium Oxysporum At Ph 6
pdb|1FY5|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDN|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FY4|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1FN8|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
pdb|1GDQ|A Chain A, Fusarium Oxysporum Trypsin At Atomic Resolution
Length = 224
Score = 86.7 bits (213), Expect = 4e-17, Method: Composition-based stats.
Identities = 48/109 (44%), Positives = 57/109 (52%), Gaps = 6/109 (5%)
Query: 578 TGTVVGWGRVEESGQ-IASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
+ TV GWG E G +L VP++S CR G +T M CAG GGKDS
Sbjct: 117 SATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYG-TSAITNQMFCAGVSSGGKDS 175
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
CQGDSGG + +D + G VSWG GCARPN GVY V +I
Sbjct: 176 CQGDSGGPI----VDSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
Score = 49.7 bits (117), Expect = 6e-06, Method: Composition-based stats.
Identities = 30/103 (29%), Positives = 54/103 (52%), Gaps = 10/103 (9%)
Query: 20 VGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNR 79
VGG + ++P++V++ + G +CGG+L++ VLTAAHCV + I S
Sbjct: 2 VGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSRT 61
Query: 80 ATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPL 122
+ + + + RV HP Y+ +++D+A+LKL +
Sbjct: 62 SGGITSSLSSVRV-----HPSYSG-----NNNDLAILKLSTSI 94
>pdb|1LTO|A Chain A, Human Alpha1-Tryptase
pdb|1LTO|B Chain B, Human Alpha1-Tryptase
pdb|1LTO|C Chain C, Human Alpha1-Tryptase
pdb|1LTO|D Chain D, Human Alpha1-Tryptase
Length = 245
Score = 86.3 bits (212), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 47/116 (40%), Positives = 72/116 (62%), Gaps = 12/116 (10%)
Query: 581 VVGWGRVEESGQIASD--LRATQVPVMSNQECRQ------FPGFEPKLT-GNMMCAGYVE 631
V GWG V+ + L+ +VP+M N C + G + ++ +M+CAG +
Sbjct: 127 VTGWGDVDNDEPLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIIRDDMLCAGNSQ 186
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+DSC+GDSGG L+ + ++G +L AGVVSW GCA+PN PG+YTRV +Y++WI +
Sbjct: 187 --RDSCKGDSGGPLVCK-VNGTWLQAGVVSWDEGCAQPNRPGIYTRVTYYLDWIHH 239
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 37/113 (32%), Positives = 60/113 (53%), Gaps = 9/113 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKF---FCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG +++PW V+L ++ FCGG+LI ++VLTAAHC+ KDL +
Sbjct: 1 IVGGQEAPRSKWPWQVSLRVRDRYWMHFCGGSLIHPQWVLTAAHCLGPDV--KDLATLRV 58
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ +Y Q + V +++ HP++ + DIALL+L+ P+ V
Sbjct: 59 QLREQHLY-YQDQLLPVSRIIVHPQFYIIQTGA---DIALLELEEPVNISSRV 107
>pdb|2OLG|A Chain A, Crystal Structure Of The Serine Protease Domain Of
Prophenoloxidase Activating Factor-I In A Zymogen Form
Length = 278
Score = 86.3 bits (212), Expect = 5e-17, Method: Compositional matrix adjust.
Identities = 47/112 (41%), Positives = 68/112 (60%), Gaps = 3/112 (2%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
TVVGWGR E +GQ ++ + VPV+ ++C + F ++ + +CAG E KDSC
Sbjct: 168 TVVGWGRTE-TGQYSTIKQKLAVPVVHAEQCAKTFGAAGVRVRSSQLCAGG-EKAKDSCG 225
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
GDSGG LL E + +F + G+VS+G C PG+YT+V Y +WI+ N R
Sbjct: 226 GDSGGPLLAERANQQFFLEGLVSFGATCGTEGWPGIYTKVGKYRDWIEGNIR 277
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 48/158 (30%), Positives = 74/158 (46%), Gaps = 23/158 (14%)
Query: 3 PDLKIAGCGVPNRMDRIVGGWTTEVNEYPWVVAL-----EQAGKFFCGGTLISDRYVLTA 57
P+L CG D+I+ G T E+PW + +F CGG+LI++RY++TA
Sbjct: 7 PELLPNDCGYQVEADKILNGDDTVPEEFPWTAMIGYKNSSNFEQFACGGSLINNRYIVTA 66
Query: 58 AHCVRSSKRHKDLIAVIS-----EHNRATVYETQIETRRVV----------KVLTHPKYN 102
AHCV + R ++ ++ E N AT + R V + + HP Y
Sbjct: 67 AHCV--AGRVLRVVGALNKVRLGEWNTATDPDCYGAVRVCVPDKPIDLGIEETIQHPDY- 123
Query: 103 AQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDPKSEL 140
G+K HDIAL++L+ +EF + P P E+
Sbjct: 124 VDGSKDRYHDIALIRLNRQVEFTNYIRPVCLPQPNEEV 161
>pdb|1PPZ|A Chain A, Trypsin Complexes At Atomic And Ultra-High Resolution
pdb|1PQA|A Chain A, Trypsin With Pmsf At Atomic Resolution
Length = 224
Score = 85.1 bits (209), Expect = 1e-16, Method: Composition-based stats.
Identities = 47/109 (43%), Positives = 56/109 (51%), Gaps = 6/109 (5%)
Query: 578 TGTVVGWGRVEESGQ-IASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
+ TV GWG E G +L VP++S CR G +T M CAG GGKDS
Sbjct: 117 SATVAGWGATSEGGSSTPVNLLKVTVPIVSRATCRAQYG-TSAITNQMFCAGVSSGGKDS 175
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
CQGD GG + +D + G VSWG GCARPN GVY V +I
Sbjct: 176 CQGDXGGPI----VDSSNTLIGAVSWGNGCARPNYSGVYASVGALRSFI 220
Score = 51.2 bits (121), Expect = 2e-06, Method: Composition-based stats.
Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 10/104 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG + ++P++V++ + G +CGG+L++ VLTAAHCV + I S
Sbjct: 1 IVGGTSASAGDFPFIVSISRNGGPWCGGSLLNANTVLTAAHCVSGYAQSGFQIRAGSLSR 60
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPL 122
+ + + + RV HP Y+ +++D+A+LKL +
Sbjct: 61 TSGGITSSLSSVRV-----HPSYSG-----NNNDLAILKLSTSI 94
>pdb|1L2E|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor
pdb|1LO6|A Chain A, Human Kallikrein 6 (Hk6) Active Form With Benzamidine
Inhibitor At 1.56 A Resolution
Length = 223
Score = 84.7 bits (208), Expect = 2e-16, Method: Composition-based stats.
Identities = 45/112 (40%), Positives = 64/112 (57%), Gaps = 11/112 (9%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQG 639
++GWG+ + G ++ + ++S +EC +PG ++T NM+CAG + GKDSCQG
Sbjct: 119 ILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAYPG---QITQNMLCAGDEKYGKDSCQG 174
Query: 640 DSGGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L+ D + G+VSWG I C PGVYT V Y WIQ +
Sbjct: 175 DSGGPLVCGD-----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 221
Score = 67.0 bits (162), Expect = 3e-11, Method: Composition-based stats.
Identities = 39/112 (34%), Positives = 56/112 (50%), Gaps = 9/112 (8%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+V G + +P+ AL +G CGG LI +VLTAAHC + +L + +HN
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC-----KKPNLQVFLGKHN 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+Q E VV+ + HP Y+ A SHD DI LL+L P + + P
Sbjct: 56 LRQRESSQ-EQSSVVRAVIHPDYD---AASHDQDIMLLRLARPAKLSELIQP 103
>pdb|1GVL|A Chain A, Human Prokallikrein 6 (Hk6) PROZYME PROPROTEASE M
Proneurosin
Length = 223
Score = 84.0 bits (206), Expect = 2e-16, Method: Composition-based stats.
Identities = 45/112 (40%), Positives = 64/112 (57%), Gaps = 11/112 (9%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQG 639
++GWG+ + G ++ + ++S +EC +PG ++T NM+CAG + GKDSCQG
Sbjct: 120 ILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAYPG---QITQNMLCAGDEKYGKDSCQG 175
Query: 640 DSGGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L+ D + G+VSWG I C PGVYT V Y WIQ +
Sbjct: 176 DSGGPLVCGD-----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 222
Score = 62.4 bits (150), Expect = 9e-10, Method: Composition-based stats.
Identities = 39/113 (34%), Positives = 57/113 (50%), Gaps = 9/113 (7%)
Query: 18 RIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
++V G + +P+ AL +G CGG LI +VLTAAHC + +L + +H
Sbjct: 1 KLVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC-----KKPNLQVFLGKH 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
N E+ E VV+ + HP Y+ A SHD DI LL+L P + + P
Sbjct: 56 N-LRQQESSQEQSSVVRAVIHPDYD---AASHDQDIMLLRLARPAKLSELIQP 104
>pdb|4D8N|A Chain A, Human Kallikrein 6 Inhibitors With A
Para-Amidobenzylanmine P1 Group Carry A High Binding
Efficiency
pdb|3VFE|A Chain A, Virtual Screening And X-Ray Crystallography For Human
Kallikrein 6 Inhibitors With An Amidinothiophene P1
Group
Length = 223
Score = 84.0 bits (206), Expect = 2e-16, Method: Composition-based stats.
Identities = 45/112 (40%), Positives = 64/112 (57%), Gaps = 11/112 (9%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQG 639
++GWG+ + G ++ + ++S +EC +PG ++T NM+CAG + GKDSCQG
Sbjct: 119 ILGWGKTAD-GDFPDTIQCAYIHLVSREECEHAYPG---QITQNMLCAGDEKYGKDSCQG 174
Query: 640 DSGGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L+ D + G+VSWG I C PGVYT V Y WIQ +
Sbjct: 175 DSGGPLVCGD-----HLRGLVSWGNIPCGSKEKPGVYTNVCRYTNWIQKTIQ 221
Score = 62.0 bits (149), Expect = 1e-09, Method: Composition-based stats.
Identities = 39/112 (34%), Positives = 56/112 (50%), Gaps = 9/112 (8%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+V G + +P+ AL +G CGG LI +VLTAAHC + +L + +HN
Sbjct: 1 LVHGGPCDKTSHPYQAALYTSGHLLCGGVLIHPLWVLTAAHC-----KKPNLQVFLGKHN 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+Q E VV+ + HP Y+ A SHD DI LL+L P + + P
Sbjct: 56 LGQQESSQ-EQSSVVRAVIHPDYD---AASHDQDIMLLRLARPAKLSELIQP 103
>pdb|1FIZ|A Chain A, Three Dimensional Structure Of Beta-Acrosin From Boar
Spermatozoa
Length = 263
Score = 84.0 bits (206), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 42/116 (36%), Positives = 66/116 (56%), Gaps = 2/116 (1%)
Query: 575 SKRTGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGG 633
+ +T V GWG ++E G + + L+ +V ++ + C + ++ +CAGY G
Sbjct: 132 APQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYNGRIRSTNVCAGYPRGK 191
Query: 634 KDSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNN 688
D+CQGDSGG L+ D + F++ G+ SWG+GCAR PGVYT Y+ WI +
Sbjct: 192 IDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTSTWPYLNWIASK 247
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 52/206 (25%), Positives = 88/206 (42%), Gaps = 23/206 (11%)
Query: 19 IVGGWTTEVNEYPWVVALE------QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIA 72
+VGG + E +PW+V+L+ CGG L++ +VLTAAHC ++ K+ D
Sbjct: 1 VVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWRL 60
Query: 73 VISEHN----RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ + + ++ R V +++ H KY + +DIAL+K+ P+ P +
Sbjct: 61 IFGANEVVWGSNKPVKPPLQERFVEEIIIHEKYV---SGLEINDIALIKITPPVPCGPFI 117
Query: 129 SPDNKDDPKSELTQFKPGNQKSYK--WDIVWFNLIGFAVLHLATLY-GYYLMFTGEVKFA 185
P L QFK G ++ + W W L TL + E+ +
Sbjct: 118 GPGC-------LPQFKAGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNS 170
Query: 186 TFLWSKSVISTDSIVEEPSSMTDTCS 211
T ++ + ST+ P DTC
Sbjct: 171 TRWYNGRIRSTNVCAGYPRGKIDTCQ 196
>pdb|1RTF|B Chain B, Complex Of Benzamidine With The Catalytic Domain Of Human
Two Chain Tissue Plasminogen Activator [(Tc)-T-Pa]
pdb|1A5H|A Chain A, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
pdb|1A5H|B Chain B, Catalytic Domain Of Human Two-Chain Tissue Plasminogen
Activator Complex Of A Bis-Benzamidine
Length = 252
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 43/115 (37%), Positives = 66/115 (57%), Gaps = 8/115 (6%)
Query: 583 GWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGG------KD 635
G+G+ E S+ L+ V + + C +T NM+CAG G D
Sbjct: 138 GYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHD 197
Query: 636 SCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+CQGDSGG L+ + DGR + G++SWG+GC + + PGVYT+V +Y++WI++N R
Sbjct: 198 ACQGDSGGPLVCLN-DGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNMR 251
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 10/108 (9%)
Query: 19 IVGGWTTEVNEYPWVVAL------EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIA 72
I GG ++ +PW A+ +F CGG LIS ++L+AAHC + L
Sbjct: 1 IKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLTV 60
Query: 73 VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
++ R E + + V K + H +++ ++D+DIALL+L +
Sbjct: 61 ILGRTYRVVPGEEE-QKFEVEKYIVHKEFDDD---TYDNDIALLQLKS 104
>pdb|1BDA|A Chain A, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
pdb|1BDA|B Chain B, Catalytic Domain Of Human Single Chain Tissue Plasminogen
Activator In Complex With Dansyl-Egr-Cmk
(Dansyl-Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 83.6 bits (205), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 43/115 (37%), Positives = 66/115 (57%), Gaps = 8/115 (6%)
Query: 583 GWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGG------KD 635
G+G+ E S+ L+ V + + C +T NM+CAG G D
Sbjct: 151 GYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHD 210
Query: 636 SCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+CQGDSGG L+ + DGR + G++SWG+GC + + PGVYT+V +Y++WI++N R
Sbjct: 211 ACQGDSGGPLVCLN-DGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNMR 264
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL------EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLI 71
RI GG ++ +PW A+ +F CGG LIS ++L+AAHC + L
Sbjct: 13 RIKGGLFADIASHPWQAAIFAKHRRSPGERFLCGGILISSCWILSAAHCFQERFPPHHLT 72
Query: 72 AVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
++ R E + + V K + H +++ ++D+DIALL+L +
Sbjct: 73 VILGRTYRVVPGEEE-QKFEVEKYIVHKEFDDD---TYDNDIALLQLKS 117
>pdb|1FIW|A Chain A, Three-Dimensional Structure Of Beta-Acrosin From Ram
Spermatozoa
Length = 290
Score = 83.2 bits (204), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 41/110 (37%), Positives = 64/110 (58%), Gaps = 2/110 (1%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG ++E+ + S L+ +V ++ C + ++ +CAGY EG D+CQG
Sbjct: 138 VAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRWYNGRIRSTNVCAGYPEGKIDTCQG 197
Query: 640 DSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNN 688
DSGG L+ +D + +++ G+ SWG+GCAR PGVYT Y+ WI +
Sbjct: 198 DSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVYTSTWSYLNWIASK 247
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 43/138 (31%), Positives = 67/138 (48%), Gaps = 20/138 (14%)
Query: 19 IVGGWTTEVNEYPWVVALE------QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKD--L 70
I+GG +PW+V+L+ CGG+L++ +++LTAAHC R K+ D L
Sbjct: 1 IIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRL 60
Query: 71 IAVISEHNRAT--VYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
I E T + ++ R V K++ H KY+ A S +DIAL+K+ P+ +
Sbjct: 61 IFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYS---ASSEANDIALMKITPPVTCGHFI 117
Query: 129 SPDNKDDPKSELTQFKPG 146
P L QF+ G
Sbjct: 118 GPGC-------LPQFRAG 128
>pdb|1SPJ|A Chain A, Structure Of Mature Human Tissue Kallikrein (Human
Kallikrein 1 Or Klk1) At 1.70 Angstrom Resolution With
Vacant Active Site
Length = 238
Score = 82.8 bits (203), Expect = 5e-16, Method: Compositional matrix adjust.
Identities = 44/107 (41%), Positives = 65/107 (60%), Gaps = 9/107 (8%)
Query: 583 GWGRVE-ESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDS 641
GWG +E E+ DL+ + ++ N EC++ K+T M+C G++EGGKD+C GDS
Sbjct: 133 GWGSIEPENFSFPDDLQCVDLKILPNDECKK--AHVQKVTDFMLCVGHLEGGKDTCVGDS 190
Query: 642 GGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQN 687
GG L+ DG ++ GV SWG + C PN P V RV Y++WI++
Sbjct: 191 GGPLM---CDG--VLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIED 232
Score = 56.6 bits (135), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 36/113 (31%), Positives = 52/113 (46%), Gaps = 14/113 (12%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGGW E + PW AL F CGG L+ ++VLTAAHC+ + + + HN
Sbjct: 1 IVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQ-----LWLGRHN 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNA--------QGAKSHDHDIALLKLDAPLE 123
E + V + HP +N Q + + HD+ LL+L P +
Sbjct: 56 LFD-DENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPAD 107
>pdb|3I78|A Chain A, 3599170186220-Loops Of Fxa In Sgt
Length = 229
Score = 82.8 bits (203), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 62/118 (52%), Gaps = 1/118 (0%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
Y++ T TV GWG E G L VP +S+ CR F + M+CAGY
Sbjct: 111 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSF-ILVANEMICAGYDTK 169
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + +D ++ G+VSWG GCAR GVYT V+ + I + R
Sbjct: 170 QEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAAR 227
Score = 52.4 bits (124), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 35/111 (31%), Positives = 56/111 (50%), Gaps = 8/111 (7%)
Query: 19 IVGGWTTEVNEYPWVVAL-EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
+VGG E+P++V L + + FCGG L + VLTAAHCV S + + A
Sbjct: 1 VVGGTRAAQGEFPFMVRLINEENEGFCGGALYAQDIVLTAAHCVSGSGNNTSITATGGVV 60
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ + ++ R KVL P + + ++ D AL+KL P+ +PT+
Sbjct: 61 DLQSSSAVKV---RSTKVLQAPGFTKE---TYGKDWALIKLAQPIN-QPTL 104
>pdb|3BEU|A Chain A, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
pdb|3BEU|B Chain B, Na+-Dependent Allostery Mediates Coagulation Factor
Protease Active Site Selectivity
Length = 224
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 46/118 (38%), Positives = 62/118 (52%), Gaps = 1/118 (0%)
Query: 573 VYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
Y++ T TV GWG E G L VP +S+ CR F + M+CAGY
Sbjct: 106 AYNQGTFTVAGWGANREGGSQQRYLLKANVPFVSDAACRSSSSF-ILVANEMICAGYDTK 164
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+D+CQGDSGG + +D ++ G+VSWG GCAR GVYT V+ + I + R
Sbjct: 165 QEDTCQGDSGGPMFRKDNADEWVQVGIVSWGEGCARKGKYGVYTEVSTFASAIASAAR 222
Score = 49.7 bits (117), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 11/110 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+VGG E+P++V L CGG L + VLTAAHCV S + + A +
Sbjct: 1 VVGGTRAAQGEFPFMVRLSMG----CGGALYAQDIVLTAAHCVSGSGNNTSITATGGVVD 56
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ ++ R KVL P + + ++ D AL+KL P+ +PT+
Sbjct: 57 LQSSSAVKV---RSTKVLQAPGFTKE---TYGKDWALIKLAQPIN-QPTL 99
>pdb|4E7N|A Chain A, Crystal Structure Of Ahv_tl-I, A Glycosylated Snake-Venom
Thrombin- Like Enzyme From Agkistrodon Halys
Length = 238
Score = 82.4 bits (202), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 71/120 (59%), Gaps = 12/120 (10%)
Query: 581 VVGWGRVEESGQIASDL-RATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
++GWGR+ + D+ + ++ + CR +P FE T +CAG +EGGKD+C+
Sbjct: 122 IMGWGRISPTEGTYPDVPHCVNINLLEYEMCRAPYPEFELPATSRTLCAGILEGGKDTCK 181
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWIQN----NTRDAC 693
GDSGG L+ +G+F G+ SWG CA+P+ P YT+V +++WI+N NT +C
Sbjct: 182 GDSGGPLI---CNGQF--QGIASWGDDPCAQPHKPAAYTKVFDHLDWIENIIAGNTDASC 236
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 40/110 (36%), Positives = 62/110 (56%), Gaps = 16/110 (14%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
I+GG +NE+ ++VAL ++ FCGGTLI+ +VLTAAHC R + R K +
Sbjct: 1 IIGGDECNINEHRFLVALYTSRSRTLFCGGTLINQEWVLTAAHCDRKNFRIK-----LGM 55
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSH---DHDIALLKLDAPLE 123
H++ E E RV K K+ +K++ D DI L++LD+P++
Sbjct: 56 HSKKVPNED--EQTRVPK----EKFFCLSSKNYTLWDKDIMLIRLDSPVK 99
>pdb|1SGF|G Chain G, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|Z Chain Z, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 237
Score = 81.6 bits (200), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 42/112 (37%), Positives = 66/112 (58%), Gaps = 9/112 (8%)
Query: 578 TGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
T GWG + + Q DL + ++ N++C + K+T M+CAG ++GGKD+
Sbjct: 127 TCLASGWGSITPTKFQFTDDLYCVNLKLLPNEDCAK--AHIEKVTDAMLCAGEMDGGKDT 184
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQN 687
C+GDSGG L+ DG ++ G+ SWG C P+ PGVYT++N + WI++
Sbjct: 185 CKGDSGGPLI---CDG--VLQGITSWGHTPCGEPDMPGVYTKLNKFTSWIKD 231
Score = 63.9 bits (154), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 40/120 (33%), Positives = 56/120 (46%), Gaps = 14/120 (11%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ E N PW VA+ + ++ CGG L+ +VLTAAHC + D V N
Sbjct: 1 IVGGFKCEKNSQPWHVAVYRYTQYLCGGVLLDPNWVLTAAHC------YDDNYKVWLGKN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSH--------DHDIALLKLDAPLEFKPTVSP 130
E + R V K + HP +N + H +D+ LL+L P + TV P
Sbjct: 55 NLFKDEPSAQHRFVSKAIPHPGFNMSLMRKHIRFLEYDYSNDLMLLRLSKPADITDTVKP 114
>pdb|2QY0|B Chain B, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
pdb|2QY0|D Chain D, Active Dimeric Structure Of The Catalytic Domain Of C1r
Reveals Enzyme-product Like Contacts
Length = 242
Score = 79.7 bits (195), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 46/117 (39%), Positives = 72/117 (61%), Gaps = 8/117 (6%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKL---TGNMMCAGYVEGGKD 635
G V G+G +EE +IA DLR ++PV + Q C + + ++ + NM CAG+ +D
Sbjct: 128 GYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQD 185
Query: 636 SCQGDSGGALLMEDLD-GRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
+CQGDSGG + D + R++ G+VSWGIGC+R G YT+V +Y++WI+ +
Sbjct: 186 ACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSR--GYGFYTKVLNYVDWIKKEMEE 240
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 4/114 (3%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG ++ +PW V G+ GG L+ DR++LTAAH + + A +
Sbjct: 1 IIGGQKAKMGNFPWQVFTNIHGR--GGGALLGDRWILTAAHTLYPKEHEAQSNASLDVFL 58
Query: 79 RATVYE--TQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
T E ++ + +V HP Y + + + DIALL+L+ + P + P
Sbjct: 59 GHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVTLGPNLLP 112
>pdb|1GPZ|A Chain A, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
pdb|1GPZ|B Chain B, The Crystal Structure Of The Zymogen Catalytic Domain Of
Complement Protease C1r
Length = 399
Score = 79.3 bits (194), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 46/117 (39%), Positives = 72/117 (61%), Gaps = 8/117 (6%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKL---TGNMMCAGYVEGGKD 635
G V G+G +EE +IA DLR ++PV + Q C + + ++ + NM CAG+ +D
Sbjct: 285 GYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQD 342
Query: 636 SCQGDSGGALLMEDLD-GRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
+CQGDSGG + D + R++ G+VSWGIGC+R G YT+V +Y++WI+ +
Sbjct: 343 ACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSR--GYGFYTKVLNYVDWIKKEMEE 397
Score = 52.4 bits (124), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 8/127 (6%)
Query: 10 CGVP----NRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSK 65
CG P + +I+GG ++ +PW V G+ GG L+ DR++LTAAH + +
Sbjct: 145 CGKPVNPVEQRQQIIGGQKAKMGNFPWQVFTNIHGRG--GGALLGDRWILTAAHTLYPKE 202
Query: 66 RHKDLIAVISEHNRATVYET--QIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLE 123
A + T E ++ + +V HP Y + + + DIALL+L+ +
Sbjct: 203 HEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVT 262
Query: 124 FKPTVSP 130
P + P
Sbjct: 263 LGPNLLP 269
>pdb|1MD8|A Chain A, Monomeric Structure Of The Active Catalytic Domain Of
Complement Protease C1r
Length = 329
Score = 79.0 bits (193), Expect = 8e-15, Method: Compositional matrix adjust.
Identities = 46/117 (39%), Positives = 72/117 (61%), Gaps = 8/117 (6%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKL---TGNMMCAGYVEGGKD 635
G V G+G +EE +IA DLR ++PV + Q C + + ++ + NM CAG+ +D
Sbjct: 217 GYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQD 274
Query: 636 SCQGDSGGALLMEDLD-GRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
+CQGDSGG + D + R++ G+VSWGIGC+R G YT+V +Y++WI+ +
Sbjct: 275 ACQGDSGGVFAVRDPNTDRWVATGIVSWGIGCSR--GYGFYTKVLNYVDWIKKEMEE 329
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 8/127 (6%)
Query: 10 CGVP----NRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSK 65
CG P + RI+GG ++ +PW V G+ GG L+ DR++LTAAH + +
Sbjct: 77 CGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNIHGRG--GGALLGDRWILTAAHTLYPKE 134
Query: 66 RHKDLIAVISEHNRATVYET--QIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLE 123
A + T E ++ + +V HP Y + + + DIALL+L+ +
Sbjct: 135 HEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVT 194
Query: 124 FKPTVSP 130
P + P
Sbjct: 195 LGPNLLP 201
>pdb|1ELV|A Chain A, Crystal Structure Of The Catalytic Domain Of Human
Complement C1s Protease
Length = 333
Score = 78.6 bits (192), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 47/122 (38%), Positives = 72/122 (59%), Gaps = 14/122 (11%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPK-------LTGNMMCAGYVE 631
G + GWGR E+ + A L+A ++PV ++C++ +P T NM+CAG E
Sbjct: 210 GLISGWGRTEKRDR-AVRLKAARLPVAPLRKCKEVKVEKPTADAEAYVFTPNMICAGG-E 267
Query: 632 GGKDSCQGDSGGALLMEDLDG--RFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNT 689
G DSC+GDSGGA ++D + +F AG+VSWG C + G+YTRV +Y++WI
Sbjct: 268 KGMDSCKGDSGGAFAVQDPNDKTKFYAAGLVSWGPQCG---TYGLYTRVKNYVDWIMKTM 324
Query: 690 RD 691
++
Sbjct: 325 QE 326
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 30/137 (21%)
Query: 10 CGVP----NRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSK 65
CGVP RI+GG ++ +PW V + + GG LI++ +VLTAAH V ++
Sbjct: 70 CGVPREPFEEKQRIIGGSDADIKNFPWQVFFDNP---WAGGALINEYWVLTAAHVVEGNR 126
Query: 66 RHKDLIAVISEHNRATVYETQIETRRVVK--------VLTHPKYN----AQGAKSHDHDI 113
+ T ++T R+ K V HP + +G + D+DI
Sbjct: 127 EPTMYVG-----------STSVQTSRLAKSKMLTPEHVFIHPGWKLLAVPEGRTNFDNDI 175
Query: 114 ALLKLDAPLEFKPTVSP 130
AL++L P++ PTVSP
Sbjct: 176 ALVRLKDPVKMGPTVSP 192
>pdb|2PUX|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par3
pdb|2PV9|B Chain B, Crystal Structure Of Murine Thrombin In Complex With The
Extracellular Fragment Of Murine Par4
Length = 258
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 50/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV GW E PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE +E ++ K+ HP+YN + ++ D DIALLKL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNVEKISMLEKIYVHPRYNWR--ENLDRDIALLKLKKPVPFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDKQTVTSLLRAG 133
Score = 65.9 bits (159), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 42/118 (35%), Positives = 61/118 (51%), Gaps = 12/118 (10%)
Query: 579 GTVVGWGRVEES-----GQIA-SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGY-VE 631
G V GWG + E+ +I S L+ +P++ C+ ++T NM CAG+ V
Sbjct: 136 GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKA--STRIRITDNMFCAGFKVN 193
Query: 632 GGK--DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
K D+C+GD+GG +M+ + R+ G+VSWG GC R G YT V WIQ
Sbjct: 194 DTKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKRWIQ 251
>pdb|2OCV|B Chain B, Structural Basis Of Na+ Activation Mimicry In Murine
Thrombin
Length = 259
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 50/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV GW E PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE +E ++ K+ HP+YN + ++ D DIALLKL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNVEKISMLEKIYVHPRYNWR--ENLDRDIALLKLKKPVPFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDKQTVTSLLRAG 133
Score = 66.2 bits (160), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 43/118 (36%), Positives = 61/118 (51%), Gaps = 12/118 (10%)
Query: 579 GTVVGWGRVEES-----GQIA-SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGY-VE 631
G V GWG + E+ +I S L+ +P++ C+ ++T NM CAG+ V
Sbjct: 136 GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKA--STRIRITDNMFCAGFKVN 193
Query: 632 GGK--DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
K D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V WIQ
Sbjct: 194 DTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKAWIQ 251
>pdb|3EDX|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|D Chain D, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3EDX|F Chain F, Crystal Structure Of The W215aE217A MUTANT OF MURINE
THROMBIN
pdb|3HK3|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(ONE Molecule In The Asymmetric Unit)
pdb|3HK6|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HK6|D Chain D, Crystal Structure Of Murine Thrombin Mutant W215aE217A
(TWO Molecules In The Asymmetric Unit)
pdb|3HKI|B Chain B, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
pdb|3HKI|E Chain E, Crystal Structure Of Murine Thrombin Mutant W215a/e217a In
Complex With The Extracellular Fragment Of Human Par1
Length = 258
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 50/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV GW E PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGWDAEKGIAPWQVMLFRKSPQELLCGASLISDRWVLTAAHCILYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE +E ++ K+ HP+YN + ++ D DIALLKL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNVEKISMLEKIYVHPRYNWR--ENLDRDIALLKLKKPVPFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDKQTVTSLLRAG 133
Score = 62.8 bits (151), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 42/118 (35%), Positives = 60/118 (50%), Gaps = 12/118 (10%)
Query: 579 GTVVGWGRVEES-----GQIA-SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGY-VE 631
G V GWG + E+ +I S L+ +P++ C+ ++T NM CAG+ V
Sbjct: 136 GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKA--STRIRITDNMFCAGFKVN 193
Query: 632 GGK--DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
K D+C+GDSGG +M+ + R+ G+VS G GC R G YT V WIQ
Sbjct: 194 DTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRKGKYGFYTHVFRLKRWIQ 251
>pdb|1A5I|A Chain A, Catalytic Domain Of Vampire Bat (Desmodus Rotundus) Saliva
Plasminogen Activator In Complex With Egr-Cmk
(Glu-Gly-Arg Chloromethyl Ketone)
Length = 265
Score = 78.2 bits (191), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 41/115 (35%), Positives = 65/115 (56%), Gaps = 8/115 (6%)
Query: 581 VVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGK----- 634
+ G+G+ + S S+ L+ V + + C F +T NM+CAG G+
Sbjct: 149 LSGYGKHKSSSPFYSEQLKEGHVRLYPSSRCAPKFLFNKTVTNNMLCAGDTRSGEIYPNV 208
Query: 635 -DSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNN 688
D+CQGDSGG L+ + D + G++SWG+GC + PGVYT+V +Y+ WI++N
Sbjct: 209 HDACQGDSGGPLVCMN-DNHMTLLGIISWGVGCGEKDVPGVYTKVTNYLGWIRDN 262
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 37/110 (33%), Positives = 58/110 (52%), Gaps = 12/110 (10%)
Query: 20 VGGWTTEVNEYPWVVAL------EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
GG T++ +PW A+ +F CGG LIS +VLTAAHC + S L V
Sbjct: 15 TGGLFTDITSHPWQAAIFAQNRRSSGERFLCGGILISSCWVLTAAHCFQESYLPDQLKVV 74
Query: 74 ISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL--DAP 121
+ R E + +T +V K + H +++ ++++DIALL+L D+P
Sbjct: 75 LGRTYRVKPGEEE-QTFKVKKYIVHKEFDDD---TYNNDIALLQLKSDSP 120
>pdb|2XRC|A Chain A, Human Complement Factor I
pdb|2XRC|B Chain B, Human Complement Factor I
pdb|2XRC|C Chain C, Human Complement Factor I
pdb|2XRC|D Chain D, Human Complement Factor I
Length = 565
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 47/110 (42%), Positives = 67/110 (60%), Gaps = 8/110 (7%)
Query: 578 TGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPG--FEPKLTGNMMCAGYVEGGKD 635
T V GWGR +++ ++ S L+ +V ++SN C +F G F K M CAG +G D
Sbjct: 448 TCIVSGWGREKDNERVFS-LQWGEVKLISN--CSKFYGNRFYEK---EMECAGTYDGSID 501
Query: 636 SCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
+C+GDSGG L+ D + + GVVSWG C +P PGVYT+V +Y +WI
Sbjct: 502 ACKGDSGGPLVCMDANNVTYVWGVVSWGENCGKPEFPGVYTKVANYFDWI 551
Score = 67.0 bits (162), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 44/123 (35%), Positives = 67/123 (54%), Gaps = 13/123 (10%)
Query: 1 MFPDLKIAGCGVPNRM----DRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLT 56
+ P L CGV NRM RIVGG ++ + PW VA++ A CGG I ++LT
Sbjct: 303 LLPKL---SCGVKNRMHIRRKRIVGGKRAQLGDLPWQVAIKDASGITCGGIYIGGCWILT 359
Query: 57 AAHCVRSSKRHKDLI-AVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIAL 115
AAHC+R+SK H+ I + + + IE V +++ H YN A ++ +DIAL
Sbjct: 360 AAHCLRASKTHRYQIWTTVVDWIHPDLKRIVIEY--VDRIIFHENYN---AGTYQNDIAL 414
Query: 116 LKL 118
+++
Sbjct: 415 IEM 417
>pdb|2QXG|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXG|B Chain B, Crystal Structure Of Human Kallikrein 7 In Complex With
Ala- Ala-phe-chloromethylketone
pdb|2QXH|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXI|A Chain A, High Resolution Structure Of Human Kallikrein 7 In Complex
With Suc-Ala-Ala-Pro-Phe-Chloromethylketone
pdb|2QXJ|A Chain A, Crystal Structure Of Human Kallikrein 7 In Complex With
Suc- Ala-ala-pro-phe-chloromethylketone And Copper
Length = 224
Score = 78.2 bits (191), Expect = 2e-14, Method: Composition-based stats.
Identities = 43/115 (37%), Positives = 63/115 (54%), Gaps = 9/115 (7%)
Query: 578 TGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
T TV GWG SDL V ++S Q+C + ++ L +M+CAG + K++
Sbjct: 114 TCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKV--YKDLLENSMLCAGIPDSKKNA 171
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQNNTR 690
C GDSGG L+ R + G+VSWG C +PN PGVYT+V + +WI + +
Sbjct: 172 CNGDSGGPLVC-----RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMK 221
Score = 53.9 bits (128), Expect = 3e-07, Method: Composition-based stats.
Identities = 32/102 (31%), Positives = 56/102 (54%), Gaps = 11/102 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+ G +PW VAL + CGG L+++R+VLTAAHC K ++ + + S+
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHC----KMNEYTVHLGSD-- 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
T+ + + + + K HP Y+ Q +H +D+ L+KL++
Sbjct: 55 --TLGDRRAQRIKASKSFRHPGYSTQ---THVNDLMLVKLNS 91
>pdb|3BSQ|A Chain A, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|B Chain B, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
pdb|3BSQ|C Chain C, Crystal Structure Of Human Kallikrein 7 Produced As A
Secretion Protein In E.Coli
Length = 227
Score = 78.2 bits (191), Expect = 2e-14, Method: Composition-based stats.
Identities = 43/115 (37%), Positives = 63/115 (54%), Gaps = 9/115 (7%)
Query: 578 TGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
T TV GWG SDL V ++S Q+C + ++ L +M+CAG + K++
Sbjct: 114 TCTVSGWGTTTSPDVTFPSDLMCVDVKLISPQDCTKV--YKDLLENSMLCAGIPDSKKNA 171
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQNNTR 690
C GDSGG L+ R + G+VSWG C +PN PGVYT+V + +WI + +
Sbjct: 172 CNGDSGGPLVC-----RGTLQGLVSWGTFPCGQPNDPGVYTQVCKFTKWINDTMK 221
Score = 53.9 bits (128), Expect = 3e-07, Method: Composition-based stats.
Identities = 32/102 (31%), Positives = 56/102 (54%), Gaps = 11/102 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+ G +PW VAL + CGG L+++R+VLTAAHC K ++ + + S+
Sbjct: 1 IIDGAPCARGSHPWQVALLSGNQLHCGGVLVNERWVLTAAHC----KMNEYTVHLGSD-- 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
T+ + + + + K HP Y+ Q +H +D+ L+KL++
Sbjct: 55 --TLGDRRAQRIKASKSFRHPGYSTQ---THVNDLMLVKLNS 91
>pdb|1MD7|A Chain A, Monomeric Structure Of The Zymogen Of Complement Protease
C1r
Length = 328
Score = 77.8 bits (190), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 45/112 (40%), Positives = 71/112 (63%), Gaps = 8/112 (7%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKL---TGNMMCAGYVEGGKD 635
G V G+G +EE +IA DLR ++PV + Q C + + ++ + NM CAG+ +D
Sbjct: 217 GYVSGFGVMEE--KIAHDLRFVRLPVANPQACENWLRGKNRMDVFSQNMFCAGHPSLKQD 274
Query: 636 SCQGDSGGALLMEDLD-GRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
+CQGD+GG + D + R++ G+VSWGIGC+R G YT+V +Y++WI+
Sbjct: 275 ACQGDAGGVFAVRDPNTDRWVATGIVSWGIGCSR--GYGFYTKVLNYVDWIK 324
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 8/127 (6%)
Query: 10 CGVP----NRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSK 65
CG P + RI+GG ++ +PW V G+ GG L+ DR++LTAAH + +
Sbjct: 77 CGKPVNPVEQRQRIIGGQKAKMGNFPWQVFTNIHGRG--GGALLGDRWILTAAHTLYPKE 134
Query: 66 RHKDLIAVISEHNRATVYET--QIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLE 123
A + T E ++ + +V HP Y + + + DIALL+L+ +
Sbjct: 135 HEAQSNASLDVFLGHTNVEELMKLGNHPIRRVSVHPDYRQDESYNFEGDIALLELENSVT 194
Query: 124 FKPTVSP 130
P + P
Sbjct: 195 LGPNLLP 201
>pdb|1VZQ|H Chain H, Complex Of Thrombin With Designed Inhibitor 7165
Length = 250
Score = 77.8 bits (190), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 45/113 (39%), Positives = 64/113 (56%), Gaps = 7/113 (6%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV--EGGK-D 635
G V GWG ++E+GQ S L+ +P++ C+ ++T NM CAGY EG + D
Sbjct: 136 GRVTGWGNLKETGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKPDEGKRGD 192
Query: 636 SCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 ACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 245
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TAYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
>pdb|1MKW|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|K Chain K, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
Length = 308
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 50/121 (41%), Positives = 69/121 (57%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHK-----DL 70
RIV G EV PW V L + + CG +LISDR+VLTAAHC+ K DL
Sbjct: 49 RIVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDL 108
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE ++E ++ K+ HP+YN + ++ D DIALLKL P+E +
Sbjct: 109 LVRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWK--ENLDRDIALLKLKRPIELSDYIH 165
Query: 130 P 130
P
Sbjct: 166 P 166
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/119 (36%), Positives = 61/119 (51%), Gaps = 12/119 (10%)
Query: 579 GTVVGWGRVEESGQIA------SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
G V GWG E+ + S L+ +P++ C+ ++T NM CAGY G
Sbjct: 185 GRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRI--RITDNMFCAGYKPG 242
Query: 633 -GK--DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
GK D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 243 EGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 301
>pdb|4IGD|A Chain A, Crystal Structure Of The Zymogen Catalytic Region Of Human
Masp-1
Length = 406
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 68/111 (61%), Gaps = 3/111 (2%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG+ + + L ++P++ + C++ + + K+T +M+CAG EGGKD+C G
Sbjct: 293 VSGWGK-QFLQRFPETLMEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACAG 351
Query: 640 DSGGALLMEDLD-GRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNT 689
DSGG ++ + + G++ + G VSWG C + + GVY+ ++H +WIQ T
Sbjct: 352 DSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQRVT 402
Score = 47.8 bits (112), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 22/127 (17%)
Query: 10 CGVPN----RMDRIVGGWTTEVNEYPWVVALEQA-GKFFCGGTLISDRYVLTAAHCVRSS 64
CG+P M +I G + PW+ L G+ FCGG+L+ +++TAAHC+ S
Sbjct: 143 CGLPKFSRKLMAQIFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQS 202
Query: 65 -------KRHKDLIA------VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDH 111
R DL++ ++ +H R E + + V HP+Y+ + ++
Sbjct: 203 LDPEDPTLRDSDLLSPSDFKIILGKHWRLRSDENE-QHLGVKHTTLHPQYDPN---TFEN 258
Query: 112 DIALLKL 118
D+AL++L
Sbjct: 259 DVALVEL 265
>pdb|1H8D|H Chain H, X-Ray Structure Of The Human Alpha-Thrombin Complex With A
Tripeptide Phosphonate Inhibitor
Length = 260
Score = 77.4 bits (189), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 45/113 (39%), Positives = 64/113 (56%), Gaps = 7/113 (6%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV--EGGK-D 635
G V GWG ++E+GQ S L+ +P++ C+ ++T NM CAGY EG + D
Sbjct: 136 GRVTGWGNLKETGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKPDEGKRGD 192
Query: 636 SCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 ACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 245
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
>pdb|3GOV|B Chain B, Crystal Structure Of The Catalytic Region Of Human Masp-1
pdb|4DJZ|B Chain B, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
pdb|4DJZ|D Chain D, Catalytic Fragment Of Masp-1 In Complex With Its Specific
Inhibitor Developed By Directed Evolution On Sgci
Scaffold
Length = 251
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 68/111 (61%), Gaps = 3/111 (2%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG+ + + L ++P++ + C++ + + K+T +M+CAG EGGKD+C G
Sbjct: 138 VSGWGK-QFLQRFPETLMEIEIPIVDHSTCQKAYAPLKKKVTRDMICAGEKEGGKDACAG 196
Query: 640 DSGGALLMEDLD-GRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNT 689
DSGG ++ + + G++ + G VSWG C + + GVY+ ++H +WIQ T
Sbjct: 197 DSGGPMVTLNRERGQWYLVGTVSWGDDCGKKDRYGVYSYIHHNKDWIQRVT 247
Score = 43.5 bits (101), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 31/114 (27%), Positives = 55/114 (48%), Gaps = 18/114 (15%)
Query: 19 IVGGWTTEVNEYPWVVALEQA-GKFFCGGTLISDRYVLTAAHCVRSS-------KRHKDL 70
I G + PW+ L G+ FCGG+L+ +++TAAHC+ S R DL
Sbjct: 1 IFNGRPAQKGTTPWIAMLSHLNGQPFCGGSLLGSSWIVTAAHCLHQSLDPKDPTLRDSDL 60
Query: 71 IA------VISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
++ ++ +H R E + + V HP+Y+ + ++D+AL++L
Sbjct: 61 LSPSDFKIILGKHWRLRSDENE-QHLGVKHTTLHPQYD---PNTFENDVALVEL 110
>pdb|2BVR|H Chain H, Human Thrombin Complexed With Fragment-based Small
Molecules Occupying The S1 Pocket
Length = 252
Score = 77.0 bits (188), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 45/113 (39%), Positives = 63/113 (55%), Gaps = 7/113 (6%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV--EGGK-D 635
G V GWG ++E GQ S L+ +P++ C+ ++T NM CAGY EG + D
Sbjct: 136 GRVTGWGNLKEKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKPDEGKRGD 192
Query: 636 SCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 ACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 245
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 47/120 (39%), Positives = 67/120 (55%), Gaps = 11/120 (9%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
>pdb|1NPM|A Chain A, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
pdb|1NPM|B Chain B, Neuropsin, A Serine Protease Expressed In The Limbic
System Of Mouse Brain
Length = 225
Score = 77.0 bits (188), Expect = 3e-14, Method: Composition-based stats.
Identities = 43/109 (39%), Positives = 61/109 (55%), Gaps = 12/109 (11%)
Query: 581 VVGWGRVEESGQ-IASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+ GWG V + + L +V + S +C R +PG K+T M+CAG G D+CQ
Sbjct: 122 ISGWGTVTSPQENFPNTLNCAEVKIYSQNKCERAYPG---KITEGMVCAG-SSNGADTCQ 177
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWIQ 686
GDSGG L+ DG ++ G+ SWG C +P PGVYT++ Y WI+
Sbjct: 178 GDSGGPLV---CDG--MLQGITSWGSDPCGKPEKPGVYTKICRYTTWIK 221
Score = 65.1 bits (157), Expect = 1e-10, Method: Composition-based stats.
Identities = 35/100 (35%), Positives = 52/100 (52%), Gaps = 6/100 (6%)
Query: 31 PWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRATVYETQIETR 90
PW AL Q + CGG L+ DR+VLTAAHC K+ K + + +H+ + + + E
Sbjct: 13 PWQAALFQGERLICGGVLVGDRWVLTAAHC----KKQKYSVR-LGDHSLQSRDQPEQEI- 66
Query: 91 RVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+V + + HP YN + H HDI L++L V P
Sbjct: 67 QVAQSIQHPCYNNSNPEDHSHDIMLIRLQNSANLGDKVKP 106
>pdb|1DM4|B Chain B, Ser195ala Mutant Of Human Thrombin Complexed With
Fibrinopeptide A (7- 16)
pdb|1JMO|H Chain H, Crystal Structure Of The Heparin Cofactor Ii-S195a
Thrombin Complex
Length = 260
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 50/137 (36%), Positives = 74/137 (54%), Gaps = 11/137 (8%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 1 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 60
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 61 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 117
Query: 130 PDNKDDPKSELTQFKPG 146
P D ++ + + G
Sbjct: 118 PVCLPDRETAASLLQAG 134
Score = 69.7 bits (169), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 137 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 193
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GD+GG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 194 DEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 253
>pdb|1MH0|A Chain A, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1MH0|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
Length = 287
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 90 LVRIGKHSR-TRYEANIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 146
Query: 130 P 130
P
Sbjct: 147 P 147
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 166 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 222
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 223 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
>pdb|3K65|B Chain B, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex
Length = 308
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 49 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 108
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 109 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 165
Query: 130 P 130
P
Sbjct: 166 P 166
Score = 69.7 bits (169), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 185 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 241
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GD+GG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 242 DEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 301
>pdb|1NM6|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
At 1.8a
pdb|1NT1|A Chain A, Thrombin In Complex With Selective Macrocyclic Inhibitor
pdb|1TA2|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 1
pdb|1TA6|A Chain A, Crystal Structure Of Thrombin In Complex With Compound 14b
pdb|1SL3|A Chain A, Crystal Structue Of Thrombin In Complex With A Potent P1
Heterocycle- Aryl Based Inhibitor
pdb|1Z71|A Chain A, Thrombin And P2 Pyridine N-oxide Inhibitor Complex
Structure
pdb|1ZRB|A Chain A, Thrombin In Complex With An Azafluorenyl Inhibitor 23b
pdb|1ZGI|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 21
pdb|1ZGV|A Chain A, Thrombin In Complex With An Oxazolopyridine Inhibitor 2
pdb|3C1K|A Chain A, Crystal Structure Of Thrombin In Complex With Inhibitor 15
Length = 287
Score = 76.6 bits (187), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 29 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 88
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 89 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 145
Query: 130 P 130
P
Sbjct: 146 P 146
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 165 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 221
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 222 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 281
>pdb|1D9I|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electophilic Inhibitors Having Cyclohexyl Moieties
At P1
Length = 288
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 90 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 146
Query: 130 P 130
P
Sbjct: 147 P 147
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 166 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 222
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 223 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
>pdb|1EOJ|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
pdb|1EOL|A Chain A, Design Of P1' And P3' Residues Of Trivalent Thrombin
Inhibitors And Their Crystal Structures
Length = 289
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 91
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 92 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 148
Query: 130 P 130
P
Sbjct: 149 P 149
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 168 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 224
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 225 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 284
>pdb|2BDY|A Chain A, Thrombin In Complex With Inhibitor
Length = 289
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 90 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 146
Query: 130 P 130
P
Sbjct: 147 P 147
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 166 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 222
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 223 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
>pdb|1JWT|A Chain A, Crystal Structure Of Thrombin In Complex With A Novel
Bicyclic Lactam Inhibitor
Length = 305
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 95
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 96 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 152
Query: 130 P 130
P
Sbjct: 153 P 153
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 172 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 228
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 229 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 288
>pdb|1HAG|E Chain E, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1DOJ|A Chain A, Crystal Structure Of Human Alpha-ThrombinRwj-51438 Complex
At 1.7 A
pdb|1XM1|A Chain A, Nonbasic Thrombin Inhibitor Complex
Length = 295
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 36 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 95
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 96 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 152
Query: 130 P 130
P
Sbjct: 153 P 153
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 172 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 228
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 229 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 288
>pdb|3GIC|B Chain B, Structure Of Thrombin Mutant Delta(146-149e) In The Free
Form
Length = 250
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 58/163 (35%), Positives = 85/163 (52%), Gaps = 17/163 (10%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPGNQKSYKWDIV-WFNLIGF-AVLHLATL 171
D ++ + + G YK + W NL G +VL + L
Sbjct: 118 VCLPDRETAASLLQAG----YKGRVTGWGNLKGQPSVLQVVNL 156
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 44/113 (38%), Positives = 62/113 (54%), Gaps = 9/113 (7%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV--EGGK-D 635
G V GWG ++ GQ S L+ +P++ C+ ++T NM CAGY EG + D
Sbjct: 136 GRVTGWGNLK--GQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKPDEGKRGD 190
Query: 636 SCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 191 ACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 243
>pdb|3SQE|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The
Alternative Form
pdb|3SQH|E Chain E, Crystal Structure Of Prethrombin-2 Mutant S195a In The The
Open Form
Length = 290
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 31 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 90
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 91 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 147
Query: 130 P 130
P
Sbjct: 148 P 148
Score = 69.3 bits (168), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 167 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 223
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GD+GG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 224 DEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 283
>pdb|1D6W|A Chain A, Structure Of Thrombin Complexed With Selective
Non-Electrophilic Inhibitors Having Cyclohexyl Moieties
At P1
pdb|1G37|A Chain A, Crystal Structure Of Human Alpha-thrombin Complexed With
Bch-10556 And Exosite-directed Peptide
Length = 287
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 30 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 89
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 90 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 146
Query: 130 P 130
P
Sbjct: 147 P 147
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 166 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 222
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 223 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 282
>pdb|1NU9|A Chain A, Staphylocoagulase-prethrombin-2 Complex
pdb|1NU9|D Chain D, Staphylocoagulase-prethrombin-2 Complex
Length = 291
Score = 76.3 bits (186), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 32 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 91
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 92 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 148
Query: 130 P 130
P
Sbjct: 149 P 149
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 168 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 224
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 225 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 284
>pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1
Length = 424
Score = 76.3 bits (186), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 48/121 (39%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDL 70
RIV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL
Sbjct: 165 RIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDL 224
Query: 71 IAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F +
Sbjct: 225 LVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIH 281
Query: 130 P 130
P
Sbjct: 282 P 282
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 45/119 (37%), Positives = 64/119 (53%), Gaps = 14/119 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 301 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 357
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 358 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQ 416
>pdb|3F6U|H Chain H, Crystal Structure Of Human Activated Protein C (Apc)
Complexed With Ppack
Length = 240
Score = 75.9 bits (185), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 40/116 (34%), Positives = 65/116 (56%), Gaps = 8/116 (6%)
Query: 581 VVGWGRVEESGQIASDLRA-----TQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKD 635
V GWG + A R ++PV+ + EC + ++ NM+CAG + +D
Sbjct: 128 VTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEV--MSNMVSENMLCAGILGDRQD 185
Query: 636 SCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
+C+GDSGG ++ G + + G+VSWG GC ++ GVYT+V+ Y++WI + RD
Sbjct: 186 ACEGDSGGPMVAS-FHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHIRD 240
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 39/115 (33%), Positives = 59/115 (51%), Gaps = 12/115 (10%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
++ G T + PW VV L+ K CG LI +VLTAAHC+ SK+ L+ + E+
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKK---LLVRLGEY 57
Query: 78 N--RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ R +E ++ + +V HP Y+ + D+DIALL L P T+ P
Sbjct: 58 DLRRWEKWELDLDIK---EVFVHPNYSKS---TTDNDIALLHLAQPATLSQTIVP 106
>pdb|1ID5|H Chain H, Crystal Structure Of Bovine Thrombin Complex With Protease
Inhibitor Ecotin
Length = 256
Score = 75.9 bits (185), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 54/138 (39%), Positives = 73/138 (52%), Gaps = 15/138 (10%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHK-----DLI 71
IV G EV PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFK----P 126
I +H+R T YE ++E ++ K+ HP+YN + ++ D DIALLKL P+E P
Sbjct: 61 VRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWK--ENLDRDIALLKLKRPIELSDYIHP 117
Query: 127 TVSPDNKDDPKSELTQFK 144
PD + K FK
Sbjct: 118 VCLPDKQTAAKLLHAGFK 135
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 44/119 (36%), Positives = 61/119 (51%), Gaps = 12/119 (10%)
Query: 579 GTVVGWGRVEESGQIA------SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
G V GWG E+ + S L+ +P++ C+ ++T NM CAGY G
Sbjct: 136 GRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRI--RITDNMFCAGYKPG 193
Query: 633 -GK--DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
GK D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 194 EGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1AUT|C Chain C, Human Activated Protein C
Length = 250
Score = 75.9 bits (185), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 40/116 (34%), Positives = 65/116 (56%), Gaps = 8/116 (6%)
Query: 581 VVGWGRVEESGQIASDLRA-----TQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKD 635
V GWG + A R ++PV+ + EC + ++ NM+CAG + +D
Sbjct: 128 VTGWGYHSSREKEAKRNRTFVLNFIKIPVVPHNECSEV--MSNMVSENMLCAGILGDRQD 185
Query: 636 SCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
+C+GDSGG ++ G + + G+VSWG GC ++ GVYT+V+ Y++WI + RD
Sbjct: 186 ACEGDSGGPMVAS-FHGTWFLVGLVSWGEGCGLLHNYGVYTKVSRYLDWIHGHIRD 240
Score = 58.5 bits (140), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 39/115 (33%), Positives = 59/115 (51%), Gaps = 12/115 (10%)
Query: 19 IVGGWTTEVNEYPW-VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
++ G T + PW VV L+ K CG LI +VLTAAHC+ SK+ L+ + E+
Sbjct: 1 LIDGKMTRRGDSPWQVVLLDSKKKLACGAVLIHPSWVLTAAHCMDESKK---LLVRLGEY 57
Query: 78 N--RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ R +E ++ + +V HP Y+ + D+DIALL L P T+ P
Sbjct: 58 DLRRWEKWELDLDIK---EVFVHPNYSKS---TTDNDIALLHLAQPATLSQTIVP 106
>pdb|1BBR|K Chain K, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1BBR|N Chain N, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1ETR|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETS|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1ETT|H Chain H, Refined 2.3 Angstroms X-Ray Crystal Structure Of Bovine
Thrombin Complexes Formed With The Benzamidine And
Arginine-Based Thrombin Inhibitors Napap, 4-Tapap And
Mqpa: A Starting Point For Improving Antithrombotics
pdb|1HRT|H Chain H, The Structure Of A Complex Of Bovine Alpha-Thrombin And
Recombinant Hirudin At 2.8 Angstroms Resolution
pdb|1TBR|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBR|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|H Chain H, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1TBQ|K Chain K, Crystal Structure Of Insect Derived Double Domain Kazal
Inhibitor Rhodniin In Complex With Thrombin
pdb|1UCY|K Chain K, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1UCY|N Chain N, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|H Chain H, Thrombin:hirudin 51-65 Complex
pdb|1MKW|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1MKX|H Chain H, The Co-Crystal Structure Of Unliganded Bovine Alpha-
Thrombin And Prethrombin-2: Movement Of The Yppw Segment
And Active Site Residues Upon Ligand Binding
pdb|1TOC|B Chain B, Structure Of Serine Proteinase
pdb|1TOC|D Chain D, Structure Of Serine Proteinase
pdb|1TOC|F Chain F, Structure Of Serine Proteinase
pdb|1TOC|H Chain H, Structure Of Serine Proteinase
pdb|1UVT|H Chain H, Bovine Thrombin--Bm14.1248 Complex
pdb|1UVU|H Chain H, Bovine Thrombin--Bm12.1700 Complex
pdb|1YCP|H Chain H, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
pdb|1A0H|B Chain B, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1A0H|E Chain E, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1:
KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN
INTERACTIONS AND Location Of The Linker Chain
pdb|1AVG|H Chain H, Thrombin Inhibitor From Triatoma Pallidipennis
pdb|2A1D|B Chain B, Staphylocoagulase Bound To Bovine Thrombin
pdb|2A1D|F Chain F, Staphylocoagulase Bound To Bovine Thrombin
pdb|2ODY|B Chain B, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|2ODY|D Chain D, Thrombin-bound Boophilin Displays A Functional And
Accessible Reactive-site Loop
pdb|3PMA|B Chain B, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMA|D Chain D, 2.2 Angstrom Crystal Structure Of The Complex Between
Bovine Thrombin And Sucrose Octasulfate
pdb|3PMB|B Chain B, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
pdb|3PMB|D Chain D, 2.9 Angstrom Crystal Structure Of Bovine Thrombin In
Tetragonal Spacegroup
Length = 259
Score = 75.9 bits (185), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 54/138 (39%), Positives = 73/138 (52%), Gaps = 15/138 (10%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHK-----DLI 71
IV G EV PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFK----P 126
I +H+R T YE ++E ++ K+ HP+YN + ++ D DIALLKL P+E P
Sbjct: 61 VRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWK--ENLDRDIALLKLKRPIELSDYIHP 117
Query: 127 TVSPDNKDDPKSELTQFK 144
PD + K FK
Sbjct: 118 VCLPDKQTAAKLLHAGFK 135
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/119 (36%), Positives = 61/119 (51%), Gaps = 12/119 (10%)
Query: 579 GTVVGWGRVEESGQIA------SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
G V GWG E+ + S L+ +P++ C+ ++T NM CAGY G
Sbjct: 136 GRVTGWGNRRETWTTSVAEVQPSVLQVVNLPLVERPVCKASTRI--RITDNMFCAGYKPG 193
Query: 633 -GK--DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
GK D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 194 EGKRGDACEGDSGGPFVMKSPYNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1BBR|H Chain H, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|H Chain H, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|F Chain F, Thrombin:hirudin 51-65 Complex
pdb|1YCP|K Chain K, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 150
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 49/120 (40%), Positives = 68/120 (56%), Gaps = 11/120 (9%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHK-----DLI 71
IV G EV PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGQDAEVGLSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTVDDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE ++E ++ K+ HP+YN + ++ D DIALLKL P+E + P
Sbjct: 61 VRIGKHSR-TRYERKVEKISMLDKIYIHPRYNWK--ENLDRDIALLKLKRPIELSDYIHP 117
>pdb|2JET|C Chain C, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 99
Score = 75.1 bits (183), Expect = 1e-13, Method: Composition-based stats.
Identities = 39/90 (43%), Positives = 56/90 (62%), Gaps = 5/90 (5%)
Query: 597 LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLI 656
L+ +P++S +C++ G K+T M CAG G DSC GDSGG L+ + DG + +
Sbjct: 9 LQQAALPIVSEADCKKSWG--SKITDVMTCAG--ASGVDSCMGDSGGPLVCQK-DGVWTL 63
Query: 657 AGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
AG+VSWG G ++PGVY+RV M W+Q
Sbjct: 64 AGIVSWGSGVCSTSTPGVYSRVTALMPWVQ 93
>pdb|2A0Q|B Chain B, Structure Of Thrombin In 400 Mm Potassium Chloride
pdb|2A0Q|D Chain D, Structure Of Thrombin In 400 Mm Potassium Chloride
Length = 257
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYEANIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1SFQ|B Chain B, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SFQ|E Chain E, Fast Form Of Thrombin Mutant R(77a)a Bound To Ppack
pdb|1SG8|B Chain B, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SG8|E Chain E, Crystal Structure Of The Procoagulant Fast Form Of
Thrombin
pdb|1SGI|B Chain B, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SGI|E Chain E, Crystal Structure Of The Anticoagulant Slow Form Of
Thrombin
pdb|1SHH|B Chain B, Slow Form Of Thrombin Bound With Ppack
pdb|1SHH|E Chain E, Slow Form Of Thrombin Bound With Ppack
pdb|2HWL|B Chain B, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|2HWL|D Chain D, Crystal Structure Of Thrombin In Complex With Fibrinogen
Gamma' Peptide
pdb|3BV9|B Chain B, Structure Of Thrombin Bound To The Inhibitor Fm19
Length = 259
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYEANIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1H8I|H Chain H, X-Ray Crystal Structure Of Human Alpha-Thrombin With A
Tripeptide Phosphonate Inhibitor
Length = 253
Score = 75.1 bits (183), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 43/113 (38%), Positives = 62/113 (54%), Gaps = 6/113 (5%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV--EGGK-D 635
G V GWG ++E+ S L+ +P++ C+ ++T NM CAGY EG + D
Sbjct: 136 GRVTGWGNLKETWGQPSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKPDEGKRGD 193
Query: 636 SCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 194 ACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 246
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
>pdb|1VR1|H Chain H, Specifity For Plasminogen Activator Inhibitor-1
Length = 261
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 50/140 (35%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 19 IVGGWTTEVNEYPWVVAL------EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRH 67
IV G E+ PW V L +F CG +LISDR+VLTAAHC+ +
Sbjct: 1 IVEGSDAEIGMSPWQVMLFAKHRRSPGERFLCGASLISDRWVLTAAHCLLYPPWDKNFTE 60
Query: 68 KDLIAVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKP 126
DL+ I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F
Sbjct: 61 NDLLVRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSD 117
Query: 127 TVSPDNKDDPKSELTQFKPG 146
+ P D ++ + + G
Sbjct: 118 YIHPVCLPDRETAASLLQAG 137
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 63/120 (52%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CA Y
Sbjct: 140 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKD--STRIRITDNMFCAYYKP 196
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 197 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 256
>pdb|2KAI|B Chain B, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization, Patterson
Search, Structure Determination, Refinement, Structure
And Comparison With Its Components And With The Bovine
Trypsin- Pancreatic Trypsin Inhibitor Complex
pdb|2PKA|B Chain B, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|Y Chain Y, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|B Chain B, Kallikrein Complexed With Hirustasin
pdb|1HIA|Y Chain Y, Kallikrein Complexed With Hirustasin
Length = 152
Score = 74.7 bits (182), Expect = 1e-13, Method: Composition-based stats.
Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 11/109 (10%)
Query: 583 GWGRVE---ESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
GWG +E + + +++ Q+ ++ N C K+T +M+CAGY+ GGKD+C G
Sbjct: 45 GWGSIEPGPDDFEFPDEIQCVQLTLLQNTFCAD--AHPDKVTESMLCAGYLPGGKDTCMG 102
Query: 640 DSGGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQN 687
DSGG L+ + G+ SWG C N P +YT++ Y++WI +
Sbjct: 103 DSGGPLICNG-----MWQGITSWGHTPCGSANKPSIYTKLIFYLDWIDD 146
>pdb|2OD3|B Chain B, Human Thrombin Chimera With Human Residues 184a, 186,
186a, 186b, 186c And 222 Replaced By Murine Thrombin
Equivalents
Length = 259
Score = 74.7 bits (182), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 63/120 (52%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGY-V 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAG+ V
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGFKV 192
Query: 631 EGGK--DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
K D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 NDTKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRKGKYGFYTHVFRLKKWIQK 252
>pdb|1THP|B Chain B, Structure Of Human Alpha-Thrombin Y225p Mutant Bound To
D-Phe-Pro-Arg- Chloromethylketone
pdb|3S7H|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|B Chain B, Structure Of Thrombin Mutant Y225p In The E Form
pdb|3S7K|D Chain D, Structure Of Thrombin Mutant Y225p In The E Form
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 46/120 (38%), Positives = 65/120 (54%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R PG YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKPGFYTHVFRLKKWIQK 252
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
>pdb|1GJ5|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190ALA190 PROTEASE, Structure-Based Drug Design
pdb|1SB1|H Chain H, Novel Non-Covalent Thrombin Inhibitors Incorporating P1
4,5,6,7- Tetrahydrobenzothiazole Arginine Side Chain
Mimetics
pdb|2PW8|H Chain H, Crystal Structure Of Sulfo-Hirudin Complexed To Thrombin
pdb|3DD2|H Chain H, Crystal Structure Of An Rna Aptamer Bound To Human
Thrombin
pdb|1GJ4|H Chain H, Selectivity At S1, H2o Displacement, Upa, Tpa,
Ser190/ala190 Protease, Structure-based Drug Design
Length = 258
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1QUR|H Chain H, Human Alpha-Thrombin In Complex With Bivalent,
Benzamidine-Based Synthetic Inhibitor
pdb|1D3D|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzothiophene Inhibitor 4
pdb|1EB1|H Chain H, Complex Structure Of Human Thrombin With N-Methyl-Arginine
Inhibitor
pdb|1GHV|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1YPE|H Chain H, Thrombin Inhibitor Complex
pdb|1YPG|H Chain H, Thrombin Inhibitor Complex
pdb|1YPJ|H Chain H, Thrombin Inhibitor Complex
pdb|1YPK|H Chain H, Thrombin Inhibitor Complex
pdb|1YPL|H Chain H, X-Ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1008
pdb|1YPM|H Chain H, X-ray Crystal Structure Of Thrombin Inhibited By Synthetic
Cyanopeptide Analogue Ra-1014
pdb|2ANM|H Chain H, Ternary Complex Of An Orally Active Thrombin Inhibitor
With Human Thrombin And A C-Terminal Hirudin Derived
Exo-Sit Inhibitor
pdb|2CF9|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|1GHX|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|1GHY|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-Centered Short Hydrogen Bonding Network At The
Active Site
pdb|2CF8|H Chain H, Complex Of Recombinant Human Thrombin With A Inhibitor
pdb|2CN0|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Inhibitor
pdb|3BIU|H Chain H, Human Thrombin-In Complex With Ub-Thr10
pdb|3BIV|H Chain H, Human Thrombin-In Complex With Ub-Thr11
pdb|2V3H|H Chain H, Thrombin With 3-Cycle No F
pdb|2V3O|H Chain H, Thrombin With 3-Cycle With F
pdb|4AX9|H Chain H, Human Thrombin Complexed With Napsagatran, Ro0466240
pdb|4AYV|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AYY|B Chain B, Human Thrombin - Inhibitor Complex
pdb|4AZ2|B Chain B, Human Thrombin - Inhibitor Complex
pdb|1GHW|H Chain H, A Novel Serine Protease Inhibition Motif Involving A
Multi-centered Short Hydrogen Bonding Network At The
Active Site
Length = 257
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1TWX|B Chain B, Crystal Structure Of The Thrombin Mutant D221aD222K
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 46/120 (38%), Positives = 65/120 (54%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GCAR G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCARKGKYGFYTHVFRLKKWIQK 252
>pdb|2THF|B Chain B, Structure Of Human Alpha-thrombin Y225f Mutant Bound To
D-phe-pro-arg- Chloromethylketone
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKFGFYTHVFRLKKWIQK 252
>pdb|1JOU|B Chain B, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|D Chain D, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1JOU|F Chain F, Crystal Structure Of Native S195a Thrombin With An
Unoccupied Active Site
pdb|1TB6|H Chain H, 2.5a Crystal Structure Of The
Antithrombin-Thrombin-Heparin Ternary Complex
pdb|2B5T|B Chain B, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|2B5T|D Chain D, 2.1 Angstrom Structure Of A Nonproductive Complex Between
Antithrombin, Synthetic Heparin Mimetic Sr123781 And Two
S195a Thrombin Molecules
pdb|3B9F|H Chain H, 1.6 A Structure Of The Pci-Thrombin-Heparin Complex
pdb|3GIS|B Chain B, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|D Chain D, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3GIS|F Chain F, Crystal Structure Of Na-Free Thrombin In Complex With
Thrombomodulin
pdb|3LU9|B Chain B, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|3LU9|E Chain E, Crystal Structure Of Human Thrombin Mutant S195a In
Complex Extracellular Fragment Of Human Par1
pdb|4DT7|B Chain B, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DT7|D Chain D, Crystal Structure Of Thrombin Bound To The Activation
Domain Qedqvdprlidgkmtrrgds Of Protein C
pdb|4DY7|B Chain B, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
pdb|4DY7|E Chain E, Crystal Structures Of Protease Nexin-1 In Complex With
S195a Thrombin
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 69.7 bits (169), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GD+GG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDAGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1ABI|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1ABJ|H Chain H, Structure Of The Hirulog 3-Thrombin Complex And Nature Of
The S' Subsites Of Substrates And Inhibitors
pdb|1DWB|H Chain H, Crystallographic Analysis At 3.0-angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-directed Inhibitors
pdb|1DWC|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWD|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1DWE|H Chain H, Crystallographic Analysis At 3.0-Angstroms Resolution Of
The Binding To Human Thrombin Of Four Active
Site-Directed Inhibitors
pdb|1FPH|H Chain H, The Interaction Of Thrombin With Fibrinogen: A Structural
Basis For Its Specificity
pdb|1HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of Alpha-
Thrombin
pdb|1IHS|H Chain H, Crystal Structure Of The Complex Of Human Alpha-thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1IHT|H Chain H, Crystal Structure Of The Complex Of Human Alpha-Thrombin
And Non- Hydrolyzable Bifunctional Inhibitors,
Hirutonin-2 And Hirutonin-6
pdb|1PPB|H Chain H, The Refined 1.9 Angstroms Crystal Structure Of Human
Alpha-Thrombin: Interaction With D-Phe-Pro-Arg
Chloromethylketone And Significance Of The
Tyr-Pro-Pro-Trp Insertion Segment
pdb|1THR|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1THS|H Chain H, Structures Of Thrombin Complexes With A Designed And A
Natural Exosite Inhibitor
pdb|1TMB|H Chain H, Molecular Basis For The Inhibition Of Human Alpha-thrombin
By The Macrocyclic Peptide Cyclotheonamide A
pdb|2HGT|H Chain H, Structure Of The Hirugen And Hirulog 1 Complexes Of
Alpha-Thrombin
pdb|2HPP|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin
pdb|2HPQ|H Chain H, Structures Of The Noncovalent Complexes Of Human And
Bovine Prothrombin Fragment 2 With Human Ppack-thrombin
pdb|3HTC|H Chain H, The Structure Of A Complex Of Recombinant Hirudin And
Human Alpha-Thrombin
pdb|4HTC|H Chain H, The Refined Structure Of The Hirudin-Thrombin Complex
pdb|1HUT|H Chain H, The Structure Of Alpha-Thrombin Inhibited By A 15-Mer
Single-Stranded Dna Aptamer
pdb|1NRN|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRO|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRP|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRQ|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRR|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1NRS|H Chain H, Crystallographic Structures Of Thrombin Complexed With
Thrombin Receptor Peptides: Existence Of Expected And
Novel Binding Modes
pdb|1TMT|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1TMU|H Chain H, Changes In Interactions In Complexes Of Hirudin
Derivatives And Human Alpha-Thrombin Due To Different
Crystal Forms
pdb|1HLT|H Chain H, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HLT|K Chain K, The Structure Of A Nonadecapeptide Of The Fifth Egf Domain
Of Thrombomodulin Complexed With Thrombin
pdb|1HAH|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|1HAI|H Chain H, The Isomorphous Structures Of Prethrombin2, Hirugen-And
Ppack- Thrombin: Changes Accompanying Activation And
Exosite Binding To Thrombin
pdb|3HAT|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1FPC|H Chain H, Active Site Mimetic Inhibition Of Thrombin
pdb|1HBT|H Chain H, Human Alpha-Thrombin Complexed With A Peptidyl Pyridinium
Methyl Ketone Containing Bivalent Inhibitor
pdb|1HDT|H Chain H, Structure Of A Retro-Binding Peptide Inhibitor Complexed
With Human Alpha-Thrombin
pdb|1HAO|H Chain H, Complex Of Human Alpha-thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (based On Nmr Model Of
Dna)
pdb|1HAP|H Chain H, Complex Of Human Alpha-Thrombin With A 15mer
Oligonucleotide Ggttggtgtggttgg (Based On X-Ray Model Of
Dna)
pdb|1AHT|H Chain H, Crystal Structure Of Human Alpha-Thrombin Complexed With
Hirugen And P-Amidinophenylpyruvate At 1.6 Angstroms
Resolution
pdb|1DIT|H Chain H, Complex Of A Divalent Inhibitor With Thrombin
pdb|1TOM|H Chain H, Alpha-Thrombin Complexed With Hirugen
pdb|1HXF|H Chain H, Human Thrombin Complex With Hirudin Variant
pdb|1BMM|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-4-[(Aminoiminomethyl)
Amino]-N-[[1-[3-Hydroxy-2-[(2-
Naphthalenylsulfonyl)amino]-1-
Oxopropyl]-2-Pyrrolidinyl] Methyl]butanamide
(Bms-186282)
pdb|1BMN|H Chain H, Human Alpha-Thrombin Complexed With
[s-(R,R)]-1-(Aminoiminomethyl)-
N-[[1-[n-[(2-Naphthalenylsulfonyl)-L-Seryl]-
Pyrrolidinyl]methyl]-3- Piperidenecarboxamide
(Bms-189090)
pdb|1UMA|H Chain H, Alpha-Thrombin (Hirugen) Complexed With
Na-(N,N-Dimethylcarbamoyl)- Alpha-Azalysine
pdb|1LHD|H Chain H, Human Alpha-thrombin Complexed With
Ac-(d)phe-pro-borolys-oh
pdb|1LHE|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-N-
Butyl-Amidino-Glycine-Oh
pdb|1LHF|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-Boro-
Homolys-Oh
pdb|1LHG|H Chain H, Human Alpha-Thrombin Complexed With Ac-(D)phe-Pro-
Boroornithine-Oh
pdb|1LHC|H Chain H, Human Alpha-Thrombin Complexed With
Ac-(D)phe-Pro-Boroarg-Oh
pdb|1AD8|H Chain H, Complex Of Thrombin With And Inhibitor Containing A Novel
P1 Moiety
pdb|1AI8|H Chain H, Human Alpha-Thrombin Ternary Complex With The Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Borompg
pdb|1AIX|H Chain H, Human Alpha-Thrombin Ternary Complex With Exosite
Inhibitor Hirugen And Active Site Inhibitor
Phch2oco-D-Dpa-Pro-Boroval
pdb|1AE8|H Chain H, Human Alpha-Thrombin Inhibition By
Eoc-D-Phe-Pro-Azalys-Onp
pdb|1AFE|H Chain H, Human Alpha-Thrombin Inhibition By Cbz-Pro-Azalys-Onp
pdb|1UVS|H Chain H, Bovine Thrombin--Bm51.1011 Complex
pdb|5GDS|H Chain H, Hirunorms Are True Hirudin Mimetics. The Crystal Structure
Of Human Alpha-Thrombin:hirunorm V Complex
pdb|1AY6|H Chain H, Thrombin Inhibitor From Theonalla, Cyclotheanamide-Based
Macrocyclic Tripeptide Motif
pdb|1A46|H Chain H, Thrombin Complexed With Hirugen And A Beta-Strand Mimetic
Inhibitor
pdb|1A4W|H Chain H, Crystal Structures Of Thrombin With Thiazole-Containing
Inhibitors: Probes Of The S1' Binding Site
pdb|1A5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1B5G|H Chain H, Human Thrombin Complexed With Novel Synthetic Peptide
Mimetic Inhibitor And Hirugen
pdb|1TBZ|H Chain H, Human Thrombin With Active Site N-Methyl-D
Phenylalanyl-N-[5-
(Aminoiminomethyl)amino]-1-{{benzothiazolyl)carbonyl]
Butyl]-L- Prolinamide Trifluroacetate And
Exosite-Hirugen
pdb|1A2C|H Chain H, Structure Of Thrombin Inhibited By Aeruginosin298-A From A
Blue-Green Alga
pdb|1A61|H Chain H, Thrombin Complexed With A Beta-Mimetic Thiazole-Containing
Inhibitor
pdb|1A3B|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog1
pdb|1A3E|H Chain H, Complex Of Human Alpha-Thrombin With The Bifunctional
Boronate Inhibitor Borolog2
pdb|1AWF|H Chain H, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|B Chain B, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1AWH|D Chain D, Novel Covalent Thrombin Inhibitor From Plant Extract
pdb|1BCU|H Chain H, Alpha-Thrombin Complexed With Hirugen And Proflavin
pdb|8KME|2 Chain 2, Crystal Structure Of Human Alpha-thrombin Inhibited With
Sel2770.
pdb|1BA8|B Chain B, Thrombin Inhibitor With A Rigid Tripeptidyl Aldehydes
pdb|1BB0|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|1CA8|B Chain B, Thrombin Inhibitors With Rigid Tripeptidyl Aldehydes
pdb|4THN|H Chain H, The Crystal Structure Of Alpha-Thrombin-Hirunorm Iv
Complex Reveals A Novel Specificity Site Recognition
Mode.
pdb|1QBV|H Chain H, Crystal Structure Of Thrombin Complexed With An
Guanidine-Mimetic Inhibitor
pdb|1D4P|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
5- Amidinoindole-4-benzylpiperidine Inhibitor
pdb|7KME|H Chain H, Crystal Structure Of Human Alpha-Thrombin Inhibited With
Sel2711.
pdb|1QHR|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ1|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ6|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1QJ7|B Chain B, Novel Covalent Active Site Thrombin Inhibitors
pdb|1D3P|B Chain B, Crystal Structure Of Human Aplha-Thrombin In Complex With
Benzo[b]thiophene Inhibitor 3
pdb|1D3Q|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 2
pdb|1D3T|B Chain B, Crystal Structure Of Human Alpha Thrombin In Complex With
Benzo[b]thiophene Inhibitor 1
pdb|1C4U|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4V|2 Chain 2, Selective Non Electrophilic Thrombin Inhibitors With
Cyclohexyl Moieties.
pdb|1C4Y|2 Chain 2, Selective Non-Electrophilic Thrombin Inhibitors
pdb|1DE7|H Chain H, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1DE7|K Chain K, Interaction Of Factor Xiii Activation Peptide With
Alpha-Thrombin: Crystal Structure Of The
Enzyme-Substrate Complex
pdb|1G30|B Chain B, Thrombin Inhibitor Complex
pdb|1G32|B Chain B, Thrombin Inhibitor Complex
pdb|1KTS|B Chain B, Thrombin Inhibitor Complex
pdb|1KTT|B Chain B, Thrombin Inhibitor Complex
pdb|1K21|H Chain H, Human Thrombin-Inhibitor Complex
pdb|1K22|H Chain H, Human Thrombin-inhibitor Complex
pdb|1NY2|2 Chain 2, Human Alpha Thrombin Inhibited By Rppgf And Hirugen
pdb|1O2G|H Chain H, Elaborate Manifold Of Short Hydrogen Bond Arrays Mediating
Binding Of Active Site-Directed Serine Protease
Inhibitors
pdb|1OYT|H Chain H, Complex Of Recombinant Human Thrombin With A Designed
Fluorinated Inhibitor
pdb|1NO9|H Chain H, Design Of Weakly Basic Thrombin Inhibitors Incorporating
Novel P1 Binding Functions: Molecular And X-Ray
Crystallographic Studies.
pdb|1OOK|B Chain B, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Human Alpha-thrombin
pdb|1P8V|C Chain C, Crystal Structure Of The Complex Of Platelet Receptor
Gpib-alpha And Alpha-thrombin At 2.6a
pdb|1NU7|B Chain B, Staphylocoagulase-Thrombin Complex
pdb|1NU7|F Chain F, Staphylocoagulase-Thrombin Complex
pdb|1NZQ|H Chain H, D-Phe-Pro-Arg-Type Thrombin Inhibitor
pdb|1O0D|H Chain H, Human Thrombin Complexed With A D-Phe-Pro-Arg-Type
Inhibitor And A C- Terminal Hirudin Derived Exo-Site
Inhibitor
pdb|1MU6|B Chain B, Crystal Structure Of Thrombin In Complex With L-378,622
pdb|1MU8|B Chain B, Thrombin-Hirugen_l-378,650
pdb|1MUE|B Chain B, Thrombin-Hirugen-L405,426
pdb|1SR5|C Chain C, Antithrombin-Anhydrothrombin-Heparin Ternary Complex
Structure
pdb|1O5G|H Chain H, Dissecting And Designing Inhibitor Selectivity
Determinants At The S1 Site Using An Artificial Ala190
Protease (Ala190 Upa)
pdb|1XMN|B Chain B, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|D Chain D, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|F Chain F, Crystal Structure Of Thrombin Bound To Heparin
pdb|1XMN|H Chain H, Crystal Structure Of Thrombin Bound To Heparin
pdb|1WAY|B Chain B, Active Site Thrombin Inhibitors
pdb|1T4U|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|1T4V|H Chain H, Crystal Structure Analysis Of A Novel Oxyguanidine Bound
To Thrombin
pdb|2AFQ|B Chain B, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2AFQ|D Chain D, 1.9 Angstrom Crytal Structure Of Wild-Type Human Thrombin
In The Sodium Free State
pdb|2A45|B Chain B, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|2A45|E Chain E, Crystal Structure Of The Complex Between Thrombin And The
Central "e" Region Of Fibrin
pdb|1W7G|H Chain H, Alpha-Thrombin Complex With Sulfated Hirudin (Residues
54-65) And L- Arginine Template Inhibitor Cs107
pdb|2FES|H Chain H, Orally Active Thrombin Inhibitors
pdb|2C8W|B Chain B, Thrombin Inhibitors
pdb|2C8X|B Chain B, Thrombin Inhibitors
pdb|2C8Y|B Chain B, Thrombin Inhibitors
pdb|2C8Z|B Chain B, Thrombin Inhibitors
pdb|2C90|B Chain B, Thrombin Inhibitors
pdb|2C93|B Chain B, Thrombin Inhibitors
pdb|2FEQ|H Chain H, Orally Active Thrombin Inhibitors
pdb|2BVS|H Chain H, Human Thrombin Complexed With Fragment-Based Small
Molecules Occupying The S1 Pocket
pdb|2BVX|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-P2-Linker
pdb|2BXT|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2BXU|H Chain H, Design And Discovery Of Novel, Potent Thrombin Inhibitors
With A Solubilizing Cationic P1-p2-linker
pdb|2A2X|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
Inh12
pdb|2ANK|H Chain H, Orally Active Thrombin Inhibitors In Complex With Thrombin
And An Exosite Decapeptide
pdb|2GDE|H Chain H, Thrombin In Complex With Inhibitor
pdb|2H9T|H Chain H, Crystal Structure Of Human Alpha-Thrombin In Complex With
Suramin
pdb|2JH0|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH5|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|2JH6|D Chain D, Human Thrombin Hirugen Inhibitor Complex
pdb|1C1U|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1V|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C1W|H Chain H, Recruiting Zinc To Mediate Potent, Specific Inhibition Of
Serine Proteases
pdb|1C5L|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5N|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1C5O|H Chain H, Structural Basis For Selectivity Of A Small Molecule,
S1-Binding, Sub- Micromolar Inhibitor Of Urokinase Type
Plasminogen Activator
pdb|1HXE|H Chain H, Serine Protease
pdb|2UUF|B Chain B, Thrombin-Hirugen Binary Complex At 1.26a Resolution
pdb|2UUJ|B Chain B, Thrombin-Hirugen-Gw473178 Ternary Complex At 1.32a
Resolution
pdb|2UUK|B Chain B, Thrombin-Hirugen-Gw420128 Ternary Complex At 1.39a
Resolution
pdb|3BF6|H Chain H, Thrombin:suramin Complex
pdb|2R2M|B Chain B, 2-(2-chloro-6-fluorophenyl)acetamides As Potent Thrombin
Inhibitors
pdb|3EGK|H Chain H, Knoble Inhibitor
pdb|2ZC9|H Chain H, Thrombin In Complex With Inhibitor
pdb|2ZDA|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZDV|H Chain H, Exploring Thrombin S1 Pocket
pdb|2ZF0|H Chain H, Exploring Thrombin S1 Pocket
pdb|3E6P|H Chain H, Crystal Structure Of Human Meizothrombin Desf1
pdb|2ZFF|H Chain H, Exploring Thrombin S1-Pocket
pdb|2ZFP|H Chain H, Thrombin Inibition
pdb|2ZGB|H Chain H, Thrombin Inhibition
pdb|2ZGX|H Chain H, Thrombin Inhibition
pdb|2ZFQ|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZFR|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHQ|H Chain H, Thrombin Inhibition
pdb|2ZI2|H Chain H, Thrombin Inhibition
pdb|2ZIQ|H Chain H, Thrombin Inhibition
pdb|2ZG0|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHE|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHF|H Chain H, Exploring Thrombin S3 Pocket
pdb|2ZHW|H Chain H, Exploring Thrombin S3 Pocket
pdb|3C27|B Chain B, Cyanofluorophenylacetamides As Orally Efficacious Thrombin
Inhibitors
pdb|2ZNK|H Chain H, Thrombin Inhibition
pdb|2ZO3|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3D49|H Chain H, Thrombin Inhibition
pdb|3DA9|B Chain B, Crystal Structure Of Thrombin In Complex With Inhibitor
pdb|3DHK|H Chain H, Bisphenylic Thrombin Inhibitors
pdb|3DT0|H Chain H, Understanding Thrombin Inhibition
pdb|3DUX|H Chain H, Understanding Thrombin Inhibition
pdb|3EQ0|H Chain H, Thrombin Inhibitor
pdb|3F68|H Chain H, Thrombin Inhibition
pdb|3PMH|B Chain B, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib
Interaction With Two Distinct Alpha-Thrombin Sites
pdb|3P6Z|B Chain B, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P6Z|H Chain H, Structural Basis Of Thrombin Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3LDX|H Chain H, Discovery And Clinical Evaluation Of Rwj-671818, A
Thrombin Inhibitor With An Oxyguanidine P1 Motif
pdb|3P70|B Chain B, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|D Chain D, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|F Chain F, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3P70|H Chain H, Structural Basis Of Thrombin-Mediated Factor V Activation:
Essential Role Of The Hirudin-Like Sequence
Glu666-Glu672 For Processing At The Heavy Chain-B Domain
Junction
pdb|3TU7|H Chain H, Human Alpha-Thrombin Complexed With
N-(Methylsulfonyl)-D-Phenylalanyl-
N-((1-Carbamimidoyl-4-Piperidinyl)methyl)-L-Prolinamide
(Bms-189664)
pdb|3QLP|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And A Modified Thrombin Binding Aptamer (Mtba)
pdb|3P17|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3B23|B Chain B, Crystal Structure Of Thrombin-Variegin Complex: Insights
Of A Novel Mechanism Of Inhibition And Design Of Tunable
Thrombin Inhibitors
pdb|3QTO|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QTV|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QX5|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3QWC|H Chain H, Thrombin Inhibition By Pyridin Derivatives
pdb|3U69|H Chain H, Unliganded Wild-Type Human Thrombin
pdb|3U8T|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Cys
pdb|3RLW|H Chain H, Human Thrombin In Complex With Mi328
pdb|3RLY|H Chain H, Human Thrombin In Complex With Mi329
pdb|3RM0|H Chain H, Human Thrombin In Complex With Mi354
pdb|3RM2|H Chain H, Human Thrombin In Complex With Mi003
pdb|3RML|H Chain H, Human Thrombin In Complex With Mi331
pdb|3RMM|H Chain H, Human Thrombin In Complex With Mi332
pdb|3RMN|H Chain H, Human Thrombin In Complex With Mi341
pdb|3RMO|H Chain H, Human Thrombin In Complex With Mi004
pdb|3U8O|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-D-Thr
pdb|3U8R|H Chain H, Human Thrombin Complexed With D-Phe-Pro-D-Arg-Ile
pdb|3SHA|H Chain H, Human Thrombin In Complex With Ubthr97
pdb|3SHC|H Chain H, Human Thrombin In Complex With Ubthr101
pdb|3SI3|H Chain H, Human Thrombin In Complex With Ubthr103
pdb|3SI4|H Chain H, Human Thrombin In Complex With Ubthr104
pdb|3SV2|H Chain H, Human Thrombin In Complex With Ubthr105
pdb|4E7R|H Chain H, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4E7R|G Chain G, Thrombin In Complex With 3-Amidinophenylalanine Inhibitor
pdb|4DIH|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Sodium Ions
pdb|4DII|H Chain H, X-Ray Structure Of The Complex Between Human Alpha
Thrombin And Thrombin Binding Aptamer In The Presence Of
Potassium Ions
pdb|3T5F|H Chain H, Human Thrombin In Complex With Mi340
pdb|3UTU|H Chain H, High Affinity Inhibitor Of Human Thrombin
pdb|3U98|H Chain H, Human Thrombin In Complex With Mi001
pdb|3U9A|H Chain H, Human Thrombin In Complex With Mi330
pdb|4E05|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|4E06|H Chain H, Anophelin From The Malaria Vector Inhibits Thrombin
Through A Novel Reverse-Binding Mechanism
pdb|3UWJ|H Chain H, Human Thrombin In Complex With Mi353
pdb|4BAH|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAK|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAM|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAN|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAO|B Chain B, Thrombin In Complex With Inhibitor
pdb|4BAQ|B Chain B, Thrombin In Complex With Inhibitor
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1WBG|B Chain B, Active Site Thrombin Inhibitors
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 63/120 (52%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCRDDGKYGFYTHVFRLKKWIQK 252
>pdb|1Z8I|B Chain B, Crystal Structure Of The Thrombin Mutant G193a Bound To
Ppack
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 63/120 (52%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+ DSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEADSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1BTH|H Chain H, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
pdb|1BTH|K Chain K, Structure Of Thrombin Complexed With Bovine Pancreatic
Trypsin Inhibitor
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 46/120 (38%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTTNVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+CQGDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACQGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1RD3|B Chain B, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
pdb|1RD3|D Chain D, 2.5a Structure Of Anticoagulant Thrombin Variant E217k
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGKGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1TQ0|B Chain B, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ0|D Chain D, Crystal Structure Of The Potent Anticoagulant Thrombin
Mutant W215aE217A IN FREE FORM
pdb|1TQ7|B Chain B, Crystal Structure Of The Anticoagulant Thrombin Mutant
W215aE217A Bound To Ppack
Length = 257
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 67.0 bits (162), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 63/120 (52%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VS G GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1B7X|B Chain B, Structure Of Human Alpha-Thrombin Y225i Mutant Bound To D-
Phe-Pro-Arg-Chloromethylketone
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKIGFYTHVFRLKKWIQK 252
>pdb|3R3G|B Chain B, Structure Of Human Thrombin With Residues 145-150 Of
Murine Thrombin
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 69.7 bits (169), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 44/118 (37%), Positives = 63/118 (53%), Gaps = 12/118 (10%)
Query: 579 GTVVGWGRVEES-----GQIA-SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV-- 630
G V GWG + E+ +I S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLRETWTTNINEIQPSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKPD 193
Query: 631 EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 194 EGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQ 251
>pdb|3JZ1|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E:na+
Form
pdb|3JZ2|B Chain B, Crystal Structure Of Human Thrombin Mutant N143p In E Form
pdb|3QGN|B Chain B, The Allosteric E-E Equilibrium Is A Key Property Of The
Trypsin Fold
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.1 bits (170), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGPLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|2PGB|B Chain B, Inhibitor-Free Human Thrombin Mutant C191a-C220a
pdb|2PGQ|B Chain B, Human Thrombin Mutant C191a-C220a In Complex With The
Inhibitor Ppack
Length = 259
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 63.5 bits (153), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 43/120 (35%), Positives = 62/120 (51%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+ +GDSGG +M+ + R+ G+VSWG G R G YT V +WIQ
Sbjct: 193 DEGKRGDAAEGDSGGPFVMKSPFNNRWYQMGIVSWGEGADRDGKYGFYTHVFRLKKWIQK 252
>pdb|1TON|A Chain A, Rat Submaxillary Gland Serine Protease, Tonin. Structure
Solution And Refinement At 1.8 Angstroms Resolution
Length = 235
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 39/111 (35%), Positives = 66/111 (59%), Gaps = 9/111 (8%)
Query: 583 GWGRVEESGQIAS-DLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDS 641
GWG S + S DL+ + ++SN++C + ++ +T M+CAG +EGGKD+C GDS
Sbjct: 130 GWGSTNPSEMVVSHDLQCVNIHLLSNEKCIET--YKDNVTDVMLCAGEMEGGKDTCAGDS 187
Query: 642 GGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQNNTRD 691
GG L+ DG ++ G+ S G CA+P +P +Y ++ + WI+ ++
Sbjct: 188 GGPLI---CDG--VLQGITSGGATPCAKPKTPAIYAKLIKFTSWIKKVMKE 233
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 36/114 (31%), Positives = 51/114 (44%), Gaps = 16/114 (14%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+ E N PW VA+ ++ CGG LI +V+TAAHC ++ + V+ N
Sbjct: 1 IVGGYKCEKNSQPWQVAV--INEYLCGGVLIDPSWVITAAHCYSNNYQ------VLLGRN 52
Query: 79 RATVYETQIETRRVVKVLTHPKY--------NAQGAKSHDHDIALLKLDAPLEF 124
E + R V + HP Y Q H +D+ LL L P +
Sbjct: 53 NLFKDEPFAQRRLVRQSFRHPDYIPLIVTNDTEQPVHDHSNDLMLLHLSEPADI 106
>pdb|3EE0|B Chain B, Crystal Structure Of The W215aE217A MUTANT OF HUMAN
Thrombin (Space Group P2(1)2(1)2(1))
pdb|3HKJ|B Chain B, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
pdb|3HKJ|E Chain E, Crystal Structure Of Human Thrombin Mutant W215aE217A IN
COMPLEX WITH The Extracellular Fragment Of Human Par1
Length = 259
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 66.6 bits (161), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 63/120 (52%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VS G GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSAGAGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1Z8J|B Chain B, Crystal Structure Of The Thrombin Mutant G193p Bound To
Ppack
Length = 259
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 44/120 (36%), Positives = 63/120 (52%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+ DSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEPDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1DX5|M Chain M, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|N Chain N, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|O Chain O, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1DX5|P Chain P, Crystal Structure Of The Thrombin-Thrombomodulin Complex
pdb|1E0F|D Chain D, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|F Chain F, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
pdb|1E0F|E Chain E, Crystal Structure Of The Human Alpha-Thrombin-Haemadin
Complex: An Exosite Ii-Binding Inhibitor
Length = 259
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 50/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHK-----DLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ K DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFIENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1BHX|B Chain B, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|B Chain B, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
pdb|2PKS|B Chain B, Thrombin In Complex With Inhibitor
pdb|3PO1|B Chain B, Thrombin In Complex With Benzothiazole Guanidine
Length = 147
Score = 74.3 bits (181), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 49/136 (36%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D DIAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
>pdb|1KDQ|B Chain B, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 99
Score = 73.2 bits (178), Expect = 5e-13, Method: Composition-based stats.
Identities = 38/90 (42%), Positives = 55/90 (61%), Gaps = 5/90 (5%)
Query: 597 LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLI 656
L+ +P++S +C++ G K+T M CAG G DSC GDSGG L+ + DG + +
Sbjct: 9 LQQAALPIVSEADCKKSWG--SKITDVMTCAG--ASGVDSCMGDSGGPLVCQK-DGVWTL 63
Query: 657 AGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
AG+VSWG G ++P VY+RV M W+Q
Sbjct: 64 AGIVSWGSGVCSTSTPAVYSRVTALMPWVQ 93
>pdb|2GP9|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A Self-
Inhibited Conformation
pdb|3BEI|B Chain B, Crystal Structure Of The Slow Form Of Thrombin In A
Self_inhibited Conformation
pdb|3BEF|B Chain B, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3BEF|E Chain E, Crystal Structure Of Thrombin Bound To The Extracellular
Fragment Of Par1
pdb|3QDZ|B Chain B, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4.
pdb|3QDZ|D Chain D, Crystal Structure Of The Human Thrombin Mutant D102n In
Complex With The Extracellular Fragment Of Human Par4
Length = 259
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 48/136 (35%), Positives = 73/136 (53%), Gaps = 11/136 (8%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNRATVYETQIETRRVV-KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
I +H+R T YE IE ++ K+ HP+YN + ++ D +IAL+KL P+ F + P
Sbjct: 61 VRIGKHSR-TRYERNIEKISMLEKIYIHPRYNWR--ENLDRNIALMKLKKPVAFSDYIHP 117
Query: 131 DNKDDPKSELTQFKPG 146
D ++ + + G
Sbjct: 118 VCLPDRETAASLLQAG 133
Score = 70.5 bits (171), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 14/120 (11%)
Query: 579 GTVVGWGRVEES-------GQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV- 630
G V GWG ++E+ GQ S L+ +P++ C+ ++T NM CAGY
Sbjct: 136 GRVTGWGNLKETWTANVGKGQ-PSVLQVVNLPIVERPVCKDSTRI--RITDNMFCAGYKP 192
Query: 631 -EGGK-DSCQGDSGGALLMED-LDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
EG + D+C+GDSGG +M+ + R+ G+VSWG GC R G YT V +WIQ
Sbjct: 193 DEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 252
>pdb|1ORF|A Chain A, The Oligomeric Structure Of Human Granzyme A Reveals The
Molecular Determinants Of Substrate Specificity
Length = 234
Score = 72.8 bits (177), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 41/110 (37%), Positives = 58/110 (52%), Gaps = 10/110 (9%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC--RQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
V GWGR S + LR ++ ++ + C R F P + NM+CAG + GG+DSC
Sbjct: 122 VAGWGRTHNSASWSDTLREVEITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGRDSCN 181
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGI--GCARPNSPGVYTRVN-HYMEWI 685
GDSG LL E + GV S+G+ C P PGVY ++ ++ WI
Sbjct: 182 GDSGSPLLCEG-----VFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWI 226
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 37/123 (30%), Positives = 55/123 (44%), Gaps = 12/123 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG + P++V L K C G LI+ +VLTAAHC +KR + VI +
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHC-NLNKRSQ----VILGAH 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS----PDNKD 134
T E + V K +P Y+ + + D+ LL+L + V+ P D
Sbjct: 56 SITREEPTKQIMLVKKEFPYPCYDPA---TREGDLKLLQLTEKAKINKYVTILHLPKKGD 112
Query: 135 DPK 137
D K
Sbjct: 113 DVK 115
>pdb|1OP8|A Chain A, Crystal Structure Of Human Granzyme A
pdb|1OP8|B Chain B, Crystal Structure Of Human Granzyme A
pdb|1OP8|C Chain C, Crystal Structure Of Human Granzyme A
pdb|1OP8|D Chain D, Crystal Structure Of Human Granzyme A
pdb|1OP8|E Chain E, Crystal Structure Of Human Granzyme A
pdb|1OP8|F Chain F, Crystal Structure Of Human Granzyme A
Length = 234
Score = 72.0 bits (175), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 41/110 (37%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQEC--RQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
V GWGR S + LR + ++ + C R F P + NM+CAG + GG+DSC
Sbjct: 122 VAGWGRTHNSASWSDTLREVNITIIDRKVCNDRNHYNFNPVIGMNMVCAGSLRGGRDSCN 181
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGI--GCARPNSPGVYTRVN-HYMEWI 685
GDSG LL E + GV S+G+ C P PGVY ++ ++ WI
Sbjct: 182 GDSGSPLLCEG-----VFRGVTSFGLENKCGDPRGPGVYILLSKKHLNWI 226
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 37/123 (30%), Positives = 55/123 (44%), Gaps = 12/123 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG + P++V L K C G LI+ +VLTAAHC +KR + VI +
Sbjct: 1 IIGGNEVTPHSRPYMVLLSLDRKTICAGALIAKDWVLTAAHC-NLNKRSQ----VILGAH 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS----PDNKD 134
T E + V K +P Y+ + + D+ LL+L + V+ P D
Sbjct: 56 SITREEPTKQIMLVKKEFPYPCYDPA---TREGDLKLLQLTEKAKINKYVTILHLPKKGD 112
Query: 135 DPK 137
D K
Sbjct: 113 DVK 115
>pdb|2ZCH|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|2ZCK|P Chain P, Crystal Structure Of A Ternary Complex Between Psa, A
Substrat-Acyl Intermediate And An Activating Antibody
pdb|2ZCL|P Chain P, Crystal Structure Of Human Prostate Specific Antigen
Complexed With An Activating Antibody
pdb|3QUM|P Chain P, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
pdb|3QUM|Q Chain Q, Crystal Structure Of Human Prostate Specific Antigen (Psa)
In Fab Sandwich With A High Affinity And A Pca Selective
Antibody
Length = 237
Score = 71.6 bits (174), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 42/108 (38%), Positives = 58/108 (53%), Gaps = 9/108 (8%)
Query: 583 GWGRVE-ESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDS 641
GWG +E E L+ + V+SN C Q K+T M+CAG GGK +C GDS
Sbjct: 132 GWGSIEPEEFLTPKKLQCVDLHVISNDVCAQV--HPQKVTKFMLCAGRWTGGKSTCSGDS 189
Query: 642 GGALLMEDLDGRFLIAGVVSWGI-GCARPNSPGVYTRVNHYMEWIQNN 688
GG L+ ++ G+ SWG CA P P +YT+V HY +WI++
Sbjct: 190 GGPLVCNG-----VLQGITSWGSEPCALPERPSLYTKVVHYRKWIKDT 232
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 14/118 (11%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGGW E + PW V + G+ CGG L+ ++VLTAAHC+R+ + ++ H+
Sbjct: 1 IVGGWECEKHSQPWQVLVASRGRAVCGGVLVHPQWVLTAAHCIRNKS-----VILLGRHS 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSH--------DHDIALLKLDAPLEFKPTV 128
+T + +V HP Y+ K+ HD+ LL+L P E V
Sbjct: 56 LFHPEDTG-QVFQVSHSFPHPLYDMSLLKNRFLRPGDDSSHDLMLLRLSEPAELTDAV 112
>pdb|1DST|A Chain A, Mutant Of Factor D With Enhanced Catalytic Activity
Length = 228
Score = 71.2 bits (173), Expect = 2e-12, Method: Composition-based stats.
Identities = 39/108 (36%), Positives = 55/108 (50%), Gaps = 8/108 (7%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG V +G+ L+ +PV+ C + + +T +MCA +DSC+GD
Sbjct: 125 VAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE--SNRRDSCKGD 182
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWIQN 687
SGG L+ ++ GVVSWG C PG+YTRV Y WI +
Sbjct: 183 SGGPLVCGG-----VLEGVVSWGSRVCGNRKKPGIYTRVASYAAWIDS 225
Score = 59.3 bits (142), Expect = 7e-09, Method: Composition-based stats.
Identities = 32/112 (28%), Positives = 57/112 (50%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG E + P++ +++ G CGG L+++++VL+AAHC+ + K + V+ +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGK--VQVLLGAH 58
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ E V++ + HP Y + DHD+ LL+L P V P
Sbjct: 59 SLSQPEPSKRLYDVLRAVPHPDYQPD---TIDHDLLLLQLSEKATLGPAVRP 107
>pdb|1SI5|H Chain H, Protease-Like Domain From 2-Chain Hepatocyte Growth Factor
Length = 240
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 42/115 (36%), Positives = 62/115 (53%), Gaps = 6/115 (5%)
Query: 575 SKRTGTVVGWGRVEESGQIASD--LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
K + +V GWG +G I D LR + +M N++C Q + L + +CAG +
Sbjct: 114 EKTSCSVYGWGY---TGLINYDGLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKI 170
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
G C+GD GG L+ E R ++ GV+ G GCA PN PG++ RV +Y +WI
Sbjct: 171 GSGPCEGDYGGPLVCEQHKMR-MVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHK 224
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 46/155 (29%), Positives = 69/155 (44%), Gaps = 15/155 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+V G T N W+V+L K CGG+LI + +VLTA C S+ KD A + H+
Sbjct: 1 VVNGIPTRTN-IGWMVSLRYRNKHICGGSLIKESWVLTARQCF-PSRDLKDYEAWLGIHD 58
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDPKS 138
V+ E + V ++ Y +G+ D+ L+KL P VS D P
Sbjct: 59 ---VHGRGDEKCKQVLNVSQLVYGPEGS-----DLVLMKLARPAVLDDFVS--TIDLPNY 108
Query: 139 ELTQFKPGNQKSYKWDIVWFNLIGF-AVLHLATLY 172
T + + Y W + LI + +L +A LY
Sbjct: 109 GSTIPEKTSCSVYGWG--YTGLINYDGLLRVAHLY 141
>pdb|1SHY|A Chain A, The Crystal Structure Of Hgf Beta-Chain In Complex With
The Sema Domain Of The Met Receptor
Length = 234
Score = 70.9 bits (172), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 42/115 (36%), Positives = 62/115 (53%), Gaps = 6/115 (5%)
Query: 575 SKRTGTVVGWGRVEESGQIASD--LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
K + +V GWG +G I D LR + +M N++C Q + L + +CAG +
Sbjct: 114 EKTSCSVYGWGY---TGLINYDGLLRVAHLYIMGNEKCSQHHRGKVTLNESEICAGAEKI 170
Query: 633 GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
G C+GD GG L+ E R ++ GV+ G GCA PN PG++ RV +Y +WI
Sbjct: 171 GSGPCEGDYGGPLVCEQHKMR-MVLGVIVPGRGCAIPNRPGIFVRVAYYAKWIHK 224
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 46/155 (29%), Positives = 69/155 (44%), Gaps = 15/155 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+V G T N W+V+L K CGG+LI + +VLTA C S+ KD A + H+
Sbjct: 1 VVNGIPTRTN-IGWMVSLRYRNKHICGGSLIKESWVLTARQCF-PSRDLKDYEAWLGIHD 58
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDPKS 138
V+ E + V ++ Y +G+ D+ L+KL P VS D P
Sbjct: 59 ---VHGRGDEKCKQVLNVSQLVYGPEGS-----DLVLMKLARPAVLDDFVS--TIDLPNY 108
Query: 139 ELTQFKPGNQKSYKWDIVWFNLIGF-AVLHLATLY 172
T + + Y W + LI + +L +A LY
Sbjct: 109 GSTIPEKTSCSVYGWG--YTGLINYDGLLRVAHLY 141
>pdb|1DLK|B Chain B, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
pdb|1DLK|D Chain D, Crystal Structure Analysis Of Delta-Chymotrypsin Bound To
A Peptidyl Chloromethyl Ketone Inhibitor
Length = 230
Score = 70.9 bits (172), Expect = 3e-12, Method: Composition-based stats.
Identities = 39/110 (35%), Positives = 59/110 (53%), Gaps = 6/110 (5%)
Query: 578 TGTVVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
T GWG + D L+ +P++SN C+++ G K+ M+CAG G S
Sbjct: 120 TCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWG--TKIKDAMICAG--ASGVSS 175
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
C GDSGG L+ + +G + + G+VSWG ++PGVY RV + W+Q
Sbjct: 176 CMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 224
Score = 60.1 bits (144), Expect = 4e-09, Method: Composition-based stats.
Identities = 42/122 (34%), Positives = 66/122 (54%), Gaps = 13/122 (10%)
Query: 19 IVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IV G +PW V+L+ + G FCGG+LI++ +V+TAAHC ++ + V E
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEF 56
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS----PDNK 133
++ + E +I+ ++ KV + KYN+ + ++DI LLKL F TVS P
Sbjct: 57 DQGSSSE-KIQKLKIAKVFKNSKYNSL---TINNDITLLKLSTAASFSQTVSAVCLPSAS 112
Query: 134 DD 135
DD
Sbjct: 113 DD 114
>pdb|2PSX|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin
pdb|2PSY|A Chain A, Crystal Structure Of Human Kallikrein 5 In Complex With
Leupeptin And Zinc
Length = 227
Score = 70.5 bits (171), Expect = 3e-12, Method: Composition-based stats.
Identities = 42/109 (38%), Positives = 60/109 (55%), Gaps = 12/109 (11%)
Query: 581 VVGWGRVEESGQI--ASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
V GWG +S Q+ L+ + V+S + C + ++ M CAG + G+DSCQ
Sbjct: 121 VSGWG-TTKSPQVHFPKVLQCLNISVLSQKRCED--AYPRQIDDTMFCAGD-KAGRDSCQ 176
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQ 686
GDSGG ++ + G+VSWG CARPN PGVYT + + +WIQ
Sbjct: 177 GDSGGPVVCNGS-----LQGLVSWGDYPCARPNRPGVYTNLCKFTKWIQ 220
Score = 55.1 bits (131), Expect = 1e-07, Method: Composition-based stats.
Identities = 34/115 (29%), Positives = 59/115 (51%), Gaps = 9/115 (7%)
Query: 19 IVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
I+ G +++ PW AL + + +CG L+ +++LTAAHC R K + +
Sbjct: 1 IINGSDCDMHTQPWQAALLLRPNQLYCGAVLVHPQWLLTAAHC-----RKKVFRVRLGHY 55
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDN 132
+ + VYE+ + + VK + HP Y+ G H +D+ L+KL+ + V P N
Sbjct: 56 SLSPVYESGQQMFQGVKSIPHPGYSHPG---HSNDLMLIKLNRRIRPTKDVRPIN 107
>pdb|1AKS|A Chain A, Crystal Structure Of The First Active Autolysate Form Of
The Porcine Alpha Trypsin
pdb|1UHB|A Chain A, Crystal Structure Of Porcine Alpha Trypsin Bound With Auto
Catalyticaly Produced Native Peptide At 2.15 A
Resolution
Length = 125
Score = 70.1 bits (170), Expect = 4e-12, Method: Composition-based stats.
Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 10/111 (9%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +S + + + EHN
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYKSRIQVR-----LGEHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
V E + K++THP +N + D+DI L+KL +P V+
Sbjct: 55 -IDVLEGNEQFINAAKIITHPNFNGN---TLDNDIMLIKLSSPATLNSRVA 101
>pdb|2CGA|A Chain A, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|2CGA|B Chain B, Bovine Chymotrypsinogen A. X-Ray Crystal Structure
Analysis And Refinement Of A New Crystal Form At 1.8
Angstroms Resolution
pdb|1ACB|E Chain E, Crystal And Molecular Structure Of The Bovine
Alpha-Chymotrypsin-Eglin C Complex At 2.0 Angstroms
Resolution
pdb|1CGI|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1CGJ|E Chain E, Three-Dimensional Structure Of The Complexes Between
Bovine ChymotrypsinogenA And Two Recombinant Variants Of
Human Pancreatic Secretory Trypsin Inhibitor
(Kazal-Type)
pdb|1EX3|A Chain A, Crystal Structure Of Bovine Chymotrypsinogen A
(Tetragonal)
pdb|1GL1|A Chain A, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|B Chain B, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL1|C Chain C, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-C, An Inhibitor From The Insect Locusta
Migratoria
pdb|1GL0|E Chain E, Structure Of The Complex Between Bovine Alpha-Chymotrypsin
And Pmp-D2v, An Inhibitor From The Insect Locusta
Migratoria
pdb|1K2I|1 Chain 1, Crystal Structure Of Gamma-Chymotrypsin In Complex With 7-
Hydroxycoumarin
pdb|1P2M|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2M|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2N|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2O|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|A Chain A, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1P2Q|C Chain C, Structural Consequences Of Accommodation Of Four Non-
Cognate Amino-Acid Residues In The S1 Pocket Of Bovine
Trypsin And Chymotrypsin
pdb|1OXG|A Chain A, Crystal Structure Of A Complex Formed Between Organic
Solvent Treated Bovine Alpha-Chymotrypsin And Its
Autocatalytically Produced Highly Potent 14-Residue
Peptide At 2.2 Resolution
pdb|1T7C|A Chain A, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T7C|C Chain C, Crystal Structure Of The P1 Glu Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|A Chain A, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8L|C Chain C, Crystal Structure Of The P1 Met Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|A Chain A, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8M|C Chain C, Crystal Structure Of The P1 His Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|A Chain A, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8N|C Chain C, Crystal Structure Of The P1 Thr Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|A Chain A, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1T8O|C Chain C, Crystal Structure Of The P1 Trp Bpti Mutant- Bovine
Chymotrypsin Complex
pdb|1CHG|A Chain A, Chymotrypsinogen,2.5 Angstroms Crystal Structure,
Comparison With Alpha-Chymotrypsin,And Implications For
Zymogen Activation
pdb|1GCD|A Chain A, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2Y6T|A Chain A, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|B Chain B, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|C Chain C, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|2Y6T|D Chain D, Molecular Recognition Of Chymotrypsin By The Serine
Protease Inhibitor Ecotin From Yersinia Pestis
pdb|3T62|A Chain A, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|B Chain B, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
pdb|3T62|C Chain C, Crystal Structure Of Recombinant Kunitz Type Serine
Protease Inhibitor-1 From The Caribbean Sea Anemone
Stichodactyla Helianthus In Complex With Bovine
Chymotrypsin
Length = 245
Score = 69.7 bits (169), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 47/137 (34%), Positives = 72/137 (52%), Gaps = 19/137 (13%)
Query: 10 CGVP------NRMDRIVGGWTTEVNEYPWVVALEQAGKF-FCGGTLISDRYVLTAAHCVR 62
CGVP + + RIV G +PW V+L+ F FCGG+LI++ +V+TAAHC
Sbjct: 1 CGVPAIQPVLSGLSRIVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGV 60
Query: 63 SSKRHKDLIAVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPL 122
++ + V E ++ + E +I+ ++ KV + KYN+ + ++DI LLKL
Sbjct: 61 TTSD----VVVAGEFDQGSSSE-KIQKLKIAKVFKNSKYNSL---TINNDITLLKLSTAA 112
Query: 123 EFKPTVS----PDNKDD 135
F TVS P DD
Sbjct: 113 SFSQTVSAVCLPSASDD 129
Score = 68.9 bits (167), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 39/110 (35%), Positives = 59/110 (53%), Gaps = 6/110 (5%)
Query: 578 TGTVVGWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
T GWG + D L+ +P++SN C+++ G K+ M+CAG G S
Sbjct: 135 TCVTTGWGLTRYTNANTPDRLQQASLPLLSNTNCKKYWG--TKIKDAMICAG--ASGVSS 190
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
C GDSGG L+ + +G + + G+VSWG ++PGVY RV + W+Q
Sbjct: 191 CMGDSGGPLVCKK-NGAWTLVGIVSWGSSTCSTSTPGVYARVTALVNWVQ 239
>pdb|1YM0|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component B: A Novel, Glycosylated Two-chained Trypsin
Length = 238
Score = 69.7 bits (169), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 44/117 (37%), Positives = 61/117 (52%), Gaps = 5/117 (4%)
Query: 574 YSKRTGTVVGWGRVEESGQIA-SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG 632
Y R GWG + G + LR + + +N C + + +M+CA G
Sbjct: 119 YVYRKSQCSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTSD-TIYDDMICATDNTG 177
Query: 633 --GKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+DSCQGDSGG L ++D G F + G+VSWGIGCA PGVY+RV + WI +
Sbjct: 178 MTDRDSCQGDSGGPLSVKDGSGIFSLVGIVSWGIGCAS-GYPGVYSRVGFHAGWITD 233
Score = 60.5 bits (145), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 48/201 (23%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 19 IVGGWTTEVNEYPWVVALEQ--AGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
IVGG E+PW V++ + + FCGG++I+DR+V+ AAHC++ L++++
Sbjct: 1 IVGGIEARPYEFPWQVSVRRKSSDSHFCGGSIINDRWVVCAAHCMQGEAPA--LVSLVVG 58
Query: 77 HNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDP 136
+ ++ T +T V + + Y+ + ++D++++K + F V P DP
Sbjct: 59 EHDSSAASTVRQTHDVDSIFVNENYD---PATLENDVSVIKTAVAITFDINVGPICAPDP 115
Query: 137 KSELTQFKPGNQKSYKWDIVWFNLIGFAVLHLATLYGYYLMFTGEVKFATFLWSKSVIST 196
++ K +Q S I + AVL TL F V + ++ + +T
Sbjct: 116 ANDYVYRK--SQCSGWGTINSGGVCCPAVLRYVTLNITTNAFCDAVYTSDTIYDDMICAT 173
Query: 197 DS--IVEEPSSMTDTCSPRPI 215
D+ + + S D+ P +
Sbjct: 174 DNTGMTDRDSCQGDSGGPLSV 194
>pdb|1BRU|P Chain P, Structure Of Porcine Pancreatic Elastase Complexed With
The Elastase Inhibitor Gr143783
Length = 241
Score = 69.3 bits (168), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 39/109 (35%), Positives = 65/109 (59%), Gaps = 3/109 (2%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWGR++ +G L+ Q+ V+ C + + + NM+CAG +G SC GD
Sbjct: 129 VTGWGRLQTNGASPDILQQGQLLVVDYATCSKPGWWGSTVKTNMICAGG-DGIISSCNGD 187
Query: 641 SGGALLMEDLDGRFLIAGVVSWG--IGCARPNSPGVYTRVNHYMEWIQN 687
SGG L + +G++ + G+VS+G +GC + P V+TRV++Y++WI +
Sbjct: 188 SGGPLNCQGANGQWQVHGIVSFGSSLGCNYYHKPSVFTRVSNYIDWINS 236
Score = 65.5 bits (158), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 39/114 (34%), Positives = 66/114 (57%), Gaps = 9/114 (7%)
Query: 19 IVGGWTTEVNEYPWVVALE--QAGKF--FCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
+VGG N +PW V+L+ +G++ CGGTL+ +VLTAAHC+ SS+ ++ V+
Sbjct: 1 VVGGEDARPNSWPWQVSLQYDSSGQWRHTCGGTLVDQSWVLTAAHCISSSRTYR---VVL 57
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
H+ +T + +V K++ H +N+ S+ +DIALLKL +P+ +
Sbjct: 58 GRHSLSTNEPGSLAV-KVSKLVVHQDWNSN-QLSNGNDIALLKLASPVSLTDKI 109
>pdb|2XXL|A Chain A, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
pdb|2XXL|B Chain B, Crystal Structure Of Drosophila Grass Clip Serine Protease
Of Toll Pathway
Length = 408
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 44/129 (34%), Positives = 70/129 (54%), Gaps = 21/129 (16%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAG--KFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
R+ G+ +++ PW+ L +Q G +F CGG +IS+RY+LTAAHCV + DL +
Sbjct: 118 RVSNGYEVKLSSRPWMALLRYQQFGESRFLCGGAMISERYILTAAHCVHGLQ--NDLYEI 175
Query: 74 -ISEHNRATVYETQIETRR-----------VVKVLTHPKYNAQGAKSHDHDIALLKLDAP 121
+ EH +T + + + R+ + K L H KY+A+ HDIALLKL+
Sbjct: 176 RLGEHRISTEEDCRQQGRKKKCAPPVVNVGIEKHLIHEKYDARHIM---HDIALLKLNRS 232
Query: 122 LEFKPTVSP 130
+ F+ + P
Sbjct: 233 VPFQKHIKP 241
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 14/115 (12%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGG--KDSCQ 638
V GWG E+G + L VP+ C Q + + + +C G GG +DSC+
Sbjct: 262 VTGWG-TTENGSSSDVLLQANVPLQPRSACSQ--AYRRAVPLSQLCVG---GGDLQDSCK 315
Query: 639 GDSGGALL-----MEDLDGRFLIAGVVSWGI-GCARPNSPGVYTRVNHYMEWIQN 687
GDSGG L + + + + G+VS G+ C + + PG+YT V Y++WI +
Sbjct: 316 GDSGGPLQAPAQYLGEYAPKMVEFGIVSQGVVTCGQISLPGLYTNVGEYVQWITD 370
>pdb|1MZA|A Chain A, Crystal Structure Of Human Pro-Granzyme K
pdb|1MZD|A Chain A, Crystal Structure Of Human Pro-Granzyme K
Length = 240
Score = 68.2 bits (165), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 44/121 (36%), Positives = 65/121 (53%), Gaps = 12/121 (9%)
Query: 575 SKRTGT---VVGWGRVEESGQIASD-LRATQVPVMSNQEC--RQFPGFEPKLTGNMMCAG 628
S R+GT V GWG + SD LR V V+S + C + + +P +T +M+CAG
Sbjct: 118 SLRSGTKCKVTGWGATDPDSLRPSDTLREVTVTVLSRKLCNSQSYYNGDPFITKDMVCAG 177
Query: 629 YVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRV-NHYMEWIQN 687
+G KDSC+GD+GG L+ + + +VS G C PG+YT + Y WI++
Sbjct: 178 DAKGQKDSCKGDAGGPLIC-----KGVFHAIVSGGHECGVATKPGIYTLLTKKYQTWIKS 232
Query: 688 N 688
N
Sbjct: 233 N 233
Score = 45.1 bits (105), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/112 (25%), Positives = 52/112 (46%), Gaps = 14/112 (12%)
Query: 18 RIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
I+GG + P++ +++ G CGG LI ++VLTAAHC + + V+ H
Sbjct: 2 EIIGGKEVSPHSRPFMASIQYGGHHVCGGVLIDPQWVLTAAHCQYRFTKGQSPTVVLGAH 61
Query: 78 --NRATVYETQIETRRVV---KVLTHPKYNAQGAKSHDHDIALLKLDAPLEF 124
++ + +E ++ + +V + P+ N DI L+KL +
Sbjct: 62 SLSKNEASKQTLEIKKFIPFSRVTSDPQSN---------DIMLVKLQTAAKL 104
>pdb|4H4F|A Chain A, Crystal Structure Of Human Chymotrypsin C (ctrc) Bound To
Inhibitor Eglin C From Hirudo Medicinalis
Length = 249
Score = 67.8 bits (164), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 3/112 (2%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWGR+ +G IA L+ PV+ + C + + ++ M+CAG +G +C GD
Sbjct: 128 VTGWGRLWTNGPIADKLQQGLQPVVDHATCSRIDWWGFRVKKTMVCAGG-DGVISACNGD 186
Query: 641 SGGALLMEDLDGRFLIAGVVSWGI--GCARPNSPGVYTRVNHYMEWIQNNTR 690
SGG L + +G + + G+VS+G GC P VYTRV+ Y++WI +
Sbjct: 187 SGGPLNCQLENGSWEVFGIVSFGSRRGCNTRKKPVVYTRVSAYIDWINEKMQ 238
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/115 (28%), Positives = 59/115 (51%), Gaps = 10/115 (8%)
Query: 19 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
+VGG + +PW ++L+ + CGGTLI+ +VLTAAHC+ +++ ++ +
Sbjct: 1 VVGGEDARPHSWPWQISLQYLKNDTWRHTCGGTLIASNFVLTAAHCISNTRTYR---VAV 57
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
++N E V + H ++NA + +DIAL+KL +E T+
Sbjct: 58 GKNNLEVEDEEGSLFVGVDTIHVHKRWNALLLR---NDIALIKLAEHVELSDTIQ 109
>pdb|1BQY|A Chain A, Plasminogen Activator (tsv-pa) From Snake Venom
pdb|1BQY|B Chain B, Plasminogen Activator (tsv-pa) From Snake Venom
Length = 234
Score = 67.4 bits (163), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 35/109 (32%), Positives = 62/109 (56%), Gaps = 8/109 (7%)
Query: 581 VVGWGRVEESGQIASDL-RATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
++GWG+ + +I D+ + ++ + CR + ++ +CAG ++GG+D+C
Sbjct: 120 IMGWGKTIPTKEIYPDVPHCANINILDHAVCRTAYSWR-QVANTTLCAGILQGGRDTCHF 178
Query: 640 DSGGALLMEDLDGRFLIAGVVSW-GIGCARPNSPGVYTRVNHYMEWIQN 687
DSGG L+ + G+VSW G C +P PGVYT+V Y++WI++
Sbjct: 179 DSGGPLICNG-----IFQGIVSWGGHPCGQPGEPGVYTKVFDYLDWIKS 222
Score = 49.7 bits (117), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 8/104 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+ GG +NE+ +V L + F CGGTLI+ +V+TAAHC S + L V H+
Sbjct: 1 VFGGDECNINEHRSLVVLFNSNGFLCGGTLINQDWVVTAAHC--DSNNFQLLFGV---HS 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPL 122
+ + E + +TR + P N + D DI L+KLD+ +
Sbjct: 56 KKILNEDE-QTRDPKEKFFCP--NRKKDDEVDKDIMLIKLDSSV 96
>pdb|2AIP|A Chain A, Crystal Structure Of Native Protein C Activator From The
Venom Of Copperhead Snake Agkistrodon Contortrix
Contortrix
pdb|2AIQ|A Chain A, Crystal Structure Of Benzamidine-Inhibited Protein C
Activator From The Venom Of Copperhead Snake Agkistrodon
Contortrix Contortrix
Length = 231
Score = 67.0 bits (162), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 12/110 (10%)
Query: 581 VVGWGRVEESGQIASDL-RATQVPVMSNQECRQ-FPGFEPKLTGNMMCAGYVEGGKDSCQ 638
++GWG + D+ + ++ C+ + G L +CAG +EGGKD+C+
Sbjct: 119 IMGWGTITSPNATLPDVPHCANINILDYAVCQAAYKG----LAATTLCAGILEGGKDTCK 174
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWIQN 687
GDSGG L+ +G+F G++S G CA+P PG+YT+V Y +WIQ+
Sbjct: 175 GDSGGPLI---CNGQF--QGILSVGGNPCAQPRKPGIYTKVFDYTDWIQS 219
Score = 47.0 bits (110), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 15/115 (13%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
++GG +NE+ ++ AL A CGGTLI+ +VLTA HC R + R + HN
Sbjct: 1 VIGGDECNINEHRFL-ALVYANGSLCGGTLINQEWVLTARHCDRGNMR-----IYLGMHN 54
Query: 79 RATVYETQIETRRVVKVLTHPKY---NAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
++ + ++ KY N + D DI L++L+ P+ ++P
Sbjct: 55 ------LKVLNKDALRRFPKEKYFCLNTRNDTIWDKDIMLIRLNRPVRNSAHIAP 103
>pdb|1PYT|D Chain D, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 251
Score = 67.0 bits (162), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 4/112 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWGR+ +G IA++L+ PV+ C Q + + M+CAG +G +C GD
Sbjct: 141 VTGWGRLYTNGPIAAELQQGLQPVVDYATCSQRDWWGTTVKETMVCAGG-DGVISACNGD 199
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIG--CARPNSPGVYTRVNHYMEWIQNNTR 690
SGG L + DG++ + G+VS+G G C P V+TRV+ Y++WI +
Sbjct: 200 SGGPLNCQ-ADGQWDVRGIVSFGSGLSCNTFKKPTVFTRVSAYIDWINQKLQ 250
Score = 55.1 bits (131), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 40/137 (29%), Positives = 65/137 (47%), Gaps = 10/137 (7%)
Query: 13 PNRMDRIVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHK 68
PN R+VGG + +PW ++L+ + CGGTLI+ +VLTAAHC+ ++ ++
Sbjct: 8 PNLSARVVGGEDAIPHSWPWQISLQYLRDNTWRHTCGGTLITPNHVLTAAHCISNTLTYR 67
Query: 69 DLIAVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
+ ++N E V + H K+N+ + +DIAL+KL +E T+
Sbjct: 68 ---VALGKNNLEVEDEAGSLYVGVDTIFVHEKWNSFLVR---NDIALIKLAETVELGDTI 121
Query: 129 SPDNKDDPKSELTQFKP 145
S L Q P
Sbjct: 122 QVACLPSEGSLLPQDYP 138
>pdb|1KDQ|A Chain A, Crystal Structure Analysis Of The Mutant S189d Rat
Chymotrypsin
Length = 131
Score = 67.0 bits (162), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 50/139 (35%), Positives = 72/139 (51%), Gaps = 29/139 (20%)
Query: 14 NRMDRIVGGWTTEVNEYPWVVALEQAGKF-FCGGTLISDRYVLTAAHC-VRSSKRHKDLI 71
N D I G W PW V+L+ F FCGG+LIS+ +V+TAAHC V++S +
Sbjct: 3 NGEDAIPGSW-------PWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSD-----V 50
Query: 72 AVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS-- 129
V E ++ + E I+ ++ +V +PK+N + +DI LLKL P +F TVS
Sbjct: 51 VVAGEFDQGS-DEENIQVLKIAQVFKNPKFNMFTVR---NDITLLKLATPAQFSETVSAV 106
Query: 130 --PDNKDDPKSELTQFKPG 146
P+ DD F PG
Sbjct: 107 SLPNVDDD-------FPPG 118
>pdb|1MTN|C Chain C, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|G Chain G, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|C Chain C, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|H Chain H, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|C Chain C, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|H Chain H, Bovine Chymotrypsin Complexed To Bpti
pdb|1VGC|C Chain C, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|C Chain C, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|C Chain C, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|C Chain C, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|C Chain C, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|C Chain C, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|C Chain C, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|E Chain E, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|F Chain F, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|C Chain C, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|G Chain G, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|C Chain C, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|G Chain G, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|G Chain G, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|G Chain G, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|G Chain G, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|G Chain G, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|G Chain G, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|G Chain G, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|G Chain G, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|G Chain G, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|C Chain C, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|G Chain G, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|C Chain C, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|G Chain G, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|C Chain C, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|G Chain G, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|G Chain G, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|C Chain C, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|C Chain C, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|C Chain C, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|G Chain G, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|C Chain C, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|C Chain C, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
Length = 97
Score = 66.6 bits (161), Expect = 4e-11, Method: Composition-based stats.
Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 597 LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLI 656
L+ +P++SN C+++ G K+ M+CAG G SC GDSGG L+ + +G + +
Sbjct: 7 LQQASLPLLSNTNCKKYWG--TKIKDAMICAG--ASGVSSCMGDSGGPLVCKK-NGAWTL 61
Query: 657 AGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
G+VSWG ++PGVY RV + W+Q
Sbjct: 62 VGIVSWGSSTCSTSTPGVYARVTALVNWVQ 91
>pdb|1AFQ|C Chain C, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|3RU4|E Chain E, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 96
Score = 66.6 bits (161), Expect = 5e-11, Method: Composition-based stats.
Identities = 34/90 (37%), Positives = 53/90 (58%), Gaps = 5/90 (5%)
Query: 597 LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLI 656
L+ +P++SN C+++ G K+ M+CAG G SC GDSGG L+ + +G + +
Sbjct: 6 LQQASLPLLSNTNCKKYWG--TKIKDAMICAG--ASGVSSCMGDSGGPLVCKK-NGAWTL 60
Query: 657 AGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
G+VSWG ++PGVY RV + W+Q
Sbjct: 61 VGIVSWGSSTCSTSTPGVYARVTALVNWVQ 90
>pdb|2B9L|A Chain A, Crystal Structure Of Prophenoloxidase Activating Factor-Ii
From The Beetle Holotrichia Diomphalia
Length = 394
Score = 66.2 bits (160), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 40/117 (34%), Positives = 58/117 (49%), Gaps = 10/117 (8%)
Query: 583 GWGRVE--ESGQIASDLRATQVPVMSNQECRQ-----FPGFEPKLTGNMMCAGYVEGGKD 635
GWG+ E + ++ L+ Q+P + +C+ G + L +CAG E GKD
Sbjct: 268 GWGKKEFGSRHRYSNILKKIQLPTVDRDKCQADLRNTRLGLKFVLDQTFVCAGG-EQGKD 326
Query: 636 SCQGDSGGALLMEDL--DGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+C GD G L D R++ G+V+WGIGC N PGVY V H+ WI +
Sbjct: 327 TCTGDGGSPLFCPDPRNPSRYMQMGIVAWGIGCGDENVPGVYANVAHFRNWIDQEMQ 383
Score = 62.4 bits (150), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 45/132 (34%), Positives = 68/132 (51%), Gaps = 27/132 (20%)
Query: 10 CGVPNR--MDRIVGGWTTEVN--EYPWVVALEQAG--------KFFCGGTLISDRYVLTA 57
CG+ N +D + G T E E+PW+VA+ +A + CGG+LI+ VLT
Sbjct: 118 CGIRNERGLDFKITGQTNEAEYGEFPWMVAVLKANVIPGSGEEQLVCGGSLIAPSVVLTG 177
Query: 58 AHCVRSSKRHKDLIAVISEHNRATVYETQIET-------RRVVKVLTHPKYNAQGAKSHD 110
AHCV S + + D I + RA ++T E R++ +V+ H +N K+
Sbjct: 178 AHCVNSYQSNLDAIKI-----RAGEWDTLTEKERLPYQERKIRQVIIHSNFN---PKTVV 229
Query: 111 HDIALLKLDAPL 122
+D+ALL LD PL
Sbjct: 230 NDVALLLLDRPL 241
>pdb|1AO5|A Chain A, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
pdb|1AO5|B Chain B, Mouse Glandular Kallikrein-13 (Prorenin Converting Enzyme)
Length = 237
Score = 65.9 bits (159), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 36/107 (33%), Positives = 61/107 (57%), Gaps = 9/107 (8%)
Query: 583 GWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDS 641
GWG + + Q DL+ + ++ N+ C + + K+T M+CAG + GGKD+C+ DS
Sbjct: 132 GWGSITPTRWQKPDDLQCVFITLLPNENCAKV--YLQKVTDVMLCAGEMGGGKDTCRDDS 189
Query: 642 GGALLMEDLDGRFLIAGVVSWG-IGCARPNSPGVYTRVNHYMEWIQN 687
GG L+ DG ++ G S+G + C +P P +YT + + WI++
Sbjct: 190 GGPLI---CDG--ILQGTTSYGPVPCGKPGVPAIYTNLIKFNSWIKD 231
Score = 57.4 bits (137), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 43/134 (32%), Positives = 58/134 (43%), Gaps = 20/134 (14%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
+VGG+ E N PW VA+ + CGG L+ +VLTAAHC + D V N
Sbjct: 1 VVGGFNCEKNSQPWQVAVYYQKEHICGGVLLDRNWVLTAAHC------YVDQYEVWLGKN 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQ---------GAKSHDHDIALLKLDAPLEF----K 125
+ E + R V K HP +N GA D D+ LL+L P + K
Sbjct: 55 KLFQEEPSAQHRLVSKSFPHPGFNMSLLMLQTIPPGADFSD-DLMLLRLSKPADITDVVK 113
Query: 126 PTVSPDNKDDPKSE 139
P P + P S+
Sbjct: 114 PIALPTKEPKPGSK 127
>pdb|4D9Q|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9Q|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 65.9 bits (159), Expect = 8e-11, Method: Composition-based stats.
Identities = 38/107 (35%), Positives = 51/107 (47%), Gaps = 6/107 (5%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG V +G+ L+ +PV+ C + + +T MMCA +DSC+GD
Sbjct: 125 VAGWGIVSHAGRRPDRLQHVLLPVLDRATCNRRTHHDGAITQRMMCAE--SNRRDSCKGD 182
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
SGG L+ G L V S C PG+YTRV Y WI +
Sbjct: 183 SGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 225
Score = 56.6 bits (135), Expect = 5e-08, Method: Composition-based stats.
Identities = 31/112 (27%), Positives = 57/112 (50%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG E + P++ +++ G+ CGG L+++++VL+AAHC+ + K + V+ +
Sbjct: 1 ILGGREAEAHARPYMASVQVNGEHLCGGVLVAEQWVLSAAHCLEDAADGK--VQVLLGAH 58
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ E V++ + HP + DHD+ LL+L P V P
Sbjct: 59 SLSQPEPSKRLYDVLRAVPHPDSRPD---TIDHDLLLLQLSEKATLGPAVRP 107
>pdb|2XWA|A Chain A, Crystal Structure Of Complement Factor D Mutant R202a
pdb|2XWA|B Chain B, Crystal Structure Of Complement Factor D Mutant R202a
Length = 228
Score = 65.9 bits (159), Expect = 8e-11, Method: Composition-based stats.
Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 8/108 (7%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG V +G+ L+ +PV+ C + + +T +MCA +DSC+GD
Sbjct: 125 VAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE--SNRRDSCKGD 182
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWIQN 687
SGG L+ ++ GVV+ G C PG+YTRV Y WI +
Sbjct: 183 SGGPLVCGG-----VLEGVVTSGSAVCGNRKKPGIYTRVASYAAWIDS 225
Score = 56.2 bits (134), Expect = 7e-08, Method: Composition-based stats.
Identities = 31/112 (27%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG E + P++ +++ G CGG L+++++VL+AAHC+ + K + V+ +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGK--VQVLLGAH 58
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ E V++ + HP + DHD+ LL+L P V P
Sbjct: 59 SLSQPEPSKRLYDVLRAVPHPDSQPD---TIDHDLLLLQLSEKATLGPAVRP 107
>pdb|1SGF|A Chain A, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
pdb|1SGF|X Chain X, Crystal Structure Of 7s Ngf: A Complex Of Nerve Growth
Factor With Four Binding Proteins (serine Proteinases)
Length = 240
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 37/111 (33%), Positives = 59/111 (53%), Gaps = 9/111 (8%)
Query: 578 TGTVVGWGRVEESG-QIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
T GWG + DL+ + ++ N++C + E K+T M+CAG ++GG +
Sbjct: 130 TCLASGWGSTTPIKFKYPDDLQCVNLKLLPNEDCDK--AHEMKVTDAMLCAGEMDGGSYT 187
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGI-GCARPNSPGVYTRVNHYMEWIQ 686
C+ DSGG L+ DG ++ G+ SWG C P P VYT++ + WI+
Sbjct: 188 CEHDSGGPLI---CDG--ILQGITSWGPEPCGEPTEPSVYTKLIKFSSWIR 233
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 35/111 (31%), Positives = 49/111 (44%), Gaps = 14/111 (12%)
Query: 28 NEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRATVYETQI 87
N PW VA+ + K+ CGG L+ +VLTAAHC + D V N E
Sbjct: 13 NSQPWHVAVYRFNKYQCGGVLLDRNWVLTAAHC------YNDKYQVWLGKNNFLEDEPSD 66
Query: 88 ETRRVVKVLTHPKYN--------AQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ R V K + HP +N Q + +D+ LL+L P + V P
Sbjct: 67 QHRLVSKAIPHPDFNMSLLNEHTPQPEDDYSNDLMLLRLSKPADITDVVKP 117
>pdb|2PKS|C Chain C, Thrombin In Complex With Inhibitor
pdb|3PO1|C Chain C, Thrombin In Complex With Benzothiazole Guanidine
Length = 102
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 37/96 (38%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 595 SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV--EGGK-DSCQGDSGGALLMED-L 650
S L+ +P++ C+ ++T NM CAGY EG + D+C+GDSGG +M+
Sbjct: 4 SVLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 61
Query: 651 DGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
+ R+ G+VSWG GC R G YT V +WIQ
Sbjct: 62 NNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQ 97
>pdb|4GSO|A Chain A, Structure Of Jararacussin-I
Length = 232
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 40/111 (36%), Positives = 62/111 (55%), Gaps = 11/111 (9%)
Query: 581 VVGWGRVEESGQIASDLR-ATQVPVMSNQECR-QFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
++GWG + + D+ + ++ + C+ + G K T +CAG +EGGKD+C
Sbjct: 119 IMGWGSITIPNETYPDVPYCANINLVDYEVCQGAYNGLPAKTT---LCAGVLEGGKDTCV 175
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGI-GCARPNSPGVYTRVNHYMEWIQNN 688
GDSGG L+ +G+F G+VS+G C + PG+YT V Y +WIQ N
Sbjct: 176 GDSGGPLI---CNGQF--QGIVSYGAHSCGQGPKPGIYTNVFDYTDWIQRN 221
Score = 55.5 bits (132), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 34/112 (30%), Positives = 62/112 (55%), Gaps = 9/112 (8%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
++GG ++NE+P++ L G +FCG TLI+ +V+TAAHC ++ + + + H+
Sbjct: 1 VLGGDECDINEHPFLAFLYSHG-YFCGLTLINQEWVVTAAHCDSTNFQMQ-----LGVHS 54
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ + E + +TR + P N ++ D DI L+KLD P+ ++P
Sbjct: 55 KKVLNEDE-QTRNPKEKFICPNKNM--SEVLDKDIMLIKLDKPISNSKHIAP 103
>pdb|2HNT|F Chain F, Crystallographic Structure Of Human Gamma-Thrombin
pdb|1BHX|F Chain F, X-Ray Structure Of The Complex Of Human Alpha Thrombin
With The Inhibitor Sdz 229-357
pdb|1RIW|C Chain C, Thrombin In Complex With Natural Product Inhibitor
Oscillarin
Length = 105
Score = 65.1 bits (157), Expect = 1e-10, Method: Composition-based stats.
Identities = 37/96 (38%), Positives = 53/96 (55%), Gaps = 6/96 (6%)
Query: 595 SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYV--EGGK-DSCQGDSGGALLMED-L 650
S L+ +P++ C+ ++T NM CAGY EG + D+C+GDSGG +M+
Sbjct: 4 SVLQVVNLPIVERPVCKD--STRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPF 61
Query: 651 DGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQ 686
+ R+ G+VSWG GC R G YT V +WIQ
Sbjct: 62 NNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQ 97
>pdb|2JET|B Chain B, Crystal Structure Of A Trypsin-Like Mutant (S189d, A226g)
Chymotrypsin
Length = 128
Score = 65.1 bits (157), Expect = 1e-10, Method: Composition-based stats.
Identities = 49/136 (36%), Positives = 72/136 (52%), Gaps = 29/136 (21%)
Query: 17 DRIVGGWTTEVNEYPWVVALE-QAGKFFCGGTLISDRYVLTAAHC-VRSSKRHKDLIAVI 74
D I G W PW V+L+ + G FCGG+LIS+ +V+TAAHC V++S + V
Sbjct: 3 DAIPGSW-------PWQVSLQDKTGFHFCGGSLISEDWVVTAAHCGVKTSD-----VVVA 50
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS----P 130
E ++ + E I+ ++ +V +PK+N ++ DI LLKL P +F TVS P
Sbjct: 51 GEFDQGS-DEENIQVLKIAQVFKNPKFNMFTVRN---DITLLKLATPAQFSETVSAVCLP 106
Query: 131 DNKDDPKSELTQFKPG 146
+ DD F PG
Sbjct: 107 NVDDD-------FPPG 115
>pdb|1EAI|A Chain A, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1EAI|B Chain B, Complex Of Ascaris Chymotrpsin/elastase Inhibitor With
Porcine Elastase
pdb|1C1M|A Chain A, Porcine Elastase Under Xenon Pressure (8 Bar)
pdb|1HV7|A Chain A, Porcine Pancreatic Elastase Complexed With Gw311616a
pdb|1FZZ|A Chain A, The Crystal Structure Of The Complex Of Non-Peptidic
Inhibitor Ono-6818 And Porcine Pancreatic Elastase.
pdb|1GWA|A Chain A, Triiodide Derivative Of Porcine Pancreas Elastase
pdb|1L0Z|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Dry Paraffin
Oil
pdb|1L1G|A Chain A, The Structure Of Porcine Pancreatic Elastase Complexed
With Xenon And Bromide, Cryoprotected With Glycerol
pdb|1LKA|A Chain A, Porcine Pancreatic ElastaseCA-Complex
pdb|1LKB|A Chain A, Porcine Pancreatic Elastase/na-complex
pdb|1MMJ|N Chain N, Porcine Pancreatic Elastase Complexed With A Potent
Peptidyl Inhibitor, Fr136706
pdb|1MCV|A Chain A, Crystal Structure Analysis Of A Hybrid Squash Inhibitor In
Complex With Porcine Pancreatic Elastase
pdb|1UO6|A Chain A, Porcine Pancreatic ElastaseXE-Complex
pdb|1UVO|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(crystal A)
pdb|1UVP|A Chain A, Structure Of The Complex Of Porcine Pancreatic Elastase In
Complex With Cadmium Refined At 1.85 A Resolution
(Crystal B)
pdb|2A7C|A Chain A, On The Routine Use Of Soft X-rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2A7J|A Chain A, On The Routine Use Of Soft X-Rays In Macromolecular
Crystallography, Part Iii- The Optimal Data Collection
Wavelength
pdb|2BLO|A Chain A, Elastase Before A High Dose X-Ray "burn"
pdb|2BLQ|A Chain A, Elastase After A High Dose X-Ray "burn"
pdb|2D26|C Chain C, Active Site Distortion Is Sufficient For Proteinase
Inhibit Second Crystal Structure Of Covalent
Serpin-Proteinase Complex
pdb|2CV3|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With A Macroclyclic Peptide Inhibitor
pdb|2DE8|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With A
Unique Conformation Induced By Tris
pdb|2DE9|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase Complexed
With Tris After Soaking A Tris-Free Solution
pdb|2G4T|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastase (na)
pdb|2G4U|A Chain A, Anomalous Substructure Of Porcine Pancreatic Elastaase
(ca)
pdb|2OQU|A Chain A, High Pressure Cryocooling Of Capillary Sample
Cryoprotection And Diffraction Phasing At Long
Wavelengths
pdb|1QNJ|A Chain A, The Structure Of Native Porcine Pancreatic Elastase At
Atomic Resolution (1.1 A)
pdb|2IOT|A Chain A, Clavulanic Acid Bound To Elastase
pdb|2V0B|A Chain A, Sad Structure Solution Porcine Pancreatic Elastase From A
Selenate Derivative
pdb|2V35|A Chain A, Porcine Pancreatic Elastase In Complex With Inhibitor Jm54
pdb|3HGP|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By High
Resolution Crystallography
pdb|3HGN|A Chain A, Structure Of Porcine Pancreatic Elastase Complexed With A
Potent Peptidyl Inhibitor Fr130180 Determined By Neutron
Crystallography
pdb|3UOU|A Chain A, Crystal Structure Of The Kunitz-Type Protease Inhibitor
Shpi-1 Lys13leu Mutant In Complex With Pancreatic
Elastase
Length = 240
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
+ GWG +GQ+A L+ +P + C + + +M+CAG +G + CQGD
Sbjct: 129 ITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGG-DGVRSGCQGD 187
Query: 641 SGGALLMEDLDGRFLIAGVVSW--GIGCARPNSPGVYTRVNHYMEWIQN 687
SGG L ++G++ + GV S+ +GC P V+TRV+ Y+ WI N
Sbjct: 188 SGGPLHCL-VNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINN 235
Score = 52.8 bits (125), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 38/114 (33%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 19 IVGGWTTEVNEYPWVVALE-QAGKFF---CGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
+VGG + N +P ++L+ ++G + CGGTLI +V+TAAHCV R V+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCV---DRELTFRVVV 57
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
EHN T+ + V K++ HP +N + +DIALL+L + V
Sbjct: 58 GEHNLNQNDGTE-QYVGVQKIVVHPYWNTDDVAA-GYDIALLRLAQSVTLNSYV 109
>pdb|2EST|E Chain E, Crystallographic Study Of The Binding Of A Trifluoroacetyl
Dipeptide Anilide Inhibitor With Elastase
pdb|4EST|E Chain E, Crystal Structure Of The Covalent Complex Formed By A
Peptidyl Alpha, Alpha-Difluoro-Beta-Keto Amide With
Porcine Pancreatic Elastase At 1.78-Angstroms Resolution
pdb|5EST|E Chain E, Crystallographic Analysis Of The Inhibition Of Porcine
Pancreatic Elastase By A Peptidyl Boronic Acid:
Structure Of A Reaction Intermediate
pdb|7EST|E Chain E, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|8EST|E Chain E, Reaction Of Porcine Pancreatic Elastase With 7-substituted
3-alkoxy-4-chloroisocoumarins: Design Of Potent
Inhibitors Using The Crystal Structure Of The Complex
Formed With 4- Chloro-3-ethoxy-7-guanidino-isocoumarin
pdb|1ELA|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELC|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELB|A Chain A, Analogous Inhibitors Of Elastase Do Not Always Bind
Analogously
pdb|1ELD|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1ELE|E Chain E, Structural Analysis Of The Active Site Of Porcine
Pancreatic Elastase Based On The X-Ray Crystal
Structures Of Complexes With
Trifluoroacetyl-Dipeptide-Anilide Inhibitors
pdb|1NES|E Chain E, Structure Of The Product Complex Of Acetyl-ala-pro-ala
With Porcine Pancreatic Elastase At 1.65 Angstroms
Resolution
pdb|1BMA|A Chain A, Benzyl Methyl Aminimide Inhibitor Complexed To Porcine
Pancreatic Elastase
pdb|1FLE|E Chain E, Crystal Structure Of Elafin Complexed With Porcine
Pancreatic Elastase
pdb|1B0E|A Chain A, Crystal Structure Of Porcine Pancreatic Elastase With Mdl
101,146
pdb|1QGF|A Chain A, Porcine Pancreatic Elastase Complexed With (3r, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One
pdb|1QIX|B Chain B, Porcine Pancreatic Elastase Complexed With Human
Beta-casomorphin-7
pdb|1QR3|E Chain E, Structure Of Porcine Pancreatic Elastase In Complex With
Fr901277, A Novel Macrocyclic Inhibitor Of Elastases At
1.6 Angstrom Resolution
pdb|1E34|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2- One Soaked In Ph 9 Buffer For One Minute
pdb|1E35|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Toluenesulphonyl-3-Ethyl-4-(Carboxylic
Acid)pyrrolidin-2- One Soaked In Ph 9 Buffer For Two
Minutes
pdb|1E36|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One
pdb|1E37|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 1 Minute
pdb|1E38|B Chain B, Porcine Pancreatic Elastase Complexed With (3s, 4s)n-Para-
Nitrobenzenesulphonyl-3-Ethyl-4-(Carboxylic Acid)
Pyrrolidin-2-One Soaked In Ph 9 Buffer For 2 Minutes
pdb|1HAZ|B Chain B, Snapshots Of Serine Protease Catalysis: (c) Acyl-enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-casomorphin-7 Jumped To Ph 9 For 1 Minute
pdb|1H9L|B Chain B, Porcine Pancreatic Elastase Complexed With
Acetyl-Val-Glu-Pro-Ile-Cooh
pdb|1OKX|A Chain A, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|1OKX|B Chain B, Binding Structure Of Elastase Inhibitor Scyptolin A
pdb|2FO9|A Chain A, Structure Of Porcine Pancreatic Elastase In 95% Acetone
pdb|2FOA|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010 %
BENZENE
pdb|2FOB|A Chain A, Structure Of Porcine Pancreatic Elastase In 405010
CYCLOHEXANE
pdb|2FOC|A Chain A, Structure Of Porcine Pancreatic Elastase In 55%
Dimethylformamide
pdb|2FOD|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Ethanol
pdb|2FOE|A Chain A, Structure Of Porcine Pancreatic Elastase In 80% Hexane
pdb|2FOF|A Chain A, Structure Of Porcine Pancreatic Elastase In 80%
Isopropanol
pdb|2FOG|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2FOH|A Chain A, Structure Of Porcine Pancreatic Elastase In 40%
Trifluoroethanol
pdb|2BD4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin- 7 And Lys-Ser At Ph 5.0
pdb|2BD5|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Lys- Ser At Ph 5 And Immersed In
Ph 9 Buffer For 30 Seconds
pdb|2BD9|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 28 Seconds (2nd Ph Jump)
pdb|2BDC|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile At
Ph 5.0
pdb|2H1U|A Chain A, Porcine Pancreatic Elastase Complexed With Metpheleuglu At
Ph 5.0
pdb|1BTU|A Chain A, Porcine Pancreatic Elastase Complexed With (3s, 4r)-1-
Toluenesulphonyl-3-Ethyl-Azetidin-2-One-4-Carboxylic
Acid
pdb|1EAS|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 3.
Design, Synthesis, X-Ray Crystallographic Analysis, And
Structure-Activity Relationships For A Series Of Orally
Active 3-Amino-6-Phenylpyridin- 2-One Trifluoromethyl
Ketones
pdb|1EAT|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 5.
Design, Synthesis, And X-Ray Crystallography Of A Series
Of Orally Active 5- Amino-Pyrimidin-6-One-Containing
Trifluoromethylketones
pdb|1EAU|A Chain A, Nonpeptidic Inhibitors Of Human Leukocyte Elastase. 6.
Design Of A Potent, Intratracheally Active,
Pyridone-Based Trifluoromethyl Ketone
pdb|1ELF|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ELG|A Chain A, Nature Of The Inactivation Of Elastase By N-Peptidyl-O-
Aroyl Hydroxylamine As A Function Of Ph
pdb|1ESA|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|1EST|A Chain A, The Atomic Structure Of Crystalline Porcine Pancreatic
Elastase At 2.5 Angstroms Resolution. Comparisons With
The Structure Of Alpha- Chymotrypsin
pdb|1INC|A Chain A, Crystal Structures Of The Complex Of Porcine Pancreatic
Elastase With Two Valine-Derived Benzoxazinone
Inhibitors
pdb|1JIM|A Chain A, Stereospecific Reaction Of 3-Methoxy-4-Chloro-7-
Aminoisocoumarin With Crystalline Porcine Pancreatic
Elastase
pdb|1LVY|A Chain A, Porcine Elastase
pdb|3EST|A Chain A, Structure Of Native Porcine Pancreatic Elastase At 1.65
Angstroms Resolution
pdb|6EST|A Chain A, Interaction Of The Peptide Cf3-Leu-Ala-Nh-C6h4-Cf3(Tfla)
With Porcine Pancreatic Elastase. X-Ray Studies At 1.8
Angstroms
pdb|9EST|A Chain A, Structural Study Of Porcine Pancreatic Elastase Complexed
With 7- Amino-3-(2-Bromoethoxy)-4-Chloroisocoumarin As A
Nonreactivatable Doubly Covalent Enzyme-Inhibitor
Complex
pdb|1GVK|B Chain B, Porcine Pancreatic Elastase Acyl Enzyme At 0.95 A
Resolution
pdb|3E3T|A Chain A, Structure Of Porcine Pancreatic Elastase With The Magic
Triangle I3c
pdb|3MNB|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. First Stage Of
Radiation Damage
pdb|3MNC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Second Stage Of
Radiation Damage
pdb|3MNS|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Third Stage Of
Radiation Damage
pdb|3MNX|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fourth Stage Of
Radiation Damage
pdb|3MO3|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Fifth Stage Of
Radiation Damage
pdb|3MO6|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Sixth Stage Of
Radiation Damage
pdb|3MO9|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Seventh Stage Of
Radiation Damage
pdb|3MOC|A Chain A, Investigation Of Global And Local Effects Of Radiation
Damage On Porcine Pancreatic Elastase. Eighth Stage Of
Radiation Damage
pdb|3MTY|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. First Step Of Radiation
Damage
pdb|3MU0|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU1|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3MU4|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. First Step Of Radiation
Damage
pdb|3MU5|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Third Step Of Radiation
Damage
pdb|3MU8|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Fifth Step Of Radiation
Damage
pdb|3ODD|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region B Of The Crystal. Second Step Of Radiation
Damage
pdb|3ODF|A Chain A, Comparison Of The Character And The Speed Of X-Ray-Induced
Structural Changes Of Porcine Pancreatic Elastase At Two
Temperatures, 100 And 15k. The Data Set Was Collected
From Region A Of The Crystal. Second Step Of Radiation
Damage
pdb|2BB4|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Asp- Phe At Ph 5.0
pdb|2BD2|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Arg- Phe At Ph 5.0
pdb|2BD3|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-casomorphin-7 And Lys- Ala-nh2 At Ph 5.0
pdb|2BD7|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
pdb|2BD8|A Chain A, Porcine Pancreatic Elastase Complexed With
Beta-Casomorphin-7 And Arg- Phe At Ph 5.0 (50 Min Soak)
And Immersed In Ph 9 Buffer For 30 Seconds
pdb|2BDA|A Chain A, Porcine Pancreatic Elastase Complexed With N-Acetyl-Npi
And Ala-Ala At Ph 5.0
pdb|2BDB|A Chain A, Porcine Pancreatic Elastase Complexed With Asn-pro-ile And
Ala-ala At Ph 5.0
pdb|1ESB|A Chain A, Direct Structure Observation Of An Acyl-Enzyme
Intermediate In The Hydrolysis Of An Ester Substrate By
Elastase
pdb|4GVU|A Chain A, Lyngbyastatin 7-porcine Pancreatic Elastase Co-crystal
Structure
Length = 240
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
+ GWG +GQ+A L+ +P + C + + +M+CAG +G + CQGD
Sbjct: 129 ITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGG-DGVRSGCQGD 187
Query: 641 SGGALLMEDLDGRFLIAGVVSW--GIGCARPNSPGVYTRVNHYMEWIQN 687
SGG L ++G++ + GV S+ +GC P V+TRV+ Y+ WI N
Sbjct: 188 SGGPLHCL-VNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINN 235
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 38/114 (33%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 19 IVGGWTTEVNEYPWVVALE-QAGKFF---CGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
+VGG + N +P ++L+ ++G + CGGTLI +V+TAAHCV R V+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCV---DRELTFRVVV 57
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
EHN T+ + V K++ HP +N + +DIALL+L + V
Sbjct: 58 GEHNLNQNNGTE-QYVGVQKIVVHPYWNTDDVAA-GYDIALLRLAQSVTLNSYV 109
>pdb|1HAX|B Chain B, Snapshots Of Serine Protease Catalysis: (A) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 At Ph 5
pdb|1HAY|B Chain B, Snapshots Of Serine Protease Catalysis: (B) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 10 Seconds
pdb|1HB0|B Chain B, Snapshots Of Serine Protease Catalysis: (D) Acyl-Enzyme
Intermediate Between Porcine Pancreatic Elastase And
Human Beta-Casomorphin-7 Jumped To Ph 10 For 2 Minutes
Length = 240
Score = 65.1 bits (157), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 37/109 (33%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
+ GWG +GQ+A L+ +P + C + + +M+CAG +G + CQGD
Sbjct: 129 ITGWGLTRTNGQLAQTLQQAYLPTVDYAICSSSSYWGSTVKNSMVCAGG-DGVRSGCQGD 187
Query: 641 SGGALLMEDLDGRFLIAGVVSW--GIGCARPNSPGVYTRVNHYMEWIQN 687
SGG L ++G++ + GV S+ +GC P V+TRV+ Y+ WI N
Sbjct: 188 SGGPLHCL-VNGQYAVHGVTSFVSRLGCNVTRKPTVFTRVSAYISWINN 235
Score = 53.1 bits (126), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 38/114 (33%), Positives = 59/114 (51%), Gaps = 9/114 (7%)
Query: 19 IVGGWTTEVNEYPWVVALE-QAGKFF---CGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
+VGG + N +P ++L+ ++G + CGGTLI +V+TAAHCV R V+
Sbjct: 1 VVGGTEAQRNSWPSQISLQYRSGSSWAHTCGGTLIRQNWVMTAAHCV---DRELTFRVVV 57
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
EHN T+ + V K++ HP +N + +DIALL+L + V
Sbjct: 58 GEHNLNQNNGTE-QYVGVQKIVVHPYWNTDDVAA-GYDIALLRLAQSVTLNSYV 109
>pdb|1DSU|A Chain A, Human Factor D, Complement Activating Enzyme
pdb|1DSU|B Chain B, Human Factor D, Complement Activating Enzyme
pdb|1DFP|A Chain A, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DFP|B Chain B, Factor D Inhibited By Diisopropyl Fluorophosphate
pdb|1DIC|A Chain A, Structure Of 3,4-Dichloroisocoumarin-Inhibited Factor D
pdb|1BIO|A Chain A, Human Complement Factor D In Complex With Isatoic
Anhydride Inhibitor
pdb|1HFD|A Chain A, Human Complement Factor D In A P21 Crystal Form
pdb|4D9R|A Chain A, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
pdb|4D9R|B Chain B, Inhibiting Alternative Pathway Complement Activation By
Targeting The Exosite On Factor D
Length = 228
Score = 64.7 bits (156), Expect = 2e-10, Method: Composition-based stats.
Identities = 37/107 (34%), Positives = 51/107 (47%), Gaps = 6/107 (5%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG V +G+ L+ +PV+ C + + +T +MCA +DSC+GD
Sbjct: 125 VAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE--SNRRDSCKGD 182
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
SGG L+ G L V S C PG+YTRV Y WI +
Sbjct: 183 SGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 225
Score = 56.2 bits (134), Expect = 7e-08, Method: Composition-based stats.
Identities = 31/112 (27%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG E + P++ +++ G CGG L+++++VL+AAHC+ + K + V+ +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGK--VQVLLGAH 58
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ E V++ + HP + DHD+ LL+L P V P
Sbjct: 59 SLSQPEPSKRLYDVLRAVPHPDSQPD---TIDHDLLLLQLSEKATLGPAVRP 107
>pdb|1M9U|A Chain A, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|B Chain B, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
pdb|1M9U|C Chain C, Crystal Structure Of Earthworm Fibrinolytic Enzyme
Component A From Eisenia Fetida
Length = 241
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 40/122 (32%), Positives = 61/122 (50%), Gaps = 8/122 (6%)
Query: 574 YSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQ-FPGFE-PKLTGNMMCAGYVE 631
Y+ T + GWGR + + + L+ + +PV++ +C G + N +C
Sbjct: 122 YAGTTCVISGWGRTDGTNNLPDILQKSSIPVITTAQCTAAMVGVGGANIWDNHICVQDPA 181
Query: 632 GGKDSCQGDSGGALLMEDLDGRFLIAGVVSW----GIGCARPNSPGVYTRVNHYMEWIQN 687
G +C GDSGG L D G + GV SW G+G P+ P VYTRV+ Y+ WI +
Sbjct: 182 GNTGACNGDSGGPLNCPD--GGTRVVGVTSWVVSSGLGACLPDYPSVYTRVSAYLGWIGD 239
Query: 688 NT 689
N+
Sbjct: 240 NS 241
Score = 29.6 bits (65), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 33/125 (26%), Positives = 59/125 (47%), Gaps = 13/125 (10%)
Query: 19 IVGGWTTEVNEYPWVVALE-QAGKFF--CGGTLISDRYVLTAAHCVRSS-KRHKDLIAVI 74
++GG E+PW ++ + Q+G + CG +L+S L+A+HCV + +IA +
Sbjct: 1 VIGGTNASPGEFPWQLSQQRQSGSWSHSCGASLLSSTSALSASHCVDGVLPNNIRVIAGL 60
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEF----KPTVSP 130
+ + + +T V H Y A G S+ +DIA+L L + + V P
Sbjct: 61 WQQSD----TSGTQTANVDSYTMHENYGA-GTASYSNDIAILHLATSISLGGNIQAAVLP 115
Query: 131 DNKDD 135
N ++
Sbjct: 116 ANNNN 120
>pdb|2XW9|A Chain A, Crystal Structure Of Complement Factor D Mutant S183a
pdb|2XWB|I Chain I, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|J Chain J, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 228
Score = 63.5 bits (153), Expect = 4e-10, Method: Composition-based stats.
Identities = 36/107 (33%), Positives = 51/107 (47%), Gaps = 6/107 (5%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG V +G+ L+ +PV+ C + + +T +MCA +DSC+GD
Sbjct: 125 VAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAE--SNRRDSCKGD 182
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+GG L+ G L V S C PG+YTRV Y WI +
Sbjct: 183 AGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 225
Score = 56.2 bits (134), Expect = 7e-08, Method: Composition-based stats.
Identities = 31/112 (27%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG E + P++ +++ G CGG L+++++VL+AAHC+ + K + V+ +
Sbjct: 1 ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGK--VQVLLGAH 58
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ E V++ + HP + DHD+ LL+L P V P
Sbjct: 59 SLSQPEPSKRLYDVLRAVPHPDSQPD---TIDHDLLLLQLSEKATLGPAVRP 107
>pdb|1MTN|B Chain B, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1MTN|F Chain F, Bovine Alpha-Chymotrypsin:bpti Crystallization
pdb|1AB9|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin
pdb|1CA0|B Chain B, Bovine Chymotrypsin Complexed To Appi
pdb|1CA0|G Chain G, Bovine Chymotrypsin Complexed To Appi
pdb|1CBW|B Chain B, Bovine Chymotrypsin Complexed To Bpti
pdb|1CBW|G Chain G, Bovine Chymotrypsin Complexed To Bpti
pdb|1AFQ|B Chain B, Crystal Structure Of Bovine Gamma-Chymotrypsin Complexed
With A Synthetic Inhibitor
pdb|1VGC|B Chain B, Gamma-Chymotrypsin L-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|2VGC|B Chain B, Gamma-Chymotrypsin D-Para-Chloro-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|3VGC|B Chain B, Gamma-Chymotrypsin L-Naphthyl-1-Acetamido Boronic Acid
Acid Inhibitor Complex
pdb|4VGC|B Chain B, Gamma-Chymotrypsin D-Naphthyl-1-Acetamido Boronic Acid
Inhibitor Complex
pdb|1HJA|B Chain B, Lys 18 Variant Of Turkey Ovomucoid Inhibitor Third Domain
Complexed With Alpha-Chymotrypsin
pdb|1GG6|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With N-Acetyl-
Phenylalanine Trifluoromethyl Ketone Bound At The Active
Site
pdb|1GGD|B Chain B, Crystal Stucture Of Gamma Chymotrypsin With
N-Acetyl-Leucil- Phenylalanine Aldehyde Bound At The
Active Site
pdb|1N8O|B Chain B, Crystal Structure Of A Complex Between Bovine Chymotrypsin
And Ecotin
pdb|1YPH|C Chain C, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|1YPH|D Chain D, High Resolution Structure Of Bovine Alpha-Chymotrypsin
pdb|2P8O|B Chain B, Crystal Structure Of A Benzohydroxamic AcidVANADATE
Complex Bound To Chymotrypsin A
pdb|1GMH|F Chain F, Refined Crystal Structure Of "aged" And "non-Aged"
Organophosphoryl Conjugates Of Gamma-Chymotrypsin
pdb|2CHA|B Chain B, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2CHA|F Chain F, The Structure Of Crystalline Alpha-Chymotrypsin, v.The
Atomic Structure Of Tosyl-Alpha-Chymotrypsin At 2
Angstroms Resolution
pdb|2GCH|F Chain F, Refined Crystal Structure Of Gamma-chymotrypsin At 1.9
Angstroms Resolution
pdb|4GCH|F Chain F, Structure And Activity Of Two Photoreversible Cinnamates
Bound To Chymotrypsin
pdb|5GCH|F Chain F, Chemistry Of Caged Enzymes II. Photoactivation Of
Inhibited Chymotrypsin
pdb|6GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|7GCH|F Chain F, Structure Of Chymotrypsin-Trifluoromethyl Ketone Inhibitor
Complexes. Comparison Of Slowly And Rapidly
Equilibrating Inhibitors
pdb|1CHO|F Chain F, Crystal And Molecular Structures Of The Complex Of Alpha-
Chymotrypsin With Its Inhibitor Turkey Ovomucoid Third
Domain At 1.8 Angstroms Resolution
pdb|1GHA|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|1GMC|F Chain F, The X-Ray Crystal Structure Of The Tetrahedral
Intermediate Of Gamma- Chymotrypsin In Hexane
pdb|1GMD|F Chain F, X-Ray Crystal Structure Of Gamma-Chymotrypsin In Hexane
pdb|3GCT|F Chain F, Structure Of Gamma-Chymotrypsin In The Range pH 2.0 To pH
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low pH
pdb|4CHA|B Chain B, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|4CHA|F Chain F, Structure Of Alpha-Chymotrypsin Refined At 1.68 Angstroms
Resolution
pdb|5CHA|B Chain B, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|5CHA|F Chain F, The Refinement And The Structure Of The Dimer Of Alpha-
Chymotrypsin At 1.67-Angstroms Resolution
pdb|6CHA|B Chain B, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|6CHA|F Chain F, Structure Of A Tetrahedral Transition State Complex Of
Alpha-Chymotrypsin At 1.8-Angstroms Resolution
pdb|8GCH|F Chain F, Gamma-Chymotrypsin Is A Complex Of Alpha-Chymotrypsin With
Its Own Autolysis Products
pdb|3BG4|B Chain B, The Crystal Structure Of Guamerin In Complex With
Chymotrypsin And The Development Of An Elastase-Specific
Inhibitor
pdb|1GCT|B Chain B, Is Gamma-Chymotrypsin A Tetrapeptide Acyl-Enzyme Adduct Of
Gamma- Chymotrypsin?
pdb|2GCT|B Chain B, Structure Of Gamma-Chymotrypsin In The Range Ph 2.0 To Ph
10.5 Suggests That Gamma-Chymotrypsin Is A Covalent
Acyl-Enzyme Adduct At Low Ph
pdb|1GHB|F Chain F, A Second Active Site In Chymotrypsin? The X-Ray Crystal
Structure Of N-Acetyl-D-Tryptophan Bound To
Gamma-Chymotrypsin
pdb|2GMT|B Chain B, Three-Dimensional Structure Of Chymotrypsin Inactivated
With (2s) N- Acetyl-L-Alanyl-L-Phenylalanyl-Chloroethyl
Ketone: Implications For The Mechanism Of Inactivation
Of Serine Proteases By Chloroketones
pdb|3GCH|B Chain B, Chemistry Of Caged Enzymes. Binding Of Photoreversible
Cinnamates To Chymotrypsin
pdb|3RU4|D Chain D, Crystal Structure Of The Bowman-Birk Serine Protease
Inhibitor Btci In Complex With Trypsin And Chymotrypsin
Length = 131
Score = 63.2 bits (152), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 42/122 (34%), Positives = 65/122 (53%), Gaps = 13/122 (10%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKF-FCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
IV G +PW V+L+ F FCGG+LI++ +V+TAAHC ++ + V E
Sbjct: 1 IVNGEEAVPGSWPWQVSLQDKTGFHFCGGSLINENWVVTAAHCGVTTSD----VVVAGEF 56
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS----PDNK 133
++ + E +I+ ++ KV + KYN+ + ++DI LLKL F TVS P
Sbjct: 57 DQGSSSE-KIQKLKIAKVFKNSKYNSL---TINNDITLLKLSTAASFSQTVSAVCLPSAS 112
Query: 134 DD 135
DD
Sbjct: 113 DD 114
>pdb|1PYT|C Chain C, Ternary Complex Of Procarboxypeptidase A, Proproteinase E,
And Chymotrypsinogen C
Length = 253
Score = 63.2 bits (152), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 4/108 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
+ GWGR+ G + L+ +PV+ + C Q+ + + M+CAG + C GD
Sbjct: 142 ISGWGRLYTGGPLPDKLQEALLPVVDYEHCSQYDWWGITVKKTMVCAG--GDTRSGCDGD 199
Query: 641 SGGALLMEDLDGRFLIAGVVSW--GIGCARPNSPGVYTRVNHYMEWIQ 686
SGG L DG + + GV S+ GC P V+TRV+ +++WI
Sbjct: 200 SGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFIDWIN 247
Score = 48.9 bits (115), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 33/106 (31%), Positives = 59/106 (55%), Gaps = 9/106 (8%)
Query: 18 RIVGGWTTEVNEYPWVVAL--EQAGKFF--CGGTLISDRYVLTAAHCVRSSKRHKDLIAV 73
R+V G + W V+L E+ G F CGG+LI+ +V+TA HC+ +S+ ++ V
Sbjct: 11 RVVNGEDAVPYSWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTYQ---VV 67
Query: 74 ISEHNRATVYET-QIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
+ E++R+ + + Q+ + HP +N+ + +DIAL+KL
Sbjct: 68 LGEYDRSVLQGSEQVIPINAGDLFVHPLWNSN-CVACGNDIALVKL 112
>pdb|1AZZ|A Chain A, Fiddler Crab Collagenase Complexed To Ecotin
pdb|1AZZ|B Chain B, Fiddler Crab Collagenase Complexed To Ecotin
Length = 226
Score = 62.8 bits (151), Expect = 7e-10, Method: Composition-based stats.
Identities = 46/117 (39%), Positives = 61/117 (52%), Gaps = 16/117 (13%)
Query: 579 GTVV---GWGRVEESGQIASD-LRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGK 634
GTVV GWG +S SD LR VP+MSN +C G +T +C GGK
Sbjct: 116 GTVVTPTGWGLPSDSALGISDVLRQVDVPIMSNADCDAVYGI---VTDGNICIDST-GGK 171
Query: 635 DSCQGDSGGALLMEDLDGRFLIAGVVSWG--IGCARPNSPGVYTRVNHYMEWIQNNT 689
+C GDSGG L + +G L G+ S+G GC P +TRV ++++WIQ T
Sbjct: 172 GTCNGDSGGPL---NYNG--LTYGITSFGAAAGC-EAGYPDAFTRVTYFLDWIQTQT 222
Score = 49.3 bits (116), Expect = 6e-06, Method: Composition-based stats.
Identities = 35/111 (31%), Positives = 54/111 (48%), Gaps = 7/111 (6%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG N +P AL +FCGG+LIS ++LTAAHC+ + + V+ HN
Sbjct: 1 IVGGVEAVPNSWPHQAALFIDDMYFCGGSLISPEWILTAAHCMDGAGF---VDVVLGAHN 57
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
TQ+ T + H YN+ +DIA+++L P+ ++
Sbjct: 58 IREDEATQV-TIQSTDFTVHENYNSFVIS---NDIAVIRLPVPVTLTAAIA 104
>pdb|1OP0|A Chain A, Crystal Structure Of Aav-sp-i, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 62.4 bits (150), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 40/112 (35%), Positives = 63/112 (56%), Gaps = 12/112 (10%)
Query: 581 VVGWGRVEESGQIASDLR-ATQVPVMSNQECRQFPGFEPKLTGN--MMCAGYVEGGKDSC 637
++GWG + + D+ + ++ + C+ G+ P+L +CAG V+GGKD+C
Sbjct: 120 IMGWGSITPVKETFPDVPYCANINLLDHAVCQA--GY-PELLAEYRTLCAGIVQGGKDTC 176
Query: 638 QGDSGGALLMEDLDGRFLIAGVVSWGI-GCARPNSPGVYTRVNHYMEWIQNN 688
GDSGG L+ +G+F G+VS+G C + PG+YT V Y +WIQ N
Sbjct: 177 GGDSGGPLI---CNGQF--QGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRN 223
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 35/104 (33%), Positives = 56/104 (53%), Gaps = 8/104 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
++GG ++NE+ ++VA FFCGGTLI+ +V+TAAHC + D + H+
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHCDST-----DFQMQLGVHS 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPL 122
+ + E + +TR + P N + D DI L+KLD P+
Sbjct: 56 KKVLNEDE-QTRNPKEKFICPNKNNN--EVLDKDIMLIKLDKPI 96
>pdb|1OP2|A Chain A, Crystal Structure Of Aav-Sp-Ii, A Glycosylated Snake Venom
Serine Proteinase From Agkistrodon Acutus
Length = 234
Score = 62.4 bits (150), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 40/112 (35%), Positives = 63/112 (56%), Gaps = 12/112 (10%)
Query: 581 VVGWGRVEESGQIASDLR-ATQVPVMSNQECRQFPGFEPKLTGN--MMCAGYVEGGKDSC 637
++GWG + + D+ + ++ + C+ G+ P+L +CAG V+GGKD+C
Sbjct: 120 IMGWGSITPVKETFPDVPYCANINLLDHAVCQA--GY-PELLAEYRTLCAGIVQGGKDTC 176
Query: 638 QGDSGGALLMEDLDGRFLIAGVVSWGI-GCARPNSPGVYTRVNHYMEWIQNN 688
GDSGG L+ +G+F G+VS+G C + PG+YT V Y +WIQ N
Sbjct: 177 GGDSGGPLI---CNGQF--QGIVSYGAHPCGQGPKPGIYTNVFDYTDWIQRN 223
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 34/104 (32%), Positives = 58/104 (55%), Gaps = 8/104 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
++GG ++NE+ ++VA FFCGGTLI+ +V+TAAHC ++ + + + H+
Sbjct: 1 VIGGNECDINEHRFLVAFFNTTGFFCGGTLINPEWVVTAAHCDSTNFQMQ-----LGVHS 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPL 122
+ + E + +TR + P N + D DI L+KLD P+
Sbjct: 56 KKVLNEDE-QTRNPKEKFICPNKNNN--EVLDKDIMLIKLDKPI 96
>pdb|1BBR|E Chain E, The Structure Of Residues 7-16 Of The A Alpha Chain Of
Human Fibrinogen Bound To Bovine Thrombin At 2.3
Angstroms Resolution
pdb|1UCY|E Chain E, Thrombin Complexed With Fibrinopeptide A Alpha (Residues
7- 19). Three Complexes, One With Epsilon-Thrombin And
Two With Alpha-Thrombin
pdb|1VIT|G Chain G, Thrombin:hirudin 51-65 Complex
pdb|1YCP|M Chain M, The Crystal Structure Of Fibrinogen-Aa Peptide 1-23 (F8y)
Bound To Bovine Thrombin Explains Why The Mutation Of
Phe-8 To Tyrosine Strongly Inhibits Normal Cleavage At
Arginine-16
Length = 109
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 38/97 (39%), Positives = 53/97 (54%), Gaps = 6/97 (6%)
Query: 595 SDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEG-GK--DSCQGDSGGALLMED-L 650
S L+ +P++ C+ ++T NM CAGY G GK D+C+GDSGG +M+
Sbjct: 8 SVLQVVNLPLVERPVCKA--STRIRITDNMFCAGYKPGEGKRGDACEGDSGGPFVMKSPY 65
Query: 651 DGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+ R+ G+VSWG GC R G YT V +WIQ
Sbjct: 66 NNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQK 102
>pdb|1ELT|A Chain A, Structure Of Native Pancreatic Elastase From North
Atlantic Salmon At 1.61 Angstroms Resolution
Length = 236
Score = 61.6 bits (148), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 42/134 (31%), Positives = 66/134 (49%), Gaps = 19/134 (14%)
Query: 19 IVGGWTTEVNEYPWVVALE-QAGKFF---CGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
+VGG + N +PW ++L+ ++G + CGG+LI +V+TAAHCV S++ + V+
Sbjct: 1 VVGGRVAQPNSWPWQISLQYKSGSSYYHTCGGSLIRQGWVMTAAHCVDSARTWR---VVL 57
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKD 134
EHN T E + + V V H +N+ +DIALL+L+ V
Sbjct: 58 GEHNLNT-NEGKEQIMTVNSVFIHSGWNSDDVAG-GYDIALLRLNTQASLNSAV------ 109
Query: 135 DPKSELTQFKPGNQ 148
+L P NQ
Sbjct: 110 ----QLAALPPSNQ 119
Score = 57.8 bits (138), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 5/108 (4%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
+ GWG+ G ++ L+ +P + + C + + M+CAG G C GD
Sbjct: 129 ITGWGKTSTGGPLSDSLKQAWLPSVDHATCSSSGWWGSTVKTTMVCAG--GGANSGCNGD 186
Query: 641 SGGALLMEDLDGRFLIAGVVSW--GIGCARPNSPGVYTRVNHYMEWIQ 686
SGG L + ++G + + GV S+ GC P V+TRV+ Y+ W+
Sbjct: 187 SGGPLNCQ-VNGSYYVHGVTSFVSSSGCNASKKPTVFTRVSAYISWMN 233
>pdb|1FDP|A Chain A, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|B Chain B, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|C Chain C, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
pdb|1FDP|D Chain D, Proenzyme Of Human Complement Factor D, Recombinant
Profactor D
Length = 235
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 37/107 (34%), Positives = 51/107 (47%), Gaps = 6/107 (5%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG V +G+ L+ +PV+ C + + +T +MCA +DSC+GD
Sbjct: 132 VAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCA--ESNRRDSCKGD 189
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
SGG L+ G L V S C PG+YTRV Y WI +
Sbjct: 190 SGGPLVC----GGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDS 232
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 57/113 (50%), Gaps = 5/113 (4%)
Query: 18 RIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
RI+GG E + P++ +++ G CGG L+++++VL+AAHC+ + K + V+
Sbjct: 7 RILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGK--VQVLLGA 64
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
+ + E V++ + HP + DHD+ LL+L P V P
Sbjct: 65 HSLSQPEPSKRLYDVLRAVPHPDSQPD---TIDHDLLLLQLSEKATLGPAVRP 114
>pdb|1FON|A Chain A, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
pdb|1FON|B Chain B, Crystal Structure Of Bovine Procarboxypeptidase A-S6
Subunit Iii, A Highly Structured Truncated Zymogen E
Length = 240
Score = 60.5 bits (145), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
+ GWGR+ G + L+ +P + + C Q+ + + M+CAG + C GD
Sbjct: 129 ISGWGRLYTGGPLPDKLQQALLPTVDYEHCSQWDWWGITVKKTMVCAG--GDTRSGCNGD 186
Query: 641 SGGALLMEDLDGRFLIAGVVSW--GIGCARPNSPGVYTRVNHYMEWIQ 686
SGG L DG + + GV S+ GC P V+TRV+ +++WI
Sbjct: 187 SGGPLNCPAADGSWQVHGVTSFVSAFGCNTIKKPTVFTRVSAFIDWID 234
Score = 46.6 bits (109), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/109 (29%), Positives = 58/109 (53%), Gaps = 9/109 (8%)
Query: 29 EYPWVVAL--EQAGKFF--CGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRATVYE 84
+ W V+L E+ G F CGG+LI+ +V+TA HC+ +S+ ++ V+ E++R+ +
Sbjct: 9 SWSWQVSLQYEKDGAFHHTCGGSLIAPDWVVTAGHCISTSRTYQ---VVLGEYDRSVLEG 65
Query: 85 T-QIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDN 132
+ Q+ + HP +N+ + +DIAL+KL + V N
Sbjct: 66 SEQVIPINAGDLFVHPLWNSN-CVACGNDIALVKLSRSAQLGDKVQLAN 113
>pdb|1AU8|A Chain A, Human Cathepsin G
pdb|1T32|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|1CGH|A Chain A, Human Cathepsin G
Length = 224
Score = 60.1 bits (144), Expect = 4e-09, Method: Composition-based stats.
Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 14/113 (12%)
Query: 580 TVVGWGRVEESGQIASD-LRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSC 637
TV GWGRV S + +D LR Q+ V +++C R F ++P+ +C G K +
Sbjct: 123 TVAGWGRV--SMRRGTDTLREVQLRVQRDRQCLRIFGSYDPR---RQICVGDRRERKAAF 177
Query: 638 QGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
+GDSGG LL ++ G+VS+G P P V+TRV+ ++ WI+ R
Sbjct: 178 KGDSGGPLLCNNV-----AHGIVSYGKSSGVP--PEVFTRVSSFLPWIRTTMR 223
Score = 49.7 bits (117), Expect = 5e-06, Method: Composition-based stats.
Identities = 34/105 (32%), Positives = 55/105 (52%), Gaps = 16/105 (15%)
Query: 19 IVGGWTTEVNEYPWVVALE---QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
I+GG + + P++ L+ AG+ CGG L+ + +VLTAAHC S ++ +
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGS-----NINVTLG 55
Query: 76 EHN--RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
HN R + I RR ++ HP+YN ++ +DI LL+L
Sbjct: 56 AHNIQRRENTQQHITARRAIR---HPQYN---QRTIQNDIMLLQL 94
>pdb|1KLT|A Chain A, Crystal Structure Of Pmsf-Treated Human Chymase At 1.9
Angstroms Resolution
Length = 226
Score = 59.7 bits (143), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 10/111 (9%)
Query: 577 RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
R V GWGR + L+ ++ +M Q C F F+ L +C G K +
Sbjct: 121 RMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNL---QLCVGNPRKTKSA 177
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+GDSGG LL + G+VS+G A+P P V+TR++HY WI
Sbjct: 178 FKGDSGGPLLCAGV-----AQGIVSYGRSDAKP--PAVFTRISHYRPWINQ 221
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 38/104 (36%), Positives = 50/104 (48%), Gaps = 13/104 (12%)
Query: 19 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+GG ++ + P++ LE FCGG LI +VLTAAHC S + +
Sbjct: 1 IIGGTESKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS-----ITVTL 55
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
HN T E + V+K HPKYN + HDI LLKL
Sbjct: 56 GAHN-ITEEEDTWQKLEVIKQFRHPKYNTS---TLHHDIMLLKL 95
>pdb|4AFQ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFQ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFS|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFU|B Chain B, Human Chymase - Fynomer Complex
pdb|4AFZ|A Chain A, Human Chymase - Fynomer Complex
pdb|4AFZ|B Chain B, Human Chymase - Fynomer Complex
pdb|4AG1|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|A Chain A, Human Chymase - Fynomer Complex
pdb|4AG2|B Chain B, Human Chymase - Fynomer Complex
Length = 226
Score = 59.7 bits (143), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 10/111 (9%)
Query: 577 RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
R V GWGR + L+ ++ +M Q C F F+ L +C G K +
Sbjct: 121 RMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNL---QLCVGNPRKTKSA 177
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+GDSGG LL + G+VS+G A+P P V+TR++HY WI
Sbjct: 178 FKGDSGGPLLCAGV-----AQGIVSYGRSDAKP--PAVFTRISHYRPWINQ 221
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/104 (36%), Positives = 49/104 (47%), Gaps = 13/104 (12%)
Query: 19 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+GG + + P++ LE FCGG LI +VLTAAHC S + +
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS-----ITVTL 55
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
HN T E + V+K HPKYN + HDI LLKL
Sbjct: 56 GAHN-ITEEEDTWQKLEVIKQFRHPKYNTS---TLHHDIMLLKL 95
>pdb|1NN6|A Chain A, Human Pro-Chymase
Length = 228
Score = 59.3 bits (142), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 10/111 (9%)
Query: 577 RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
R V GWGR + L+ ++ +M Q C F F+ L +C G K +
Sbjct: 123 RMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNL---QLCVGNPRKTKSA 179
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+GDSGG LL + G+VS+G A+P P V+TR++HY WI
Sbjct: 180 FKGDSGGPLLCAGV-----AQGIVSYGRSDAKP--PAVFTRISHYRPWINQ 223
Score = 54.3 bits (129), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 38/104 (36%), Positives = 49/104 (47%), Gaps = 13/104 (12%)
Query: 19 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+GG + + P++ LE FCGG LI +VLTAAHC S + +
Sbjct: 3 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS-----ITVTL 57
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
HN T E + V+K HPKYN + HDI LLKL
Sbjct: 58 GAHN-ITEEEDTWQKLEVIKQFRHPKYNTS---TLHHDIMLLKL 97
>pdb|3S69|A Chain A, Crystal Structure Of Saxthrombin
Length = 234
Score = 59.3 bits (142), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 40/110 (36%), Positives = 61/110 (55%), Gaps = 10/110 (9%)
Query: 581 VVGWGRVEESGQIASDLR-ATQVPVMSNQECRQFPGFEPKLTG-NMMCAGYVEGGKDSCQ 638
++GWG + D+ + ++ + C+ G+ LT +CAG +EGGKD+C
Sbjct: 120 IMGWGSITPIKVTYPDVPYCAYINLLDDAVCQA--GYPELLTEYRTLCAGILEGGKDTCG 177
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGI-GCARPNSPGVYTRVNHYMEWIQN 687
GDSGG L+ +G+F G+VS+G C + PGVYT+V Y WIQ+
Sbjct: 178 GDSGGPLI---CNGQF--QGIVSFGAHPCGQGLKPGVYTKVFDYNHWIQS 222
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 8/102 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
++GG +NE+ +VA + FFC GTLI++ +VLTAAHC ++ + K + H+
Sbjct: 1 VIGGDECNINEHRSLVAFFNSTGFFCSGTLINEEWVLTAAHCDNTNFQMK-----LGVHS 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDA 120
+ + E + +TR + P N + + D DI L+KLD+
Sbjct: 56 KKVLNEDE-QTRNPKEKFICP--NKKNDEVLDKDIMLIKLDS 94
>pdb|3N7O|A Chain A, X-Ray Structure Of Human Chymase In Complex With Small
Molecule Inhibitor
Length = 226
Score = 58.9 bits (141), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 37/111 (33%), Positives = 52/111 (46%), Gaps = 10/111 (9%)
Query: 577 RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
R V GWGR + L+ ++ +M Q C F F+ L +C G K +
Sbjct: 121 RMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNL---QLCVGNPRKTKSA 177
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+GDSGG LL G+VS+G A+P P V+TR++HY WI
Sbjct: 178 FKGDSGGPLLCAGA-----AQGIVSYGRSDAKP--PAVFTRISHYQPWINQ 221
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/104 (36%), Positives = 49/104 (47%), Gaps = 13/104 (12%)
Query: 19 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+GG + + P++ LE FCGG LI +VLTAAHC S + +
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS-----ITVTL 55
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
HN T E + V+K HPKYN + HDI LLKL
Sbjct: 56 GAHN-ITEEEDTWQKLEVIKQFRHPKYNTS---TLHHDIMLLKL 95
>pdb|1PJP|A Chain A, The 2.2 A Crystal Structure Of Human Chymase In Complex
With Succinyl- Ala-Ala-Pro-Phe-Chloromethylketone
pdb|1T31|A Chain A, A Dual Inhibitor Of The Leukocyte Proteases Cathepsin G
And Chymase With Therapeutic Efficacy In Animals Models
Of Inflammation
pdb|2HVX|A Chain A, Discovery Of Potent, Orally Active, Nonpeptide Inhibitors
Of Human Mast Cell Chymase By Using Structure-Based Drug
Design
pdb|3S0N|A Chain A, Crystal Structure Of Human Chymase With Benzimidazolone
Inhibitor
Length = 226
Score = 58.9 bits (141), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 37/111 (33%), Positives = 52/111 (46%), Gaps = 10/111 (9%)
Query: 577 RTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDS 636
R V GWGR + L+ ++ +M Q C F F+ L +C G K +
Sbjct: 121 RMCRVAGWGRTGVLKPGSDTLQEVKLRLMDPQACSHFRDFDHNL---QLCVGNPRKTKSA 177
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
+GDSGG LL G+VS+G A+P P V+TR++HY WI
Sbjct: 178 FKGDSGGPLLCAGA-----AQGIVSYGRSDAKP--PAVFTRISHYQPWINQ 221
Score = 53.9 bits (128), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 38/104 (36%), Positives = 49/104 (47%), Gaps = 13/104 (12%)
Query: 19 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+GG + + P++ LE FCGG LI +VLTAAHC S + +
Sbjct: 1 IIGGTECKPHSRPYMAYLEIVTSNGPSKFCGGFLIRRNFVLTAAHCAGRS-----ITVTL 55
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
HN T E + V+K HPKYN + HDI LLKL
Sbjct: 56 GAHN-ITEEEDTWQKLEVIKQFRHPKYNTS---TLHHDIMLLKL 95
>pdb|2RDL|A Chain A, Hamster Chymase 2
pdb|2RDL|B Chain B, Hamster Chymase 2
Length = 226
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 37/124 (29%), Positives = 61/124 (49%), Gaps = 14/124 (11%)
Query: 570 SHRVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGF--EPKLTGNMMCA 627
S+ + R VGWGR + + L+ ++ ++ Q C+ F F EP+L C
Sbjct: 114 SNSIPPGRVCRAVGWGRTNVNEPPSDTLQEVKMRILDPQACKHFEDFHQEPQL-----CV 168
Query: 628 GYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
G + ++ +GDSGG LL + G+ S+ + A+P P V+TR++HY WI
Sbjct: 169 GNPKKIRNVYKGDSGGPLLCAG-----IAQGIASYVLRNAKP--PSVFTRISHYRPWINK 221
Query: 688 NTRD 691
R+
Sbjct: 222 ILRE 225
Score = 40.8 bits (94), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 33/104 (31%), Positives = 48/104 (46%), Gaps = 13/104 (12%)
Query: 19 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+GG + P++ LE + C G LI +V+TAAHC S + ++
Sbjct: 1 IIGGTECRPHARPYMAYLEIVTPENHLSACSGFLIRRNFVMTAAHCAGRS-----ITVLL 55
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKL 118
HN+ V E + V K HPKY+ + + DI LLKL
Sbjct: 56 GAHNK-KVKEDTWQKLEVEKQFPHPKYDDRLVLN---DIMLLKL 95
>pdb|2ZGC|A Chain A, Crystal Structure Of Active Human Granzyme M
pdb|2ZGH|A Chain A, Crystal Structure Of Active Granzyme M Bound To Its
Product
pdb|2ZKS|A Chain A, Structural Insights Into The Proteolytic Machinery Of
Apoptosis- Inducing Granzyme M
Length = 240
Score = 58.2 bits (139), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 33/112 (29%), Positives = 60/112 (53%), Gaps = 8/112 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG + P++ +L++ G CGG L+ ++VLTAAHC+ ++R L V+ H
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCL--AQRMAQLRLVLGLHT 58
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
++ T + + HP+Y + ++D+ALL+LD ++ T+ P
Sbjct: 59 ----LDSPGLTFHIKAAIQHPRYKP--VPALENDLALLQLDGKVKPSRTIRP 104
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
++ GWG + G+++ LR + V+ + C + L+ +M+C + C+G
Sbjct: 121 SMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQAPCKG 180
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWIQNNT 689
DSGG L+ GR L AGV+S+ C P V T V Y+ WI+ T
Sbjct: 181 DSGGPLVCG--KGRVL-AGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKVT 228
>pdb|2BDG|A Chain A, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDG|B Chain B, Human Kallikrein 4 Complex With Nickel And
P-aminobenzamidine
pdb|2BDH|A Chain A, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|B Chain B, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|C Chain C, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDH|D Chain D, Human Kallikrein 4 Complex With Zinc And
P-Aminobenzamidine
pdb|2BDI|A Chain A, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|B Chain B, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|C Chain C, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|D Chain D, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|E Chain E, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|F Chain F, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|G Chain G, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|H Chain H, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|I Chain I, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|J Chain J, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|K Chain K, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|L Chain L, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|M Chain M, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|N Chain N, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|O Chain O, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
pdb|2BDI|P Chain P, Human Kallikrein 4 Complex With Cobalt And P-
Aminobenzamidine
Length = 223
Score = 57.8 bits (138), Expect = 2e-08, Method: Composition-based stats.
Identities = 38/111 (34%), Positives = 60/111 (54%), Gaps = 9/111 (8%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG + +G++ + L+ V V+S + C + ++P +M CAG + KDSC GD
Sbjct: 120 VSGWGLLA-NGRMPTVLQCVNVSVVSEEVCSKL--YDPLYHPSMFCAGGGQDQKDSCNGD 176
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWIQNNTR 690
SGG L+ + G+VS+G C + PGVYT + + EWI+ +
Sbjct: 177 SGGPLICNG-----YLQGLVSFGKAPCGQVGVPGVYTNLCKFTEWIEKTVQ 222
Score = 43.1 bits (100), Expect = 6e-04, Method: Composition-based stats.
Identities = 29/110 (26%), Positives = 48/110 (43%), Gaps = 8/110 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+ G + PW AL + FC G L+ ++VL+AAHC ++S + H+
Sbjct: 1 IINGEDCSPHSQPWQAALVMENELFCSGVLVHPQWVLSAAHCFQNS-----YTIGLGLHS 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTV 128
E + + HP+YN + D+ L+KLD + T+
Sbjct: 56 LEADQEPGSQMVEASLSVRHPEYNRPLLAN---DLMLIKLDESVSESDTI 102
>pdb|3RP2|A Chain A, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
pdb|3RP2|B Chain B, The Structure Of Rat Mast Cell Protease Ii At
1.9-Angstroms Resolution
Length = 224
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 37/115 (32%), Positives = 61/115 (53%), Gaps = 13/115 (11%)
Query: 19 IVGGWTTEVNEYPWVVAL----EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+GG + + P++ L E+ + CGG LIS ++VLTAAHC + +++ ++
Sbjct: 1 IIGGVESIPHSRPYMAHLDIVTEKGLRVICGGFLISRQFVLTAAHC-----KGREITVIL 55
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
H+ TQ + +V K + H YN+ + HDI LLKL+ +E P V+
Sbjct: 56 GAHDVRKRESTQ-QKIKVEKQIIHESYNSV---PNLHDIMLLKLEKKVELTPAVN 106
Score = 47.0 bits (110), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 10/103 (9%)
Query: 583 GWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGDSG 642
GWG+ + LR ++ +M + C + +E K +C G + + GDSG
Sbjct: 127 GWGKTGVRDPTSYTLREVELRIMDEKACVDYRYYEYKF---QVCVGSPTTLRAAFMGDSG 183
Query: 643 GALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWI 685
G LL + G+VS+G A+P P ++TRV+ Y+ WI
Sbjct: 184 GPLLCAGVA-----HGIVSYGHPDAKP--PAIFTRVSTYVPWI 219
>pdb|3G01|A Chain A, Structure Of Grc Mutant E192rE193G
pdb|3G01|B Chain B, Structure Of Grc Mutant E192rE193G
Length = 227
Score = 57.4 bits (137), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 43/134 (32%), Positives = 61/134 (45%), Gaps = 16/134 (11%)
Query: 19 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+GG + P++ E K FCGG L+ D++VLTAAHC + + + +
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHC-----KGRSMTVTL 55
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKD 134
HN ETQ + V K + HP YN +DI LLKL + V P N
Sbjct: 56 GAHNIKAKEETQ-QIIPVAKAIPHPDYNPD---DRSNDIMLLKLVRNAKRTRAVRPLNL- 110
Query: 135 DPKSELTQFKPGNQ 148
P+ KPG++
Sbjct: 111 -PRRN-AHVKPGDE 122
Score = 47.4 bits (111), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 10/111 (9%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECR-QFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG+V G+ L ++ V +Q C QF + N +C G + S +G
Sbjct: 125 VAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNR--ANEICVGDSKIKGASFRG 182
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L+ + AG+VS+G ++P V+TRV ++ WI+ +
Sbjct: 183 DSGGPLVC-----KRAAAGIVSYGQ--TDGSAPQVFTRVLSFVSWIKKTMK 226
>pdb|1FI8|A Chain A, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
pdb|1FI8|B Chain B, Rat Granzyme B [n66q] Complexed To Ecotin [81-84 Iepd]
Length = 228
Score = 57.0 bits (136), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 44/133 (33%), Positives = 67/133 (50%), Gaps = 16/133 (12%)
Query: 19 IVGGWTTEVNEYPWVVAL----EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+GG + + P++ L E +G CGG LI + +VLTAAHC S + +
Sbjct: 1 IIGGHEAKPHSRPYMAYLQIMDEYSGSKKCGGFLIREDFVLTAAHCSGSK-----IQVTL 55
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKD 134
HN + Q + VVK++ HP YN +K+ +DI LLKL + + V P N
Sbjct: 56 GAHNIKEQEKMQ-QIIPVVKIIPHPAYN---SKTISNDIMLLKLKSKAKRSSAVKPLNL- 110
Query: 135 DPKSELTQFKPGN 147
P+ + + KPG+
Sbjct: 111 -PRRNV-KVKPGD 121
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 31/114 (27%), Positives = 61/114 (53%), Gaps = 12/114 (10%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPG--FEPKLTGNMMCAGYVEGGKDSCQ 638
V GWG++ G+ + L+ ++ V +Q+C + F+ N +CAG + + S +
Sbjct: 125 VAGWGKLGPMGKYSDTLQEVELTVQEDQKCESYLKNYFD---KANEICAGDPKIKRASFR 181
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRDA 692
GDSGG L+ + + AG+VS+G ++P +T+V+ ++ WI+ + +
Sbjct: 182 GDSGGPLVCKK-----VAAGIVSYGQNDG--STPRAFTKVSTFLSWIKKTMKKS 228
>pdb|4F4O|C Chain C, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|F Chain F, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|I Chain I, Structure Of The Haptoglobin-Haemoglobin Complex
pdb|4F4O|L Chain L, Structure Of The Haptoglobin-Haemoglobin Complex
Length = 347
Score = 57.0 bits (136), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 39/129 (30%), Positives = 58/129 (44%), Gaps = 18/129 (13%)
Query: 579 GTVVGWGRVEESGQIASDLRATQVPVMSNQECRQF---------------PGFEPKLTGN 623
G V GWGR + L+ +PV ++C Q+ G +P L +
Sbjct: 220 GYVSGWGR-NANLNFTEHLKYVMLPVADQEKCVQYYEGSTVPEKKTPKSPVGVQPILNEH 278
Query: 624 MMCAGYVEGGKDSCQGDSGGALLMEDL-DGRFLIAGVVSWGIGCARPNSPGVYTRVNHYM 682
CAG + +D+C GD+G A + D D + AG++S+ C R GVY RV +
Sbjct: 279 TFCAGLSKYQEDTCYGDAGSAFAVHDKDDDTWYAAGILSFDKSC-RTAEYGVYVRVTSIL 337
Query: 683 EWIQNNTRD 691
+WIQ D
Sbjct: 338 DWIQTTIAD 346
Score = 39.3 bits (90), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 32/127 (25%), Positives = 55/127 (43%), Gaps = 13/127 (10%)
Query: 8 AGCGVP----NRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRS 63
A CG P +++ RI+GG +PW + G TLI+++++LT A +R
Sbjct: 88 AVCGKPKNPVDQVQRIMGGSLDAKGSFPWQAKMISHHNLTSGATLINEQWLLTTAKNLRL 147
Query: 64 SKRHKDLIAVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLE 123
++ I+ R +Y + + + KV+ HP + DI L+KL +
Sbjct: 148 GHKNDTKAKDIAPTLR--LYVGKKQEVEIEKVIFHPDNSTV-------DIGLIKLKQKVP 198
Query: 124 FKPTVSP 130
V P
Sbjct: 199 VNERVMP 205
>pdb|1HYL|A Chain A, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|1HYL|B Chain B, The 1.8 A Structure Of Collagenase From Hypoderma Lineatum
pdb|2HLC|A Chain A, Hl Collagenase Structure At 1.7a Resolution
pdb|2HLC|B Chain B, Hl Collagenase Structure At 1.7a Resolution
Length = 230
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 41/112 (36%), Positives = 54/112 (48%), Gaps = 11/112 (9%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
TV GWG+ I L+ T V+ N C Q + P + G GK C G
Sbjct: 124 TVSGWGQSNTDTVI---LQYTYNLVIDNDRCAQ--EYPPGIIVESTICGDTSDGKSPCFG 178
Query: 640 DSGGALLMEDLDGRFLIAGVVSW--GIGCARPNSPGVYTRVNHYMEWIQNNT 689
DSGG ++ D + L+ GVVS+ G GC P ++RV YM+WIQ NT
Sbjct: 179 DSGGPFVLSD---KNLLIGVVSFVSGAGC-ESGKPVGFSRVTSYMDWIQQNT 226
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 37/170 (21%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 19 IVGGWTTEVNEYPWV----VALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+ G+ +P+ + L+ + +CGG+LI ++++LTAAHCV D ++V+
Sbjct: 1 IINGYEAYTGLFPYQAGLDITLQDQRRVWCGGSLIDNKWILTAAHCVH------DAVSVV 54
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKD 134
A YE + ++++H +N ++ +D+AL+K+ +E+ + P
Sbjct: 55 VYLGSAVQYEGEAVVNS-ERIISHSMFN---PDTYLNDVALIKI-PHVEYTDNIQP---- 105
Query: 135 DPKSELTQFKPGNQKSYKWDIVWFNLIGFAVLHLATL---YGYYLMFTGE 181
+ G + + K++ +W + G+ + T+ Y Y L+ +
Sbjct: 106 ------IRLPSGEELNNKFENIWATVSGWGQSNTDTVILQYTYNLVIDND 149
>pdb|3FZZ|A Chain A, Structure Of Grc
pdb|3FZZ|B Chain B, Structure Of Grc
Length = 227
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 43/134 (32%), Positives = 61/134 (45%), Gaps = 16/134 (11%)
Query: 19 IVGGWTTEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVI 74
I+GG + P++ E K FCGG L+ D++VLTAAHC + + + +
Sbjct: 1 IIGGNEISPHSRPYMAYYEFLKVGGKKMFCGGFLVRDKFVLTAAHC-----KGRSMTVTL 55
Query: 75 SEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKD 134
HN ETQ + V K + HP YN +DI LLKL + V P N
Sbjct: 56 GAHNIKAKEETQ-QIIPVAKAIPHPDYNPD---DRSNDIMLLKLVRNAKRTRAVRPLNL- 110
Query: 135 DPKSELTQFKPGNQ 148
P+ KPG++
Sbjct: 111 -PRRN-AHVKPGDE 122
Score = 44.7 bits (104), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 10/111 (9%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECR-QFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
V GWG+V G+ L ++ V +Q C QF + N +C G + S +
Sbjct: 125 VAGWGKVTPDGEFPKTLHEVKLTVQKDQVCESQFQSSYNR--ANEICVGDSKIKGASFEE 182
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L+ + AG+VS+G ++P V+TRV ++ WI+ +
Sbjct: 183 DSGGPLVC-----KRAAAGIVSYGQ--TDGSAPQVFTRVLSFVSWIKKTMK 226
>pdb|1GVZ|A Chain A, Prostate Specific Antigen (Psa) From Stallion Seminal
Plasma
Length = 237
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 36/118 (30%), Positives = 53/118 (44%), Gaps = 14/118 (11%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GGW E + PW VA+ G F CGG L+ ++VLTAAHC+ D + HN
Sbjct: 1 IIGGWECEKHSKPWQVAVYHQGHFQCGGVLVHPQWVLTAAHCMSD-----DYQIWLGRHN 55
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSH--------DHDIALLKLDAPLEFKPTV 128
+ +T + +V P+++ K HD+ LL+L P V
Sbjct: 56 LSKDEDT-AQFHQVSDSFLDPQFDLSLLKKKYLRPYDDISHDLMLLRLAQPARITDAV 112
Score = 52.4 bits (124), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 36/108 (33%), Positives = 59/108 (54%), Gaps = 11/108 (10%)
Query: 583 GWGRVEE-SGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
GWG + + + + L+ ++ + SN++C R +P K+T ++CA + + C GD
Sbjct: 132 GWGLISTFTNRGSGTLQCVELRLQSNEKCARAYP---EKMTEFVLCATHRDDSGSICLGD 188
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWIQN 687
SGGAL+ DG F G+ SWG CA N V+T+V + +WI+
Sbjct: 189 SGGALI---CDGVF--QGITSWGYSECADFNDNFVFTKVMPHKKWIKE 231
>pdb|2ZGJ|A Chain A, Crystal Structure Of D86n-gzmm Complexed With Its Optimal
Synthesized Substrate
Length = 240
Score = 56.6 bits (135), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 32/112 (28%), Positives = 60/112 (53%), Gaps = 8/112 (7%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG + P++ +L++ G CGG L+ ++VLTAAHC+ ++R L V+ H
Sbjct: 1 IIGGREVIPHSRPYMASLQRNGSHLCGGVLVHPKWVLTAAHCL--AQRMAQLRLVLGLHT 58
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
++ T + + HP+Y + ++++ALL+LD ++ T+ P
Sbjct: 59 ----LDSPGLTFHIKAAIQHPRYKP--VPALENNLALLQLDGKVKPSRTIRP 104
Score = 48.5 bits (114), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
++ GWG + G+++ LR + V+ + C + L+ +M+C + C+G
Sbjct: 121 SMAGWGLTHQGGRLSRVLRELDLQVLDTRMCNNSRFWNGSLSPSMVCLAADSKDQAPCKG 180
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWIQNNT 689
DSGG L+ GR L AGV+S+ C P V T V Y+ WI+ T
Sbjct: 181 DSGGPLVCG--KGRVL-AGVLSFSSRVCTDIFKPPVATAVAPYVSWIRKVT 228
>pdb|1KYN|B Chain B, Cathepsin-G
pdb|1KYN|A Chain A, Cathepsin-G
Length = 235
Score = 56.2 bits (134), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 40/114 (35%), Positives = 61/114 (53%), Gaps = 14/114 (12%)
Query: 580 TVVGWGRVEESGQIASD-LRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSC 637
TV GWGRV S + +D LR Q+ V +++C R F ++P+ +C G K +
Sbjct: 123 TVAGWGRV--SMRRGTDTLREVQLRVQRDRQCLRIFGSYDPR---RQICVGDRRERKAAF 177
Query: 638 QGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTRD 691
+GDSGG LL ++ G+VS+G P P V+TRV+ ++ WI+ R
Sbjct: 178 KGDSGGPLLCNNV-----AHGIVSYGKSSGVP--PEVFTRVSSFLPWIRTTMRS 224
Score = 49.7 bits (117), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 16/106 (15%)
Query: 19 IVGGWTTEVNEYPWVVALE---QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
I+GG + + P++ L+ AG+ CGG L+ + +VLTAAHC S ++ +
Sbjct: 1 IIGGRESRPHSRPYMAYLQIQSPAGQSRCGGFLVREDFVLTAAHCWGS-----NINVTLG 55
Query: 76 EHNRATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLD 119
HN TQ I RR ++ HP+YN ++ +DI LL+L
Sbjct: 56 AHNIQRRENTQQHITARRAIR---HPQYN---QRTIQNDIMLLQLS 95
>pdb|1EUF|A Chain A, Bovine Duodenase(New Serine Protease), Crystal Structure
Length = 227
Score = 55.8 bits (133), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 47/133 (35%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGK-FFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
I+GG + + P++ L + +GK CGG L+ + +VLTAAHC+ SS + +
Sbjct: 1 IIGGHEAKPHSRPYMAFLLFKTSGKSHICGGFLVREDFVLTAAHCLGSS-----INVTLG 55
Query: 76 EHNRATVYETQ--IETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNK 133
HN TQ I RR + HP YN + + +DI LLKL + VSP N
Sbjct: 56 AHNIMERERTQQVIPVRRPIP---HPDYNDE---TLANDIMLLKLTRKADITDKVSPINL 109
Query: 134 DDPKSELTQFKPG 146
P+S L + KPG
Sbjct: 110 --PRS-LAEVKPG 119
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 9/111 (8%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
+V GWGR+ + L+ + V S ++C F+ + +CAG K+S G
Sbjct: 123 SVAGWGRLGVNMPSTDKLQEVDLEVQSEEKC--IARFKNYIPFTQICAGDPSKRKNSFSG 180
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L+ + G+VS+G +P VYTR++ ++ WI + R
Sbjct: 181 DSGGPLVCNGV-----AQGIVSYGRNDG--TTPDVYTRISSFLSWIHSTMR 224
>pdb|1FUJ|A Chain A, Pr3 (Myeloblastin)
pdb|1FUJ|B Chain B, Pr3 (Myeloblastin)
pdb|1FUJ|C Chain C, Pr3 (Myeloblastin)
pdb|1FUJ|D Chain D, Pr3 (Myeloblastin)
Length = 221
Score = 55.5 bits (132), Expect = 1e-07, Method: Composition-based stats.
Identities = 43/130 (33%), Positives = 64/130 (49%), Gaps = 12/130 (9%)
Query: 19 IVGGWTTEVNEYPWVVALE---QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
IVGG + + P++ +L+ G FCGGTLI +VLTAAHC+R + + + V+
Sbjct: 1 IVGGHEAQPHSRPYMASLQMRGNPGSHFCGGTLIHPSFVLTAAHCLRDIPQ-RLVNVVLG 59
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFK---PTVSPDN 132
HN T TQ + V +V N A++ +DI L++L +P TV
Sbjct: 60 AHNVRTQEPTQ-QHFSVAQVF----LNNYDAENKLNDILLIQLSSPANLSASVATVQLPQ 114
Query: 133 KDDPKSELTQ 142
+D P TQ
Sbjct: 115 QDQPVPHGTQ 124
Score = 41.6 bits (96), Expect = 0.001, Method: Composition-based stats.
Identities = 37/115 (32%), Positives = 52/115 (45%), Gaps = 27/115 (23%)
Query: 582 VGWGRV---EESGQIASDLRATQVPVMSNQECR--QFPGFEPKLTGNMMCAGYVEGGKDS 636
+GWGRV + Q+ +L T V CR F P+ +
Sbjct: 128 MGWGRVGAHDPPAQVLQELNVTVVTFF----CRPHNICTFVPRRKAGI------------ 171
Query: 637 CQGDSGGALLMEDLDGRFLIAGVVSWGI-GCARPNSPGVYTRVNHYMEWIQNNTR 690
C GDSGG L+ DG +I G+ S+ I GCA P +TRV Y++WI++ R
Sbjct: 172 CFGDSGGPLI---CDG--IIQGIDSFVIWGCATRLFPDFFTRVALYVDWIRSTLR 221
>pdb|1EQ9|A Chain A, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
pdb|1EQ9|B Chain B, Crystal Structure Of Fire Ant Chymotrypsin Complexed To
Pmsf
Length = 222
Score = 53.1 bits (126), Expect = 5e-07, Method: Composition-based stats.
Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 10/111 (9%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQG 639
T+ GWG G + L+ ++ V ++C + + ++ + +C + G+ +C G
Sbjct: 121 TLTGWGSTRLGGNTPNALQEIELIVHPQKQCERD---QWRVIDSHICT-LTKRGEGACHG 176
Query: 640 DSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
DSGG L+ G+VS+G CA P VYTRV+ ++ WI N +
Sbjct: 177 DSGGPLVANGAQ-----IGIVSFGSPCAL-GEPDVYTRVSSFVSWINANLK 221
Score = 49.3 bits (116), Expect = 7e-06, Method: Composition-based stats.
Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 23/120 (19%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG V +YP+ V+L +G CG +++ + VLTAAHCV +S N
Sbjct: 1 IVGGKDAPVGKYPYQVSLRLSGSHRCGASILDNNNVLTAAHCVDG----------LSNLN 50
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGA---KSHD-----HDIALLKLDAPLEFKPTVSP 130
R V+ + T + + + Y+ + A K++D +D+AL+ L P++F V P
Sbjct: 51 RLKVH---VGTNYLSE--SGDVYDVEDAVVNKNYDDFLLRNDVALVHLTNPIKFNDLVQP 105
>pdb|3H7O|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
pdb|3H7O|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-I1 (Smipp-S-I1)
Length = 228
Score = 53.1 bits (126), Expect = 5e-07, Method: Composition-based stats.
Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 15/126 (11%)
Query: 21 GGWTTEVNEYPWVVALEQ---AGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEH 77
GG T++ + PW VA+ CGG ++S +VLTAAHCV K ++ ++
Sbjct: 2 GGEKTDIKQVPWTVAVRTYPGEESLTCGGAILSQWFVLTAAHCVFDQKPE----TIVIQY 57
Query: 78 NRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEF-----KPTVSPDN 132
++E ++ V +H + ++ ++DIA+L+L PL+ KP PD
Sbjct: 58 ESTNLWEDPGKSDPYV---SHVYLSFYRQETMENDIAILELSRPLKLDGLKSKPAKLPDI 114
Query: 133 KDDPKS 138
+ PK+
Sbjct: 115 EFRPKT 120
Score = 36.2 bits (82), Expect = 0.062, Method: Composition-based stats.
Identities = 35/120 (29%), Positives = 58/120 (48%), Gaps = 18/120 (15%)
Query: 574 YSKRTGT---VVGWGRVEESGQIASDLRATQVPVMSNQECRQF--PGFEPKLTGNMMCAG 628
+ +TG+ V G+G + DL++ Q+ V+ ECR P F L+ + CA
Sbjct: 116 FRPKTGSDVLVSGYGDGQTMDPKDHDLKSAQLTVVDLDECRTKYGPIF---LSLQVFCAQ 172
Query: 629 YVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPN-SPGVYTRVNHYMEWIQN 687
V +S GD+G + +D + GV ++ RP +P V+T+V Y+ WIQ+
Sbjct: 173 KVGVSLES--GDAGDPTVQQDT-----LVGVAAYFP--KRPEGAPEVFTKVGSYVSWIQD 223
>pdb|2XWB|F Chain F, Crystal Structure Of Complement C3b In Complex With
Factors B And D
pdb|2XWB|H Chain H, Crystal Structure Of Complement C3b In Complex With
Factors B And D
Length = 732
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 19/116 (16%)
Query: 25 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRA 80
T+ ++ PW + G C G ++S+ +VLTAAHC + + + R
Sbjct: 454 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 512
Query: 81 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDAPLEFKPTVSP 130
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P
Sbjct: 513 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRP 560
Score = 36.6 bits (83), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 620 LTGNMMCAGYVE--GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGI 664
+T +C G V ++C+GDSGG L++ RF+ GV+SWG+
Sbjct: 642 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 687
>pdb|2OK5|A Chain A, Human Complement Factor B
Length = 752
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 19/116 (16%)
Query: 25 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRA 80
T+ ++ PW + G C G ++S+ +VLTAAHC + + + R
Sbjct: 473 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 531
Query: 81 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDAPLEFKPTVSP 130
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P
Sbjct: 532 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRP 579
Score = 36.6 bits (83), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 620 LTGNMMCAGYVE--GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGI 664
+T +C G V ++C+GDSGG L++ RF+ GV+SWG+
Sbjct: 661 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 706
>pdb|3HRZ|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|D Chain D, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|3HS0|I Chain I, Cobra Venom Factor (Cvf) In Complex With Human Factor B
pdb|2XWJ|I Chain I, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|J Chain J, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|K Chain K, Crystal Structure Of Complement C3b In Complex With Factor
B
pdb|2XWJ|L Chain L, Crystal Structure Of Complement C3b In Complex With Factor
B
Length = 741
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 19/116 (16%)
Query: 25 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRA 80
T+ ++ PW + G C G ++S+ +VLTAAHC + + + R
Sbjct: 463 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 521
Query: 81 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDAPLEFKPTVSP 130
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P
Sbjct: 522 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRP 569
Score = 36.6 bits (83), Expect = 0.044, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 620 LTGNMMCAGYVE--GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGI 664
+T +C G V ++C+GDSGG L++ RF+ GV+SWG+
Sbjct: 651 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 696
>pdb|2WIN|I Chain I, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|J Chain J, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|K Chain K, C3 Convertase (C3bbb) Stabilized By Scin
pdb|2WIN|L Chain L, C3 Convertase (C3bbb) Stabilized By Scin
Length = 507
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 19/116 (16%)
Query: 25 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRA 80
T+ ++ PW + G C G ++S+ +VLTAAHC + + + R
Sbjct: 229 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 287
Query: 81 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDAPLEFKPTVSP 130
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P
Sbjct: 288 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRP 335
Score = 37.4 bits (85), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 620 LTGNMMCAGYVE--GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGI 664
+T +C G V ++C+GDSGG L++ RF+ GV+SWG+
Sbjct: 417 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 462
>pdb|1RRK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
pdb|1RS0|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With Di-Isopropyl-Phosphate (Dip)
pdb|1RTK|A Chain A, Crystal Structure Analysis Of The Bb Segment Of Factor B
Complexed With 4-Guanidinobenzoic Acid
Length = 497
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 19/116 (16%)
Query: 25 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHNRA 80
T+ ++ PW + G C G ++S+ +VLTAAHC + + + R
Sbjct: 221 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 279
Query: 81 TVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDAPLEFKPTVSP 130
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P
Sbjct: 280 ---DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRP 327
Score = 37.4 bits (85), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 620 LTGNMMCAGYVE--GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGI 664
+T +C G V ++C+GDSGG L++ RF+ GV+SWG+
Sbjct: 409 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 454
>pdb|4GAW|A Chain A, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|B Chain B, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|C Chain C, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|D Chain D, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|E Chain E, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|F Chain F, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|G Chain G, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|H Chain H, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|I Chain I, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|J Chain J, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|K Chain K, Crystal Structure Of Active Human Granzyme H
pdb|4GAW|L Chain L, Crystal Structure Of Active Human Granzyme H
Length = 226
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 41/132 (31%), Positives = 62/132 (46%), Gaps = 15/132 (11%)
Query: 19 IVGGWTTEVNEYPW---VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
I+GG + + P+ V L++ + CGG L+ +VLTAAHC SS + +
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSS-----INVTLG 55
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDD 135
HN TQ + V + + HP YN K+ +DI LL+L+ ++ V P
Sbjct: 56 AHNIKEQERTQ-QFIPVKRPIPHPAYN---PKNFSNDIMLLQLERKAKWTTAVRPLRLPS 111
Query: 136 PKSELTQFKPGN 147
K+ Q KPG
Sbjct: 112 SKA---QVKPGQ 120
Score = 49.3 bits (116), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 11/112 (9%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+V GWG V S +A+ L+ + V + +C R F G + T +C G + + +
Sbjct: 123 SVAGWGYVSMS-TLATTLQEVLLTVQKDCQCERLFHGNYSRAT--EICVGDPKKTQTGFK 179
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
GDSGG L+ +D+ G++S+G P PGVY +V+H++ WI+ +
Sbjct: 180 GDSGGPLVCKDV-----AQGILSYGNKKGTP--PGVYIKVSHFLPWIKRTMK 224
>pdb|3S9A|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Closed-Form)
pdb|3S9B|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V (Open-Form)
pdb|3S9C|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V In Complex
With The Fragment (Residues 1533-1546) Of Human Factor V
pdb|3SBK|A Chain A, Russell's Viper Venom Serine Proteinase, Rvv-V
(Ppack-Bound Form)
Length = 234
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 15/132 (11%)
Query: 557 AMVKYRATKRGDGSHRVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGF 616
A V + RG GS ++GWG++ + T + ++ ++ C +
Sbjct: 105 APVSLPSRSRGVGSR-------CRIMGWGKISTT-TYPDVPHCTNIFIVKHKWCEPLYPW 156
Query: 617 EPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGI-GCARPNSPGVY 675
P +CAG ++GG+D+C GDSGG L+ + G+V+ G C + P VY
Sbjct: 157 VPA-DSRTLCAGILKGGRDTCHGDSGGPLICNG-----EMHGIVAGGSEPCGQHLKPAVY 210
Query: 676 TRVNHYMEWIQN 687
T+V Y WIQ+
Sbjct: 211 TKVFDYNNWIQS 222
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 12/115 (10%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISE 76
+VGG +NE+P++VAL + C G LI+ +VLTAAHC R + R K +
Sbjct: 1 VVGGDECNINEHPFLVALYTSASSTIHCAGALINREWVLTAAHCDRRNIRIK-----LGM 55
Query: 77 HNRATVYE-TQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSP 130
H++ E QI R + K+ D DI L++L P+ + ++P
Sbjct: 56 HSKNIRNEDEQIRVPRGKYFCLNTKF----PNGLDKDIMLIRLRRPVTYSTHIAP 106
>pdb|1DLE|A Chain A, Factor B Serine Protease Domain
pdb|1DLE|B Chain B, Factor B Serine Protease Domain
Length = 298
Score = 50.4 bits (119), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 21/117 (17%)
Query: 25 TEVNEYPWVVALE----QAGKFFCGGTLISDRYVLTAAHC-VRSSKRHKDLIAVISEHNR 79
T+ ++ PW + G C G ++S+ +VLTAAHC K H ++V E
Sbjct: 22 TDYHKQPWQAKISVIRPSKGHESCMGAVVSEYFVLTAAHCFTVDDKEHSIKVSVGGEKR- 80
Query: 80 ATVYETQIETRRVVKVLTHPKYNAQGAKS------HDHDIALLKLDAPLEFKPTVSP 130
+ +IE VL HP YN G K +D+D+AL+KL L++ T+ P
Sbjct: 81 ----DLEIEV-----VLFHPNYNINGKKEAGIPEFYDYDVALIKLKNKLKYGQTIRP 128
Score = 37.4 bits (85), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 18/47 (38%), Positives = 28/47 (59%), Gaps = 3/47 (6%)
Query: 620 LTGNMMCAGYVE--GGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGI 664
+T +C G V ++C+GDSGG L++ RF+ GV+SWG+
Sbjct: 210 VTPRFLCTGGVSPYADPNTCRGDSGGPLIVHKR-SRFIQVGVISWGV 255
>pdb|1FQ3|A Chain A, Crystal Structure Of Human Granzyme B
pdb|1FQ3|B Chain B, Crystal Structure Of Human Granzyme B
Length = 227
Score = 49.7 bits (117), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 44/136 (32%), Positives = 62/136 (45%), Gaps = 23/136 (16%)
Query: 19 IVGGWTTEVNEYPWVVAL---EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
I+GG + + P++ L +Q CGG LI D +VLTAAHC SS + +
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIQDDFVLTAAHCWGSS-----INVTLG 55
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLE----FKPTVSPD 131
HN TQ + V + + HP YN K+ +DI LL+L+ + +P P
Sbjct: 56 AHNIKEQEPTQ-QFIPVKRPIPHPAYN---PKNFSNDIMLLQLERKAKRTRAVQPLRLPS 111
Query: 132 NKDDPKSELTQFKPGN 147
NK Q KPG
Sbjct: 112 NK-------AQVKPGQ 120
Score = 43.1 bits (100), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 16/123 (13%)
Query: 572 RVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC----RQFPGFEPKLTGNMMCA 627
+V +T +V GWG+ G+ + L+ ++ V +++C R + ++ + +C
Sbjct: 115 QVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHY--YDSTIE---LCV 169
Query: 628 GYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
G E K S +GDSGG L+ + G+VS+G P P T+V+ ++ WI+
Sbjct: 170 GDPEIKKTSFKGDSGGPLVCNK-----VAQGIVSYGRNNGMP--PRACTKVSSFVHWIKK 222
Query: 688 NTR 690
+
Sbjct: 223 TMK 225
>pdb|1IAU|A Chain A, Human Granzyme B In Complex With Ac-Iepd-Cho
Length = 227
Score = 49.3 bits (116), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 44/136 (32%), Positives = 62/136 (45%), Gaps = 23/136 (16%)
Query: 19 IVGGWTTEVNEYPWVVAL---EQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
I+GG + + P++ L +Q CGG LI D +VLTAAHC SS + +
Sbjct: 1 IIGGHEAKPHSRPYMAYLMIWDQKSLKRCGGFLIRDDFVLTAAHCWGSS-----INVTLG 55
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLE----FKPTVSPD 131
HN TQ + V + + HP YN K+ +DI LL+L+ + +P P
Sbjct: 56 AHNIKEQEPTQ-QFIPVKRPIPHPAYN---PKNFSNDIMLLQLERKAKRTRAVQPLRLPS 111
Query: 132 NKDDPKSELTQFKPGN 147
NK Q KPG
Sbjct: 112 NK-------AQVKPGQ 120
Score = 43.1 bits (100), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 32/123 (26%), Positives = 60/123 (48%), Gaps = 16/123 (13%)
Query: 572 RVYSKRTGTVVGWGRVEESGQIASDLRATQVPVMSNQEC----RQFPGFEPKLTGNMMCA 627
+V +T +V GWG+ G+ + L+ ++ V +++C R + ++ + +C
Sbjct: 115 QVKPGQTCSVAGWGQTAPLGKHSHTLQEVKMTVQEDRKCESDLRHY--YDSTIE---LCV 169
Query: 628 GYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQN 687
G E K S +GDSGG L+ + G+VS+G P P T+V+ ++ WI+
Sbjct: 170 GDPEIKKTSFKGDSGGPLVCNK-----VAQGIVSYGRNNGMP--PRACTKVSSFVHWIKK 222
Query: 688 NTR 690
+
Sbjct: 223 TMK 225
>pdb|1FY3|A Chain A, [g175q]hbp, A Mutant Of Human Heparin Binding Protein
(cap37)
Length = 225
Score = 49.3 bits (116), Expect = 7e-06, Method: Composition-based stats.
Identities = 30/111 (27%), Positives = 54/111 (48%), Gaps = 5/111 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG ++P++ +++ G+ FCGG LI R+V+TAA C +S + + +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
R E Q + ++ Y+ Q + +D+ LL+LD +V+
Sbjct: 61 RRR--ERQSRQTFSISSMSENGYDPQ---QNLNDLMLLQLDREANLTSSVT 106
Score = 45.4 bits (106), Expect = 1e-04, Method: Composition-based stats.
Identities = 32/106 (30%), Positives = 44/106 (41%), Gaps = 18/106 (16%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG G+++ R V V +CR N +C G + C GD
Sbjct: 125 VAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP----------NNVCTGVLTRRGGICNGD 174
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWI 685
G L+ E L GV S+ +G C R P +TRV + +WI
Sbjct: 175 QGTPLVCEG-----LAHGVASFSLGPCGR--GPDFFTRVALFRDWI 213
>pdb|1A7S|A Chain A, Atomic Resolution Structure Of Hbp
pdb|1AE5|A Chain A, Human Heparin Binding Protein
Length = 225
Score = 49.3 bits (116), Expect = 7e-06, Method: Composition-based stats.
Identities = 30/111 (27%), Positives = 54/111 (48%), Gaps = 5/111 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG ++P++ +++ G+ FCGG LI R+V+TAA C +S + + +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGRHFCGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
R E Q + ++ Y+ Q + +D+ LL+LD +V+
Sbjct: 61 RRR--ERQSRQTFSISSMSENGYDPQ---QNLNDLMLLQLDREANLTSSVT 106
Score = 45.4 bits (106), Expect = 1e-04, Method: Composition-based stats.
Identities = 32/106 (30%), Positives = 44/106 (41%), Gaps = 18/106 (16%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG G+++ R V V +CR N +C G + C GD
Sbjct: 125 VAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP----------NNVCTGVLTRRGGICNGD 174
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWI 685
G L+ E L GV S+ +G C R P +TRV + +WI
Sbjct: 175 GGTPLVCEG-----LAHGVASFSLGPCGR--GPDFFTRVALFRDWI 213
>pdb|3TJU|A Chain A, Crystal Structure Of Human Granzyme H With An Inhibitor
pdb|3TJV|A Chain A, Crystal Structure Of Human Granzyme H With A Peptidyl
Substrate
pdb|3TK9|A Chain A, Crystal Structure Of Human Granzyme H
Length = 226
Score = 49.3 bits (116), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 40/132 (30%), Positives = 62/132 (46%), Gaps = 15/132 (11%)
Query: 19 IVGGWTTEVNEYPW---VVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVIS 75
I+GG + + P+ V L++ + CGG L+ +VLTAAHC SS + +
Sbjct: 1 IIGGHEAKPHSRPYMAFVQFLQEKSRKRCGGILVRKDFVLTAAHCQGSS-----INVTLG 55
Query: 76 EHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDD 135
HN TQ + V + + HP YN K+ ++I LL+L+ ++ V P
Sbjct: 56 AHNIKEQERTQ-QFIPVKRPIPHPAYN---PKNFSNNIMLLQLERKAKWTTAVRPLRLPS 111
Query: 136 PKSELTQFKPGN 147
K+ Q KPG
Sbjct: 112 SKA---QVKPGQ 120
Score = 49.3 bits (116), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 35/112 (31%), Positives = 59/112 (52%), Gaps = 11/112 (9%)
Query: 580 TVVGWGRVEESGQIASDLRATQVPVMSNQEC-RQFPGFEPKLTGNMMCAGYVEGGKDSCQ 638
+V GWG V S +A+ L+ + V + +C R F G + T +C G + + +
Sbjct: 123 SVAGWGYVSMS-TLATTLQEVLLTVQKDCQCERLFHGNYSRAT--EICVGDPKKTQTGFK 179
Query: 639 GDSGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
GDSGG L+ +D+ G++S+G P PGVY +V+H++ WI+ +
Sbjct: 180 GDSGGPLVCKDV-----AQGILSYGNKKGTP--PGVYIKVSHFLPWIKRTMK 224
>pdb|2KAI|A Chain A, Refined 2.5 Angstroms X-Ray Crystal Structure Of The
Complex Formed By Porcine Kallikrein A And The Bovine
Pancreatic Trypsin Inhibitor. Crystallization,
Patterson Search, Structure Determination, Refinement,
Structure And Comparison With Its Components And With
The Bovine Trypsin- Pancreatic Trypsin Inhibitor
Complex
pdb|2PKA|A Chain A, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|2PKA|X Chain X, Refined 2 Angstroms X-Ray Crystal Structure Of Porcine
Pancreatic Kallikrein A, A Specific Trypsin-Like Serine
Proteinase. Crystallization, Structure Determination,
Crystallographic Refinement, Structure And Its
Comparison With Bovine Trypsin
pdb|1HIA|A Chain A, Kallikrein Complexed With Hirustasin
pdb|1HIA|X Chain X, Kallikrein Complexed With Hirustasin
Length = 80
Score = 49.3 bits (116), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 21/42 (50%), Positives = 28/42 (66%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHC 60
I+GG E N +PW VA+ F CGG L++ ++VLTAAHC
Sbjct: 1 IIGGRECEKNSHPWQVAIYHYSSFQCGGVLVNPKWVLTAAHC 42
>pdb|3H7T|A Chain A, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
pdb|3H7T|B Chain B, Crystal Structure Of Scabies Mite Inactivated Protease
Paralogue S-D1 (Smipp-S-D1)
Length = 235
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 31/122 (25%), Positives = 61/122 (50%), Gaps = 15/122 (12%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
I+GG +++ + PW V + K FCGG++++ +V+TAA CV +K I++ +
Sbjct: 1 IIGGKKSDITKEPWAVGVLVDEKPFCGGSILTANFVITAAQCVDGTKPSD--ISIHYGSS 58
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDPKS 138
T T + +++ V HP + ++ A+++ + P++ D+K K
Sbjct: 59 YRTTKGTSVMAKKIYIVRYHP-------LTMQNNYAVIETEMPIKL------DDKTTKKI 105
Query: 139 EL 140
EL
Sbjct: 106 EL 107
>pdb|1B0F|A Chain A, Crystal Structure Of Human Neutrophil Elastase With Mdl
101, 146
Length = 218
Score = 48.5 bits (114), Expect = 1e-05, Method: Composition-based stats.
Identities = 20/42 (47%), Positives = 30/42 (71%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHC 60
IVGG + +P++V+L+ AG FCG TLI+ +V++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQLAGGHFCGATLIAPNFVMSAAHC 42
>pdb|3H5C|B Chain B, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex
Length = 317
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/129 (29%), Positives = 63/129 (48%), Gaps = 20/129 (15%)
Query: 8 AGCGVPNRMDRIVGGWTTEVNEYPWVVALEQA-GKFFCGGTLISDRYVLTAAHCVRSSKR 66
CGV R ++ + PW V L + GK FCGG +I + +VLT A C S
Sbjct: 88 CACGVLTSEKR-----APDLQDLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKC---SLL 139
Query: 67 HKDLIAVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFK- 125
H++ I V + NR + I ++ V H +Y+A ++D++LL+L+ P++
Sbjct: 140 HRN-ITVKTYFNRTSQDPLMI---KITHVHVHMRYDADAG---ENDLSLLELEWPIQCPG 192
Query: 126 ---PTVSPD 131
P +P+
Sbjct: 193 AGLPVCTPE 201
>pdb|2HNT|C Chain C, Crystallographic Structure Of Human Gamma-Thrombin
Length = 70
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/68 (39%), Positives = 37/68 (54%), Gaps = 7/68 (10%)
Query: 19 IVGGWTTEVNEYPWVVAL--EQAGKFFCGGTLISDRYVLTAAHCV-----RSSKRHKDLI 71
IV G E+ PW V L + + CG +LISDR+VLTAAHC+ + DL+
Sbjct: 1 IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLL 60
Query: 72 AVISEHNR 79
I +H+R
Sbjct: 61 VRIGKHSR 68
>pdb|3F1S|B Chain B, Crystal Structure Of Protein Z Complexed With Protein
Z-Dependent Inhibitor
Length = 283
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/130 (29%), Positives = 63/130 (48%), Gaps = 20/130 (15%)
Query: 8 AGCGVPNRMDRIVGGWTTEVNEYPWVVALEQA-GKFFCGGTLISDRYVLTAAHCVRSSKR 66
CGV R ++ + PW V L + GK FCGG +I + +VLT A C S
Sbjct: 47 CACGVLTSEKR-----APDLQDLPWQVKLTNSEGKDFCGGVIIRENFVLTTAKC---SLL 98
Query: 67 HKDLIAVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFK- 125
H++ I V + NR + I ++ V H +Y+A ++D++LL+L+ P++
Sbjct: 99 HRN-ITVKTYFNRTSQDPLMI---KITHVHVHMRYDADAG---ENDLSLLELEWPIQCPG 151
Query: 126 ---PTVSPDN 132
P +P+
Sbjct: 152 AGLPVCTPEK 161
>pdb|1EPT|A Chain A, Refined 1.8 Angstroms Resolution Crystal Structure Of
Porcine Epsilon-Trypsin
Length = 43
Score = 47.0 bits (110), Expect = 3e-05, Method: Composition-based stats.
Identities = 21/44 (47%), Positives = 32/44 (72%), Gaps = 1/44 (2%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVR 62
IVGG+T N P+ V+L +G FCGG+LI+ ++V++AAHC +
Sbjct: 1 IVGGYTCAANSIPYQVSL-NSGSHFCGGSLINSQWVVSAAHCYK 43
>pdb|1PPF|E Chain E, X-Ray Crystal Structure Of The Complex Of Human
Leukocyte Elastase (Pmn Elastase) And The Third Domain
Of The Turkey Ovomucoid Inhibitor
Length = 218
Score = 46.2 bits (108), Expect = 6e-05, Method: Composition-based stats.
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHC 60
IVGG + +P++V+L+ G FCG TLI+ +V++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
>pdb|1PPG|E Chain E, The Refined 2.3 Angstroms Crystal Structure Of Human
Leukocyte Elastase In A Complex With A Valine
Chloromethyl Ketone Inhibitor
pdb|1H1B|A Chain A, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|1H1B|B Chain B, Crystal Structure Of Human Neutrophil Elastase Complexed
With An Inhibitor (Gw475151)
pdb|2Z7F|E Chain E, Crystal Structure Of The Complex Of Human Neutrophil
Elastase With 12SLPI
pdb|3Q76|A Chain A, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q76|B Chain B, Structure Of Human Neutrophil Elastase (uncomplexed)
pdb|3Q77|A Chain A, Structure Of Human Neutrophil Elastase In Complex With A
Dihydropyrimidone Inhibitor
Length = 218
Score = 46.2 bits (108), Expect = 6e-05, Method: Composition-based stats.
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHC 60
IVGG + +P++V+L+ G FCG TLI+ +V++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
>pdb|1HNE|E Chain E, Structure Of Human Neutrophil Elastase In Complex With A
Peptide Chloromethyl Ketone Inhibitor At 1.84-Angstroms
Resolution
Length = 218
Score = 46.2 bits (108), Expect = 6e-05, Method: Composition-based stats.
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHC 60
IVGG + +P++V+L+ G FCG TLI+ +V++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
>pdb|2RG3|A Chain A, Covalent Complex Structure Of Elastase
Length = 218
Score = 46.2 bits (108), Expect = 6e-05, Method: Composition-based stats.
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHC 60
IVGG + +P++V+L+ G FCG TLI+ +V++AAHC
Sbjct: 1 IVGGRRARPHAWPFMVSLQLRGGHFCGATLIAPNFVMSAAHC 42
>pdb|1FY1|A Chain A, [r23s,F25e]hbp, A Mutant Of Human Heparin Binding Protein
(Cap37)
Length = 225
Score = 45.4 bits (106), Expect = 1e-04, Method: Composition-based stats.
Identities = 32/106 (30%), Positives = 44/106 (41%), Gaps = 18/106 (16%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
V GWG G+++ R V V +CR N +C G + C GD
Sbjct: 125 VAGWGSQRSGGRLSRFPRFVNVTVTPEDQCRP----------NNVCTGVLTRRGGICNGD 174
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIG-CARPNSPGVYTRVNHYMEWI 685
G L+ E L GV S+ +G C R P +TRV + +WI
Sbjct: 175 GGTPLVCEG-----LAHGVASFSLGPCGR--GPDFFTRVALFRDWI 213
Score = 44.7 bits (104), Expect = 2e-04, Method: Composition-based stats.
Identities = 29/111 (26%), Positives = 52/111 (46%), Gaps = 5/111 (4%)
Query: 19 IVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKDLIAVISEHN 78
IVGG ++P++ +++ G CGG LI R+V+TAA C +S + + +
Sbjct: 1 IVGGRKARPRQFPFLASIQNQGSHECGGALIHARFVMTAASCFQSQNPGVSTVVLGAYDL 60
Query: 79 RATVYETQIETRRVVKVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVS 129
R E Q + ++ Y+ Q + +D+ LL+LD +V+
Sbjct: 61 RRR--ERQSRQTFSISSMSENGYDPQ---QNLNDLMLLQLDREANLTSSVT 106
>pdb|2ODP|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
pdb|2ODQ|A Chain A, Complement Component C2a, The Catalytic Fragment Of C3-
And C5- Convertase Of Human Complement
Length = 509
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 30/58 (51%), Gaps = 5/58 (8%)
Query: 10 CGVPNRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRH 67
CGV N + ++ PW V ++ + C G LISD++VLTAAHC R H
Sbjct: 220 CGVGN-----MSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDH 272
Score = 37.7 bits (86), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 10/73 (13%)
Query: 607 NQECRQFPGF---EPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWG 663
+QE FP +T +C+G E + C+G+SGGA+ +E RF G+VSWG
Sbjct: 400 SQEKTMFPNLTDVREVVTDQFLCSGTQED-ESPCKGESGGAVFLER-RFRFFQVGLVSWG 457
Query: 664 -----IGCARPNS 671
+G A NS
Sbjct: 458 LYNPCLGSADKNS 470
>pdb|2I6Q|A Chain A, Complement Component C2a
pdb|2I6S|A Chain A, Complement Component C2a
Length = 517
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 36/127 (28%), Positives = 52/127 (40%), Gaps = 16/127 (12%)
Query: 10 CGVPNRMDRIVGGWTTEVNEYPWVVALEQAGKFFCGGTLISDRYVLTAAHCVRSSKRHKD 69
CGV N + ++ PW V ++ + C G LISD++VLTAAHC R H
Sbjct: 228 CGVGN-----MSANASDQERTPWHVTIKPKSQETCRGALISDQWVLTAAHCFRDGNDHSL 282
Query: 70 LIAVISEHNRATVYETQIETRRVVKVLTHPKYNAQGAKSH------DHDIALLKLDAPLE 123
+ + E IE K + P ++ K+ DIALLKL ++
Sbjct: 283 WRVNVGDPKSQWGKEFLIE-----KAVISPGFDVFAKKNQGILEFYGDDIALLKLAQKVK 337
Query: 124 FKPTVSP 130
P
Sbjct: 338 MSTHARP 344
Score = 37.4 bits (85), Expect = 0.029, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 37/73 (50%), Gaps = 10/73 (13%)
Query: 607 NQECRQFPGF---EPKLTGNMMCAGYVEGGKDSCQGDSGGALLMEDLDGRFLIAGVVSWG 663
+QE FP +T +C+G E + C+G+SGGA+ +E RF G+VSWG
Sbjct: 408 SQEKTMFPNLTDVREVVTDQFLCSGTQED-ESPCKGESGGAVFLER-RFRFFQVGLVSWG 465
Query: 664 -----IGCARPNS 671
+G A NS
Sbjct: 466 LYNPCLGSADKNS 478
>pdb|2ASU|B Chain B, Crystal Structure Of The Beta-Chain Of HgflMSP
Length = 234
Score = 43.9 bits (102), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 4/110 (3%)
Query: 581 VVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKLTGNMMCAGYVEGGKDSCQGD 640
+ GWG + +G + L + V+SNQEC ++ + MC + +C+GD
Sbjct: 121 IAGWGETKGTGN-DTVLNVALLNVISNQECNI--KHRGRVRESEMCTEGLLAPVGACEGD 177
Query: 641 SGGALLMEDLDGRFLIAGVVSWGIGCARPNSPGVYTRVNHYMEWIQNNTR 690
GG L + +++ G++ CAR P V+TRV+ +++WI R
Sbjct: 178 YGGPLACFTHNS-WVLEGIIIPNRVCARSRWPAVFTRVSVFVDWIHKVMR 226
Score = 37.0 bits (84), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 15/34 (44%), Positives = 24/34 (70%), Gaps = 1/34 (2%)
Query: 31 PWVVALE-QAGKFFCGGTLISDRYVLTAAHCVRS 63
PW V+L + G+ FCGG+L+ ++++LTA C S
Sbjct: 10 PWTVSLRNRQGQHFCGGSLVKEQWILTARQCFSS 43
>pdb|2DPF|A Chain A, Crystal Structure Of Curculin1 Homodimer
pdb|2DPF|B Chain B, Crystal Structure Of Curculin1 Homodimer
pdb|2DPF|C Chain C, Crystal Structure Of Curculin1 Homodimer
pdb|2DPF|D Chain D, Crystal Structure Of Curculin1 Homodimer
Length = 115
Score = 32.7 bits (73), Expect = 0.66, Method: Composition-based stats.
Identities = 17/38 (44%), Positives = 22/38 (57%), Gaps = 3/38 (7%)
Query: 636 SCQGDSGGALLMEDLDGRFLIAGVVSWGI---GCARPN 670
+C GD+G L+ DGRF+I G V W + GC R N
Sbjct: 77 ACWGDNGKYALVLQKDGRFVIYGPVLWSLGPNGCRRVN 114
>pdb|2D04|B Chain B, Crystal Structure Of Neoculin, A Sweet Protein With
Taste-Modifying Activity.
pdb|2D04|D Chain D, Crystal Structure Of Neoculin, A Sweet Protein With
Taste-Modifying Activity.
pdb|2D04|F Chain F, Crystal Structure Of Neoculin, A Sweet Protein With
Taste-Modifying Activity.
pdb|2D04|H Chain H, Crystal Structure Of Neoculin, A Sweet Protein With
Taste-Modifying Activity
Length = 114
Score = 32.7 bits (73), Expect = 0.72, Method: Composition-based stats.
Identities = 17/38 (44%), Positives = 22/38 (57%), Gaps = 3/38 (7%)
Query: 636 SCQGDSGGALLMEDLDGRFLIAGVVSWGI---GCARPN 670
+C GD+G L+ DGRF+I G V W + GC R N
Sbjct: 76 ACWGDNGKYALVLQKDGRFVIYGPVLWSLGPNGCRRVN 113
>pdb|2HNT|E Chain E, Crystallographic Structure Of Human Gamma-Thrombin
Length = 81
Score = 32.3 bits (72), Expect = 0.90, Method: Compositional matrix adjust.
Identities = 17/53 (32%), Positives = 29/53 (54%), Gaps = 2/53 (3%)
Query: 94 KVLTHPKYNAQGAKSHDHDIALLKLDAPLEFKPTVSPDNKDDPKSELTQFKPG 146
K+ HP+YN + ++ D DIAL+KL P+ F + P D ++ + + G
Sbjct: 10 KIYIHPRYNWR--ENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAG 60
>pdb|1E5M|A Chain A, Beta Ketoacyl Acyl Carrier Protein Synthase Ii (Kasii)
From Synechocystis Sp
Length = 416
Score = 32.0 bits (71), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/115 (21%), Positives = 48/115 (41%), Gaps = 14/115 (12%)
Query: 61 VRSSKRHKDLIAVISEHNRATVYETQIETRRVVKVLTHPKYNAQ------------GAKS 108
++ S ++++ I+ H +T ETR + + L + YN G
Sbjct: 291 LKDSGLKPEMVSYINAHGTSTPANDVTETRAIKQALGNHAYNIAVSSTKSMTGHLLGGSG 350
Query: 109 HDHDIALLKLDAPLEFKPTVSPDNKDDPKSELTQFKPGNQKSYKWDIVWFNLIGF 163
+A + A + PT++ +N DP+ +L + PG ++ D+ N GF
Sbjct: 351 GIEAVATVMAIAEDKVPPTINLENP-DPECDL-DYVPGQSRALIVDVALSNSFGF 403
>pdb|3NZJ|H Chain H, Crystal Structure Of Yeast 20s Proteasome In Complex With
Ligand 2a
pdb|3NZJ|V Chain V, Crystal Structure Of Yeast 20s Proteasome In Complex With
Ligand 2a
pdb|3NZW|H Chain H, Crystal Structure Of The Yeast 20s Proteasome In Complex
With 2b
pdb|3NZW|V Chain V, Crystal Structure Of The Yeast 20s Proteasome In Complex
With 2b
pdb|3NZX|H Chain H, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Ligand 2c
pdb|3NZX|V Chain V, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Ligand 2c
pdb|4B4T|2 Chain 2, Near-Atomic Resolution Structural Model Of The Yeast 26s
Proteasome
Length = 261
Score = 31.2 bits (69), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 13/43 (30%), Positives = 24/43 (55%)
Query: 578 TGTVVGWGRVEESGQIASDLRATQVPVMSNQECRQFPGFEPKL 620
TGT + + IA+D R+TQ P+++++ C + PK+
Sbjct: 28 TGTTIVGVKFNNGVVIAADTRSTQGPIVADKNCAKLHRISPKI 70
>pdb|1RYP|I Chain I, Crystal Structure Of The 20s Proteasome From Yeast At 2.4
Angstroms Resolution
pdb|1RYP|W Chain W, Crystal Structure Of The 20s Proteasome From Yeast At 2.4
Angstroms Resolution
pdb|1G65|H Chain H, Crystal Structure Of Epoxomicin:20s Proteasome Reveals A
Molecular Basis For Selectivity Of
Alpha,Beta-Epoxyketone Proteasome Inhibitors
pdb|1G65|V Chain V, Crystal Structure Of Epoxomicin:20s Proteasome Reveals A
Molecular Basis For Selectivity Of
Alpha,Beta-Epoxyketone Proteasome Inhibitors
pdb|1G0U|H Chain H, A Gated Channel Into The Proteasome Core Particle
pdb|1G0U|V Chain V, A Gated Channel Into The Proteasome Core Particle
pdb|1JD2|H Chain H, Crystal Structure Of The Yeast 20s Proteasome:tmc-95a
Complex: A Non- Covalent Proteasome Inhibitor
pdb|1JD2|O Chain O, Crystal Structure Of The Yeast 20s Proteasome:tmc-95a
Complex: A Non- Covalent Proteasome Inhibitor
pdb|1Z7Q|I Chain I, Crystal Structure Of The 20s Proteasome From Yeast In
Complex With The Proteasome Activator Pa26 From
Trypanosome Brucei At 3.2 Angstroms Resolution
pdb|1Z7Q|W Chain W, Crystal Structure Of The 20s Proteasome From Yeast In
Complex With The Proteasome Activator Pa26 From
Trypanosome Brucei At 3.2 Angstroms Resolution
pdb|2F16|H Chain H, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Bortezomib
pdb|2F16|V Chain V, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Bortezomib
pdb|2FAK|H Chain H, Crystal Structure Of Salinosporamide A In Complex With The
Yeast 20s Proteasome
pdb|2FAK|V Chain V, Crystal Structure Of Salinosporamide A In Complex With The
Yeast 20s Proteasome
pdb|2GPL|H Chain H, Tmc-95 Based Biphenyl-Ether Macrocycles: Specific
Proteasome Inhibitors
pdb|2GPL|V Chain V, Tmc-95 Based Biphenyl-Ether Macrocycles: Specific
Proteasome Inhibitors
pdb|3D29|H Chain H, Proteasome Inhibition By Fellutamide B
pdb|3D29|V Chain V, Proteasome Inhibition By Fellutamide B
pdb|3E47|H Chain H, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Homobelactosin C
pdb|3E47|V Chain V, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Homobelactosin C
pdb|3DY3|H Chain H, Crystal Structure Of Yeast 20s Proteasome In Complex With
The Epimer Form Of Spirolactacystin
pdb|3DY3|V Chain V, Crystal Structure Of Yeast 20s Proteasome In Complex With
The Epimer Form Of Spirolactacystin
pdb|3DY4|H Chain H, Crystal Structure Of Yeast 20s Proteasome In Complex With
Spirolactacystin
pdb|3DY4|V Chain V, Crystal Structure Of Yeast 20s Proteasome In Complex With
Spirolactacystin
pdb|3GPJ|H Chain H, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Syringolin B
pdb|3GPJ|V Chain V, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Syringolin B
pdb|3GPT|H Chain H, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Salinosporamide Derivatives: Slow Substrate Ligand
pdb|3GPT|V Chain V, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Salinosporamide Derivatives: Slow Substrate Ligand
pdb|3GPW|H Chain H, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Salinosporamide Derivatives: Irreversible Inhibitor
Ligand
pdb|3GPW|V Chain V, Crystal Structure Of The Yeast 20s Proteasome In Complex
With Salinosporamide Derivatives: Irreversible Inhibitor
Ligand
pdb|3HYE|H Chain H, Crystal Structure Of 20s Proteasome In Complex With
Hydroxylated Salinosporamide
pdb|3HYE|V Chain V, Crystal Structure Of 20s Proteasome In Complex With
Hydroxylated Salinosporamide
pdb|1VSY|I Chain I, Proteasome Activator Complex
pdb|1VSY|W Chain W, Proteasome Activator Complex
pdb|3L5Q|M Chain M, Proteasome Activator Complex
pdb|3L5Q|Y Chain Y, Proteasome Activator Complex
pdb|3MG4|H Chain H, Structure Of Yeast 20s Proteasome With Compound 1
pdb|3MG4|V Chain V, Structure Of Yeast 20s Proteasome With Compound 1
pdb|3MG0|H Chain H, Structure Of Yeast 20s Proteasome With Bortezomib
pdb|3MG0|V Chain V, Structure Of Yeast 20s Proteasome With Bortezomib
pdb|3MG6|H Chain H, Structure Of Yeast 20s Open-Gate Proteasome With Compound
6
pdb|3MG6|V Chain V, Structure Of Yeast 20s Open-Gate Proteasome With Compound
6
pdb|3MG7|H Chain H, Structure Of Yeast 20s Open-Gate Proteasome With Compound
8
pdb|3MG7|V Chain V, Structure Of Yeast 20s Open-Gate Proteasome With Compound
8
pdb|3MG8|H Chain H, Structure Of Yeast 20s Open-Gate Proteasome With Compound
16
pdb|3MG8|V Chain V, Structure Of Yeast 20s Open-Gate Proteasome With Compound
16
pdb|3OKJ|H Chain H, Alpha-Keto-Aldehyde Binding Mechanism Reveals A Novel Lead
Structure Motif For Proteasome Inhibition
pdb|3OKJ|V Chain V, Alpha-Keto-Aldehyde Binding Mechanism Reveals A Novel Lead
Structure Motif For Proteasome Inhibition
pdb|3OEU|H Chain H, Structure Of Yeast 20s Open-Gate Proteasome With Compound
24
pdb|3OEU|V Chain V, Structure Of Yeast 20s Open-Gate Proteasome With Compound
24
pdb|3OEV|H Chain H, Structure Of Yeast 20s Open-Gate Proteasome With Compound
25
pdb|3OEV|V Chain V, Structure Of Yeast 20s Open-Gate Proteasome With Compound
25
pdb|3TDD|H Chain H, Crystal Structure Of Yeast Cp In Complex With Belactosin C
pdb|3TDD|V Chain V, Crystal Structure Of Yeast Cp In Complex With Belactosin C
pdb|3SHJ|H Chain H, Proteasome In Complex With Hydroxyurea Derivative Hu10
pdb|3SHJ|V Chain V, Proteasome In Complex With Hydroxyurea Derivative Hu10
pdb|3SDI|H Chain H, Structure Of Yeast 20s Open-Gate Proteasome With Compound
20
pdb|3SDI|V Chain V, Structure Of Yeast 20s Open-Gate Proteasome With Compound
20
pdb|3SDK|H Chain H, Structure Of Yeast 20s Open-Gate Proteasome With Compound
34
pdb|3SDK|V Chain V, Structure Of Yeast 20s Open-Gate Proteasome With Compound
34
pdb|4GK7|H Chain H, Yeast 20s Proteasome In Complex With The
Syringolin-Glidobactin Chimera
pdb|4GK7|V Chain V, Yeast 20s Proteasome In Complex With The
Syringolin-Glidobactin Chimera
pdb|4FZC|H Chain H, 20s Yeast Proteasome In Complex With Cepafungin I
pdb|4FZC|V Chain V, 20s Yeast Proteasome In Complex With Cepafungin I
pdb|4FZG|H Chain H, 20s Yeast Proteasome In Complex With Glidobactin
pdb|4FZG|V Chain V, 20s Yeast Proteasome In Complex With Glidobactin
Length = 222
Score = 30.4 bits (67), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 10/28 (35%), Positives = 19/28 (67%)
Query: 593 IASDLRATQVPVMSNQECRQFPGFEPKL 620
IA+D R+TQ P+++++ C + PK+
Sbjct: 14 IAADTRSTQGPIVADKNCAKLHRISPKI 41
>pdb|1FNT|I Chain I, Crystal Structure Of The 20s Proteasome From Yeast In
Complex With The Proteasome Activator Pa26 From
Trypanosome Brucei At 3.2 Angstroms Resolution
pdb|1FNT|W Chain W, Crystal Structure Of The 20s Proteasome From Yeast In
Complex With The Proteasome Activator Pa26 From
Trypanosome Brucei At 3.2 Angstroms Resolution
pdb|2ZCY|H Chain H, Yeast 20s Proteasome:syringolin A-Complex
pdb|2ZCY|V Chain V, Yeast 20s Proteasome:syringolin A-Complex
pdb|3BDM|H Chain H, Yeast 20s Proteasome:glidobactin A-Complex
pdb|3BDM|V Chain V, Yeast 20s Proteasome:glidobactin A-Complex
pdb|3UN4|H Chain H, Yeast 20s Proteasome In Complex With Pr-957 (Morpholine)
pdb|3UN4|V Chain V, Yeast 20s Proteasome In Complex With Pr-957 (Morpholine)
pdb|3UN8|H Chain H, Yeast 20s Proteasome In Complex With Pr-957 (Epoxide)
pdb|3UN8|V Chain V, Yeast 20s Proteasome In Complex With Pr-957 (Epoxide)
pdb|4G4S|I Chain I, Structure Of Proteasome-Pba1-Pba2 Complex
pdb|4INR|H Chain H, Yeast 20s Proteasome In Complex With The Vinyl Sulfone
Lu102
pdb|4INR|V Chain V, Yeast 20s Proteasome In Complex With The Vinyl Sulfone
Lu102
pdb|4INT|H Chain H, Yeast 20s Proteasome In Complex With The Vinyl Sulfone
Lu122
pdb|4INT|V Chain V, Yeast 20s Proteasome In Complex With The Vinyl Sulfone
Lu122
pdb|4INU|H Chain H, Yeast 20s Proteasome In Complex With The Vinyl Sulfone
Lu112
pdb|4INU|V Chain V, Yeast 20s Proteasome In Complex With The Vinyl Sulfone
Lu112
Length = 232
Score = 30.0 bits (66), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 10/28 (35%), Positives = 19/28 (67%)
Query: 593 IASDLRATQVPVMSNQECRQFPGFEPKL 620
IA+D R+TQ P+++++ C + PK+
Sbjct: 14 IAADTRSTQGPIVADKNCAKLHRISPKI 41
>pdb|4FM2|A Chain A, Pyrococcus Abyssi B Family Dna Polymerase (Triple Mutant)
Bound To A Dsdna, In Edition Mode
Length = 793
Score = 29.6 bits (65), Expect = 6.7, Method: Compositional matrix adjust.
Identities = 10/23 (43%), Positives = 16/23 (69%)
Query: 603 PVMSNQECRQFPGFEPKLTGNMM 625
P + ++ C+ FPGF P L GN++
Sbjct: 458 PQVGHRFCKDFPGFIPSLLGNLL 480
>pdb|4FLT|A Chain A, Pyrococcus Abyssi B Family Dna Polymerase Bound To A
Dsdna, In Edition Mode
pdb|4FLU|A Chain A, Pyrococcus Abyssi B Family Dna Polymerase Bound To A
Dsdna, In Edition Mode
pdb|4FLV|A Chain A, Pyrococcus Abyssi B Family Dna Polymerase Bound To A
Dsdna, In Edition Mode
pdb|4FLW|A Chain A, Pyrococcus Abyssi B Family Dna Polymerase Bound To A
Dsdna, In Edition Mode
pdb|4FLX|A Chain A, Pyrococcus Abyssi B Family Dna Polymerase Bound To A
Dsdna, In Edition Mode
pdb|4FLY|A Chain A, Pyrococcus Abyssi B Family Dna Polymerase Bound To A
Dsdna, In Edition Mode
pdb|4FLZ|A Chain A, Pyrococcus Abyssi B Family Dna Polymerase Bound To A
Dsdna, In Edition Mode
pdb|4FM0|A Chain A, Pyrococcus Abyssi B Family Dna Polymerase Bound To A
Dsdna, In Edition Mode
pdb|4FM1|A Chain A, Pyrococcus Abyssi B Family Dna Polymerase Bound To A
Dsdna, In Edition Mode
Length = 793
Score = 29.3 bits (64), Expect = 6.7, Method: Compositional matrix adjust.
Identities = 10/23 (43%), Positives = 16/23 (69%)
Query: 603 PVMSNQECRQFPGFEPKLTGNMM 625
P + ++ C+ FPGF P L GN++
Sbjct: 458 PQVGHRFCKDFPGFIPSLLGNLL 480
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.323 0.138 0.461
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 23,992,872
Number of Sequences: 62578
Number of extensions: 1122770
Number of successful extensions: 3708
Number of sequences better than 100.0: 369
Number of HSP's better than 100.0 without gapping: 351
Number of HSP's successfully gapped in prelim test: 18
Number of HSP's that attempted gapping in prelim test: 2104
Number of HSP's gapped (non-prelim): 719
length of query: 696
length of database: 14,973,337
effective HSP length: 106
effective length of query: 590
effective length of database: 8,340,069
effective search space: 4920640710
effective search space used: 4920640710
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.9 bits)
S2: 55 (25.8 bits)